*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1cqj_c00 SUCCINYL-COA SYNTHETASE BETA CHAIN user 1 4 # 1 A 208 GLU A 77 GLU~? 21.84 CL CL B 226 A 246 HIS A 75 HIS.? 25.41 CL CL B 226 B 109 TYR A 209 TYR~? 20.76 CL CL A 226 B 197 GLU A 110 GLU~? 23.70 CL CL A 226 coo 42.05 62.45 76.31 40.18 63.04 75.45 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 37.14 61.56 73.28 37.00 63.65 73.26 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 50.22 35.25 75.17 48.69 37.57 74.89 27.49 9.87 -0.64 29.01 7.64 0.00 coo 45.03 37.30 75.10 44.89 38.23 76.98 30.58 5.52 -3.71 32.09 6.67 -2.64 ULMN 4 1cqj_c00 SUCCINYL-COA SYNTHETASE BETA CHAIN user 2 4 # 2 A 208 GLU B 69 GLU^? 24.72 CL CL B 226 A 246 HIS B 75 HIS.? 25.67 CL CL A 226 B 109 TYR B 209 TYR~? 20.47 CL CL B 226 B 197 GLU B 110 GLU~? 23.32 CL CL B 226 coo 42.05 62.45 76.31 40.18 63.04 75.45 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 37.14 61.56 73.28 37.00 63.65 73.26 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 50.22 35.25 75.17 48.69 37.57 74.89 50.38 9.38 40.26 48.54 7.35 39.73 coo 45.03 37.30 75.10 44.89 38.23 76.98 46.60 5.74 43.54 45.54 7.20 42.48 1cqj_c00 source 1cqj SUCCINYL-COA SYNTHETASE BETA CHAIN : 2 hits 1cqj_c00 naa= 4 ULMN 4 1cqj_c01 SUCCINYL-COA SYNTHETASE BETA CHAIN user 1 4 # 1 D 208 GLU A 77 GLU~? 21.84 CL CL B 226 D 246 HIS A 75 HIS.? 25.41 CL CL B 226 E 109 TYR A 209 TYR~? 20.76 CL CL A 226 E 197 GLU A 110 GLU~? 23.70 CL CL A 226 coo -2.91 18.30 76.21 -1.08 17.82 77.32 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 2.87 18.34 77.03 2.47 16.92 78.50 38.68 -16.70 9.61 40.32 -17.29 8.43 coo -1.67 35.94 53.83 -0.91 34.37 56.05 27.49 9.87 -0.64 29.01 7.64 0.00 coo 1.76 35.71 58.20 0.46 36.19 59.80 30.58 5.52 -3.71 32.09 6.67 -2.64 ULMN 4 1cqj_c01 SUCCINYL-COA SYNTHETASE BETA CHAIN user 2 4 # 2 D 208 GLU B 69 GLU^? 24.72 CL CL B 226 D 246 HIS B 75 HIS.? 25.67 CL CL A 226 E 109 TYR B 209 TYR~? 20.47 CL CL B 226 E 197 GLU B 110 GLU~? 23.32 CL CL B 226 coo -2.91 18.30 76.21 -1.08 17.82 77.32 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 2.87 18.34 77.03 2.47 16.92 78.50 34.50 -15.17 32.63 32.86 -15.45 33.92 coo -1.67 35.94 53.83 -0.91 34.37 56.05 50.38 9.38 40.26 48.54 7.35 39.73 coo 1.76 35.71 58.20 0.46 36.19 59.80 46.60 5.74 43.54 45.54 7.20 42.48 1cqj_c01 source 1cqj SUCCINYL-COA SYNTHETASE BETA CHAIN : 2 hits 1cqj_c01 naa= 4 ULMN 4 1eyp_c00 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 A 48 THR B 22 THR~? 22.16 CL CL B 226 A 106 TYR B 20 TYR~? 17.36 CL CL B 226 A 113 ASN B 8 ASN.? 7.79 CL CL B 226 A 190 THR B 12 THR~? 10.36 CL CL B 226 coo 22.06 26.20 31.80 23.25 24.42 31.55 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 25.78 19.82 28.38 24.53 18.95 30.74 46.52 -15.74 17.49 47.60 -15.27 14.94 coo 31.98 16.71 37.61 32.38 18.76 37.14 51.02 -6.75 16.28 50.85 -6.79 18.40 coo 28.27 16.17 41.32 28.66 15.49 39.31 45.94 -3.45 20.21 43.90 -3.11 20.94 ULMN 4 1eyp_c00 CHALCONE-FLAVONONE ISOMERASE 1 user 2 4 # 2 A 48 THR B 76 THR~? 22.20 CL CL A 226 A 106 TYR A 20 TYR~? 17.28 CL CL A 226 A 113 ASN A 8 ASN.? 6.94 CL CL A 226 A 190 THR A 12 THR~? 10.60 CL CL A 226 coo 22.06 26.20 31.80 23.25 24.42 31.55 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 25.78 19.82 28.38 24.53 18.95 30.74 26.99 -13.27 24.47 26.16 -12.32 26.98 coo 31.98 16.71 37.61 32.38 18.76 37.14 24.44 -3.01 24.75 23.45 -2.96 22.86 coo 28.27 16.17 41.32 28.66 15.49 39.31 29.83 -1.59 20.81 31.94 -1.62 20.25 1eyp_c00 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 2 hits 1eyp_c00 naa= 4 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 B 48 THR A 120 THR~? 33.80 CL CL A 226 B 106 TYR A 116 TYR~? 32.73 CL CL A 226 B 113 ASN A 149 ASN.? 31.68 CL CL A 226 B 190 THR A 150 THR.? 27.06 CL CL A 226 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 22.90 -11.90 -11.33 24.82 -12.79 -11.66 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 27.90 -5.01 -12.58 28.96 -2.59 -13.59 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 37.01 -8.84 -7.60 35.18 -8.21 -8.48 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 34.17 -10.48 -4.43 34.61 -9.24 -2.66 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 2 4 # 2 B 48 THR B 22 THR~? 22.16 CL CL B 226 B 106 TYR B 20 TYR~? 17.36 CL CL B 226 B 113 ASN B 8 ASN.? 7.79 CL CL B 226 B 190 THR B 12 THR~? 10.36 CL CL B 226 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 46.52 -15.74 17.49 47.60 -15.27 14.94 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 51.02 -6.75 16.28 50.85 -6.79 18.40 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 45.94 -3.45 20.21 43.90 -3.11 20.94 1eyp_c01 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 2 hits 1eyp_c01 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU A 175 GLU~? 15.88 CL CL A 226 A 485 LYS A 178 LYS~? 16.45 CL CL A 226 A 488 GLU A 182 GLU~? 21.95 CL CL A 226 A 603 LYS A 60 LYS.? 19.24 CL CL A 226 coo -7.79 3.39 10.29 -9.01 4.74 9.32 15.56 2.16 3.91 14.40 0.59 4.79 coo -9.44 10.08 8.58 -11.94 6.98 8.10 17.52 -4.22 5.13 11.68 -3.87 7.49 coo -13.30 11.40 4.76 -13.95 9.40 5.16 13.02 -8.29 1.26 11.61 -6.76 1.56 coo -21.26 6.97 3.81 -20.43 4.23 9.21 9.83 -11.93 8.36 13.65 -13.48 11.58 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 1 hits 1jxa_c01 naa= 4 ULMN 4 1nlu_c00 PSEUDO-IODOTYROSTATIN user 1 4 # 1 A 80 GLU A 110 GLU~? 23.70 CL CL A 226 A 84 ASP A 111 ASP~? 26.09 CL CL A 226 A 170 ASP A 102 ASP~? 17.30 CL CL A 226 A 287 SER A 106 SER~? 22.03 CL CL A 226 coo 23.89 18.61 12.79 25.29 17.35 13.81 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 27.00 22.87 14.47 26.64 20.92 13.76 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 27.92 8.51 14.90 28.11 10.58 15.35 32.53 7.12 5.29 31.66 9.04 5.62 coo 29.00 16.00 15.34 27.04 15.11 14.25 31.10 3.01 0.33 33.40 3.02 -0.51 1nlu_c00 source 1nlu PSEUDO-IODOTYROSTATIN : 1 hits 1nlu_c00 naa= 4 ULMN 4 2nmt_c00 MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRAuser 1 4 # 1 A 169 ASN A 155 ASN~? 24.40 CL CL A 226 A 170 PHE A 114 PHE~? 22.97 CL CL A 226 A 171 LEU A 118 LEU~? 25.85 CL CL A 226 A 455 LEU A 159 LEU~? 17.31 CL CL A 226 coo 29.34 24.41 78.19 29.76 25.72 76.57 29.36 -7.90 -1.01 30.77 -7.17 -2.34 coo 30.60 22.78 74.02 32.69 24.70 74.02 27.44 -4.93 -3.68 25.47 -5.75 -1.86 coo 23.47 21.19 75.19 21.55 20.19 75.05 22.61 -7.03 -6.79 22.70 -6.57 -4.65 coo 34.24 28.84 77.53 36.19 29.18 78.46 27.44 -4.92 4.24 27.68 -3.61 2.49 ULMN 4 2nmt_c00 MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRAuser 2 4 # 2 A 169 ASN B 155 ASN~? 24.46 CL CL B 226 A 170 PHE B 114 PHE~? 23.12 CL CL B 226 A 171 LEU B 118 LEU~? 26.00 CL CL B 226 A 455 LEU B 159 LEU~? 17.08 CL CL B 226 coo 29.34 24.41 78.19 29.76 25.72 76.57 44.94 -7.51 42.45 43.54 -6.44 43.59 coo 30.60 22.78 74.02 32.69 24.70 74.02 47.16 -4.85 44.78 49.00 -6.29 43.28 coo 23.47 21.19 75.19 21.55 20.19 75.05 51.19 -7.22 48.32 51.33 -7.18 46.14 coo 34.24 28.84 77.53 36.19 29.18 78.46 47.78 -5.57 36.87 48.07 -4.09 38.43 2nmt_c00 source 2nmt MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE : 2 hits 2nmt_c00 naa= 4 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 1 4 # 1 A 283 GLU A 9 GLU.? 16.20 CL CL A 226 C 12 THR A 16 THR~? 12.20 CL CL A 226 C 25 TYR A 20 TYR~? 17.28 CL CL A 226 C 89 THR A 12 THR~? 10.60 CL CL A 226 coo 60.56 18.92 0.90 61.14 20.52 2.16 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 55.95 25.18 2.21 55.69 23.16 3.11 29.10 -8.06 22.96 27.29 -7.40 23.91 coo 55.67 19.31 -0.41 56.70 20.51 1.90 26.99 -13.27 24.47 26.16 -12.32 26.98 coo 59.81 26.53 8.25 58.00 25.30 8.32 29.83 -1.59 20.81 31.94 -1.62 20.25 3eca_c04 source 3eca ASPARAGINASE TYPE II : 1 hits 3eca_c04 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP B 186 ASP.? 30.73 CL CL B 226 A 100 ARG B 65 ARG.? 31.41 CL CL B 226 A 116 GLN B 66 GLN.? 26.19 CL CL B 226 coo 32.24 20.09 5.34 30.38 19.04 5.27 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 26.40 25.34 6.28 26.15 22.33 7.25 55.55 -24.03 39.40 53.97 -26.61 39.95 coo 26.74 21.94 13.78 27.57 20.97 12.08 51.36 -17.48 40.20 49.73 -18.74 40.71 12as_c00 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c00 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 38 TYR.? 10.54 CL CL A 226 B 190 LYS A 36 LYS^? 12.38 CL CL A 226 B 222 ASP A 43 ASP.? 11.79 CL CL A 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 17.27 -3.90 25.00 15.42 -2.03 25.90 coo 13.38 20.00 35.06 11.43 22.49 39.53 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 9.76 26.58 38.10 11.63 25.78 38.76 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 58 TYR.? 17.32 CL CL A 226 B 190 LYS A 36 LYS^? 12.38 CL CL A 226 B 222 ASP A 40 ASP.? 7.65 CL CL A 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 13.38 20.00 35.06 11.43 22.49 39.53 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 9.76 26.58 38.10 11.63 25.78 38.76 20.12 -4.48 17.55 21.44 -4.89 15.96 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR A 58 TYR.? 17.32 CL CL A 226 B 190 LYS A 63 LYS.? 28.35 CL CL A 226 B 222 ASP A 61 ASP.? 23.60 CL CL A 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 13.38 20.00 35.06 11.43 22.49 39.53 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 9.76 26.58 38.10 11.63 25.78 38.76 6.80 -9.81 5.25 8.17 -9.51 3.68 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR A 160 TYR~? 15.52 CL CL A 226 B 190 LYS A 178 LYS~? 16.45 CL CL A 226 B 222 ASP A 43 ASP.? 11.79 CL CL A 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 13.38 20.00 35.06 11.43 22.49 39.53 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 9.76 26.58 38.10 11.63 25.78 38.76 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR A 209 TYR~? 20.76 CL CL A 226 B 190 LYS A 213 LYS.? 30.41 CL CL A 226 B 222 ASP A 203 ASP~? 25.03 CL CL A 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 27.49 9.87 -0.64 29.01 7.64 0.00 coo 13.38 20.00 35.06 11.43 22.49 39.53 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 9.76 26.58 38.10 11.63 25.78 38.76 16.55 6.97 -3.38 15.26 7.22 -5.04 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR B 38 TYR.? 11.29 CL CL B 226 B 190 LYS B 36 LYS^? 15.37 CL CL B 226 B 222 ASP B 43 ASP.? 11.93 CL CL B 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 58.26 -9.06 16.81 60.90 -8.31 16.35 coo 13.38 20.00 35.06 11.43 22.49 39.53 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 9.76 26.58 38.10 11.63 25.78 38.76 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 7 3 # 7 A 140 TYR B 58 TYR.? 17.22 CL CL B 226 B 190 LYS B 36 LYS^? 15.37 CL CL B 226 B 222 ASP B 40 ASP.? 7.91 CL CL B 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 13.38 20.00 35.06 11.43 22.49 39.53 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 9.76 26.58 38.10 11.63 25.78 38.76 55.19 -7.93 23.91 53.71 -7.92 25.42 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 8 3 # 8 A 140 TYR B 58 TYR.? 17.22 CL CL B 226 B 190 LYS B 63 LYS.? 30.86 CL CL B 226 B 222 ASP B 61 ASP.? 23.81 CL CL B 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 13.38 20.00 35.06 11.43 22.49 39.53 61.77 -19.16 38.03 61.33 -25.31 39.26 coo 9.76 26.58 38.10 11.63 25.78 38.76 66.70 -13.12 38.44 68.10 -11.59 37.89 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 9 3 # 9 A 140 TYR B 160 TYR~? 15.61 CL CL B 226 B 190 LYS B 178 LYS~? 16.76 CL CL B 226 B 222 ASP B 43 ASP.? 11.93 CL CL B 226 coo 7.17 16.59 41.26 8.01 19.20 40.73 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 13.38 20.00 35.06 11.43 22.49 39.53 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 9.76 26.58 38.10 11.63 25.78 38.76 58.62 -8.54 27.92 60.24 -9.54 27.09 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 9 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 36 LYS^? 12.38 CL CL A 226 A 222 ASP A 40 ASP.? 7.65 CL CL A 226 B 140 TYR A 58 TYR.? 17.32 CL CL A 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 19.01 -10.55 19.77 15.11 -7.69 20.09 coo -1.04 26.60 27.37 -2.94 25.93 26.69 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.58 -9.14 12.20 9.89 -9.91 12.27 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 36 LYS^? 12.38 CL CL A 226 A 222 ASP A 43 ASP.? 11.79 CL CL A 226 B 140 TYR A 38 TYR.? 10.54 CL CL A 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 19.01 -10.55 19.77 15.11 -7.69 20.09 coo -1.04 26.60 27.37 -2.94 25.93 26.69 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 1.51 16.60 24.17 0.82 19.23 24.79 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS A 63 LYS.? 28.35 CL CL A 226 A 222 ASP A 61 ASP.? 23.60 CL CL A 226 B 140 TYR A 58 TYR.? 17.32 CL CL A 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -1.04 26.60 27.37 -2.94 25.93 26.69 6.80 -9.81 5.25 8.17 -9.51 3.68 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.58 -9.14 12.20 9.89 -9.91 12.27 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS A 178 LYS~? 16.45 CL CL A 226 A 222 ASP A 43 ASP.? 11.79 CL CL A 226 B 140 TYR A 160 TYR~? 15.52 CL CL A 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 17.52 -4.22 5.13 11.68 -3.87 7.49 coo -1.04 26.60 27.37 -2.94 25.93 26.69 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 1.51 16.60 24.17 0.82 19.23 24.79 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS A 213 LYS.? 30.41 CL CL A 226 A 222 ASP A 203 ASP~? 25.03 CL CL A 226 B 140 TYR A 209 TYR~? 20.76 CL CL A 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 20.84 14.61 -7.95 16.28 17.34 -7.27 coo -1.04 26.60 27.37 -2.94 25.93 26.69 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 1.51 16.60 24.17 0.82 19.23 24.79 27.49 9.87 -0.64 29.01 7.64 0.00 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 190 LYS B 36 LYS^? 15.37 CL CL B 226 A 222 ASP B 40 ASP.? 7.91 CL CL B 226 B 140 TYR B 58 TYR.? 17.22 CL CL B 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 55.08 -14.30 22.43 60.90 -14.25 24.08 coo -1.04 26.60 27.37 -2.94 25.93 26.69 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 1.51 16.60 24.17 0.82 19.23 24.79 61.18 -13.09 30.12 63.87 -13.66 29.97 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 7 3 # 7 A 190 LYS B 36 LYS^? 15.37 CL CL B 226 A 222 ASP B 43 ASP.? 11.93 CL CL B 226 B 140 TYR B 38 TYR.? 11.29 CL CL B 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 55.08 -14.30 22.43 60.90 -14.25 24.08 coo -1.04 26.60 27.37 -2.94 25.93 26.69 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 1.51 16.60 24.17 0.82 19.23 24.79 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 8 3 # 8 A 190 LYS B 63 LYS.? 30.86 CL CL B 226 A 222 ASP B 61 ASP.? 23.81 CL CL B 226 B 140 TYR B 58 TYR.? 17.22 CL CL B 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 61.77 -19.16 38.03 61.33 -25.31 39.26 coo -1.04 26.60 27.37 -2.94 25.93 26.69 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 1.51 16.60 24.17 0.82 19.23 24.79 61.18 -13.09 30.12 63.87 -13.66 29.97 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 9 3 # 9 A 190 LYS B 178 LYS~? 16.76 CL CL B 226 A 222 ASP B 43 ASP.? 11.93 CL CL B 226 B 140 TYR B 160 TYR~? 15.61 CL CL B 226 coo -4.61 20.12 30.34 -2.74 22.65 25.95 57.30 -6.98 36.80 62.98 -8.03 34.22 coo -1.04 26.60 27.37 -2.94 25.93 26.69 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 1.51 16.60 24.17 0.82 19.23 24.79 49.18 -9.89 33.69 51.74 -10.51 34.51 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 9 hits 1a05_c01 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 13 ARG~? 5.03 CL CL A 226 265 HIS A 86 HIS~? 10.02 CL CL A 226 274 TYR A 21 TYR~? 21.90 CL CL A 226 coo -15.18 55.46 8.55 -14.82 52.98 10.38 24.18 -3.56 18.28 25.11 -1.28 16.40 coo -14.48 45.59 11.18 -14.02 47.49 10.42 32.84 2.26 17.60 31.66 3.53 18.78 coo 0.94 52.26 9.16 1.95 54.78 9.91 31.69 -16.23 18.31 32.96 -18.03 16.63 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 81 ARG~? 19.72 CL CL B 226 265 HIS A 75 HIS.? 25.41 CL CL B 226 274 TYR A 160 TYR~? 15.52 CL CL A 226 coo -15.18 55.46 8.55 -14.82 52.98 10.38 40.18 -5.93 10.28 41.49 -8.31 8.89 coo -14.48 45.59 11.18 -14.02 47.49 10.42 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 0.94 52.26 9.16 1.95 54.78 9.91 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG B 13 ARG~? 5.25 CL CL B 226 265 HIS B 86 HIS~? 9.45 CL CL B 226 274 TYR B 21 TYR~? 21.81 CL CL B 226 coo -15.18 55.46 8.55 -14.82 52.98 10.38 51.04 -6.15 23.43 50.81 -3.67 25.23 coo -14.48 45.59 11.18 -14.02 47.49 10.42 44.03 1.12 22.86 45.41 1.90 21.48 coo 0.94 52.26 9.16 1.95 54.78 9.91 41.23 -17.00 23.95 39.78 -18.41 25.81 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG B 65 ARG.? 31.41 CL CL B 226 265 HIS B 56 HIS^? 18.72 CL CL B 226 274 TYR B 121 TYR~? 28.97 CL CL B 226 coo -15.18 55.46 8.55 -14.82 52.98 10.38 55.55 -24.03 39.40 53.97 -26.61 39.95 coo -14.48 45.59 11.18 -14.02 47.49 10.42 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 0.94 52.26 9.16 1.95 54.78 9.91 51.39 -13.47 48.53 51.35 -15.45 46.59 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG B 81 ARG~? 19.82 CL CL A 226 265 HIS B 75 HIS.? 25.67 CL CL A 226 274 TYR B 160 TYR~? 15.61 CL CL B 226 coo -15.18 55.46 8.55 -14.82 52.98 10.38 35.26 -4.61 30.73 33.33 -6.15 32.58 coo -14.48 45.59 11.18 -14.02 47.49 10.42 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 0.94 52.26 9.16 1.95 54.78 9.91 49.18 -9.89 33.69 51.74 -10.51 34.51 1a41_c01 source 1a41 TOPOISOMERASE I : 5 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 9 GLU.? 16.20 CL CL A 226 A 60 ASP A 40 ASP.? 7.65 CL CL A 226 A 175 TYR A 20 TYR~? 17.28 CL CL A 226 coo 46.10 28.27 19.27 45.48 26.99 20.84 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 56.42 28.06 12.93 55.01 27.92 14.50 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 45.02 22.04 15.38 46.16 24.00 13.76 26.99 -13.27 24.47 26.16 -12.32 26.98 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 198 GLU~? 30.13 CL CL A 226 A 60 ASP A 111 ASP~? 26.09 CL CL A 226 A 175 TYR A 194 TYR~? 29.78 CL CL A 226 coo 46.10 28.27 19.27 45.48 26.99 20.84 19.84 0.58 -9.50 20.29 0.30 -11.52 coo 56.42 28.06 12.93 55.01 27.92 14.50 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 45.02 22.04 15.38 46.16 24.00 13.76 18.48 -5.35 -10.35 20.66 -3.63 -10.45 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 9 GLU.? 16.36 CL CL B 226 A 60 ASP B 40 ASP.? 7.91 CL CL B 226 A 175 TYR B 20 TYR~? 17.36 CL CL B 226 coo 46.10 28.27 19.27 45.48 26.99 20.84 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 56.42 28.06 12.93 55.01 27.92 14.50 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 45.02 22.04 15.38 46.16 24.00 13.76 46.52 -15.74 17.49 47.60 -15.27 14.94 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU B 110 GLU~? 23.32 CL CL B 226 A 60 ASP B 203 ASP~? 25.12 CL CL B 226 A 175 TYR B 209 TYR~? 20.47 CL CL B 226 coo 46.10 28.27 19.27 45.48 26.99 20.84 46.60 5.74 43.54 45.54 7.20 42.48 coo 56.42 28.06 12.93 55.01 27.92 14.50 60.54 4.31 43.90 62.00 4.57 45.37 coo 45.02 22.04 15.38 46.16 24.00 13.76 50.38 9.38 40.26 48.54 7.35 39.73 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU B 198 GLU~? 30.19 CL CL B 226 A 60 ASP B 111 ASP~? 25.68 CL CL B 226 A 175 TYR B 194 TYR~? 30.06 CL CL B 226 coo 46.10 28.27 19.27 45.48 26.99 20.84 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 56.42 28.06 12.93 55.01 27.92 14.50 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 45.02 22.04 15.38 46.16 24.00 13.76 55.14 -6.59 51.91 53.44 -4.41 51.82 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 5 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 58 TYR.? 17.32 CL CL A 226 A 125 HIS A 56 HIS^? 18.87 CL CL A 226 A 156 LYS A 36 LYS^? 12.38 CL CL A 226 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR A 58 TYR.? 17.32 CL CL A 226 A 125 HIS A 56 HIS^? 18.87 CL CL A 226 A 156 LYS A 63 LYS.? 28.35 CL CL A 226 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR A 58 TYR.? 17.32 CL CL A 226 A 125 HIS A 56 HIS^? 18.87 CL CL A 226 A 156 LYS A 178 LYS~? 16.45 CL CL A 226 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 4 3 # 4 A 115 TYR A 160 TYR~? 15.52 CL CL A 226 A 125 HIS A 56 HIS^? 18.87 CL CL A 226 A 156 LYS A 36 LYS^? 12.38 CL CL A 226 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 5 3 # 5 A 115 TYR B 58 TYR.? 17.22 CL CL B 226 A 125 HIS B 56 HIS^? 18.72 CL CL B 226 A 156 LYS B 36 LYS^? 15.37 CL CL B 226 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 6 3 # 6 A 115 TYR B 58 TYR.? 17.22 CL CL B 226 A 125 HIS B 56 HIS^? 18.72 CL CL B 226 A 156 LYS B 63 LYS.? 30.86 CL CL B 226 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 7 3 # 7 A 115 TYR B 58 TYR.? 17.22 CL CL B 226 A 125 HIS B 56 HIS^? 18.72 CL CL B 226 A 156 LYS B 178 LYS~? 16.76 CL CL B 226 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 8 3 # 8 A 115 TYR B 160 TYR~? 15.61 CL CL B 226 A 125 HIS B 56 HIS^? 18.72 CL CL B 226 A 156 LYS B 36 LYS^? 15.37 CL CL B 226 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 55.08 -14.30 22.43 60.90 -14.25 24.08 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 8 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 58 TYR.? 17.32 CL CL A 226 B 125 HIS A 56 HIS^? 18.87 CL CL A 226 B 156 LYS A 36 LYS^? 12.38 CL CL A 226 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR A 58 TYR.? 17.32 CL CL A 226 B 125 HIS A 56 HIS^? 18.87 CL CL A 226 B 156 LYS A 63 LYS.? 28.35 CL CL A 226 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR A 58 TYR.? 17.32 CL CL A 226 B 125 HIS A 56 HIS^? 18.87 CL CL A 226 B 156 LYS A 178 LYS~? 16.45 CL CL A 226 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR A 160 TYR~? 15.52 CL CL A 226 B 125 HIS A 56 HIS^? 18.87 CL CL A 226 B 156 LYS A 36 LYS^? 12.38 CL CL A 226 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 5 3 # 5 B 115 TYR B 58 TYR.? 17.22 CL CL B 226 B 125 HIS B 56 HIS^? 18.72 CL CL B 226 B 156 LYS B 36 LYS^? 15.37 CL CL B 226 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 6 3 # 6 B 115 TYR B 58 TYR.? 17.22 CL CL B 226 B 125 HIS B 56 HIS^? 18.72 CL CL B 226 B 156 LYS B 63 LYS.? 30.86 CL CL B 226 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 7 3 # 7 B 115 TYR B 58 TYR.? 17.22 CL CL B 226 B 125 HIS B 56 HIS^? 18.72 CL CL B 226 B 156 LYS B 178 LYS~? 16.76 CL CL B 226 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 8 3 # 8 B 115 TYR B 160 TYR~? 15.61 CL CL B 226 B 125 HIS B 56 HIS^? 18.72 CL CL B 226 B 156 LYS B 36 LYS^? 15.37 CL CL B 226 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 55.08 -14.30 22.43 60.90 -14.25 24.08 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 8 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 58 TYR.? 17.32 CL CL A 226 C 125 HIS A 56 HIS^? 18.87 CL CL A 226 C 156 LYS A 36 LYS^? 12.38 CL CL A 226 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR A 58 TYR.? 17.32 CL CL A 226 C 125 HIS A 56 HIS^? 18.87 CL CL A 226 C 156 LYS A 63 LYS.? 28.35 CL CL A 226 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 3 3 # 3 C 115 TYR A 58 TYR.? 17.32 CL CL A 226 C 125 HIS A 56 HIS^? 18.87 CL CL A 226 C 156 LYS A 178 LYS~? 16.45 CL CL A 226 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 4 3 # 4 C 115 TYR A 160 TYR~? 15.52 CL CL A 226 C 125 HIS A 56 HIS^? 18.87 CL CL A 226 C 156 LYS A 36 LYS^? 12.38 CL CL A 226 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 5 3 # 5 C 115 TYR B 58 TYR.? 17.22 CL CL B 226 C 125 HIS B 56 HIS^? 18.72 CL CL B 226 C 156 LYS B 36 LYS^? 15.37 CL CL B 226 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 6 3 # 6 C 115 TYR B 58 TYR.? 17.22 CL CL B 226 C 125 HIS B 56 HIS^? 18.72 CL CL B 226 C 156 LYS B 63 LYS.? 30.86 CL CL B 226 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 7 3 # 7 C 115 TYR B 58 TYR.? 17.22 CL CL B 226 C 125 HIS B 56 HIS^? 18.72 CL CL B 226 C 156 LYS B 178 LYS~? 16.76 CL CL B 226 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 8 3 # 8 C 115 TYR B 160 TYR~? 15.61 CL CL B 226 C 125 HIS B 56 HIS^? 18.72 CL CL B 226 C 156 LYS B 36 LYS^? 15.37 CL CL B 226 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 55.08 -14.30 22.43 60.90 -14.25 24.08 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 8 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 58 TYR.? 17.32 CL CL A 226 D 125 HIS A 56 HIS^? 18.87 CL CL A 226 D 156 LYS A 36 LYS^? 12.38 CL CL A 226 coo 54.10 1.42 85.16 54.14 4.17 85.62 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 61.27 5.43 85.32 62.73 6.38 86.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 60.28 4.62 76.00 58.35 6.41 80.65 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR A 58 TYR.? 17.32 CL CL A 226 D 125 HIS A 56 HIS^? 18.87 CL CL A 226 D 156 LYS A 63 LYS.? 28.35 CL CL A 226 coo 54.10 1.42 85.16 54.14 4.17 85.62 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 61.27 5.43 85.32 62.73 6.38 86.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 60.28 4.62 76.00 58.35 6.41 80.65 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR A 58 TYR.? 17.32 CL CL A 226 D 125 HIS A 56 HIS^? 18.87 CL CL A 226 D 156 LYS A 178 LYS~? 16.45 CL CL A 226 coo 54.10 1.42 85.16 54.14 4.17 85.62 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 61.27 5.43 85.32 62.73 6.38 86.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 60.28 4.62 76.00 58.35 6.41 80.65 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR A 160 TYR~? 15.52 CL CL A 226 D 125 HIS A 56 HIS^? 18.87 CL CL A 226 D 156 LYS A 36 LYS^? 12.38 CL CL A 226 coo 54.10 1.42 85.16 54.14 4.17 85.62 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 61.27 5.43 85.32 62.73 6.38 86.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 60.28 4.62 76.00 58.35 6.41 80.65 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 5 3 # 5 D 115 TYR B 58 TYR.? 17.22 CL CL B 226 D 125 HIS B 56 HIS^? 18.72 CL CL B 226 D 156 LYS B 36 LYS^? 15.37 CL CL B 226 coo 54.10 1.42 85.16 54.14 4.17 85.62 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 61.27 5.43 85.32 62.73 6.38 86.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 60.28 4.62 76.00 58.35 6.41 80.65 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 6 3 # 6 D 115 TYR B 58 TYR.? 17.22 CL CL B 226 D 125 HIS B 56 HIS^? 18.72 CL CL B 226 D 156 LYS B 63 LYS.? 30.86 CL CL B 226 coo 54.10 1.42 85.16 54.14 4.17 85.62 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 61.27 5.43 85.32 62.73 6.38 86.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 60.28 4.62 76.00 58.35 6.41 80.65 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 7 3 # 7 D 115 TYR B 58 TYR.? 17.22 CL CL B 226 D 125 HIS B 56 HIS^? 18.72 CL CL B 226 D 156 LYS B 178 LYS~? 16.76 CL CL B 226 coo 54.10 1.42 85.16 54.14 4.17 85.62 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 61.27 5.43 85.32 62.73 6.38 86.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 60.28 4.62 76.00 58.35 6.41 80.65 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 8 3 # 8 D 115 TYR B 160 TYR~? 15.61 CL CL B 226 D 125 HIS B 56 HIS^? 18.72 CL CL B 226 D 156 LYS B 36 LYS^? 15.37 CL CL B 226 coo 54.10 1.42 85.16 54.14 4.17 85.62 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 61.27 5.43 85.32 62.73 6.38 86.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 60.28 4.62 76.00 58.35 6.41 80.65 55.08 -14.30 22.43 60.90 -14.25 24.08 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 8 hits 1a79_c03 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 19 ARG~? 20.09 CL CL A 226 78 HIS B 75 HIS.? 25.67 CL CL A 226 122 TYR B 121 TYR~? 28.97 CL CL B 226 coo 48.32 72.26 30.89 48.69 69.28 31.53 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 53.63 68.24 34.99 53.08 69.10 33.16 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 75.01 61.87 32.93 75.34 59.26 31.96 51.39 -13.47 48.53 51.35 -15.45 46.59 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG B 19 ARG~? 20.05 CL CL B 226 78 HIS A 75 HIS.? 25.41 CL CL B 226 122 TYR A 121 TYR.? 28.41 CL CL A 226 coo 48.32 72.26 30.89 48.69 69.28 31.53 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 53.63 68.24 34.99 53.08 69.10 33.16 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 75.01 61.87 32.93 75.34 59.26 31.96 21.55 -13.30 -5.71 21.92 -15.10 -3.59 1ab4_c00 source 1ab4 GYRASE A : 2 hits 1ab4_c00 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 22 THR~? 22.52 CL CL A 226 350 PHE A 35 PHE^? 16.62 CL CL A 226 357 CYH A 33 CYH^? 23.80 CL CL A 226 coo 17.85 20.47 14.62 16.85 19.84 12.80 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 7.92 21.96 13.27 8.57 20.30 15.42 21.81 -14.26 20.74 24.44 -14.15 19.85 coo 8.82 20.77 7.90 10.59 19.75 9.80 21.65 -20.96 19.40 23.47 -21.29 21.43 1akd_c01 source 1akd CYTOCHROME P450CAM : 1 hits 1akd_c01 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 102 ASP~? 17.30 CL CL A 226 187 GLU A 172 GLU~? 15.14 CL CL A 226 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo -52.57 56.60 47.75 -51.52 54.87 46.95 32.53 7.12 5.29 31.66 9.04 5.62 coo -45.08 48.37 46.81 -46.53 49.74 45.96 20.31 7.29 3.53 20.42 8.84 4.96 coo -47.40 44.36 48.48 -50.80 49.18 46.20 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 203 ASP~? 25.03 CL CL A 226 187 GLU A 198 GLU~? 30.13 CL CL A 226 229 LYS A 195 LYS~? 35.76 CL CL A 226 coo -52.57 56.60 47.75 -51.52 54.87 46.95 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -45.08 48.37 46.81 -46.53 49.74 45.96 19.84 0.58 -9.50 20.29 0.30 -11.52 coo -47.40 44.36 48.48 -50.80 49.18 46.20 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 102 ASP~? 16.83 CL CL B 226 187 GLU B 172 GLU~? 15.62 CL CL B 226 229 LYS B 205 LYS~? 25.67 CL CL B 226 coo -52.57 56.60 47.75 -51.52 54.87 46.95 45.25 7.06 34.64 46.46 8.64 34.05 coo -45.08 48.37 46.81 -46.53 49.74 45.96 57.49 4.88 36.61 57.44 6.68 35.49 coo -47.40 44.36 48.48 -50.80 49.18 46.20 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP B 203 ASP~? 25.12 CL CL B 226 187 GLU B 198 GLU~? 30.19 CL CL B 226 229 LYS B 195 LYS~? 36.01 CL CL B 226 coo -52.57 56.60 47.75 -51.52 54.87 46.95 60.54 4.31 43.90 62.00 4.57 45.37 coo -45.08 48.37 46.81 -46.53 49.74 45.96 55.63 -0.33 50.97 54.03 -0.19 52.37 coo -47.40 44.36 48.48 -50.80 49.18 46.20 58.60 -4.05 52.32 60.39 -2.54 57.56 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 4 hits 1ald_c00 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 193 ASP~? 31.47 CL CL B 226 204 GLU B 187 GLU.? 29.51 CL CL B 226 289 ASP B 186 ASP.? 30.73 CL CL B 226 coo -0.62 65.95 29.97 0.31 67.47 31.05 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 4.34 62.44 32.05 4.22 64.48 32.53 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 9.42 68.07 30.27 7.35 68.27 30.10 56.29 -18.50 46.72 54.94 -17.46 47.93 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 151 ASP~? 28.65 CL CL B 226 227 GLU B 77 GLU~? 22.22 CL CL A 226 289 ASP B 111 ASP~? 25.68 CL CL B 226 coo -0.62 65.95 29.97 0.31 67.47 31.05 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 3.96 55.76 41.24 4.83 57.69 41.17 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 44.68 -0.98 44.91 42.92 -2.08 45.36 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c06 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 56 HIS^? 18.87 CL CL A 226 254 LYS A 60 LYS.? 19.24 CL CL A 226 333 ARG A 65 ARG.? 31.92 CL CL A 226 coo 28.11 -1.15 8.51 29.21 0.63 8.34 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 26.09 4.87 14.60 27.89 3.33 10.26 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 37.35 7.47 11.84 34.90 6.11 10.60 17.05 -18.95 -0.65 15.70 -20.36 -3.04 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 1 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 55 SER^? 14.68 CL CL A 226 A 292 ASP A 193 ASP~? 30.50 CL CL A 226 A 322 HIS A 75 HIS.? 25.41 CL CL B 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 19.73 19.18 41.39 21.50 18.65 40.34 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 41.69 45.14 46.60 41.78 47.19 46.18 38.68 -16.70 9.61 40.32 -17.29 8.43 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 82 SER~? 14.07 CL CL A 226 A 292 ASP A 151 ASP~? 27.89 CL CL A 226 A 322 HIS B 86 HIS~? 9.45 CL CL B 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 34.77 -3.21 13.72 33.13 -4.11 12.24 coo 19.73 19.18 41.39 21.50 18.65 40.34 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo 41.69 45.14 46.60 41.78 47.19 46.18 44.03 1.12 22.86 45.41 1.90 21.48 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 99 SER~? 15.47 CL CL A 226 A 292 ASP A 43 ASP.? 11.79 CL CL A 226 A 322 HIS A 93 HIS.? 23.56 CL CL B 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 34.85 6.30 9.42 33.11 7.76 8.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 41.69 45.14 46.60 41.78 47.19 46.18 46.12 1.77 -0.18 46.19 -0.30 0.15 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 106 SER~? 22.03 CL CL A 226 A 292 ASP A 43 ASP.? 11.79 CL CL A 226 A 322 HIS A 93 HIS.? 23.56 CL CL B 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 31.10 3.01 0.33 33.40 3.02 -0.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 41.69 45.14 46.60 41.78 47.19 46.18 46.12 1.77 -0.18 46.19 -0.30 0.15 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER A 106 SER~? 22.03 CL CL A 226 A 292 ASP A 193 ASP~? 30.50 CL CL A 226 A 322 HIS A 86 HIS~? 10.02 CL CL A 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 31.10 3.01 0.33 33.40 3.02 -0.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 41.69 45.14 46.60 41.78 47.19 46.18 32.84 2.26 17.60 31.66 3.53 18.78 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER A 106 SER~? 22.03 CL CL A 226 A 292 ASP A 193 ASP~? 30.50 CL CL A 226 A 322 HIS A 93 HIS.? 23.56 CL CL B 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 31.10 3.01 0.33 33.40 3.02 -0.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 41.69 45.14 46.60 41.78 47.19 46.18 46.12 1.77 -0.18 46.19 -0.30 0.15 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 82 SER~? 13.78 CL CL B 226 A 292 ASP B 151 ASP~? 28.65 CL CL B 226 A 322 HIS A 86 HIS~? 10.02 CL CL A 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 41.03 -3.36 27.11 42.38 -4.54 28.72 coo 19.73 19.18 41.39 21.50 18.65 40.34 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 41.69 45.14 46.60 41.78 47.19 46.18 32.84 2.26 17.60 31.66 3.53 18.78 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER B 99 SER~? 14.59 CL CL B 226 A 292 ASP B 43 ASP.? 11.93 CL CL B 226 A 322 HIS B 93 HIS.? 20.63 CL CL A 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 42.80 6.49 30.34 45.08 7.21 30.70 coo 19.73 19.18 41.39 21.50 18.65 40.34 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 41.69 45.14 46.60 41.78 47.19 46.18 29.92 2.50 38.47 29.09 1.13 37.10 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER B 106 SER~? 21.59 CL CL B 226 A 292 ASP B 43 ASP.? 11.93 CL CL B 226 A 322 HIS B 93 HIS.? 20.63 CL CL A 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 45.53 3.29 39.86 43.42 4.21 40.41 coo 19.73 19.18 41.39 21.50 18.65 40.34 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 41.69 45.14 46.60 41.78 47.19 46.18 29.92 2.50 38.47 29.09 1.13 37.10 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER B 106 SER~? 21.59 CL CL B 226 A 292 ASP B 193 ASP~? 31.47 CL CL B 226 A 322 HIS B 86 HIS~? 9.45 CL CL B 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 45.53 3.29 39.86 43.42 4.21 40.41 coo 19.73 19.18 41.39 21.50 18.65 40.34 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 41.69 45.14 46.60 41.78 47.19 46.18 44.03 1.12 22.86 45.41 1.90 21.48 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER B 106 SER~? 21.59 CL CL B 226 A 292 ASP B 193 ASP~? 31.47 CL CL B 226 A 322 HIS B 93 HIS.? 20.63 CL CL A 226 coo 36.34 32.23 39.60 36.43 34.62 39.93 45.53 3.29 39.86 43.42 4.21 40.41 coo 19.73 19.18 41.39 21.50 18.65 40.34 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 41.69 45.14 46.60 41.78 47.19 46.18 29.92 2.50 38.47 29.09 1.13 37.10 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 11 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 82 SER~? 14.07 CL CL A 226 B 292 ASP A 151 ASP~? 27.89 CL CL A 226 B 322 HIS B 86 HIS~? 9.45 CL CL B 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 34.77 -3.21 13.72 33.13 -4.11 12.24 coo 24.74 78.07 5.59 24.32 79.03 7.46 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo 48.81 64.16 26.34 49.30 62.16 26.73 44.03 1.12 22.86 45.41 1.90 21.48 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 99 SER~? 15.47 CL CL A 226 B 292 ASP A 43 ASP.? 11.79 CL CL A 226 B 322 HIS A 93 HIS.? 23.56 CL CL B 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 34.85 6.30 9.42 33.11 7.76 8.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 48.81 64.16 26.34 49.30 62.16 26.73 46.12 1.77 -0.18 46.19 -0.30 0.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 106 SER~? 22.03 CL CL A 226 B 292 ASP A 43 ASP.? 11.79 CL CL A 226 B 322 HIS A 93 HIS.? 23.56 CL CL B 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 31.10 3.01 0.33 33.40 3.02 -0.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 48.81 64.16 26.34 49.30 62.16 26.73 46.12 1.77 -0.18 46.19 -0.30 0.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER A 106 SER~? 22.03 CL CL A 226 B 292 ASP A 186 ASP.? 30.68 CL CL A 226 B 322 HIS A 93 HIS.? 23.56 CL CL B 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 31.10 3.01 0.33 33.40 3.02 -0.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 48.81 64.16 26.34 49.30 62.16 26.73 46.12 1.77 -0.18 46.19 -0.30 0.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER A 106 SER~? 22.03 CL CL A 226 B 292 ASP A 193 ASP~? 30.50 CL CL A 226 B 322 HIS A 86 HIS~? 10.02 CL CL A 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 31.10 3.01 0.33 33.40 3.02 -0.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 48.81 64.16 26.34 49.30 62.16 26.73 32.84 2.26 17.60 31.66 3.53 18.78 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER A 106 SER~? 22.03 CL CL A 226 B 292 ASP A 193 ASP~? 30.50 CL CL A 226 B 322 HIS A 93 HIS.? 23.56 CL CL B 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 31.10 3.01 0.33 33.40 3.02 -0.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 48.81 64.16 26.34 49.30 62.16 26.73 46.12 1.77 -0.18 46.19 -0.30 0.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER B 82 SER~? 13.78 CL CL B 226 B 292 ASP B 151 ASP~? 28.65 CL CL B 226 B 322 HIS A 86 HIS~? 10.02 CL CL A 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 41.03 -3.36 27.11 42.38 -4.54 28.72 coo 24.74 78.07 5.59 24.32 79.03 7.46 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 48.81 64.16 26.34 49.30 62.16 26.73 32.84 2.26 17.60 31.66 3.53 18.78 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER B 106 SER~? 21.59 CL CL B 226 B 292 ASP B 193 ASP~? 31.47 CL CL B 226 B 322 HIS B 86 HIS~? 9.45 CL CL B 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 45.53 3.29 39.86 43.42 4.21 40.41 coo 24.74 78.07 5.59 24.32 79.03 7.46 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 48.81 64.16 26.34 49.30 62.16 26.73 44.03 1.12 22.86 45.41 1.90 21.48 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER B 106 SER~? 21.59 CL CL B 226 B 292 ASP B 193 ASP~? 31.47 CL CL B 226 B 322 HIS B 93 HIS.? 20.63 CL CL A 226 coo 35.42 71.28 22.94 36.24 69.06 22.37 45.53 3.29 39.86 43.42 4.21 40.41 coo 24.74 78.07 5.59 24.32 79.03 7.46 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 48.81 64.16 26.34 49.30 62.16 26.73 29.92 2.50 38.47 29.09 1.13 37.10 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 9 hits 1aql_c03 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 35 PHE^? 16.62 CL CL A 226 A 223 ASP A 2 ASP.? 26.08 CL CL A 226 A 265 LYS A 63 LYS.? 28.35 CL CL A 226 coo 39.74 52.86 65.74 41.15 55.14 66.52 21.81 -14.26 20.74 24.44 -14.15 19.85 coo 30.70 47.50 67.53 29.83 49.47 67.39 12.58 -19.85 19.79 12.48 -21.80 20.57 coo 19.99 54.53 64.11 20.55 58.78 68.33 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 35 PHE^? 16.62 CL CL A 226 A 223 ASP A 40 ASP.? 7.65 CL CL A 226 A 265 LYS A 178 LYS~? 16.45 CL CL A 226 coo 39.74 52.86 65.74 41.15 55.14 66.52 21.81 -14.26 20.74 24.44 -14.15 19.85 coo 30.70 47.50 67.53 29.83 49.47 67.39 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 19.99 54.53 64.11 20.55 58.78 68.33 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE B 35 PHE^? 16.36 CL CL B 226 A 223 ASP B 40 ASP.? 7.91 CL CL B 226 A 265 LYS B 60 LYS.? 20.89 CL CL B 226 coo 39.74 52.86 65.74 41.15 55.14 66.52 51.45 -17.11 21.55 48.96 -16.17 22.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 19.99 54.53 64.11 20.55 58.78 68.33 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 35 PHE^? 16.36 CL CL B 226 A 223 ASP B 40 ASP.? 7.91 CL CL B 226 A 265 LYS B 178 LYS~? 16.76 CL CL B 226 coo 39.74 52.86 65.74 41.15 55.14 66.52 51.45 -17.11 21.55 48.96 -16.17 22.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 19.99 54.53 64.11 20.55 58.78 68.33 57.30 -6.98 36.80 62.98 -8.03 34.22 1ax4_c04 source 1ax4 TRYPTOPHANASE : 4 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 35 PHE^? 16.62 CL CL A 226 B 223 ASP A 2 ASP.? 26.08 CL CL A 226 B 265 LYS A 63 LYS.? 28.35 CL CL A 226 coo 7.48 54.94 99.62 7.67 52.27 100.42 21.81 -14.26 20.74 24.44 -14.15 19.85 coo 10.43 61.66 91.81 9.80 60.04 90.61 12.58 -19.85 19.79 12.48 -21.80 20.57 coo 5.43 58.06 80.08 8.57 53.00 79.37 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 35 PHE^? 16.62 CL CL A 226 B 223 ASP A 40 ASP.? 7.65 CL CL A 226 B 265 LYS A 178 LYS~? 16.45 CL CL A 226 coo 7.48 54.94 99.62 7.67 52.27 100.42 21.81 -14.26 20.74 24.44 -14.15 19.85 coo 10.43 61.66 91.81 9.80 60.04 90.61 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 5.43 58.06 80.08 8.57 53.00 79.37 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE B 35 PHE^? 16.36 CL CL B 226 B 223 ASP B 40 ASP.? 7.91 CL CL B 226 B 265 LYS B 60 LYS.? 20.89 CL CL B 226 coo 7.48 54.94 99.62 7.67 52.27 100.42 51.45 -17.11 21.55 48.96 -16.17 22.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 5.43 58.06 80.08 8.57 53.00 79.37 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 35 PHE^? 16.36 CL CL B 226 B 223 ASP B 40 ASP.? 7.91 CL CL B 226 B 265 LYS B 178 LYS~? 16.76 CL CL B 226 coo 7.48 54.94 99.62 7.67 52.27 100.42 51.45 -17.11 21.55 48.96 -16.17 22.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 5.43 58.06 80.08 8.57 53.00 79.37 57.30 -6.98 36.80 62.98 -8.03 34.22 1ax4_c05 source 1ax4 TRYPTOPHANASE : 4 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 35 PHE^? 16.62 CL CL A 226 C 223 ASP A 2 ASP.? 26.08 CL CL A 226 C 265 LYS A 63 LYS.? 28.35 CL CL A 226 coo -6.55 73.45 23.60 -6.77 71.48 21.66 21.81 -14.26 20.74 24.44 -14.15 19.85 coo -9.52 75.74 33.62 -8.85 73.74 33.93 12.58 -19.85 19.79 12.48 -21.80 20.57 coo -4.44 67.20 42.32 -7.50 62.41 40.49 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 35 PHE^? 16.62 CL CL A 226 C 223 ASP A 40 ASP.? 7.65 CL CL A 226 C 265 LYS A 178 LYS~? 16.45 CL CL A 226 coo -6.55 73.45 23.60 -6.77 71.48 21.66 21.81 -14.26 20.74 24.44 -14.15 19.85 coo -9.52 75.74 33.62 -8.85 73.74 33.93 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -4.44 67.20 42.32 -7.50 62.41 40.49 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE B 35 PHE^? 16.36 CL CL B 226 C 223 ASP B 40 ASP.? 7.91 CL CL B 226 C 265 LYS B 60 LYS.? 20.89 CL CL B 226 coo -6.55 73.45 23.60 -6.77 71.48 21.66 51.45 -17.11 21.55 48.96 -16.17 22.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -4.44 67.20 42.32 -7.50 62.41 40.49 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE B 35 PHE^? 16.36 CL CL B 226 C 223 ASP B 40 ASP.? 7.91 CL CL B 226 C 265 LYS B 178 LYS~? 16.76 CL CL B 226 coo -6.55 73.45 23.60 -6.77 71.48 21.66 51.45 -17.11 21.55 48.96 -16.17 22.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -4.44 67.20 42.32 -7.50 62.41 40.49 57.30 -6.98 36.80 62.98 -8.03 34.22 1ax4_c06 source 1ax4 TRYPTOPHANASE : 4 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 35 PHE^? 16.62 CL CL A 226 D 223 ASP A 2 ASP.? 26.08 CL CL A 226 D 265 LYS A 63 LYS.? 28.35 CL CL A 226 coo -38.60 55.38 52.70 -40.06 57.72 53.04 21.81 -14.26 20.74 24.44 -14.15 19.85 coo -29.46 51.67 48.51 -28.63 53.31 49.56 12.58 -19.85 19.79 12.48 -21.80 20.57 coo -18.87 56.53 54.79 -19.47 62.22 53.03 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 35 PHE^? 16.62 CL CL A 226 D 223 ASP A 40 ASP.? 7.65 CL CL A 226 D 265 LYS A 178 LYS~? 16.45 CL CL A 226 coo -38.60 55.38 52.70 -40.06 57.72 53.04 21.81 -14.26 20.74 24.44 -14.15 19.85 coo -29.46 51.67 48.51 -28.63 53.31 49.56 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -18.87 56.53 54.79 -19.47 62.22 53.03 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE B 35 PHE^? 16.36 CL CL B 226 D 223 ASP B 40 ASP.? 7.91 CL CL B 226 D 265 LYS B 60 LYS.? 20.89 CL CL B 226 coo -38.60 55.38 52.70 -40.06 57.72 53.04 51.45 -17.11 21.55 48.96 -16.17 22.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -18.87 56.53 54.79 -19.47 62.22 53.03 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE B 35 PHE^? 16.36 CL CL B 226 D 223 ASP B 40 ASP.? 7.91 CL CL B 226 D 265 LYS B 178 LYS~? 16.76 CL CL B 226 coo -38.60 55.38 52.70 -40.06 57.72 53.04 51.45 -17.11 21.55 48.96 -16.17 22.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -18.87 56.53 54.79 -19.47 62.22 53.03 57.30 -6.98 36.80 62.98 -8.03 34.22 1ax4_c07 source 1ax4 TRYPTOPHANASE : 4 hits 1ax4_c07 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 86 HIS~? 10.02 CL CL A 226 B 58 GLU B 84 GLU~? 12.79 CL CL A 226 B 92 HIS B 86 HIS~? 9.45 CL CL B 226 coo 10.74 36.24 16.20 9.81 34.52 16.97 32.84 2.26 17.60 31.66 3.53 18.78 coo 5.02 36.40 17.74 5.55 34.41 17.37 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 0.68 29.04 20.43 2.46 29.56 19.46 44.03 1.12 22.86 45.41 1.90 21.48 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 1 hits 1b2m_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 203 ASP~? 25.03 CL CL A 226 A 182 GLU A 172 GLU~? 15.14 CL CL A 226 A 286 ASN A 202 ASN~? 26.54 CL CL A 226 coo 26.03 44.66 108.90 25.67 42.61 108.82 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 18.06 44.02 105.38 18.08 45.37 107.03 20.31 7.29 3.53 20.42 8.84 4.96 coo 25.47 38.28 112.06 27.26 39.30 111.54 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 203 ASP~? 25.03 CL CL A 226 A 182 GLU A 175 GLU~? 15.88 CL CL A 226 A 286 ASN A 202 ASN~? 26.54 CL CL A 226 coo 26.03 44.66 108.90 25.67 42.61 108.82 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 18.06 44.02 105.38 18.08 45.37 107.03 15.56 2.16 3.91 14.40 0.59 4.79 coo 25.47 38.28 112.06 27.26 39.30 111.54 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP B 111 ASP~? 25.68 CL CL B 226 A 182 GLU B 110 GLU~? 23.32 CL CL B 226 A 286 ASN B 155 ASN~? 24.46 CL CL B 226 coo 26.03 44.66 108.90 25.67 42.61 108.82 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 18.06 44.02 105.38 18.08 45.37 107.03 46.60 5.74 43.54 45.54 7.20 42.48 coo 25.47 38.28 112.06 27.26 39.30 111.54 44.94 -7.51 42.45 43.54 -6.44 43.59 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP B 186 ASP.? 30.73 CL CL B 226 A 182 GLU B 182 GLU~? 22.76 CL CL B 226 A 286 ASN B 188 ASN.? 35.33 CL CL B 226 coo 26.03 44.66 108.90 25.67 42.61 108.82 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 18.06 44.02 105.38 18.08 45.37 107.03 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 25.47 38.28 112.06 27.26 39.30 111.54 58.21 -19.16 51.65 58.37 -21.08 50.71 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP B 203 ASP~? 25.12 CL CL B 226 A 182 GLU B 172 GLU~? 15.62 CL CL B 226 A 286 ASN B 202 ASN~? 26.89 CL CL B 226 coo 26.03 44.66 108.90 25.67 42.61 108.82 60.54 4.31 43.90 62.00 4.57 45.37 coo 18.06 44.02 105.38 18.08 45.37 107.03 57.49 4.88 36.61 57.44 6.68 35.49 coo 25.47 38.28 112.06 27.26 39.30 111.54 56.47 4.11 47.59 54.90 3.31 48.75 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP B 203 ASP~? 25.12 CL CL B 226 A 182 GLU B 175 GLU~? 17.14 CL CL B 226 A 286 ASN B 202 ASN~? 26.89 CL CL B 226 coo 26.03 44.66 108.90 25.67 42.61 108.82 60.54 4.31 43.90 62.00 4.57 45.37 coo 18.06 44.02 105.38 18.08 45.37 107.03 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 25.47 38.28 112.06 27.26 39.30 111.54 56.47 4.11 47.59 54.90 3.31 48.75 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 6 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 186 ASP.? 30.68 CL CL A 226 B 182 GLU A 182 GLU~? 21.95 CL CL A 226 B 286 ASN A 188 ASN.? 35.87 CL CL A 226 coo 13.82 69.26 132.27 11.87 70.14 132.51 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 8.74 63.05 136.42 9.87 62.19 134.79 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 8.26 72.60 129.22 10.14 73.45 129.80 12.80 -17.36 -8.91 13.76 -19.28 -8.90 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP A 203 ASP~? 25.03 CL CL A 226 B 182 GLU A 172 GLU~? 15.14 CL CL A 226 B 286 ASN A 202 ASN~? 26.54 CL CL A 226 coo 13.82 69.26 132.27 11.87 70.14 132.51 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 8.74 63.05 136.42 9.87 62.19 134.79 20.31 7.29 3.53 20.42 8.84 4.96 coo 8.26 72.60 129.22 10.14 73.45 129.80 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP A 203 ASP~? 25.03 CL CL A 226 B 182 GLU A 175 GLU~? 15.88 CL CL A 226 B 286 ASN A 202 ASN~? 26.54 CL CL A 226 coo 13.82 69.26 132.27 11.87 70.14 132.51 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 8.74 63.05 136.42 9.87 62.19 134.79 15.56 2.16 3.91 14.40 0.59 4.79 coo 8.26 72.60 129.22 10.14 73.45 129.80 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP B 111 ASP~? 25.68 CL CL B 226 B 182 GLU B 110 GLU~? 23.32 CL CL B 226 B 286 ASN B 155 ASN~? 24.46 CL CL B 226 coo 13.82 69.26 132.27 11.87 70.14 132.51 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 8.74 63.05 136.42 9.87 62.19 134.79 46.60 5.74 43.54 45.54 7.20 42.48 coo 8.26 72.60 129.22 10.14 73.45 129.80 44.94 -7.51 42.45 43.54 -6.44 43.59 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP B 186 ASP.? 30.73 CL CL B 226 B 182 GLU B 182 GLU~? 22.76 CL CL B 226 B 286 ASN B 188 ASN.? 35.33 CL CL B 226 coo 13.82 69.26 132.27 11.87 70.14 132.51 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 8.74 63.05 136.42 9.87 62.19 134.79 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 8.26 72.60 129.22 10.14 73.45 129.80 58.21 -19.16 51.65 58.37 -21.08 50.71 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP B 203 ASP~? 25.12 CL CL B 226 B 182 GLU B 172 GLU~? 15.62 CL CL B 226 B 286 ASN B 202 ASN~? 26.89 CL CL B 226 coo 13.82 69.26 132.27 11.87 70.14 132.51 60.54 4.31 43.90 62.00 4.57 45.37 coo 8.74 63.05 136.42 9.87 62.19 134.79 57.49 4.88 36.61 57.44 6.68 35.49 coo 8.26 72.60 129.22 10.14 73.45 129.80 56.47 4.11 47.59 54.90 3.31 48.75 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 B 109 ASP B 203 ASP~? 25.12 CL CL B 226 B 182 GLU B 175 GLU~? 17.14 CL CL B 226 B 286 ASN B 202 ASN~? 26.89 CL CL B 226 coo 13.82 69.26 132.27 11.87 70.14 132.51 60.54 4.31 43.90 62.00 4.57 45.37 coo 8.74 63.05 136.42 9.87 62.19 134.79 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 8.26 72.60 129.22 10.14 73.45 129.80 56.47 4.11 47.59 54.90 3.31 48.75 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 7 hits 1b57_c01 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 75 HIS.? 25.41 CL CL B 226 B 91 ARG B 19 ARG~? 20.05 CL CL B 226 B 129 SER A 72 SER.? 25.76 CL CL A 226 coo 18.19 17.03 40.71 18.55 17.18 38.64 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 25.60 21.10 38.54 23.57 20.93 36.25 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 21.33 14.29 34.62 19.25 14.88 35.71 34.13 -18.66 12.80 35.17 -18.58 10.66 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS B 75 HIS.? 25.67 CL CL A 226 B 91 ARG A 19 ARG~? 20.09 CL CL A 226 B 129 SER B 72 SER.? 25.86 CL CL B 226 coo 18.19 17.03 40.71 18.55 17.18 38.64 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 25.60 21.10 38.54 23.57 20.93 36.25 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 21.33 14.29 34.62 19.25 14.88 35.71 38.31 -18.13 29.75 37.15 -17.87 31.87 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 2 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 58 TYR.? 17.32 CL CL A 226 A 230 ASP A 40 ASP.? 7.65 CL CL A 226 A 273 LYS A 178 LYS~? 16.45 CL CL A 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 1.45 22.80 104.16 2.58 21.02 104.01 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 2.97 11.64 107.87 6.59 15.13 107.03 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 58 TYR.? 17.32 CL CL A 226 A 230 ASP A 61 ASP.? 23.60 CL CL A 226 A 273 LYS A 178 LYS~? 16.45 CL CL A 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 1.45 22.80 104.16 2.58 21.02 104.01 6.80 -9.81 5.25 8.17 -9.51 3.68 coo 2.97 11.64 107.87 6.59 15.13 107.03 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR A 90 TYR^? 17.82 CL CL A 226 A 230 ASP A 102 ASP~? 17.30 CL CL A 226 A 273 LYS A 96 LYS.? 26.69 CL CL B 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 38.12 1.32 8.30 36.38 -0.30 9.74 coo 1.45 22.80 104.16 2.58 21.02 104.01 32.53 7.12 5.29 31.66 9.04 5.62 coo 2.97 11.64 107.87 6.59 15.13 107.03 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR A 194 TYR~? 29.78 CL CL A 226 A 230 ASP A 193 ASP~? 30.50 CL CL A 226 A 273 LYS A 200 LYS~? 23.56 CL CL A 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 1.45 22.80 104.16 2.58 21.02 104.01 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 2.97 11.64 107.87 6.59 15.13 107.03 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR B 58 TYR.? 17.22 CL CL B 226 A 230 ASP B 40 ASP.? 7.91 CL CL B 226 A 273 LYS B 178 LYS~? 16.76 CL CL B 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 1.45 22.80 104.16 2.58 21.02 104.01 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 2.97 11.64 107.87 6.59 15.13 107.03 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR B 58 TYR.? 17.22 CL CL B 226 A 230 ASP B 61 ASP.? 23.81 CL CL B 226 A 273 LYS B 178 LYS~? 16.76 CL CL B 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 1.45 22.80 104.16 2.58 21.02 104.01 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 2.97 11.64 107.87 6.59 15.13 107.03 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR B 90 TYR^? 17.17 CL CL B 226 A 230 ASP B 102 ASP~? 16.83 CL CL B 226 A 273 LYS B 96 LYS^? 24.51 CL CL B 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 38.78 1.99 31.89 40.05 -0.11 30.63 coo 1.45 22.80 104.16 2.58 21.02 104.01 45.25 7.06 34.64 46.46 8.64 34.05 coo 2.97 11.64 107.87 6.59 15.13 107.03 35.42 10.33 36.63 41.15 11.45 39.22 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR B 194 TYR~? 30.06 CL CL B 226 A 230 ASP B 193 ASP~? 31.47 CL CL B 226 A 273 LYS B 200 LYS~? 24.54 CL CL B 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 1.45 22.80 104.16 2.58 21.02 104.01 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 2.97 11.64 107.87 6.59 15.13 107.03 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR B 208 TYR~? 15.74 CL CL B 226 A 230 ASP B 102 ASP~? 16.83 CL CL B 226 A 273 LYS B 213 LYS~? 22.42 CL CL B 226 coo 9.23 21.44 106.88 10.18 19.34 105.31 52.42 6.76 36.83 50.45 6.61 34.90 coo 1.45 22.80 104.16 2.58 21.02 104.01 45.25 7.06 34.64 46.46 8.64 34.05 coo 2.97 11.64 107.87 6.59 15.13 107.03 48.60 15.99 42.06 48.42 16.28 35.76 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 9 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 58 TYR.? 17.32 CL CL A 226 B 230 ASP A 61 ASP.? 23.60 CL CL A 226 B 273 LYS A 178 LYS~? 16.45 CL CL A 226 coo 11.81 13.41 73.03 10.00 13.03 75.12 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 19.17 11.01 76.14 17.26 10.42 76.77 6.80 -9.81 5.25 8.17 -9.51 3.68 coo 11.10 2.31 76.60 10.24 7.24 75.62 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 90 TYR^? 17.82 CL CL A 226 B 230 ASP A 102 ASP~? 17.30 CL CL A 226 B 273 LYS A 96 LYS.? 26.69 CL CL B 226 coo 11.81 13.41 73.03 10.00 13.03 75.12 38.12 1.32 8.30 36.38 -0.30 9.74 coo 19.17 11.01 76.14 17.26 10.42 76.77 32.53 7.12 5.29 31.66 9.04 5.62 coo 11.10 2.31 76.60 10.24 7.24 75.62 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR A 194 TYR~? 29.78 CL CL A 226 B 230 ASP A 193 ASP~? 30.50 CL CL A 226 B 273 LYS A 200 LYS~? 23.56 CL CL A 226 coo 11.81 13.41 73.03 10.00 13.03 75.12 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 19.17 11.01 76.14 17.26 10.42 76.77 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 11.10 2.31 76.60 10.24 7.24 75.62 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR B 58 TYR.? 17.22 CL CL B 226 B 230 ASP B 40 ASP.? 7.91 CL CL B 226 B 273 LYS B 178 LYS~? 16.76 CL CL B 226 coo 11.81 13.41 73.03 10.00 13.03 75.12 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 19.17 11.01 76.14 17.26 10.42 76.77 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 11.10 2.31 76.60 10.24 7.24 75.62 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR B 58 TYR.? 17.22 CL CL B 226 B 230 ASP B 61 ASP.? 23.81 CL CL B 226 B 273 LYS B 178 LYS~? 16.76 CL CL B 226 coo 11.81 13.41 73.03 10.00 13.03 75.12 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 19.17 11.01 76.14 17.26 10.42 76.77 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 11.10 2.31 76.60 10.24 7.24 75.62 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR B 90 TYR^? 17.17 CL CL B 226 B 230 ASP B 102 ASP~? 16.83 CL CL B 226 B 273 LYS B 96 LYS^? 24.51 CL CL B 226 coo 11.81 13.41 73.03 10.00 13.03 75.12 38.78 1.99 31.89 40.05 -0.11 30.63 coo 19.17 11.01 76.14 17.26 10.42 76.77 45.25 7.06 34.64 46.46 8.64 34.05 coo 11.10 2.31 76.60 10.24 7.24 75.62 35.42 10.33 36.63 41.15 11.45 39.22 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR B 194 TYR~? 30.06 CL CL B 226 B 230 ASP B 193 ASP~? 31.47 CL CL B 226 B 273 LYS B 200 LYS~? 24.54 CL CL B 226 coo 11.81 13.41 73.03 10.00 13.03 75.12 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 19.17 11.01 76.14 17.26 10.42 76.77 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 11.10 2.31 76.60 10.24 7.24 75.62 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR B 208 TYR~? 15.74 CL CL B 226 B 230 ASP B 102 ASP~? 16.83 CL CL B 226 B 273 LYS B 213 LYS~? 22.42 CL CL B 226 coo 11.81 13.41 73.03 10.00 13.03 75.12 52.42 6.76 36.83 50.45 6.61 34.90 coo 19.17 11.01 76.14 17.26 10.42 76.77 45.25 7.06 34.64 46.46 8.64 34.05 coo 11.10 2.31 76.60 10.24 7.24 75.62 48.60 15.99 42.06 48.42 16.28 35.76 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 8 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 109 PHE~? 18.50 CL CL A 226 A 159 ASP A 203 ASP~? 25.03 CL CL A 226 A 188 LYS A 178 LYS~? 16.45 CL CL A 226 coo 13.91 34.58 14.67 12.95 36.00 12.47 24.98 3.58 -0.85 22.97 3.50 1.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 22.55 41.65 15.60 18.92 37.20 14.63 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 109 PHE~? 18.73 CL CL B 226 A 159 ASP B 111 ASP~? 25.68 CL CL B 226 A 188 LYS B 200 LYS~? 24.54 CL CL B 226 coo 13.91 34.58 14.67 12.95 36.00 12.47 51.52 2.89 41.40 53.63 2.11 39.78 coo 20.97 28.40 16.26 20.19 30.15 15.34 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 22.55 41.65 15.60 18.92 37.20 14.63 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE B 109 PHE~? 18.73 CL CL B 226 A 159 ASP B 203 ASP~? 25.12 CL CL B 226 A 188 LYS B 178 LYS~? 16.76 CL CL B 226 coo 13.91 34.58 14.67 12.95 36.00 12.47 51.52 2.89 41.40 53.63 2.11 39.78 coo 20.97 28.40 16.26 20.19 30.15 15.34 60.54 4.31 43.90 62.00 4.57 45.37 coo 22.55 41.65 15.60 18.92 37.20 14.63 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE B 183 PHE~? 27.12 CL CL B 226 A 159 ASP B 186 ASP.? 30.73 CL CL B 226 A 188 LYS B 178 LYS~? 16.76 CL CL B 226 coo 13.91 34.58 14.67 12.95 36.00 12.47 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 20.97 28.40 16.26 20.19 30.15 15.34 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 57.30 -6.98 36.80 62.98 -8.03 34.22 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 4 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 81 ARG~? 19.72 CL CL B 226 B 141 THR A 76 THR~? 22.08 CL CL B 226 B 235 ASP A 102 ASP~? 17.30 CL CL A 226 coo 8.13 67.41 100.27 7.18 68.35 97.45 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 8.28 67.78 108.81 6.22 67.65 109.43 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 14.55 73.52 89.47 12.81 73.95 90.56 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG B 81 ARG~? 19.82 CL CL A 226 B 141 THR B 76 THR~? 22.20 CL CL A 226 B 235 ASP B 102 ASP~? 16.83 CL CL B 226 coo 8.13 67.41 100.27 7.18 68.35 97.45 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 8.28 67.78 108.81 6.22 67.65 109.43 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 14.55 73.52 89.47 12.81 73.95 90.56 45.25 7.06 34.64 46.46 8.64 34.05 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 94 ASP.? 26.16 CL CL B 226 16 HIS A 93 HIS.? 23.56 CL CL B 226 67 GLY A 78 GLY~? 19.52 CL CL A 226 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 44.86 8.73 -0.50 42.92 8.83 0.44 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 36.22 -9.15 11.05 36.43 -9.16 11.86 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 94 ASP.? 26.16 CL CL B 226 16 HIS A 93 HIS.? 23.56 CL CL B 226 67 GLY A 165 GLY.? 9.73 CL CL A 226 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 44.86 8.73 -0.50 42.92 8.83 0.44 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 30.46 -1.42 14.80 29.77 -1.25 14.46 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP B 94 ASP.? 27.62 CL CL A 226 16 HIS B 93 HIS.? 20.63 CL CL A 226 67 GLY B 165 GLY.? 9.33 CL CL B 226 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 32.35 7.85 42.25 31.25 7.59 44.05 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 29.92 2.50 38.47 29.09 1.13 37.10 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 45.52 -2.50 25.89 46.23 -2.42 26.22 1be1_c02 source 1be1 GLUTAMATE MUTASE : 3 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP B 193 ASP~? 31.47 CL CL B 226 435 GLU B 187 GLU.? 29.51 CL CL B 226 510 ASP B 186 ASP.? 30.73 CL CL B 226 coo 88.62 69.90 41.16 89.05 70.67 43.04 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 89.52 76.11 40.17 89.01 75.16 41.97 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 84.89 77.60 46.67 85.63 75.79 46.03 56.29 -18.50 46.72 54.94 -17.46 47.93 1bf2_c00 source 1bf2 ISOAMYLASE : 1 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 69 GLU^? 25.00 CL CL A 226 A 503 TYR A 160 TYR~? 15.52 CL CL A 226 A 537 GLU A 157 GLU~? 23.07 CL CL A 226 coo 24.06 146.21 11.09 22.89 146.18 9.36 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 15.91 140.69 8.32 15.71 143.39 9.13 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 16.65 144.44 13.24 18.34 145.22 12.33 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 77 GLU~? 21.84 CL CL B 226 A 503 TYR B 20 TYR~? 17.36 CL CL B 226 A 537 GLU B 9 GLU.? 16.36 CL CL B 226 coo 24.06 146.21 11.09 22.89 146.18 9.36 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 15.91 140.69 8.32 15.71 143.39 9.13 46.52 -15.74 17.49 47.60 -15.27 14.94 coo 16.65 144.44 13.24 18.34 145.22 12.33 47.73 -10.39 12.99 46.70 -12.24 13.09 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU A 110 GLU~? 23.70 CL CL A 226 A 503 TYR A 113 TYR~? 30.72 CL CL A 226 A 537 GLU A 112 GLU~? 32.50 CL CL A 226 coo 24.06 146.21 11.09 22.89 146.18 9.36 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 15.91 140.69 8.32 15.71 143.39 9.13 33.48 -4.69 -8.69 35.76 -3.13 -9.21 coo 16.65 144.44 13.24 18.34 145.22 12.33 31.64 -0.95 -10.58 32.34 0.04 -12.34 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU A 175 GLU~? 15.88 CL CL A 226 A 503 TYR A 208 TYR~? 15.64 CL CL A 226 A 537 GLU A 172 GLU~? 15.14 CL CL A 226 coo 24.06 146.21 11.09 22.89 146.18 9.36 15.56 2.16 3.91 14.40 0.59 4.79 coo 15.91 140.69 8.32 15.71 143.39 9.13 25.22 8.01 3.41 27.20 7.60 5.36 coo 16.65 144.44 13.24 18.34 145.22 12.33 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU B 11 GLU.? 11.19 CL CL B 226 A 503 TYR A 87 TYR~? 13.92 CL CL A 226 A 537 GLU A 84 GLU~? 12.94 CL CL B 226 coo 24.06 146.21 11.09 22.89 146.18 9.36 45.62 0.60 17.46 44.46 2.32 17.00 coo 15.91 140.69 8.32 15.71 143.39 9.13 36.79 3.26 19.70 35.19 2.19 21.67 coo 16.65 144.44 13.24 18.34 145.22 12.33 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 6 3 # 6 A 461 GLU B 77 GLU~? 22.22 CL CL A 226 A 503 TYR A 20 TYR~? 17.28 CL CL A 226 A 537 GLU A 9 GLU.? 16.20 CL CL A 226 coo 24.06 146.21 11.09 22.89 146.18 9.36 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 15.91 140.69 8.32 15.71 143.39 9.13 26.99 -13.27 24.47 26.16 -12.32 26.98 coo 16.65 144.44 13.24 18.34 145.22 12.33 26.61 -7.39 28.28 26.97 -9.45 28.59 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 7 3 # 7 A 461 GLU B 110 GLU~? 23.32 CL CL B 226 A 503 TYR B 113 TYR~? 30.94 CL CL B 226 A 537 GLU B 112 GLU~? 31.79 CL CL B 226 coo 24.06 146.21 11.09 22.89 146.18 9.36 46.60 5.74 43.54 45.54 7.20 42.48 coo 15.91 140.69 8.32 15.71 143.39 9.13 40.93 -2.67 49.32 39.01 -0.90 50.27 coo 16.65 144.44 13.24 18.34 145.22 12.33 43.43 0.58 50.84 42.60 2.23 51.76 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 8 3 # 8 A 461 GLU B 175 GLU~? 17.14 CL CL B 226 A 503 TYR B 208 TYR~? 15.74 CL CL B 226 A 537 GLU B 172 GLU~? 15.62 CL CL B 226 coo 24.06 146.21 11.09 22.89 146.18 9.36 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 15.91 140.69 8.32 15.71 143.39 9.13 52.42 6.76 36.83 50.45 6.61 34.90 coo 16.65 144.44 13.24 18.34 145.22 12.33 57.49 4.88 36.61 57.44 6.68 35.49 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 8 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 11 GLU.? 11.48 CL CL A 226 A 504 TYR B 87 TYR~? 13.52 CL CL B 226 A 540 GLU B 84 GLU~? 12.79 CL CL A 226 coo 81.34 87.29 87.22 82.36 86.09 88.61 31.29 2.41 22.91 32.62 4.08 23.08 coo 80.85 81.34 94.77 81.70 80.16 92.41 40.26 2.88 20.56 41.63 1.41 18.60 coo 79.94 80.46 88.84 81.11 81.36 87.27 35.35 -1.73 23.75 33.22 -1.55 23.84 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU A 69 GLU^? 25.00 CL CL A 226 A 504 TYR A 160 TYR~? 15.52 CL CL A 226 A 540 GLU A 157 GLU~? 23.07 CL CL A 226 coo 81.34 87.29 87.22 82.36 86.09 88.61 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 80.85 81.34 94.77 81.70 80.16 92.41 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 79.94 80.46 88.84 81.11 81.36 87.27 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU A 77 GLU~? 21.84 CL CL B 226 A 504 TYR B 20 TYR~? 17.36 CL CL B 226 A 540 GLU B 9 GLU.? 16.36 CL CL B 226 coo 81.34 87.29 87.22 82.36 86.09 88.61 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 80.85 81.34 94.77 81.70 80.16 92.41 46.52 -15.74 17.49 47.60 -15.27 14.94 coo 79.94 80.46 88.84 81.11 81.36 87.27 47.73 -10.39 12.99 46.70 -12.24 13.09 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 4 3 # 4 A 451 GLU A 175 GLU~? 15.88 CL CL A 226 A 504 TYR A 208 TYR~? 15.64 CL CL A 226 A 540 GLU A 172 GLU~? 15.14 CL CL A 226 coo 81.34 87.29 87.22 82.36 86.09 88.61 15.56 2.16 3.91 14.40 0.59 4.79 coo 80.85 81.34 94.77 81.70 80.16 92.41 25.22 8.01 3.41 27.20 7.60 5.36 coo 79.94 80.46 88.84 81.11 81.36 87.27 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 5 3 # 5 A 451 GLU B 11 GLU.? 11.19 CL CL B 226 A 504 TYR A 87 TYR~? 13.92 CL CL A 226 A 540 GLU A 84 GLU~? 12.94 CL CL B 226 coo 81.34 87.29 87.22 82.36 86.09 88.61 45.62 0.60 17.46 44.46 2.32 17.00 coo 80.85 81.34 94.77 81.70 80.16 92.41 36.79 3.26 19.70 35.19 2.19 21.67 coo 79.94 80.46 88.84 81.11 81.36 87.27 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 6 3 # 6 A 451 GLU B 69 GLU^? 24.72 CL CL B 226 A 504 TYR B 160 TYR~? 15.61 CL CL B 226 A 540 GLU B 157 GLU~? 23.31 CL CL B 226 coo 81.34 87.29 87.22 82.36 86.09 88.61 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 80.85 81.34 94.77 81.70 80.16 92.41 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 79.94 80.46 88.84 81.11 81.36 87.27 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 7 3 # 7 A 451 GLU B 77 GLU~? 22.22 CL CL A 226 A 504 TYR A 20 TYR~? 17.28 CL CL A 226 A 540 GLU A 9 GLU.? 16.20 CL CL A 226 coo 81.34 87.29 87.22 82.36 86.09 88.61 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 80.85 81.34 94.77 81.70 80.16 92.41 26.99 -13.27 24.47 26.16 -12.32 26.98 coo 79.94 80.46 88.84 81.11 81.36 87.27 26.61 -7.39 28.28 26.97 -9.45 28.59 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 8 3 # 8 A 451 GLU B 175 GLU~? 17.14 CL CL B 226 A 504 TYR B 208 TYR~? 15.74 CL CL B 226 A 540 GLU B 172 GLU~? 15.62 CL CL B 226 coo 81.34 87.29 87.22 82.36 86.09 88.61 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 80.85 81.34 94.77 81.70 80.16 92.41 52.42 6.76 36.83 50.45 6.61 34.90 coo 79.94 80.46 88.84 81.11 81.36 87.27 57.49 4.88 36.61 57.44 6.68 35.49 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 8 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 11 GLU.? 11.48 CL CL A 226 B 504 TYR B 87 TYR~? 13.52 CL CL B 226 B 540 GLU B 84 GLU~? 12.79 CL CL A 226 coo 86.52 35.28 112.74 87.08 36.38 110.99 31.29 2.41 22.91 32.62 4.08 23.08 coo 84.93 40.21 105.31 85.72 41.45 107.72 40.26 2.88 20.56 41.63 1.41 18.60 coo 83.38 41.19 112.55 85.47 40.59 112.72 35.35 -1.73 23.75 33.22 -1.55 23.84 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 69 GLU^? 25.00 CL CL A 226 B 504 TYR A 160 TYR~? 15.52 CL CL A 226 B 540 GLU A 157 GLU~? 23.07 CL CL A 226 coo 86.52 35.28 112.74 87.08 36.38 110.99 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 84.93 40.21 105.31 85.72 41.45 107.72 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 83.38 41.19 112.55 85.47 40.59 112.72 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU A 77 GLU~? 21.84 CL CL B 226 B 504 TYR B 20 TYR~? 17.36 CL CL B 226 B 540 GLU B 9 GLU.? 16.36 CL CL B 226 coo 86.52 35.28 112.74 87.08 36.38 110.99 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 84.93 40.21 105.31 85.72 41.45 107.72 46.52 -15.74 17.49 47.60 -15.27 14.94 coo 83.38 41.19 112.55 85.47 40.59 112.72 47.73 -10.39 12.99 46.70 -12.24 13.09 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU A 84 GLU~? 12.94 CL CL B 226 B 504 TYR A 87 TYR~? 13.92 CL CL A 226 B 540 GLU B 11 GLU.? 11.19 CL CL B 226 coo 86.52 35.28 112.74 87.08 36.38 110.99 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 84.93 40.21 105.31 85.72 41.45 107.72 36.79 3.26 19.70 35.19 2.19 21.67 coo 83.38 41.19 112.55 85.47 40.59 112.72 45.62 0.60 17.46 44.46 2.32 17.00 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 5 3 # 5 B 451 GLU B 11 GLU.? 11.19 CL CL B 226 B 504 TYR A 87 TYR~? 13.92 CL CL A 226 B 540 GLU A 84 GLU~? 12.94 CL CL B 226 coo 86.52 35.28 112.74 87.08 36.38 110.99 45.62 0.60 17.46 44.46 2.32 17.00 coo 84.93 40.21 105.31 85.72 41.45 107.72 36.79 3.26 19.70 35.19 2.19 21.67 coo 83.38 41.19 112.55 85.47 40.59 112.72 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 6 3 # 6 B 451 GLU B 69 GLU^? 24.72 CL CL B 226 B 504 TYR B 160 TYR~? 15.61 CL CL B 226 B 540 GLU B 157 GLU~? 23.31 CL CL B 226 coo 86.52 35.28 112.74 87.08 36.38 110.99 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 84.93 40.21 105.31 85.72 41.45 107.72 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 83.38 41.19 112.55 85.47 40.59 112.72 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 7 3 # 7 B 451 GLU B 77 GLU~? 22.22 CL CL A 226 B 504 TYR A 20 TYR~? 17.28 CL CL A 226 B 540 GLU A 9 GLU.? 16.20 CL CL A 226 coo 86.52 35.28 112.74 87.08 36.38 110.99 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 84.93 40.21 105.31 85.72 41.45 107.72 26.99 -13.27 24.47 26.16 -12.32 26.98 coo 83.38 41.19 112.55 85.47 40.59 112.72 26.61 -7.39 28.28 26.97 -9.45 28.59 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 8 3 # 8 B 451 GLU B 84 GLU~? 12.79 CL CL A 226 B 504 TYR B 87 TYR~? 13.52 CL CL B 226 B 540 GLU A 11 GLU.? 11.48 CL CL A 226 coo 86.52 35.28 112.74 87.08 36.38 110.99 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 84.93 40.21 105.31 85.72 41.45 107.72 40.26 2.88 20.56 41.63 1.41 18.60 coo 83.38 41.19 112.55 85.47 40.59 112.72 31.29 2.41 22.91 32.62 4.08 23.08 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 8 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 65 ARG.? 31.92 CL CL A 226 A 451 GLU A 182 GLU~? 21.95 CL CL A 226 A 540 GLU A 187 GLU.? 30.59 CL CL A 226 coo 79.04 80.20 80.81 79.58 81.40 83.63 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo 81.34 87.29 87.22 82.36 86.09 88.61 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 10.39 -14.82 -4.45 8.65 -14.21 -3.38 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 81 ARG~? 19.72 CL CL B 226 A 451 GLU B 11 GLU.? 11.19 CL CL B 226 A 540 GLU A 84 GLU~? 12.94 CL CL B 226 coo 79.04 80.20 80.81 79.58 81.40 83.63 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 81.34 87.29 87.22 82.36 86.09 88.61 45.62 0.60 17.46 44.46 2.32 17.00 coo 79.94 80.46 88.84 81.11 81.36 87.27 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG B 81 ARG~? 19.82 CL CL A 226 A 451 GLU A 11 GLU.? 11.48 CL CL A 226 A 540 GLU B 84 GLU~? 12.79 CL CL A 226 coo 79.04 80.20 80.81 79.58 81.40 83.63 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 81.34 87.29 87.22 82.36 86.09 88.61 31.29 2.41 22.91 32.62 4.08 23.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 35.35 -1.73 23.75 33.22 -1.55 23.84 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 81 ARG~? 19.72 CL CL B 226 B 451 GLU B 9 GLU.? 16.36 CL CL B 226 B 540 GLU A 77 GLU~? 21.84 CL CL B 226 coo 82.21 41.07 119.14 83.95 40.66 116.59 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 86.52 35.28 112.74 87.08 36.38 110.99 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 83.38 41.19 112.55 85.47 40.59 112.72 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 81 ARG~? 19.72 CL CL B 226 B 451 GLU B 11 GLU.? 11.19 CL CL B 226 B 540 GLU A 84 GLU~? 12.94 CL CL B 226 coo 82.21 41.07 119.14 83.95 40.66 116.59 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 86.52 35.28 112.74 87.08 36.38 110.99 45.62 0.60 17.46 44.46 2.32 17.00 coo 83.38 41.19 112.55 85.47 40.59 112.72 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 81 ARG~? 19.82 CL CL A 226 B 451 GLU A 9 GLU.? 16.20 CL CL A 226 B 540 GLU B 77 GLU~? 22.22 CL CL A 226 coo 82.21 41.07 119.14 83.95 40.66 116.59 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 86.52 35.28 112.74 87.08 36.38 110.99 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 83.38 41.19 112.55 85.47 40.59 112.72 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG B 81 ARG~? 19.82 CL CL A 226 B 451 GLU A 11 GLU.? 11.48 CL CL A 226 B 540 GLU B 84 GLU~? 12.79 CL CL A 226 coo 82.21 41.07 119.14 83.95 40.66 116.59 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 86.52 35.28 112.74 87.08 36.38 110.99 31.29 2.41 22.91 32.62 4.08 23.08 coo 83.38 41.19 112.55 85.47 40.59 112.72 35.35 -1.73 23.75 33.22 -1.55 23.84 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 27 ARG~? 25.45 CL CL A 226 183 LYS A 52 LYS^? 28.69 CL CL A 226 317 ARG A 13 ARG~? 5.03 CL CL A 226 coo 76.57 109.19 73.41 73.86 110.26 72.16 23.69 -24.29 25.50 21.75 -22.60 23.78 coo 82.09 117.51 66.37 80.60 114.32 71.44 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 65.21 120.62 58.76 63.62 123.14 59.66 24.18 -3.56 18.28 25.11 -1.28 16.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 27 ARG~? 25.45 CL CL A 226 183 LYS B 74 LYS.? 25.46 CL CL A 226 317 ARG A 13 ARG~? 5.03 CL CL A 226 coo 76.57 109.19 73.41 73.86 110.26 72.16 23.69 -24.29 25.50 21.75 -22.60 23.78 coo 82.09 117.51 66.37 80.60 114.32 71.44 32.81 -17.40 29.10 28.60 -18.34 31.99 coo 65.21 120.62 58.76 63.62 123.14 59.66 24.18 -3.56 18.28 25.11 -1.28 16.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 81 ARG~? 19.72 CL CL B 226 183 LYS A 74 LYS.? 28.20 CL CL B 226 317 ARG A 19 ARG~? 20.09 CL CL A 226 coo 76.57 109.19 73.41 73.86 110.26 72.16 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 82.09 117.51 66.37 80.60 114.32 71.44 39.76 -18.88 13.29 42.20 -24.24 11.95 coo 65.21 120.62 58.76 63.62 123.14 59.66 31.00 -11.00 27.75 29.53 -12.56 29.89 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG B 27 ARG~? 28.79 CL CL B 226 183 LYS A 74 LYS.? 28.20 CL CL B 226 317 ARG B 13 ARG~? 5.25 CL CL B 226 coo 76.57 109.19 73.41 73.86 110.26 72.16 46.17 -28.08 18.24 47.24 -27.87 15.37 coo 82.09 117.51 66.37 80.60 114.32 71.44 39.76 -18.88 13.29 42.20 -24.24 11.95 coo 65.21 120.62 58.76 63.62 123.14 59.66 51.04 -6.15 23.43 50.81 -3.67 25.23 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG B 27 ARG~? 28.79 CL CL B 226 183 LYS B 52 LYS^? 28.59 CL CL B 226 317 ARG B 13 ARG~? 5.25 CL CL B 226 coo 76.57 109.19 73.41 73.86 110.26 72.16 46.17 -28.08 18.24 47.24 -27.87 15.37 coo 82.09 117.51 66.37 80.60 114.32 71.44 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 65.21 120.62 58.76 63.62 123.14 59.66 51.04 -6.15 23.43 50.81 -3.67 25.23 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG B 27 ARG~? 28.79 CL CL B 226 183 LYS B 52 LYS^? 28.59 CL CL B 226 317 ARG B 65 ARG.? 31.41 CL CL B 226 coo 76.57 109.19 73.41 73.86 110.26 72.16 46.17 -28.08 18.24 47.24 -27.87 15.37 coo 82.09 117.51 66.37 80.60 114.32 71.44 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 65.21 120.62 58.76 63.62 123.14 59.66 55.55 -24.03 39.40 53.97 -26.61 39.95 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG B 81 ARG~? 19.82 CL CL A 226 183 LYS B 74 LYS.? 25.46 CL CL A 226 317 ARG B 19 ARG~? 20.05 CL CL B 226 coo 76.57 109.19 73.41 73.86 110.26 72.16 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 82.09 117.51 66.37 80.60 114.32 71.44 32.81 -17.40 29.10 28.60 -18.34 31.99 coo 65.21 120.62 58.76 63.62 123.14 59.66 42.78 -12.99 14.20 43.98 -15.00 12.21 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 7 hits 1bib_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 81 ARG~? 19.72 CL CL B 226 A 128 GLU B 9 GLU.? 16.36 CL CL B 226 A 225 GLU A 77 GLU~? 21.84 CL CL B 226 coo 38.56 19.11 14.83 37.12 21.00 16.76 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 36.48 24.43 22.02 36.86 26.34 21.13 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 40.16 23.71 17.01 38.52 24.96 17.40 40.16 -11.08 10.76 40.31 -13.18 10.50 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS B 56 HIS^? 18.72 CL CL B 226 A 168 ARG B 13 ARG~? 5.25 CL CL B 226 A 187 LYS B 178 LYS~? 16.76 CL CL B 226 coo 62.47 12.00 59.65 61.76 10.14 60.31 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 55.10 8.37 73.00 55.48 9.59 70.20 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 66.76 10.09 66.23 61.80 8.06 65.82 57.30 -6.98 36.80 62.98 -8.03 34.22 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 1 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 56 HIS^? 18.87 CL CL A 226 B1168 ARG A 65 ARG.? 31.92 CL CL A 226 B1187 LYS A 60 LYS.? 19.24 CL CL A 226 coo 35.03 5.72 103.61 36.82 5.00 102.79 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 41.91 5.48 91.85 40.59 6.81 94.28 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo 32.93 -0.12 99.60 37.71 2.39 99.23 9.83 -11.93 8.36 13.65 -13.48 11.58 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 1 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 54 PHE^? 23.66 CL CL A 226 A 205 ASP A 2 ASP.? 26.08 CL CL A 226 A 236 LYS A 36 LYS^? 12.38 CL CL A 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 25.68 -18.24 10.24 27.16 -20.43 9.42 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 12.58 -19.85 19.79 12.48 -21.80 20.57 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 68 PHE^? 20.15 CL CL A 226 A 205 ASP A 43 ASP.? 11.79 CL CL A 226 A 236 LYS A 60 LYS.? 19.24 CL CL A 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 24.16 -12.52 5.51 22.26 -11.92 3.55 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 68 PHE^? 20.15 CL CL A 226 A 205 ASP A 186 ASP.? 30.68 CL CL A 226 A 236 LYS A 63 LYS.? 28.35 CL CL A 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 24.16 -12.52 5.51 22.26 -11.92 3.55 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 114 PHE~? 22.97 CL CL A 226 A 205 ASP A 102 ASP~? 17.30 CL CL A 226 A 236 LYS A 205 LYS~? 25.48 CL CL A 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 27.44 -4.93 -3.68 25.47 -5.75 -1.86 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 32.53 7.12 5.29 31.66 9.04 5.62 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE A 114 PHE~? 22.97 CL CL A 226 A 205 ASP A 186 ASP.? 30.68 CL CL A 226 A 236 LYS A 195 LYS~? 35.76 CL CL A 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 27.44 -4.93 -3.68 25.47 -5.75 -1.86 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE A 114 PHE~? 22.97 CL CL A 226 A 205 ASP A 193 ASP~? 30.50 CL CL A 226 A 236 LYS A 200 LYS~? 23.56 CL CL A 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 27.44 -4.93 -3.68 25.47 -5.75 -1.86 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE A 114 PHE~? 22.97 CL CL A 226 A 205 ASP A 203 ASP~? 25.03 CL CL A 226 A 236 LYS A 195 LYS~? 35.76 CL CL A 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 27.44 -4.93 -3.68 25.47 -5.75 -1.86 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE B 68 PHE^? 20.40 CL CL B 226 A 205 ASP B 186 ASP.? 30.73 CL CL B 226 A 236 LYS B 63 LYS.? 30.86 CL CL B 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 49.27 -13.62 36.70 51.35 -13.49 38.54 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE B 114 PHE~? 23.12 CL CL B 226 A 205 ASP B 102 ASP~? 16.83 CL CL B 226 A 236 LYS B 205 LYS~? 25.67 CL CL B 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 47.16 -4.85 44.78 49.00 -6.29 43.28 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 45.25 7.06 34.64 46.46 8.64 34.05 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE B 114 PHE~? 23.12 CL CL B 226 A 205 ASP B 193 ASP~? 31.47 CL CL B 226 A 236 LYS B 200 LYS~? 24.54 CL CL B 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 47.16 -4.85 44.78 49.00 -6.29 43.28 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE B 114 PHE~? 23.12 CL CL B 226 A 205 ASP B 203 ASP~? 25.12 CL CL B 226 A 236 LYS B 195 LYS~? 36.01 CL CL B 226 coo 4.14 2.10 36.34 6.69 3.08 36.92 47.16 -4.85 44.78 49.00 -6.29 43.28 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 60.54 4.31 43.90 62.00 4.57 45.37 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 58.60 -4.05 52.32 60.39 -2.54 57.56 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 11 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 97 GLN^? 17.74 CL CL B 226 A 91 LEU A 98 LEU^? 20.23 CL CL A 226 A 133 GLU A 91 GLU^? 16.38 CL CL B 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 41.33 7.73 10.04 42.82 6.16 10.16 coo 38.58 45.09 70.44 38.28 45.21 72.59 37.33 6.14 5.59 35.88 6.41 3.98 coo 44.05 36.87 70.65 43.15 38.64 69.97 45.65 4.89 7.15 47.54 4.63 8.07 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 107 GLN~? 21.40 CL CL A 226 A 91 LEU A 108 LEU~? 17.59 CL CL A 226 A 133 GLU A 110 GLU~? 23.70 CL CL A 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 32.31 -1.54 2.10 33.98 -2.53 1.23 coo 38.58 45.09 70.44 38.28 45.21 72.59 26.05 -0.19 1.12 24.01 -0.94 1.58 coo 44.05 36.87 70.65 43.15 38.64 69.97 30.58 5.52 -3.71 32.09 6.67 -2.64 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 119 GLN~? 33.63 CL CL A 226 A 91 LEU A 118 LEU~? 25.85 CL CL A 226 A 133 GLU A 198 GLU~? 30.13 CL CL A 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 22.19 -6.11 -12.40 21.08 -5.58 -14.19 coo 38.58 45.09 70.44 38.28 45.21 72.59 22.61 -7.03 -6.79 22.70 -6.57 -4.65 coo 44.05 36.87 70.65 43.15 38.64 69.97 19.84 0.58 -9.50 20.29 0.30 -11.52 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN A 161 GLN~? 19.20 CL CL A 226 A 91 LEU A 70 LEU^? 16.48 CL CL A 226 A 133 GLU A 77 GLU~? 21.84 CL CL B 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 38.58 45.09 70.44 38.28 45.21 72.59 29.18 -12.31 12.09 27.61 -10.79 11.87 coo 44.05 36.87 70.65 43.15 38.64 69.97 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN A 161 GLN~? 19.20 CL CL A 226 A 91 LEU A 79 LEU~? 16.20 CL CL A 226 A 133 GLU A 69 GLU^? 25.00 CL CL A 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 38.58 45.09 70.44 38.28 45.21 72.59 33.80 -9.42 15.25 31.63 -9.90 15.24 coo 44.05 36.87 70.65 43.15 38.64 69.97 30.56 -16.89 8.89 31.90 -18.26 8.02 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN A 161 GLN~? 19.20 CL CL A 226 A 91 LEU A 79 LEU~? 16.20 CL CL A 226 A 133 GLU A 77 GLU~? 21.84 CL CL B 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 38.58 45.09 70.44 38.28 45.21 72.59 33.80 -9.42 15.25 31.63 -9.90 15.24 coo 44.05 36.87 70.65 43.15 38.64 69.97 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN A 161 GLN~? 19.20 CL CL A 226 A 91 LEU A 162 LEU~? 15.19 CL CL A 226 A 133 GLU A 157 GLU~? 23.07 CL CL A 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 38.58 45.09 70.44 38.28 45.21 72.59 30.92 -2.48 8.24 32.78 -2.17 7.05 coo 44.05 36.87 70.65 43.15 38.64 69.97 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN B 107 GLN~? 21.73 CL CL B 226 A 91 LEU B 108 LEU~? 17.52 CL CL B 226 A 133 GLU B 110 GLU~? 23.32 CL CL B 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 43.35 -1.25 38.76 41.89 -1.28 40.29 coo 38.58 45.09 70.44 38.28 45.21 72.59 49.83 -0.66 39.63 51.53 -1.90 39.16 coo 44.05 36.87 70.65 43.15 38.64 69.97 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN B 119 GLN~? 34.36 CL CL B 226 A 91 LEU B 118 LEU~? 26.00 CL CL B 226 A 133 GLU B 198 GLU~? 30.19 CL CL B 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 51.28 -5.62 54.09 50.79 -5.21 56.11 coo 38.58 45.09 70.44 38.28 45.21 72.59 51.19 -7.22 48.32 51.33 -7.18 46.14 coo 44.05 36.87 70.65 43.15 38.64 69.97 55.63 -0.33 50.97 54.03 -0.19 52.37 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN B 161 GLN~? 19.12 CL CL B 226 A 91 LEU B 70 LEU^? 16.29 CL CL B 226 A 133 GLU B 77 GLU~? 22.22 CL CL A 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 44.60 -13.30 29.51 46.14 -11.79 29.37 coo 44.05 36.87 70.65 43.15 38.64 69.97 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN B 161 GLN~? 19.12 CL CL B 226 A 91 LEU B 79 LEU~? 16.21 CL CL B 226 A 133 GLU B 69 GLU^? 24.72 CL CL B 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 40.62 -9.96 25.88 42.50 -11.06 26.10 coo 44.05 36.87 70.65 43.15 38.64 69.97 42.13 -16.51 33.43 40.68 -17.83 34.16 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 12 3 # 12 A 50 GLN B 161 GLN~? 19.12 CL CL B 226 A 91 LEU B 79 LEU~? 16.21 CL CL B 226 A 133 GLU B 77 GLU~? 22.22 CL CL A 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 40.62 -9.96 25.88 42.50 -11.06 26.10 coo 44.05 36.87 70.65 43.15 38.64 69.97 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 13 3 # 13 A 50 GLN B 161 GLN~? 19.12 CL CL B 226 A 91 LEU B 159 LEU~? 17.08 CL CL B 226 A 133 GLU B 157 GLU~? 23.31 CL CL B 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 47.78 -5.57 36.87 48.07 -4.09 38.43 coo 44.05 36.87 70.65 43.15 38.64 69.97 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 14 3 # 14 A 50 GLN B 161 GLN~? 19.12 CL CL B 226 A 91 LEU B 162 LEU~? 14.72 CL CL B 226 A 133 GLU B 157 GLU~? 23.31 CL CL B 226 coo 43.58 43.67 66.73 42.32 42.78 68.15 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 45.01 -2.77 32.57 43.27 -2.01 33.59 coo 44.05 36.87 70.65 43.15 38.64 69.97 44.83 -13.19 37.20 43.40 -14.70 37.59 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 14 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 97 GLN^? 17.74 CL CL B 226 B 591 LEU A 98 LEU^? 20.23 CL CL A 226 B 633 GLU A 91 GLU^? 16.38 CL CL B 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 41.33 7.73 10.04 42.82 6.16 10.16 coo 86.70 48.66 52.61 87.15 48.69 50.51 37.33 6.14 5.59 35.88 6.41 3.98 coo 95.42 44.52 54.43 93.46 45.31 54.70 45.65 4.89 7.15 47.54 4.63 8.07 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 107 GLN~? 21.40 CL CL A 226 B 591 LEU A 108 LEU~? 17.59 CL CL A 226 B 633 GLU A 110 GLU~? 23.70 CL CL A 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 32.31 -1.54 2.10 33.98 -2.53 1.23 coo 86.70 48.66 52.61 87.15 48.69 50.51 26.05 -0.19 1.12 24.01 -0.94 1.58 coo 95.42 44.52 54.43 93.46 45.31 54.70 30.58 5.52 -3.71 32.09 6.67 -2.64 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 119 GLN~? 33.63 CL CL A 226 B 591 LEU A 118 LEU~? 25.85 CL CL A 226 B 633 GLU A 198 GLU~? 30.13 CL CL A 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 22.19 -6.11 -12.40 21.08 -5.58 -14.19 coo 86.70 48.66 52.61 87.15 48.69 50.51 22.61 -7.03 -6.79 22.70 -6.57 -4.65 coo 95.42 44.52 54.43 93.46 45.31 54.70 19.84 0.58 -9.50 20.29 0.30 -11.52 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN A 161 GLN~? 19.20 CL CL A 226 B 591 LEU A 70 LEU^? 16.48 CL CL A 226 B 633 GLU A 77 GLU~? 21.84 CL CL B 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 86.70 48.66 52.61 87.15 48.69 50.51 29.18 -12.31 12.09 27.61 -10.79 11.87 coo 95.42 44.52 54.43 93.46 45.31 54.70 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN A 161 GLN~? 19.20 CL CL A 226 B 591 LEU A 79 LEU~? 16.20 CL CL A 226 B 633 GLU A 69 GLU^? 25.00 CL CL A 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 86.70 48.66 52.61 87.15 48.69 50.51 33.80 -9.42 15.25 31.63 -9.90 15.24 coo 95.42 44.52 54.43 93.46 45.31 54.70 30.56 -16.89 8.89 31.90 -18.26 8.02 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN A 161 GLN~? 19.20 CL CL A 226 B 591 LEU A 79 LEU~? 16.20 CL CL A 226 B 633 GLU A 77 GLU~? 21.84 CL CL B 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 86.70 48.66 52.61 87.15 48.69 50.51 33.80 -9.42 15.25 31.63 -9.90 15.24 coo 95.42 44.52 54.43 93.46 45.31 54.70 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN A 161 GLN~? 19.20 CL CL A 226 B 591 LEU A 162 LEU~? 15.19 CL CL A 226 B 633 GLU A 157 GLU~? 23.07 CL CL A 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 86.70 48.66 52.61 87.15 48.69 50.51 30.92 -2.48 8.24 32.78 -2.17 7.05 coo 95.42 44.52 54.43 93.46 45.31 54.70 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 8 3 # 8 B 550 GLN B 107 GLN~? 21.73 CL CL B 226 B 591 LEU B 108 LEU~? 17.52 CL CL B 226 B 633 GLU B 110 GLU~? 23.32 CL CL B 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 43.35 -1.25 38.76 41.89 -1.28 40.29 coo 86.70 48.66 52.61 87.15 48.69 50.51 49.83 -0.66 39.63 51.53 -1.90 39.16 coo 95.42 44.52 54.43 93.46 45.31 54.70 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 9 3 # 9 B 550 GLN B 119 GLN~? 34.36 CL CL B 226 B 591 LEU B 118 LEU~? 26.00 CL CL B 226 B 633 GLU B 198 GLU~? 30.19 CL CL B 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 51.28 -5.62 54.09 50.79 -5.21 56.11 coo 86.70 48.66 52.61 87.15 48.69 50.51 51.19 -7.22 48.32 51.33 -7.18 46.14 coo 95.42 44.52 54.43 93.46 45.31 54.70 55.63 -0.33 50.97 54.03 -0.19 52.37 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 10 3 # 10 B 550 GLN B 161 GLN~? 19.12 CL CL B 226 B 591 LEU B 70 LEU^? 16.29 CL CL B 226 B 633 GLU B 77 GLU~? 22.22 CL CL A 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 44.60 -13.30 29.51 46.14 -11.79 29.37 coo 95.42 44.52 54.43 93.46 45.31 54.70 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 11 3 # 11 B 550 GLN B 161 GLN~? 19.12 CL CL B 226 B 591 LEU B 79 LEU~? 16.21 CL CL B 226 B 633 GLU B 69 GLU^? 24.72 CL CL B 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 40.62 -9.96 25.88 42.50 -11.06 26.10 coo 95.42 44.52 54.43 93.46 45.31 54.70 42.13 -16.51 33.43 40.68 -17.83 34.16 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 12 3 # 12 B 550 GLN B 161 GLN~? 19.12 CL CL B 226 B 591 LEU B 79 LEU~? 16.21 CL CL B 226 B 633 GLU B 77 GLU~? 22.22 CL CL A 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 40.62 -9.96 25.88 42.50 -11.06 26.10 coo 95.42 44.52 54.43 93.46 45.31 54.70 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 13 3 # 13 B 550 GLN B 161 GLN~? 19.12 CL CL B 226 B 591 LEU B 159 LEU~? 17.08 CL CL B 226 B 633 GLU B 157 GLU~? 23.31 CL CL B 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 47.78 -5.57 36.87 48.07 -4.09 38.43 coo 95.42 44.52 54.43 93.46 45.31 54.70 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 14 3 # 14 B 550 GLN B 161 GLN~? 19.12 CL CL B 226 B 591 LEU B 162 LEU~? 14.72 CL CL B 226 B 633 GLU B 157 GLU~? 23.31 CL CL B 226 coo 88.06 44.34 57.19 89.06 45.53 55.74 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 45.01 -2.77 32.57 43.27 -2.01 33.59 coo 95.42 44.52 54.43 93.46 45.31 54.70 44.83 -13.19 37.20 43.40 -14.70 37.59 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 14 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 97 GLN^? 17.74 CL CL B 226 C1091 LEU A 98 LEU^? 20.23 CL CL A 226 C1133 GLU A 91 GLU^? 16.38 CL CL B 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 41.33 7.73 10.04 42.82 6.16 10.16 coo 65.83 38.95 47.05 65.46 38.90 49.20 37.33 6.14 5.59 35.88 6.41 3.98 coo 63.14 29.39 46.25 63.84 31.31 45.74 45.65 4.89 7.15 47.54 4.63 8.07 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 107 GLN~? 21.40 CL CL A 226 C1091 LEU A 108 LEU~? 17.59 CL CL A 226 C1133 GLU A 110 GLU~? 23.70 CL CL A 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 32.31 -1.54 2.10 33.98 -2.53 1.23 coo 65.83 38.95 47.05 65.46 38.90 49.20 26.05 -0.19 1.12 24.01 -0.94 1.58 coo 63.14 29.39 46.25 63.84 31.31 45.74 30.58 5.52 -3.71 32.09 6.67 -2.64 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 119 GLN~? 33.63 CL CL A 226 C1091 LEU A 118 LEU~? 25.85 CL CL A 226 C1133 GLU A 198 GLU~? 30.13 CL CL A 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 22.19 -6.11 -12.40 21.08 -5.58 -14.19 coo 65.83 38.95 47.05 65.46 38.90 49.20 22.61 -7.03 -6.79 22.70 -6.57 -4.65 coo 63.14 29.39 46.25 63.84 31.31 45.74 19.84 0.58 -9.50 20.29 0.30 -11.52 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN A 161 GLN~? 19.20 CL CL A 226 C1091 LEU A 70 LEU^? 16.48 CL CL A 226 C1133 GLU A 77 GLU~? 21.84 CL CL B 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 65.83 38.95 47.05 65.46 38.90 49.20 29.18 -12.31 12.09 27.61 -10.79 11.87 coo 63.14 29.39 46.25 63.84 31.31 45.74 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN A 161 GLN~? 19.20 CL CL A 226 C1091 LEU A 79 LEU~? 16.20 CL CL A 226 C1133 GLU A 69 GLU^? 25.00 CL CL A 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 65.83 38.95 47.05 65.46 38.90 49.20 33.80 -9.42 15.25 31.63 -9.90 15.24 coo 63.14 29.39 46.25 63.84 31.31 45.74 30.56 -16.89 8.89 31.90 -18.26 8.02 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN A 161 GLN~? 19.20 CL CL A 226 C1091 LEU A 162 LEU~? 15.19 CL CL A 226 C1133 GLU A 157 GLU~? 23.07 CL CL A 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 65.83 38.95 47.05 65.46 38.90 49.20 30.92 -2.48 8.24 32.78 -2.17 7.05 coo 63.14 29.39 46.25 63.84 31.31 45.74 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN B 107 GLN~? 21.73 CL CL B 226 C1091 LEU B 108 LEU~? 17.52 CL CL B 226 C1133 GLU B 110 GLU~? 23.32 CL CL B 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 43.35 -1.25 38.76 41.89 -1.28 40.29 coo 65.83 38.95 47.05 65.46 38.90 49.20 49.83 -0.66 39.63 51.53 -1.90 39.16 coo 63.14 29.39 46.25 63.84 31.31 45.74 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 8 3 # 8 C1050 GLN B 119 GLN~? 34.36 CL CL B 226 C1091 LEU B 118 LEU~? 26.00 CL CL B 226 C1133 GLU B 198 GLU~? 30.19 CL CL B 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 51.28 -5.62 54.09 50.79 -5.21 56.11 coo 65.83 38.95 47.05 65.46 38.90 49.20 51.19 -7.22 48.32 51.33 -7.18 46.14 coo 63.14 29.39 46.25 63.84 31.31 45.74 55.63 -0.33 50.97 54.03 -0.19 52.37 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 9 3 # 9 C1050 GLN B 161 GLN~? 19.12 CL CL B 226 C1091 LEU B 70 LEU^? 16.29 CL CL B 226 C1133 GLU B 77 GLU~? 22.22 CL CL A 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 44.60 -13.30 29.51 46.14 -11.79 29.37 coo 63.14 29.39 46.25 63.84 31.31 45.74 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 10 3 # 10 C1050 GLN B 161 GLN~? 19.12 CL CL B 226 C1091 LEU B 79 LEU~? 16.21 CL CL B 226 C1133 GLU B 69 GLU^? 24.72 CL CL B 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 40.62 -9.96 25.88 42.50 -11.06 26.10 coo 63.14 29.39 46.25 63.84 31.31 45.74 42.13 -16.51 33.43 40.68 -17.83 34.16 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 11 3 # 11 C1050 GLN B 161 GLN~? 19.12 CL CL B 226 C1091 LEU B 79 LEU~? 16.21 CL CL B 226 C1133 GLU B 77 GLU~? 22.22 CL CL A 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 40.62 -9.96 25.88 42.50 -11.06 26.10 coo 63.14 29.39 46.25 63.84 31.31 45.74 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 12 3 # 12 C1050 GLN B 161 GLN~? 19.12 CL CL B 226 C1091 LEU B 159 LEU~? 17.08 CL CL B 226 C1133 GLU B 157 GLU~? 23.31 CL CL B 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 47.78 -5.57 36.87 48.07 -4.09 38.43 coo 63.14 29.39 46.25 63.84 31.31 45.74 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 13 3 # 13 C1050 GLN B 161 GLN~? 19.12 CL CL B 226 C1091 LEU B 162 LEU~? 14.72 CL CL B 226 C1133 GLU B 157 GLU~? 23.31 CL CL B 226 coo 68.29 34.44 43.03 66.67 34.74 44.37 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 45.01 -2.77 32.57 43.27 -2.01 33.59 coo 63.14 29.39 46.25 63.84 31.31 45.74 44.83 -13.19 37.20 43.40 -14.70 37.59 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 13 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 107 GLN~? 21.40 CL CL A 226 A 91 LEU A 108 LEU~? 17.59 CL CL A 226 A 133 GLU A 110 GLU~? 23.70 CL CL A 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 32.31 -1.54 2.10 33.98 -2.53 1.23 coo 35.40 53.22 73.30 35.37 54.87 74.74 26.05 -0.19 1.12 24.01 -0.94 1.58 coo 45.08 56.04 70.60 43.15 55.19 70.77 30.58 5.52 -3.71 32.09 6.67 -2.64 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 119 GLN~? 33.63 CL CL A 226 A 91 LEU A 118 LEU~? 25.85 CL CL A 226 A 133 GLU A 198 GLU~? 30.13 CL CL A 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 22.19 -6.11 -12.40 21.08 -5.58 -14.19 coo 35.40 53.22 73.30 35.37 54.87 74.74 22.61 -7.03 -6.79 22.70 -6.57 -4.65 coo 45.08 56.04 70.60 43.15 55.19 70.77 19.84 0.58 -9.50 20.29 0.30 -11.52 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 161 GLN~? 19.20 CL CL A 226 A 91 LEU A 70 LEU^? 16.48 CL CL A 226 A 133 GLU A 77 GLU~? 21.84 CL CL B 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 35.40 53.22 73.30 35.37 54.87 74.74 29.18 -12.31 12.09 27.61 -10.79 11.87 coo 45.08 56.04 70.60 43.15 55.19 70.77 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN A 161 GLN~? 19.20 CL CL A 226 A 91 LEU A 79 LEU~? 16.20 CL CL A 226 A 133 GLU A 69 GLU^? 25.00 CL CL A 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 35.40 53.22 73.30 35.37 54.87 74.74 33.80 -9.42 15.25 31.63 -9.90 15.24 coo 45.08 56.04 70.60 43.15 55.19 70.77 30.56 -16.89 8.89 31.90 -18.26 8.02 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN A 161 GLN~? 19.20 CL CL A 226 A 91 LEU A 79 LEU~? 16.20 CL CL A 226 A 133 GLU A 157 GLU~? 23.07 CL CL A 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 35.40 53.22 73.30 35.37 54.87 74.74 33.80 -9.42 15.25 31.63 -9.90 15.24 coo 45.08 56.04 70.60 43.15 55.19 70.77 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN A 161 GLN~? 19.20 CL CL A 226 A 91 LEU A 162 LEU~? 15.19 CL CL A 226 A 133 GLU A 157 GLU~? 23.07 CL CL A 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 35.40 53.22 73.30 35.37 54.87 74.74 30.92 -2.48 8.24 32.78 -2.17 7.05 coo 45.08 56.04 70.60 43.15 55.19 70.77 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 119 GLN~? 34.36 CL CL B 226 A 91 LEU B 118 LEU~? 26.00 CL CL B 226 A 133 GLU B 198 GLU~? 30.19 CL CL B 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 51.28 -5.62 54.09 50.79 -5.21 56.11 coo 35.40 53.22 73.30 35.37 54.87 74.74 51.19 -7.22 48.32 51.33 -7.18 46.14 coo 45.08 56.04 70.60 43.15 55.19 70.77 55.63 -0.33 50.97 54.03 -0.19 52.37 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN B 161 GLN~? 19.12 CL CL B 226 A 91 LEU B 70 LEU^? 16.29 CL CL B 226 A 133 GLU B 77 GLU~? 22.22 CL CL A 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 35.40 53.22 73.30 35.37 54.87 74.74 44.60 -13.30 29.51 46.14 -11.79 29.37 coo 45.08 56.04 70.60 43.15 55.19 70.77 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN B 161 GLN~? 19.12 CL CL B 226 A 91 LEU B 79 LEU~? 16.21 CL CL B 226 A 133 GLU B 69 GLU^? 24.72 CL CL B 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 35.40 53.22 73.30 35.37 54.87 74.74 40.62 -9.96 25.88 42.50 -11.06 26.10 coo 45.08 56.04 70.60 43.15 55.19 70.77 42.13 -16.51 33.43 40.68 -17.83 34.16 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN B 161 GLN~? 19.12 CL CL B 226 A 91 LEU B 162 LEU~? 14.72 CL CL B 226 A 133 GLU B 157 GLU~? 23.31 CL CL B 226 coo 38.23 53.34 67.59 38.84 53.87 69.56 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 35.40 53.22 73.30 35.37 54.87 74.74 45.01 -2.77 32.57 43.27 -2.01 33.59 coo 45.08 56.04 70.60 43.15 55.19 70.77 44.83 -13.19 37.20 43.40 -14.70 37.59 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 10 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 111 ASP~? 26.09 CL CL A 226 A 354 GLU A 110 GLU~? 23.70 CL CL A 226 A 421 ASP A 102 ASP~? 17.30 CL CL A 226 coo 31.05 49.37 64.51 31.97 51.11 63.85 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 29.07 50.42 58.36 29.02 52.18 59.49 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 30.82 59.76 58.47 31.12 59.02 60.40 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 61 ASP.? 23.81 CL CL B 226 A 354 GLU B 182 GLU~? 22.76 CL CL B 226 A 421 ASP B 193 ASP~? 31.47 CL CL B 226 coo 31.05 49.37 64.51 31.97 51.11 63.85 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 29.07 50.42 58.36 29.02 52.18 59.49 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 30.82 59.76 58.47 31.12 59.02 60.40 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP B 111 ASP~? 25.68 CL CL B 226 A 354 GLU B 110 GLU~? 23.32 CL CL B 226 A 421 ASP B 102 ASP~? 16.83 CL CL B 226 coo 31.05 49.37 64.51 31.97 51.11 63.85 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 46.60 5.74 43.54 45.54 7.20 42.48 coo 30.82 59.76 58.47 31.12 59.02 60.40 45.25 7.06 34.64 46.46 8.64 34.05 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP B 193 ASP~? 31.47 CL CL B 226 A 354 GLU B 187 GLU.? 29.51 CL CL B 226 A 421 ASP B 61 ASP.? 23.81 CL CL B 226 coo 31.05 49.37 64.51 31.97 51.11 63.85 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 29.07 50.42 58.36 29.02 52.18 59.49 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 30.82 59.76 58.47 31.12 59.02 60.40 66.70 -13.12 38.44 68.10 -11.59 37.89 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 111 ASP~? 26.09 CL CL A 226 B 354 GLU A 110 GLU~? 23.70 CL CL A 226 B 421 ASP A 102 ASP~? 17.30 CL CL A 226 coo 25.90 8.19 53.87 25.36 6.97 52.29 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 27.87 10.66 47.95 27.82 8.60 48.27 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 26.02 1.87 43.38 25.90 1.97 45.49 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP B 61 ASP.? 23.81 CL CL B 226 B 354 GLU B 182 GLU~? 22.76 CL CL B 226 B 421 ASP B 193 ASP~? 31.47 CL CL B 226 coo 25.90 8.19 53.87 25.36 6.97 52.29 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 27.87 10.66 47.95 27.82 8.60 48.27 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 26.02 1.87 43.38 25.90 1.97 45.49 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP B 111 ASP~? 25.68 CL CL B 226 B 354 GLU B 110 GLU~? 23.32 CL CL B 226 B 421 ASP B 102 ASP~? 16.83 CL CL B 226 coo 25.90 8.19 53.87 25.36 6.97 52.29 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 46.60 5.74 43.54 45.54 7.20 42.48 coo 26.02 1.87 43.38 25.90 1.97 45.49 45.25 7.06 34.64 46.46 8.64 34.05 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 193 ASP~? 31.47 CL CL B 226 B 354 GLU B 187 GLU.? 29.51 CL CL B 226 B 421 ASP B 61 ASP.? 23.81 CL CL B 226 coo 25.90 8.19 53.87 25.36 6.97 52.29 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 27.87 10.66 47.95 27.82 8.60 48.27 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 26.02 1.87 43.38 25.90 1.97 45.49 66.70 -13.12 38.44 68.10 -11.59 37.89 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c09 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 9 GLU.? 16.20 CL CL A 226 A 65 ARG B 81 ARG~? 19.82 CL CL A 226 A 85 HIS B 75 HIS.? 25.67 CL CL A 226 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 26.61 -7.39 28.28 26.97 -9.45 28.59 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 35.26 -4.61 30.73 33.33 -6.15 32.58 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 34.50 -15.17 32.63 32.86 -15.45 33.92 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU A 168 GLU.? -6.12 CL CL A 226s A 65 ARG A 13 ARG~? 5.03 CL CL A 226 A 85 HIS A 86 HIS~? 10.02 CL CL A 226 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 22.70 6.74 18.04 23.60 8.22 19.21 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 24.18 -3.56 18.28 25.11 -1.28 16.40 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 32.84 2.26 17.60 31.66 3.53 18.78 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU B 9 GLU.? 16.36 CL CL B 226 A 65 ARG A 81 ARG~? 19.72 CL CL B 226 A 85 HIS A 75 HIS.? 25.41 CL CL B 226 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 47.73 -10.39 12.99 46.70 -12.24 13.09 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 40.18 -5.93 10.28 41.49 -8.31 8.89 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 38.68 -16.70 9.61 40.32 -17.29 8.43 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU B 168 GLU.? -5.97 CL CL B 226s A 65 ARG B 13 ARG~? 5.25 CL CL B 226 A 85 HIS B 86 HIS~? 9.45 CL CL B 226 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 54.77 3.34 22.36 54.93 5.08 21.18 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 51.04 -6.15 23.43 50.81 -3.67 25.23 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 44.03 1.12 22.86 45.41 1.90 21.48 1c54_c00 source 1c54 RIBONUCLEASE SA : 4 hits 1c54_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 86 HIS~? 10.02 CL CL A 226 A 408 TYR A 87 TYR~? 13.92 CL CL A 226 A 480 ARG B 13 ARG~? 5.25 CL CL B 226 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 32.84 2.26 17.60 31.66 3.53 18.78 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 36.79 3.26 19.70 35.19 2.19 21.67 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 51.04 -6.15 23.43 50.81 -3.67 25.23 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 86 HIS~? 9.45 CL CL B 226 A 408 TYR B 87 TYR~? 13.52 CL CL B 226 A 480 ARG A 13 ARG~? 5.03 CL CL A 226 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 44.03 1.12 22.86 45.41 1.90 21.48 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 40.26 2.88 20.56 41.63 1.41 18.60 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 24.18 -3.56 18.28 25.11 -1.28 16.40 1c82_c02 source 1c82 HYALURONATE LYASE : 2 hits 1c82_c02 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP B 111 ASP~? 25.68 CL CL B 226 264 GLU B 69 GLU^? 24.72 CL CL B 226 328 ASP B 151 ASP~? 28.65 CL CL B 226 coo 45.62 80.42 43.69 45.65 82.01 45.07 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 59.69 92.71 39.85 58.53 92.03 41.47 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 45.39 90.72 40.63 45.07 89.14 41.90 41.86 -11.82 45.74 42.46 -13.70 45.02 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 151 ASP~? 28.65 CL CL B 226 264 GLU B 198 GLU~? 30.19 CL CL B 226 328 ASP B 111 ASP~? 25.68 CL CL B 226 coo 45.62 80.42 43.69 45.65 82.01 45.07 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 59.69 92.71 39.85 58.53 92.03 41.47 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 45.39 90.72 40.63 45.07 89.14 41.90 44.68 -0.98 44.91 42.92 -2.08 45.36 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 186 ASP.? 30.73 CL CL B 226 264 GLU B 175 GLU~? 17.14 CL CL B 226 328 ASP B 193 ASP~? 31.47 CL CL B 226 coo 45.62 80.42 43.69 45.65 82.01 45.07 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 45.39 90.72 40.63 45.07 89.14 41.90 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 193 ASP~? 31.47 CL CL B 226 264 GLU B 157 GLU~? 23.31 CL CL B 226 328 ASP B 186 ASP.? 30.73 CL CL B 226 coo 45.62 80.42 43.69 45.65 82.01 45.07 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 59.69 92.71 39.85 58.53 92.03 41.47 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 45.39 90.72 40.63 45.07 89.14 41.90 56.29 -18.50 46.72 54.94 -17.46 47.93 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 4 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP B 186 ASP.? 30.73 CL CL B 226 257 GLU B 187 GLU.? 29.51 CL CL B 226 328 ASP B 193 ASP~? 31.47 CL CL B 226 coo 45.62 80.42 43.69 45.65 82.01 45.07 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 48.97 85.16 40.39 47.18 86.25 40.47 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 45.39 90.72 40.63 45.07 89.14 41.90 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 193 ASP~? 31.47 CL CL B 226 257 GLU B 187 GLU.? 29.51 CL CL B 226 328 ASP B 186 ASP.? 30.73 CL CL B 226 coo 45.62 80.42 43.69 45.65 82.01 45.07 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 48.97 85.16 40.39 47.18 86.25 40.47 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 45.39 90.72 40.63 45.07 89.14 41.90 56.29 -18.50 46.72 54.94 -17.46 47.93 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_c04 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 56 HIS^? 18.87 CL CL A 226 A 262 GLU A 157 GLU~? 23.07 CL CL A 226 A 358 GLU A 69 GLU^? 25.00 CL CL A 226 coo 26.19 60.87 43.98 27.48 59.27 43.30 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 27.13 54.07 50.45 26.96 54.19 48.35 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 27.06 50.43 44.36 27.99 52.27 44.74 30.56 -16.89 8.89 31.90 -18.26 8.02 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS A 75 HIS.? 25.41 CL CL B 226 A 262 GLU A 69 GLU^? 25.00 CL CL A 226 A 358 GLU A 157 GLU~? 23.07 CL CL A 226 coo 26.19 60.87 43.98 27.48 59.27 43.30 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 27.13 54.07 50.45 26.96 54.19 48.35 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 27.06 50.43 44.36 27.99 52.27 44.74 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS A 86 HIS~? 10.02 CL CL A 226 A 262 GLU B 84 GLU~? 12.79 CL CL A 226 A 358 GLU A 84 GLU~? 12.94 CL CL B 226 coo 26.19 60.87 43.98 27.48 59.27 43.30 32.84 2.26 17.60 31.66 3.53 18.78 coo 27.13 54.07 50.45 26.96 54.19 48.35 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 27.06 50.43 44.36 27.99 52.27 44.74 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS B 75 HIS.? 25.67 CL CL A 226 A 262 GLU B 69 GLU^? 24.72 CL CL B 226 A 358 GLU B 157 GLU~? 23.31 CL CL B 226 coo 26.19 60.87 43.98 27.48 59.27 43.30 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 27.13 54.07 50.45 26.96 54.19 48.35 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 27.06 50.43 44.36 27.99 52.27 44.74 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 A 232 HIS B 86 HIS~? 9.45 CL CL B 226 A 262 GLU A 84 GLU~? 12.94 CL CL B 226 A 358 GLU B 84 GLU~? 12.79 CL CL A 226 coo 26.19 60.87 43.98 27.48 59.27 43.30 44.03 1.12 22.86 45.41 1.90 21.48 coo 27.13 54.07 50.45 26.96 54.19 48.35 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 27.06 50.43 44.36 27.99 52.27 44.74 35.35 -1.73 23.75 33.22 -1.55 23.84 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 5 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 56 HIS^? 18.87 CL CL A 226 B 262 GLU A 157 GLU~? 23.07 CL CL A 226 B 358 GLU A 69 GLU^? 25.00 CL CL A 226 coo 44.98 77.01 48.39 44.42 78.67 47.18 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 41.60 83.57 54.16 42.46 83.24 52.25 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 44.05 87.61 48.73 43.15 85.67 48.52 30.56 -16.89 8.89 31.90 -18.26 8.02 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS A 75 HIS.? 25.41 CL CL B 226 B 262 GLU A 69 GLU^? 25.00 CL CL A 226 B 358 GLU A 157 GLU~? 23.07 CL CL A 226 coo 44.98 77.01 48.39 44.42 78.67 47.18 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 41.60 83.57 54.16 42.46 83.24 52.25 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 44.05 87.61 48.73 43.15 85.67 48.52 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS A 86 HIS~? 10.02 CL CL A 226 B 262 GLU B 84 GLU~? 12.79 CL CL A 226 B 358 GLU A 84 GLU~? 12.94 CL CL B 226 coo 44.98 77.01 48.39 44.42 78.67 47.18 32.84 2.26 17.60 31.66 3.53 18.78 coo 41.60 83.57 54.16 42.46 83.24 52.25 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 44.05 87.61 48.73 43.15 85.67 48.52 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS B 75 HIS.? 25.67 CL CL A 226 B 262 GLU B 69 GLU^? 24.72 CL CL B 226 B 358 GLU B 157 GLU~? 23.31 CL CL B 226 coo 44.98 77.01 48.39 44.42 78.67 47.18 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 41.60 83.57 54.16 42.46 83.24 52.25 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 44.05 87.61 48.73 43.15 85.67 48.52 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS B 86 HIS~? 9.45 CL CL B 226 B 262 GLU A 84 GLU~? 12.94 CL CL B 226 B 358 GLU B 84 GLU~? 12.79 CL CL A 226 coo 44.98 77.01 48.39 44.42 78.67 47.18 44.03 1.12 22.86 45.41 1.90 21.48 coo 41.60 83.57 54.16 42.46 83.24 52.25 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 44.05 87.61 48.73 43.15 85.67 48.52 35.35 -1.73 23.75 33.22 -1.55 23.84 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 5 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 85 GLY~? 15.77 CL CL A 226 A 228 SER A 99 SER~? 15.47 CL CL A 226 A 549 ASP A 102 ASP~? 17.30 CL CL A 226 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 37.09 1.03 13.26 36.82 0.94 14.00 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 34.85 6.30 9.42 33.11 7.76 8.92 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 89 GLY~? 17.30 CL CL A 226 A 228 SER A 101 SER~? 10.77 CL CL A 226 A 549 ASP A 102 ASP~? 17.30 CL CL A 226 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 37.90 4.36 11.39 38.58 4.02 11.72 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 29.86 4.55 8.50 28.44 5.46 10.26 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 85 GLY~? 15.33 CL CL B 226 A 228 SER B 99 SER~? 14.59 CL CL B 226 A 549 ASP B 102 ASP~? 16.83 CL CL B 226 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 39.45 1.04 27.01 39.73 0.94 26.23 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 42.80 6.49 30.34 45.08 7.21 30.70 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 45.25 7.06 34.64 46.46 8.64 34.05 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 89 GLY~? 16.64 CL CL B 226 A 228 SER B 101 SER~? 10.37 CL CL B 226 A 549 ASP B 102 ASP~? 16.83 CL CL B 226 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 39.61 4.74 28.75 38.89 4.60 28.39 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 47.36 3.83 31.66 48.67 4.20 29.68 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 45.25 7.06 34.64 46.46 8.64 34.05 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 4 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 85 GLY~? 15.77 CL CL A 226 B1228 SER A 99 SER~? 15.47 CL CL A 226 B1549 ASP A 102 ASP~? 17.30 CL CL A 226 coo 126.34 72.75 125.66 125.95 73.27 126.11 37.09 1.03 13.26 36.82 0.94 14.00 coo 131.65 74.68 129.41 130.31 72.73 128.82 34.85 6.30 9.42 33.11 7.76 8.92 coo 134.72 69.43 130.42 133.03 70.65 130.08 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 89 GLY~? 17.30 CL CL A 226 B1228 SER A 101 SER~? 10.77 CL CL A 226 B1549 ASP A 102 ASP~? 17.30 CL CL A 226 coo 126.34 72.75 125.66 125.95 73.27 126.11 37.90 4.36 11.39 38.58 4.02 11.72 coo 131.65 74.68 129.41 130.31 72.73 128.82 29.86 4.55 8.50 28.44 5.46 10.26 coo 134.72 69.43 130.42 133.03 70.65 130.08 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 85 GLY~? 15.33 CL CL B 226 B1228 SER B 99 SER~? 14.59 CL CL B 226 B1549 ASP B 102 ASP~? 16.83 CL CL B 226 coo 126.34 72.75 125.66 125.95 73.27 126.11 39.45 1.04 27.01 39.73 0.94 26.23 coo 131.65 74.68 129.41 130.31 72.73 128.82 42.80 6.49 30.34 45.08 7.21 30.70 coo 134.72 69.43 130.42 133.03 70.65 130.08 45.25 7.06 34.64 46.46 8.64 34.05 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 89 GLY~? 16.64 CL CL B 226 B1228 SER B 101 SER~? 10.37 CL CL B 226 B1549 ASP B 102 ASP~? 16.83 CL CL B 226 coo 126.34 72.75 125.66 125.95 73.27 126.11 39.61 4.74 28.75 38.89 4.60 28.39 coo 131.65 74.68 129.41 130.31 72.73 128.82 47.36 3.83 31.66 48.67 4.20 29.68 coo 134.72 69.43 130.42 133.03 70.65 130.08 45.25 7.06 34.64 46.46 8.64 34.05 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 4 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 11 GLU.? 11.48 CL CL A 226 A 89 GLU A 84 GLU~? 12.94 CL CL B 226 A 120 SER A 82 SER~? 14.07 CL CL A 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 31.29 2.41 22.91 32.62 4.08 23.08 coo -31.18 6.91 75.60 -32.39 8.51 74.91 40.51 -2.33 16.64 42.51 -2.90 16.44 coo -34.73 8.57 68.21 -33.63 9.08 70.28 34.77 -3.21 13.72 33.13 -4.11 12.24 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 26 GLU~? 31.19 CL CL A 226 A 89 GLU B 26 GLU~? 28.82 CL CL B 226 A 120 SER A 51 SER.? 28.65 CL CL A 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 31.04 -26.45 25.52 31.42 -26.09 27.62 coo -31.18 6.91 75.60 -32.39 8.51 74.91 37.69 -26.04 19.16 37.25 -23.97 18.66 coo -34.73 8.57 68.21 -33.63 9.08 70.28 30.97 -23.17 15.96 32.59 -24.12 14.38 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 26 GLU~? 31.19 CL CL A 226 A 89 GLU B 26 GLU~? 28.82 CL CL B 226 A 120 SER B 51 SER.? 28.60 CL CL B 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 31.04 -26.45 25.52 31.42 -26.09 27.62 coo -31.18 6.91 75.60 -32.39 8.51 74.91 37.69 -26.04 19.16 37.25 -23.97 18.66 coo -34.73 8.57 68.21 -33.63 9.08 70.28 40.78 -23.49 26.77 38.99 -24.36 28.19 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 77 GLU~? 21.84 CL CL B 226 A 89 GLU A 84 GLU~? 12.94 CL CL B 226 A 120 SER A 82 SER~? 14.07 CL CL A 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 40.16 -11.08 10.76 40.31 -13.18 10.50 coo -31.18 6.91 75.60 -32.39 8.51 74.91 40.51 -2.33 16.64 42.51 -2.90 16.44 coo -34.73 8.57 68.21 -33.63 9.08 70.28 34.77 -3.21 13.72 33.13 -4.11 12.24 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU A 84 GLU~? 12.94 CL CL B 226 A 89 GLU B 84 GLU~? 12.79 CL CL A 226 A 120 SER B 82 SER~? 13.78 CL CL B 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 40.51 -2.33 16.64 42.51 -2.90 16.44 coo -31.18 6.91 75.60 -32.39 8.51 74.91 35.35 -1.73 23.75 33.22 -1.55 23.84 coo -34.73 8.57 68.21 -33.63 9.08 70.28 41.03 -3.36 27.11 42.38 -4.54 28.72 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU A 110 GLU~? 23.70 CL CL A 226 A 89 GLU A 172 GLU~? 15.14 CL CL A 226 A 120 SER A 210 SER~? 21.09 CL CL A 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 30.58 5.52 -3.71 32.09 6.67 -2.64 coo -31.18 6.91 75.60 -32.39 8.51 74.91 20.31 7.29 3.53 20.42 8.84 4.96 coo -34.73 8.57 68.21 -33.63 9.08 70.28 24.15 14.96 0.00 24.37 15.67 2.31 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 11 GLU.? 11.19 CL CL B 226 A 89 GLU B 84 GLU~? 12.79 CL CL A 226 A 120 SER A 82 SER~? 14.07 CL CL A 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 45.62 0.60 17.46 44.46 2.32 17.00 coo -31.18 6.91 75.60 -32.39 8.51 74.91 35.35 -1.73 23.75 33.22 -1.55 23.84 coo -34.73 8.57 68.21 -33.63 9.08 70.28 34.77 -3.21 13.72 33.13 -4.11 12.24 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU B 11 GLU.? 11.19 CL CL B 226 A 89 GLU B 84 GLU~? 12.79 CL CL A 226 A 120 SER B 82 SER~? 13.78 CL CL B 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 45.62 0.60 17.46 44.46 2.32 17.00 coo -31.18 6.91 75.60 -32.39 8.51 74.91 35.35 -1.73 23.75 33.22 -1.55 23.84 coo -34.73 8.57 68.21 -33.63 9.08 70.28 41.03 -3.36 27.11 42.38 -4.54 28.72 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU B 26 GLU~? 28.82 CL CL B 226 A 89 GLU A 26 GLU~? 31.19 CL CL A 226 A 120 SER A 28 SER~? 26.52 CL CL A 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 37.69 -26.04 19.16 37.25 -23.97 18.66 coo -31.18 6.91 75.60 -32.39 8.51 74.91 31.04 -26.45 25.52 31.42 -26.09 27.62 coo -34.73 8.57 68.21 -33.63 9.08 70.28 26.40 -24.33 19.56 28.45 -23.49 18.56 ULMN 3 1cns_c00 CHITINASE user 10 3 # 10 A 67 GLU B 26 GLU~? 28.82 CL CL B 226 A 89 GLU A 26 GLU~? 31.19 CL CL A 226 A 120 SER B 51 SER.? 28.60 CL CL B 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 37.69 -26.04 19.16 37.25 -23.97 18.66 coo -31.18 6.91 75.60 -32.39 8.51 74.91 31.04 -26.45 25.52 31.42 -26.09 27.62 coo -34.73 8.57 68.21 -33.63 9.08 70.28 40.78 -23.49 26.77 38.99 -24.36 28.19 ULMN 3 1cns_c00 CHITINASE user 11 3 # 11 A 67 GLU B 77 GLU~? 22.22 CL CL A 226 A 89 GLU B 84 GLU~? 12.79 CL CL A 226 A 120 SER B 82 SER~? 13.78 CL CL B 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 34.33 -9.48 30.93 34.02 -11.53 31.29 coo -31.18 6.91 75.60 -32.39 8.51 74.91 35.35 -1.73 23.75 33.22 -1.55 23.84 coo -34.73 8.57 68.21 -33.63 9.08 70.28 41.03 -3.36 27.11 42.38 -4.54 28.72 ULMN 3 1cns_c00 CHITINASE user 12 3 # 12 A 67 GLU B 84 GLU~? 12.79 CL CL A 226 A 89 GLU A 84 GLU~? 12.94 CL CL B 226 A 120 SER A 82 SER~? 14.07 CL CL A 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 35.35 -1.73 23.75 33.22 -1.55 23.84 coo -31.18 6.91 75.60 -32.39 8.51 74.91 40.51 -2.33 16.64 42.51 -2.90 16.44 coo -34.73 8.57 68.21 -33.63 9.08 70.28 34.77 -3.21 13.72 33.13 -4.11 12.24 ULMN 3 1cns_c00 CHITINASE user 13 3 # 13 A 67 GLU B 157 GLU~? 23.31 CL CL B 226 A 89 GLU B 77 GLU~? 22.22 CL CL A 226 A 120 SER B 72 SER.? 25.86 CL CL B 226 coo -24.35 9.53 67.64 -25.07 11.29 68.60 44.83 -13.19 37.20 43.40 -14.70 37.59 coo -31.18 6.91 75.60 -32.39 8.51 74.91 34.33 -9.48 30.93 34.02 -11.53 31.29 coo -34.73 8.57 68.21 -33.63 9.08 70.28 38.31 -18.13 29.75 37.15 -17.87 31.87 1cns_c00 source 1cns CHITINASE : 13 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 11 GLU.? 11.48 CL CL A 226 B 89 GLU A 84 GLU~? 12.94 CL CL B 226 B 120 SER B 82 SER~? 13.78 CL CL B 226 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 31.29 2.41 22.91 32.62 4.08 23.08 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 41.03 -3.36 27.11 42.38 -4.54 28.72 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 110 GLU~? 23.70 CL CL A 226 B 89 GLU A 172 GLU~? 15.14 CL CL A 226 B 120 SER A 210 SER~? 21.09 CL CL A 226 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 20.31 7.29 3.53 20.42 8.84 4.96 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 24.15 14.96 0.00 24.37 15.67 2.31 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 157 GLU~? 23.07 CL CL A 226 B 89 GLU A 77 GLU~? 21.84 CL CL B 226 B 120 SER A 72 SER.? 25.76 CL CL A 226 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 34.13 -18.66 12.80 35.17 -18.58 10.66 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 11 GLU.? 11.19 CL CL B 226 B 89 GLU B 84 GLU~? 12.79 CL CL A 226 B 120 SER A 82 SER~? 14.07 CL CL A 226 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 45.62 0.60 17.46 44.46 2.32 17.00 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 34.77 -3.21 13.72 33.13 -4.11 12.24 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 157 GLU~? 23.31 CL CL B 226 B 89 GLU B 77 GLU~? 22.22 CL CL A 226 B 120 SER B 72 SER.? 25.86 CL CL B 226 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 38.31 -18.13 29.75 37.15 -17.87 31.87 1cns_c01 source 1cns CHITINASE : 5 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 90 TYR^? 17.82 CL CL A 226 A 173 ASP A 102 ASP~? 17.30 CL CL A 226 C 48 ARG A 81 ARG~? 19.72 CL CL B 226 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 38.12 1.32 8.30 36.38 -0.30 9.74 coo 24.35 4.55 25.11 25.94 3.23 25.53 32.53 7.12 5.29 31.66 9.04 5.62 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 40.18 -5.93 10.28 41.49 -8.31 8.89 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c00 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 111 ASP~? 26.09 CL CL A 226 315 GLU A 110 GLU~? 23.70 CL CL A 226 390 TYR A 208 TYR~? 15.64 CL CL A 226 coo 32.46 99.13 19.34 30.94 100.38 20.07 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 32.04 94.22 18.23 30.57 94.75 16.88 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 21.10 94.74 18.36 23.09 96.71 18.59 25.22 8.01 3.41 27.20 7.60 5.36 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP B 186 ASP.? 30.73 CL CL B 226 315 GLU B 187 GLU.? 29.51 CL CL B 226 390 TYR B 194 TYR~? 30.06 CL CL B 226 coo 32.46 99.13 19.34 30.94 100.38 20.07 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 32.04 94.22 18.23 30.57 94.75 16.88 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 21.10 94.74 18.36 23.09 96.71 18.59 55.14 -6.59 51.91 53.44 -4.41 51.82 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 2 hits 1ctn_c00 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 46 TYR^? 12.99 CL CL A 226 A 243 ASP A 102 ASP~? 17.30 CL CL A 226 A 272 LYS A 205 LYS~? 25.48 CL CL A 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 32.53 7.12 5.29 31.66 9.04 5.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 46 TYR^? 12.99 CL CL A 226 A 243 ASP A 111 ASP~? 26.09 CL CL A 226 A 272 LYS A 205 LYS~? 25.48 CL CL A 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 14.13 45.79 13.40 14.25 49.41 18.30 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 116 TYR~? 32.73 CL CL A 226 A 243 ASP A 102 ASP~? 17.30 CL CL A 226 A 272 LYS A 96 LYS.? 26.69 CL CL B 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 27.90 -5.01 -12.58 28.96 -2.59 -13.59 coo 16.93 55.67 9.65 17.16 54.23 11.19 32.53 7.12 5.29 31.66 9.04 5.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 121 TYR.? 28.41 CL CL A 226 A 243 ASP A 203 ASP~? 25.03 CL CL A 226 A 272 LYS A 213 LYS.? 30.41 CL CL A 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 16.93 55.67 9.65 17.16 54.23 11.19 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 14.13 45.79 13.40 14.25 49.41 18.30 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR A 160 TYR~? 15.52 CL CL A 226 A 243 ASP A 203 ASP~? 25.03 CL CL A 226 A 272 LYS A 213 LYS.? 30.41 CL CL A 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 16.93 55.67 9.65 17.16 54.23 11.19 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 14.13 45.79 13.40 14.25 49.41 18.30 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 46 TYR^? 12.90 CL CL B 226 A 243 ASP B 102 ASP~? 16.83 CL CL B 226 A 272 LYS B 205 LYS~? 25.67 CL CL B 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.25 7.06 34.64 46.46 8.64 34.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 46 TYR^? 12.90 CL CL B 226 A 243 ASP B 111 ASP~? 25.68 CL CL B 226 A 272 LYS B 205 LYS~? 25.67 CL CL B 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 16.93 55.67 9.65 17.16 54.23 11.19 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 14.13 45.79 13.40 14.25 49.41 18.30 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 87 TYR~? 13.52 CL CL B 226 A 243 ASP A 40 ASP.? 7.65 CL CL A 226 A 272 LYS A 178 LYS~? 16.45 CL CL A 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 40.26 2.88 20.56 41.63 1.41 18.60 coo 16.93 55.67 9.65 17.16 54.23 11.19 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 14.13 45.79 13.40 14.25 49.41 18.30 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR B 87 TYR~? 13.52 CL CL B 226 A 243 ASP B 43 ASP.? 11.93 CL CL B 226 A 272 LYS B 178 LYS~? 16.76 CL CL B 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 40.26 2.88 20.56 41.63 1.41 18.60 coo 16.93 55.67 9.65 17.16 54.23 11.19 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 14.13 45.79 13.40 14.25 49.41 18.30 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR B 116 TYR~? 34.40 CL CL B 226 A 243 ASP B 102 ASP~? 16.83 CL CL B 226 A 272 LYS B 96 LYS^? 24.51 CL CL B 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 45.41 -5.95 53.84 44.74 -7.73 55.90 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.25 7.06 34.64 46.46 8.64 34.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 35.42 10.33 36.63 41.15 11.45 39.22 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR B 116 TYR~? 34.40 CL CL B 226 A 243 ASP B 102 ASP~? 16.83 CL CL B 226 A 272 LYS B 213 LYS~? 22.42 CL CL B 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 45.41 -5.95 53.84 44.74 -7.73 55.90 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.25 7.06 34.64 46.46 8.64 34.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR B 194 TYR~? 30.06 CL CL B 226 A 243 ASP B 102 ASP~? 16.83 CL CL B 226 A 272 LYS B 213 LYS~? 22.42 CL CL B 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.25 7.06 34.64 46.46 8.64 34.05 coo 14.13 45.79 13.40 14.25 49.41 18.30 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR B 209 TYR~? 20.47 CL CL B 226 A 243 ASP B 43 ASP.? 11.93 CL CL B 226 A 272 LYS B 60 LYS.? 20.89 CL CL B 226 coo 2.03 68.31 21.46 0.66 68.36 23.90 50.38 9.38 40.26 48.54 7.35 39.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 14.13 45.79 13.40 14.25 49.41 18.30 65.19 -13.54 33.83 65.46 -10.39 36.65 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 13 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 52 LYS^? 28.69 CL CL A 226 A 177 GLU B 26 GLU~? 28.82 CL CL B 226 A 201 LEU A 25 LEU~? 26.14 CL CL A 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 32.61 -21.79 21.05 33.45 -21.15 19.19 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 200 LYS~? 23.56 CL CL A 226 A 177 GLU A 182 GLU~? 21.95 CL CL A 226 A 201 LEU A 179 LEU~? 19.42 CL CL A 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 16.99 -2.58 0.59 15.58 -0.93 0.30 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 205 LYS~? 25.48 CL CL A 226 A 177 GLU A 175 GLU~? 15.88 CL CL A 226 A 201 LEU A 204 LEU~? 18.22 CL CL A 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 15.56 2.16 3.91 14.40 0.59 4.79 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 19.57 4.89 0.19 17.89 4.07 1.29 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS A 205 LYS~? 25.48 CL CL A 226 A 177 GLU A 198 GLU~? 30.13 CL CL A 226 A 201 LEU A 201 LEU~? 21.75 CL CL A 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 19.84 0.58 -9.50 20.29 0.30 -11.52 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 20.53 0.98 -3.69 20.87 -0.82 -2.52 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS B 52 LYS^? 28.59 CL CL B 226 A 177 GLU B 26 GLU~? 28.82 CL CL B 226 A 201 LEU B 25 LEU~? 26.04 CL CL B 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 39.38 -21.98 21.83 38.35 -21.94 23.71 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS B 52 LYS^? 28.59 CL CL B 226 A 177 GLU B 157 GLU~? 23.31 CL CL B 226 A 201 LEU B 70 LEU^? 16.29 CL CL B 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 44.60 -13.30 29.51 46.14 -11.79 29.37 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS B 200 LYS~? 24.54 CL CL B 226 A 177 GLU B 172 GLU~? 15.62 CL CL B 226 A 201 LEU B 204 LEU~? 18.53 CL CL B 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 60.00 0.23 45.11 63.70 -4.80 44.31 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 57.49 4.88 36.61 57.44 6.68 35.49 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 57.11 3.01 40.52 58.42 1.62 39.59 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS B 200 LYS~? 24.54 CL CL B 226 A 177 GLU B 182 GLU~? 22.76 CL CL B 226 A 201 LEU B 179 LEU~? 20.02 CL CL B 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 60.00 0.23 45.11 63.70 -4.80 44.31 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 58.20 -5.10 41.26 59.69 -3.52 41.18 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS B 205 LYS~? 25.67 CL CL B 226 A 177 GLU B 175 GLU~? 17.14 CL CL B 226 A 201 LEU B 204 LEU~? 18.53 CL CL B 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 54.11 5.83 42.26 49.56 6.08 46.56 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 57.11 3.01 40.52 58.42 1.62 39.59 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 A 145 LYS B 205 LYS~? 25.67 CL CL B 226 A 177 GLU B 198 GLU~? 30.19 CL CL B 226 A 201 LEU B 201 LEU~? 21.86 CL CL B 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 54.11 5.83 42.26 49.56 6.08 46.56 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 55.20 -0.22 44.55 54.70 -2.04 43.49 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 A 145 LYS B 213 LYS~? 22.42 CL CL B 226 A 177 GLU B 110 GLU~? 23.32 CL CL B 226 A 201 LEU B 214 LEU~? 25.82 CL CL B 226 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 48.60 15.99 42.06 48.42 16.28 35.76 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 46.60 5.74 43.54 45.54 7.20 42.48 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 49.87 12.42 45.08 51.34 11.53 43.79 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 11 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 52 LYS^? 28.69 CL CL A 226 B 177 GLU B 26 GLU~? 28.82 CL CL B 226 B 201 LEU A 25 LEU~? 26.14 CL CL A 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 27.00 6.35 51.01 26.30 4.53 50.18 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 23.74 1.68 49.50 22.87 -0.24 49.97 32.61 -21.79 21.05 33.45 -21.15 19.19 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 200 LYS~? 23.56 CL CL A 226 B 177 GLU A 172 GLU~? 15.14 CL CL A 226 B 201 LEU A 204 LEU~? 18.22 CL CL A 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 27.00 6.35 51.01 26.30 4.53 50.18 20.31 7.29 3.53 20.42 8.84 4.96 coo 23.74 1.68 49.50 22.87 -0.24 49.97 19.57 4.89 0.19 17.89 4.07 1.29 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 205 LYS~? 25.48 CL CL A 226 B 177 GLU A 175 GLU~? 15.88 CL CL A 226 B 201 LEU A 204 LEU~? 18.22 CL CL A 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 27.00 6.35 51.01 26.30 4.53 50.18 15.56 2.16 3.91 14.40 0.59 4.79 coo 23.74 1.68 49.50 22.87 -0.24 49.97 19.57 4.89 0.19 17.89 4.07 1.29 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS A 205 LYS~? 25.48 CL CL A 226 B 177 GLU A 198 GLU~? 30.13 CL CL A 226 B 201 LEU A 201 LEU~? 21.75 CL CL A 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 27.00 6.35 51.01 26.30 4.53 50.18 19.84 0.58 -9.50 20.29 0.30 -11.52 coo 23.74 1.68 49.50 22.87 -0.24 49.97 20.53 0.98 -3.69 20.87 -0.82 -2.52 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS B 52 LYS^? 28.59 CL CL B 226 B 177 GLU B 26 GLU~? 28.82 CL CL B 226 B 201 LEU B 25 LEU~? 26.04 CL CL B 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 27.00 6.35 51.01 26.30 4.53 50.18 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 23.74 1.68 49.50 22.87 -0.24 49.97 39.38 -21.98 21.83 38.35 -21.94 23.71 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS B 52 LYS^? 28.59 CL CL B 226 B 177 GLU B 157 GLU~? 23.31 CL CL B 226 B 201 LEU B 70 LEU^? 16.29 CL CL B 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 27.00 6.35 51.01 26.30 4.53 50.18 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 23.74 1.68 49.50 22.87 -0.24 49.97 44.60 -13.30 29.51 46.14 -11.79 29.37 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS B 200 LYS~? 24.54 CL CL B 226 B 177 GLU B 172 GLU~? 15.62 CL CL B 226 B 201 LEU B 204 LEU~? 18.53 CL CL B 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 60.00 0.23 45.11 63.70 -4.80 44.31 coo 27.00 6.35 51.01 26.30 4.53 50.18 57.49 4.88 36.61 57.44 6.68 35.49 coo 23.74 1.68 49.50 22.87 -0.24 49.97 57.11 3.01 40.52 58.42 1.62 39.59 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS B 200 LYS~? 24.54 CL CL B 226 B 177 GLU B 182 GLU~? 22.76 CL CL B 226 B 201 LEU B 179 LEU~? 20.02 CL CL B 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 60.00 0.23 45.11 63.70 -4.80 44.31 coo 27.00 6.35 51.01 26.30 4.53 50.18 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 23.74 1.68 49.50 22.87 -0.24 49.97 58.20 -5.10 41.26 59.69 -3.52 41.18 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 B 145 LYS B 205 LYS~? 25.67 CL CL B 226 B 177 GLU B 175 GLU~? 17.14 CL CL B 226 B 201 LEU B 204 LEU~? 18.53 CL CL B 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 54.11 5.83 42.26 49.56 6.08 46.56 coo 27.00 6.35 51.01 26.30 4.53 50.18 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 23.74 1.68 49.50 22.87 -0.24 49.97 57.11 3.01 40.52 58.42 1.62 39.59 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 B 145 LYS B 205 LYS~? 25.67 CL CL B 226 B 177 GLU B 198 GLU~? 30.19 CL CL B 226 B 201 LEU B 201 LEU~? 21.86 CL CL B 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 54.11 5.83 42.26 49.56 6.08 46.56 coo 27.00 6.35 51.01 26.30 4.53 50.18 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 23.74 1.68 49.50 22.87 -0.24 49.97 55.20 -0.22 44.55 54.70 -2.04 43.49 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 B 145 LYS B 213 LYS~? 22.42 CL CL B 226 B 177 GLU B 110 GLU~? 23.32 CL CL B 226 B 201 LEU B 214 LEU~? 25.82 CL CL B 226 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 48.60 15.99 42.06 48.42 16.28 35.76 coo 27.00 6.35 51.01 26.30 4.53 50.18 46.60 5.74 43.54 45.54 7.20 42.48 coo 23.74 1.68 49.50 22.87 -0.24 49.97 49.87 12.42 45.08 51.34 11.53 43.79 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 11 hits 1daa_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 93 HIS.? 23.56 CL CL B 226 A 646 ASP A 94 ASP.? 26.16 CL CL B 226 A 739 GLY A 89 GLY~? 17.30 CL CL A 226 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 44.86 8.73 -0.50 42.92 8.83 0.44 coo 11.37 50.89 2.29 11.05 51.63 2.25 37.90 4.36 11.39 38.58 4.02 11.72 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 93 HIS.? 20.63 CL CL A 226 A 646 ASP B 94 ASP.? 27.62 CL CL A 226 A 739 GLY B 89 GLY~? 16.64 CL CL B 226 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 29.92 2.50 38.47 29.09 1.13 37.10 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 32.35 7.85 42.25 31.25 7.59 44.05 coo 11.37 50.89 2.29 11.05 51.63 2.25 39.61 4.74 28.75 38.89 4.60 28.39 1ddj_c12 source 1ddj PLASMINOGEN : 2 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 93 HIS.? 23.56 CL CL B 226 B 646 ASP A 94 ASP.? 26.16 CL CL B 226 B 739 GLY A 89 GLY~? 17.30 CL CL A 226 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 46.12 1.77 -0.18 46.19 -0.30 0.15 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 44.86 8.73 -0.50 42.92 8.83 0.44 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 37.90 4.36 11.39 38.58 4.02 11.72 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 93 HIS.? 20.63 CL CL A 226 B 646 ASP B 94 ASP.? 27.62 CL CL A 226 B 739 GLY B 89 GLY~? 16.64 CL CL B 226 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 29.92 2.50 38.47 29.09 1.13 37.10 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 32.35 7.85 42.25 31.25 7.59 44.05 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 39.61 4.74 28.75 38.89 4.60 28.39 1ddj_c13 source 1ddj PLASMINOGEN : 2 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 93 HIS.? 23.56 CL CL B 226 C 646 ASP A 94 ASP.? 26.16 CL CL B 226 C 739 GLY A 89 GLY~? 17.30 CL CL A 226 coo 15.33 59.81 59.60 13.98 60.99 60.69 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 16.06 55.72 54.73 15.97 56.49 56.70 44.86 8.73 -0.50 42.92 8.83 0.44 coo 9.38 49.29 65.28 9.01 50.03 65.31 37.90 4.36 11.39 38.58 4.02 11.72 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 93 HIS.? 20.63 CL CL A 226 C 646 ASP B 94 ASP.? 27.62 CL CL A 226 C 739 GLY B 89 GLY~? 16.64 CL CL B 226 coo 15.33 59.81 59.60 13.98 60.99 60.69 29.92 2.50 38.47 29.09 1.13 37.10 coo 16.06 55.72 54.73 15.97 56.49 56.70 32.35 7.85 42.25 31.25 7.59 44.05 coo 9.38 49.29 65.28 9.01 50.03 65.31 39.61 4.74 28.75 38.89 4.60 28.39 1ddj_c14 source 1ddj PLASMINOGEN : 2 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 93 HIS.? 23.56 CL CL B 226 D 646 ASP A 94 ASP.? 26.16 CL CL B 226 D 739 GLY A 89 GLY~? 17.30 CL CL A 226 coo -30.51 33.83 43.05 -30.50 33.12 45.03 46.12 1.77 -0.18 46.19 -0.30 0.15 coo -25.73 33.05 39.28 -27.50 34.05 39.88 44.86 8.73 -0.50 42.92 8.83 0.44 coo -27.66 47.32 40.66 -27.81 47.01 41.41 37.90 4.36 11.39 38.58 4.02 11.72 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 93 HIS.? 20.63 CL CL A 226 D 646 ASP B 94 ASP.? 27.62 CL CL A 226 D 739 GLY B 89 GLY~? 16.64 CL CL B 226 coo -30.51 33.83 43.05 -30.50 33.12 45.03 29.92 2.50 38.47 29.09 1.13 37.10 coo -25.73 33.05 39.28 -27.50 34.05 39.88 32.35 7.85 42.25 31.25 7.59 44.05 coo -27.66 47.32 40.66 -27.81 47.01 41.41 39.61 4.74 28.75 38.89 4.60 28.39 1ddj_c15 source 1ddj PLASMINOGEN : 2 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 4 GLU^? 21.78 CL CL A 226 A 226 THR A 76 THR~? 22.08 CL CL B 226 A 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 9.66 102.78 70.07 9.79 101.18 71.42 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 10.53 97.56 43.71 9.33 93.71 47.17 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 4 GLU^? 21.78 CL CL A 226 A 226 THR B 22 THR~? 22.16 CL CL B 226 A 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 9.66 102.78 70.07 9.79 101.18 71.42 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 10.53 97.56 43.71 9.33 93.71 47.17 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 91 GLU^? 16.38 CL CL B 226 A 226 THR A 76 THR~? 22.08 CL CL B 226 A 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 9.66 102.78 70.07 9.79 101.18 71.42 45.65 4.89 7.15 47.54 4.63 8.07 coo 7.24 97.46 49.60 8.11 95.69 48.80 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 10.53 97.56 43.71 9.33 93.71 47.17 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 4 GLU^? 21.62 CL CL B 226 A 226 THR A 22 THR~? 22.52 CL CL A 226 A 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 9.66 102.78 70.07 9.79 101.18 71.42 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 7.24 97.46 49.60 8.11 95.69 48.80 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 4 GLU^? 21.62 CL CL B 226 A 226 THR B 76 THR~? 22.20 CL CL A 226 A 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 9.66 102.78 70.07 9.79 101.18 71.42 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 7.24 97.46 49.60 8.11 95.69 48.80 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 10.53 97.56 43.71 9.33 93.71 47.17 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 11 GLU.? 11.19 CL CL B 226 A 226 THR A 22 THR~? 22.52 CL CL A 226 A 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 9.66 102.78 70.07 9.79 101.18 71.42 45.62 0.60 17.46 44.46 2.32 17.00 coo 7.24 97.46 49.60 8.11 95.69 48.80 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU B 91 GLU^? 18.27 CL CL A 226 A 226 THR B 76 THR~? 22.20 CL CL A 226 A 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 9.66 102.78 70.07 9.79 101.18 71.42 32.79 7.55 33.87 31.17 8.67 33.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 10.53 97.56 43.71 9.33 93.71 47.17 32.81 -17.40 29.10 28.60 -18.34 31.99 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 4 GLU^? 21.78 CL CL A 226 B 226 THR A 76 THR~? 22.08 CL CL B 226 B 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 15.90 87.61 49.61 13.92 86.96 49.36 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 20.74 95.78 68.68 19.29 96.84 69.83 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 22.32 101.61 71.64 17.89 98.63 71.55 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 4 GLU^? 21.78 CL CL A 226 B 226 THR B 22 THR~? 22.16 CL CL B 226 B 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 15.90 87.61 49.61 13.92 86.96 49.36 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 20.74 95.78 68.68 19.29 96.84 69.83 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 22.32 101.61 71.64 17.89 98.63 71.55 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 91 GLU^? 16.38 CL CL B 226 B 226 THR A 76 THR~? 22.08 CL CL B 226 B 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 15.90 87.61 49.61 13.92 86.96 49.36 45.65 4.89 7.15 47.54 4.63 8.07 coo 20.74 95.78 68.68 19.29 96.84 69.83 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 22.32 101.61 71.64 17.89 98.63 71.55 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 4 GLU^? 21.62 CL CL B 226 B 226 THR A 22 THR~? 22.52 CL CL A 226 B 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 15.90 87.61 49.61 13.92 86.96 49.36 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 20.74 95.78 68.68 19.29 96.84 69.83 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 4 GLU^? 21.62 CL CL B 226 B 226 THR B 76 THR~? 22.20 CL CL A 226 B 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 15.90 87.61 49.61 13.92 86.96 49.36 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 20.74 95.78 68.68 19.29 96.84 69.83 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 22.32 101.61 71.64 17.89 98.63 71.55 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 11 GLU.? 11.19 CL CL B 226 B 226 THR A 22 THR~? 22.52 CL CL A 226 B 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 15.90 87.61 49.61 13.92 86.96 49.36 45.62 0.60 17.46 44.46 2.32 17.00 coo 20.74 95.78 68.68 19.29 96.84 69.83 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU B 91 GLU^? 18.27 CL CL A 226 B 226 THR B 76 THR~? 22.20 CL CL A 226 B 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 15.90 87.61 49.61 13.92 86.96 49.36 32.79 7.55 33.87 31.17 8.67 33.09 coo 20.74 95.78 68.68 19.29 96.84 69.83 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 22.32 101.61 71.64 17.89 98.63 71.55 32.81 -17.40 29.10 28.60 -18.34 31.99 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 4 GLU^? 21.78 CL CL A 226 C 226 THR A 76 THR~? 22.08 CL CL B 226 C 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 5.43 40.40 61.63 4.27 41.99 60.90 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 22.16 45.88 73.63 23.23 47.70 73.25 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 28.90 45.91 73.55 25.22 49.72 72.97 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 4 GLU^? 21.78 CL CL A 226 C 226 THR B 22 THR~? 22.16 CL CL B 226 C 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 5.43 40.40 61.63 4.27 41.99 60.90 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 22.16 45.88 73.63 23.23 47.70 73.25 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 28.90 45.91 73.55 25.22 49.72 72.97 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 91 GLU^? 16.38 CL CL B 226 C 226 THR A 76 THR~? 22.08 CL CL B 226 C 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 5.43 40.40 61.63 4.27 41.99 60.90 45.65 4.89 7.15 47.54 4.63 8.07 coo 22.16 45.88 73.63 23.23 47.70 73.25 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 28.90 45.91 73.55 25.22 49.72 72.97 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 4 GLU^? 21.62 CL CL B 226 C 226 THR A 22 THR~? 22.52 CL CL A 226 C 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 5.43 40.40 61.63 4.27 41.99 60.90 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 22.16 45.88 73.63 23.23 47.70 73.25 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 4 GLU^? 21.62 CL CL B 226 C 226 THR B 76 THR~? 22.20 CL CL A 226 C 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 5.43 40.40 61.63 4.27 41.99 60.90 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 22.16 45.88 73.63 23.23 47.70 73.25 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 28.90 45.91 73.55 25.22 49.72 72.97 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 11 GLU.? 11.19 CL CL B 226 C 226 THR A 22 THR~? 22.52 CL CL A 226 C 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 5.43 40.40 61.63 4.27 41.99 60.90 45.62 0.60 17.46 44.46 2.32 17.00 coo 22.16 45.88 73.63 23.23 47.70 73.25 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU B 91 GLU^? 18.27 CL CL A 226 C 226 THR B 76 THR~? 22.20 CL CL A 226 C 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 5.43 40.40 61.63 4.27 41.99 60.90 32.79 7.55 33.87 31.17 8.67 33.09 coo 22.16 45.88 73.63 23.23 47.70 73.25 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 28.90 45.91 73.55 25.22 49.72 72.97 32.81 -17.40 29.10 28.60 -18.34 31.99 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 4 GLU^? 21.78 CL CL A 226 D 226 THR A 76 THR~? 22.08 CL CL B 226 D 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 26.07 55.89 66.14 25.33 56.50 68.01 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 11.79 47.62 52.67 10.10 46.51 53.39 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 10.05 41.79 49.80 7.94 44.71 53.76 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 4 GLU^? 21.78 CL CL A 226 D 226 THR B 22 THR~? 22.16 CL CL B 226 D 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 26.07 55.89 66.14 25.33 56.50 68.01 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 11.79 47.62 52.67 10.10 46.51 53.39 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 10.05 41.79 49.80 7.94 44.71 53.76 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 91 GLU^? 16.38 CL CL B 226 D 226 THR A 76 THR~? 22.08 CL CL B 226 D 229 LYS A 74 LYS.? 28.20 CL CL B 226 coo 26.07 55.89 66.14 25.33 56.50 68.01 45.65 4.89 7.15 47.54 4.63 8.07 coo 11.79 47.62 52.67 10.10 46.51 53.39 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 10.05 41.79 49.80 7.94 44.71 53.76 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 4 GLU^? 21.62 CL CL B 226 D 226 THR A 22 THR~? 22.52 CL CL A 226 D 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 26.07 55.89 66.14 25.33 56.50 68.01 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 11.79 47.62 52.67 10.10 46.51 53.39 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 4 GLU^? 21.62 CL CL B 226 D 226 THR B 76 THR~? 22.20 CL CL A 226 D 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 26.07 55.89 66.14 25.33 56.50 68.01 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 11.79 47.62 52.67 10.10 46.51 53.39 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 10.05 41.79 49.80 7.94 44.71 53.76 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 11 GLU.? 11.19 CL CL B 226 D 226 THR A 22 THR~? 22.52 CL CL A 226 D 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 26.07 55.89 66.14 25.33 56.50 68.01 45.62 0.60 17.46 44.46 2.32 17.00 coo 11.79 47.62 52.67 10.10 46.51 53.39 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU B 91 GLU^? 18.27 CL CL A 226 D 226 THR B 76 THR~? 22.20 CL CL A 226 D 229 LYS B 74 LYS.? 25.46 CL CL A 226 coo 26.07 55.89 66.14 25.33 56.50 68.01 32.79 7.55 33.87 31.17 8.67 33.09 coo 11.79 47.62 52.67 10.10 46.51 53.39 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 10.05 41.79 49.80 7.94 44.71 53.76 32.81 -17.40 29.10 28.60 -18.34 31.99 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 56 HIS^? 18.87 CL CL A 226 A 200 ASP A 186 ASP.? 30.68 CL CL A 226 A 229 LYS A 195 LYS~? 35.76 CL CL A 226 coo 1.13 77.49 40.64 0.62 75.57 39.98 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 0.84 91.24 49.01 2.91 91.61 49.23 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 10.53 97.56 43.71 9.33 93.71 47.17 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS A 86 HIS~? 10.02 CL CL A 226 A 200 ASP A 40 ASP.? 7.65 CL CL A 226 A 229 LYS A 178 LYS~? 16.45 CL CL A 226 coo 1.13 77.49 40.64 0.62 75.57 39.98 32.84 2.26 17.60 31.66 3.53 18.78 coo 0.84 91.24 49.01 2.91 91.61 49.23 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS A 93 HIS.? 23.56 CL CL B 226 A 200 ASP A 102 ASP~? 17.30 CL CL A 226 A 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo 1.13 77.49 40.64 0.62 75.57 39.98 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 0.84 91.24 49.01 2.91 91.61 49.23 32.53 7.12 5.29 31.66 9.04 5.62 coo 10.53 97.56 43.71 9.33 93.71 47.17 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS A 93 HIS.? 23.56 CL CL B 226 A 200 ASP A 111 ASP~? 26.09 CL CL A 226 A 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo 1.13 77.49 40.64 0.62 75.57 39.98 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 0.84 91.24 49.01 2.91 91.61 49.23 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 10.53 97.56 43.71 9.33 93.71 47.17 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS B 86 HIS~? 9.45 CL CL B 226 A 200 ASP B 40 ASP.? 7.91 CL CL B 226 A 229 LYS B 178 LYS~? 16.76 CL CL B 226 coo 1.13 77.49 40.64 0.62 75.57 39.98 44.03 1.12 22.86 45.41 1.90 21.48 coo 0.84 91.24 49.01 2.91 91.61 49.23 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 10.53 97.56 43.71 9.33 93.71 47.17 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS B 93 HIS.? 20.63 CL CL A 226 A 200 ASP B 102 ASP~? 16.83 CL CL B 226 A 229 LYS B 213 LYS~? 22.42 CL CL B 226 coo 1.13 77.49 40.64 0.62 75.57 39.98 29.92 2.50 38.47 29.09 1.13 37.10 coo 0.84 91.24 49.01 2.91 91.61 49.23 45.25 7.06 34.64 46.46 8.64 34.05 coo 10.53 97.56 43.71 9.33 93.71 47.17 48.60 15.99 42.06 48.42 16.28 35.76 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 56 HIS^? 18.87 CL CL A 226 B 200 ASP A 186 ASP.? 30.68 CL CL A 226 B 229 LYS A 195 LYS~? 35.76 CL CL A 226 coo 9.24 94.26 88.22 8.02 94.07 89.92 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 17.54 90.31 75.01 17.17 92.01 73.80 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 22.32 101.61 71.64 17.89 98.63 71.55 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS A 86 HIS~? 10.02 CL CL A 226 B 200 ASP A 40 ASP.? 7.65 CL CL A 226 B 229 LYS A 178 LYS~? 16.45 CL CL A 226 coo 9.24 94.26 88.22 8.02 94.07 89.92 32.84 2.26 17.60 31.66 3.53 18.78 coo 17.54 90.31 75.01 17.17 92.01 73.80 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS A 93 HIS.? 23.56 CL CL B 226 B 200 ASP A 102 ASP~? 17.30 CL CL A 226 B 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo 9.24 94.26 88.22 8.02 94.07 89.92 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 17.54 90.31 75.01 17.17 92.01 73.80 32.53 7.12 5.29 31.66 9.04 5.62 coo 22.32 101.61 71.64 17.89 98.63 71.55 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS A 93 HIS.? 23.56 CL CL B 226 B 200 ASP A 111 ASP~? 26.09 CL CL A 226 B 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo 9.24 94.26 88.22 8.02 94.07 89.92 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 17.54 90.31 75.01 17.17 92.01 73.80 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 22.32 101.61 71.64 17.89 98.63 71.55 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS B 86 HIS~? 9.45 CL CL B 226 B 200 ASP B 40 ASP.? 7.91 CL CL B 226 B 229 LYS B 178 LYS~? 16.76 CL CL B 226 coo 9.24 94.26 88.22 8.02 94.07 89.92 44.03 1.12 22.86 45.41 1.90 21.48 coo 17.54 90.31 75.01 17.17 92.01 73.80 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 22.32 101.61 71.64 17.89 98.63 71.55 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS B 93 HIS.? 20.63 CL CL A 226 B 200 ASP B 102 ASP~? 16.83 CL CL B 226 B 229 LYS B 213 LYS~? 22.42 CL CL B 226 coo 9.24 94.26 88.22 8.02 94.07 89.92 29.92 2.50 38.47 29.09 1.13 37.10 coo 17.54 90.31 75.01 17.17 92.01 73.80 45.25 7.06 34.64 46.46 8.64 34.05 coo 22.32 101.61 71.64 17.89 98.63 71.55 48.60 15.99 42.06 48.42 16.28 35.76 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 56 HIS^? 18.87 CL CL A 226 C 200 ASP A 186 ASP.? 30.68 CL CL A 226 C 229 LYS A 195 LYS~? 35.76 CL CL A 226 coo 26.77 65.84 83.49 27.06 67.76 84.27 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 19.52 52.01 79.59 20.28 51.65 77.65 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 28.90 45.91 73.55 25.22 49.72 72.97 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS A 86 HIS~? 10.02 CL CL A 226 C 200 ASP A 40 ASP.? 7.65 CL CL A 226 C 229 LYS A 178 LYS~? 16.45 CL CL A 226 coo 26.77 65.84 83.49 27.06 67.76 84.27 32.84 2.26 17.60 31.66 3.53 18.78 coo 19.52 52.01 79.59 20.28 51.65 77.65 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS A 93 HIS.? 23.56 CL CL B 226 C 200 ASP A 102 ASP~? 17.30 CL CL A 226 C 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo 26.77 65.84 83.49 27.06 67.76 84.27 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 19.52 52.01 79.59 20.28 51.65 77.65 32.53 7.12 5.29 31.66 9.04 5.62 coo 28.90 45.91 73.55 25.22 49.72 72.97 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS A 93 HIS.? 23.56 CL CL B 226 C 200 ASP A 111 ASP~? 26.09 CL CL A 226 C 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo 26.77 65.84 83.49 27.06 67.76 84.27 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 19.52 52.01 79.59 20.28 51.65 77.65 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 28.90 45.91 73.55 25.22 49.72 72.97 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS B 86 HIS~? 9.45 CL CL B 226 C 200 ASP B 40 ASP.? 7.91 CL CL B 226 C 229 LYS B 178 LYS~? 16.76 CL CL B 226 coo 26.77 65.84 83.49 27.06 67.76 84.27 44.03 1.12 22.86 45.41 1.90 21.48 coo 19.52 52.01 79.59 20.28 51.65 77.65 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 28.90 45.91 73.55 25.22 49.72 72.97 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS B 93 HIS.? 20.63 CL CL A 226 C 200 ASP B 102 ASP~? 16.83 CL CL B 226 C 229 LYS B 213 LYS~? 22.42 CL CL B 226 coo 26.77 65.84 83.49 27.06 67.76 84.27 29.92 2.50 38.47 29.09 1.13 37.10 coo 19.52 52.01 79.59 20.28 51.65 77.65 45.25 7.06 34.64 46.46 8.64 34.05 coo 28.90 45.91 73.55 25.22 49.72 72.97 48.60 15.99 42.06 48.42 16.28 35.76 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 56 HIS^? 18.87 CL CL A 226 D 200 ASP A 186 ASP.? 30.68 CL CL A 226 D 229 LYS A 195 LYS~? 35.76 CL CL A 226 coo -10.90 48.74 53.41 -12.98 48.90 53.67 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 4.60 52.95 52.50 5.57 51.29 53.40 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 10.05 41.79 49.80 7.94 44.71 53.76 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS A 86 HIS~? 10.02 CL CL A 226 D 200 ASP A 40 ASP.? 7.65 CL CL A 226 D 229 LYS A 178 LYS~? 16.45 CL CL A 226 coo -10.90 48.74 53.41 -12.98 48.90 53.67 32.84 2.26 17.60 31.66 3.53 18.78 coo 4.60 52.95 52.50 5.57 51.29 53.40 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS A 93 HIS.? 23.56 CL CL B 226 D 200 ASP A 102 ASP~? 17.30 CL CL A 226 D 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo -10.90 48.74 53.41 -12.98 48.90 53.67 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 4.60 52.95 52.50 5.57 51.29 53.40 32.53 7.12 5.29 31.66 9.04 5.62 coo 10.05 41.79 49.80 7.94 44.71 53.76 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS A 93 HIS.? 23.56 CL CL B 226 D 200 ASP A 111 ASP~? 26.09 CL CL A 226 D 229 LYS A 205 LYS~? 25.48 CL CL A 226 coo -10.90 48.74 53.41 -12.98 48.90 53.67 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 4.60 52.95 52.50 5.57 51.29 53.40 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 10.05 41.79 49.80 7.94 44.71 53.76 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS B 86 HIS~? 9.45 CL CL B 226 D 200 ASP B 40 ASP.? 7.91 CL CL B 226 D 229 LYS B 178 LYS~? 16.76 CL CL B 226 coo -10.90 48.74 53.41 -12.98 48.90 53.67 44.03 1.12 22.86 45.41 1.90 21.48 coo 4.60 52.95 52.50 5.57 51.29 53.40 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 10.05 41.79 49.80 7.94 44.71 53.76 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS B 93 HIS.? 20.63 CL CL A 226 D 200 ASP B 102 ASP~? 16.83 CL CL B 226 D 229 LYS B 213 LYS~? 22.42 CL CL B 226 coo -10.90 48.74 53.41 -12.98 48.90 53.67 29.92 2.50 38.47 29.09 1.13 37.10 coo 4.60 52.95 52.50 5.57 51.29 53.40 45.25 7.06 34.64 46.46 8.64 34.05 coo 10.05 41.79 49.80 7.94 44.71 53.76 48.60 15.99 42.06 48.42 16.28 35.76 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c15 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 46 TYR^? 12.99 CL CL A 226 150 LYS A 36 LYS^? 12.38 CL CL A 226 186 ASN A 50 ASN.? 30.77 CL CL A 226 coo 32.88 50.55 24.33 31.89 51.78 26.65 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 27.04 52.42 22.30 26.88 49.99 27.00 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 36.98 50.30 37.29 35.85 50.29 35.50 28.00 -25.90 12.99 26.73 -27.64 12.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 58 TYR.? 17.32 CL CL A 226 150 LYS A 60 LYS.? 19.24 CL CL A 226 186 ASN A 39 ASN.? 7.49 CL CL A 226 coo 32.88 50.55 24.33 31.89 51.78 26.65 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 27.04 52.42 22.30 26.88 49.99 27.00 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 36.98 50.30 37.29 35.85 50.29 35.50 17.97 -0.91 21.86 16.15 0.14 22.24 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 38 TYR.? 11.29 CL CL B 226 150 LYS B 36 LYS^? 15.37 CL CL B 226 186 ASN B 167 ASN.? 4.94 CL CL B 226 coo 32.88 50.55 24.33 31.89 51.78 26.65 58.26 -9.06 16.81 60.90 -8.31 16.35 coo 27.04 52.42 22.30 26.88 49.99 27.00 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 36.98 50.30 37.29 35.85 50.29 35.50 50.28 1.34 22.19 49.08 -0.16 21.24 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 46 TYR^? 12.90 CL CL B 226 150 LYS B 36 LYS^? 15.37 CL CL B 226 186 ASN B 50 ASN.? 30.91 CL CL B 226 coo 32.88 50.55 24.33 31.89 51.78 26.65 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 27.04 52.42 22.30 26.88 49.99 27.00 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 36.98 50.30 37.29 35.85 50.29 35.50 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR B 58 TYR.? 17.22 CL CL B 226 150 LYS B 60 LYS.? 20.89 CL CL B 226 186 ASN B 39 ASN.? 7.81 CL CL B 226 coo 32.88 50.55 24.33 31.89 51.78 26.65 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 27.04 52.42 22.30 26.88 49.99 27.00 65.19 -13.54 33.83 65.46 -10.39 36.65 coo 36.98 50.30 37.29 35.85 50.29 35.50 58.04 -5.16 19.24 60.05 -4.37 19.05 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 5 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 38 TYR.? 10.54 CL CL A 226 A 183 LYS A 36 LYS^? 12.38 CL CL A 226 A 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 19.43 18.53 42.32 17.66 18.80 40.15 17.27 -3.90 25.00 15.42 -2.03 25.90 coo 21.92 15.80 36.19 17.64 19.44 36.35 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 15.46 19.03 31.40 15.01 18.25 33.31 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 46 TYR^? 12.99 CL CL A 226 A 183 LYS A 36 LYS^? 12.38 CL CL A 226 A 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 19.43 18.53 42.32 17.66 18.80 40.15 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 21.92 15.80 36.19 17.64 19.44 36.35 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 15.46 19.03 31.40 15.01 18.25 33.31 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR A 160 TYR~? 15.52 CL CL A 226 A 183 LYS A 178 LYS~? 16.45 CL CL A 226 A 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 19.43 18.53 42.32 17.66 18.80 40.15 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 21.92 15.80 36.19 17.64 19.44 36.35 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 15.46 19.03 31.40 15.01 18.25 33.31 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR B 38 TYR.? 11.29 CL CL B 226 A 183 LYS B 36 LYS^? 15.37 CL CL B 226 A 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 19.43 18.53 42.32 17.66 18.80 40.15 58.26 -9.06 16.81 60.90 -8.31 16.35 coo 21.92 15.80 36.19 17.64 19.44 36.35 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 15.46 19.03 31.40 15.01 18.25 33.31 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR B 46 TYR^? 12.90 CL CL B 226 A 183 LYS B 36 LYS^? 15.37 CL CL B 226 A 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 19.43 18.53 42.32 17.66 18.80 40.15 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 21.92 15.80 36.19 17.64 19.44 36.35 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 15.46 19.03 31.40 15.01 18.25 33.31 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR B 160 TYR~? 15.61 CL CL B 226 A 183 LYS B 178 LYS~? 16.76 CL CL B 226 A 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 19.43 18.53 42.32 17.66 18.80 40.15 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 21.92 15.80 36.19 17.64 19.44 36.35 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 15.46 19.03 31.40 15.01 18.25 33.31 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c00 MALIC ENZYME user 7 3 # 7 A 112 TYR B 208 TYR~? 15.74 CL CL B 226 A 183 LYS B 205 LYS~? 25.67 CL CL B 226 A 278 ASP B 203 ASP~? 25.12 CL CL B 226 coo 19.43 18.53 42.32 17.66 18.80 40.15 52.42 6.76 36.83 50.45 6.61 34.90 coo 21.92 15.80 36.19 17.64 19.44 36.35 54.11 5.83 42.26 49.56 6.08 46.56 coo 15.46 19.03 31.40 15.01 18.25 33.31 60.54 4.31 43.90 62.00 4.57 45.37 ULMN 3 1do8_c00 MALIC ENZYME user 8 3 # 8 A 112 TYR B 209 TYR~? 20.47 CL CL B 226 A 183 LYS B 205 LYS~? 25.67 CL CL B 226 A 278 ASP B 203 ASP~? 25.12 CL CL B 226 coo 19.43 18.53 42.32 17.66 18.80 40.15 50.38 9.38 40.26 48.54 7.35 39.73 coo 21.92 15.80 36.19 17.64 19.44 36.35 54.11 5.83 42.26 49.56 6.08 46.56 coo 15.46 19.03 31.40 15.01 18.25 33.31 60.54 4.31 43.90 62.00 4.57 45.37 1do8_c00 source 1do8 MALIC ENZYME : 8 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 38 TYR.? 10.54 CL CL A 226 B 183 LYS A 36 LYS^? 12.38 CL CL A 226 B 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 58.62 15.99 58.34 60.98 14.60 58.93 17.27 -3.90 25.00 15.42 -2.03 25.90 coo 60.11 10.60 53.63 62.59 10.74 58.67 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 66.50 7.32 58.45 66.26 9.42 58.23 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 160 TYR~? 15.52 CL CL A 226 B 183 LYS A 178 LYS~? 16.45 CL CL A 226 B 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 58.62 15.99 58.34 60.98 14.60 58.93 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 60.11 10.60 53.63 62.59 10.74 58.67 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 66.50 7.32 58.45 66.26 9.42 58.23 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR B 38 TYR.? 11.29 CL CL B 226 B 183 LYS B 36 LYS^? 15.37 CL CL B 226 B 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 58.62 15.99 58.34 60.98 14.60 58.93 58.26 -9.06 16.81 60.90 -8.31 16.35 coo 60.11 10.60 53.63 62.59 10.74 58.67 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 66.50 7.32 58.45 66.26 9.42 58.23 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR B 46 TYR^? 12.90 CL CL B 226 B 183 LYS B 36 LYS^? 15.37 CL CL B 226 B 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 58.62 15.99 58.34 60.98 14.60 58.93 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 60.11 10.60 53.63 62.59 10.74 58.67 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 66.50 7.32 58.45 66.26 9.42 58.23 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR B 160 TYR~? 15.61 CL CL B 226 B 183 LYS B 178 LYS~? 16.76 CL CL B 226 B 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 58.62 15.99 58.34 60.98 14.60 58.93 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 60.11 10.60 53.63 62.59 10.74 58.67 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 66.50 7.32 58.45 66.26 9.42 58.23 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR B 208 TYR~? 15.74 CL CL B 226 B 183 LYS B 205 LYS~? 25.67 CL CL B 226 B 278 ASP B 203 ASP~? 25.12 CL CL B 226 coo 58.62 15.99 58.34 60.98 14.60 58.93 52.42 6.76 36.83 50.45 6.61 34.90 coo 60.11 10.60 53.63 62.59 10.74 58.67 54.11 5.83 42.26 49.56 6.08 46.56 coo 66.50 7.32 58.45 66.26 9.42 58.23 60.54 4.31 43.90 62.00 4.57 45.37 ULMN 3 1do8_c01 MALIC ENZYME user 7 3 # 7 B 112 TYR B 209 TYR~? 20.47 CL CL B 226 B 183 LYS B 205 LYS~? 25.67 CL CL B 226 B 278 ASP B 203 ASP~? 25.12 CL CL B 226 coo 58.62 15.99 58.34 60.98 14.60 58.93 50.38 9.38 40.26 48.54 7.35 39.73 coo 60.11 10.60 53.63 62.59 10.74 58.67 54.11 5.83 42.26 49.56 6.08 46.56 coo 66.50 7.32 58.45 66.26 9.42 58.23 60.54 4.31 43.90 62.00 4.57 45.37 1do8_c01 source 1do8 MALIC ENZYME : 7 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 38 TYR.? 10.54 CL CL A 226 C 183 LYS A 36 LYS^? 12.38 CL CL A 226 C 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 17.27 -3.90 25.00 15.42 -2.03 25.90 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 46 TYR^? 12.99 CL CL A 226 C 183 LYS A 36 LYS^? 12.38 CL CL A 226 C 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR A 160 TYR~? 15.52 CL CL A 226 C 183 LYS A 178 LYS~? 16.45 CL CL A 226 C 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR B 38 TYR.? 11.29 CL CL B 226 C 183 LYS B 36 LYS^? 15.37 CL CL B 226 C 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 58.26 -9.06 16.81 60.90 -8.31 16.35 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR B 46 TYR^? 12.90 CL CL B 226 C 183 LYS B 36 LYS^? 15.37 CL CL B 226 C 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR B 160 TYR~? 15.61 CL CL B 226 C 183 LYS B 178 LYS~? 16.76 CL CL B 226 C 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c02 MALIC ENZYME user 7 3 # 7 C 112 TYR B 208 TYR~? 15.74 CL CL B 226 C 183 LYS B 205 LYS~? 25.67 CL CL B 226 C 278 ASP B 203 ASP~? 25.12 CL CL B 226 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 52.42 6.76 36.83 50.45 6.61 34.90 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 54.11 5.83 42.26 49.56 6.08 46.56 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 60.54 4.31 43.90 62.00 4.57 45.37 ULMN 3 1do8_c02 MALIC ENZYME user 8 3 # 8 C 112 TYR B 209 TYR~? 20.47 CL CL B 226 C 183 LYS B 205 LYS~? 25.67 CL CL B 226 C 278 ASP B 203 ASP~? 25.12 CL CL B 226 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 50.38 9.38 40.26 48.54 7.35 39.73 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 54.11 5.83 42.26 49.56 6.08 46.56 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 60.54 4.31 43.90 62.00 4.57 45.37 1do8_c02 source 1do8 MALIC ENZYME : 8 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 38 TYR.? 10.54 CL CL A 226 D 183 LYS A 36 LYS^? 12.38 CL CL A 226 D 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 17.27 -3.90 25.00 15.42 -2.03 25.90 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 46 TYR^? 12.99 CL CL A 226 D 183 LYS A 36 LYS^? 12.38 CL CL A 226 D 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR A 160 TYR~? 15.52 CL CL A 226 D 183 LYS A 178 LYS~? 16.45 CL CL A 226 D 278 ASP A 43 ASP.? 11.79 CL CL A 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR A 208 TYR~? 15.64 CL CL A 226 D 183 LYS A 205 LYS~? 25.48 CL CL A 226 D 278 ASP A 203 ASP~? 25.03 CL CL A 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 25.22 8.01 3.41 27.20 7.60 5.36 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 16.55 6.97 -3.38 15.26 7.22 -5.04 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR A 209 TYR~? 20.76 CL CL A 226 D 183 LYS A 205 LYS~? 25.48 CL CL A 226 D 278 ASP A 203 ASP~? 25.03 CL CL A 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 27.49 9.87 -0.64 29.01 7.64 0.00 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 16.55 6.97 -3.38 15.26 7.22 -5.04 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR B 38 TYR.? 11.29 CL CL B 226 D 183 LYS B 36 LYS^? 15.37 CL CL B 226 D 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 58.26 -9.06 16.81 60.90 -8.31 16.35 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c03 MALIC ENZYME user 7 3 # 7 D 112 TYR B 46 TYR^? 12.90 CL CL B 226 D 183 LYS B 36 LYS^? 15.37 CL CL B 226 D 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c03 MALIC ENZYME user 8 3 # 8 D 112 TYR B 160 TYR~? 15.61 CL CL B 226 D 183 LYS B 178 LYS~? 16.76 CL CL B 226 D 278 ASP B 43 ASP.? 11.93 CL CL B 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 58.62 -8.54 27.92 60.24 -9.54 27.09 ULMN 3 1do8_c03 MALIC ENZYME user 9 3 # 9 D 112 TYR B 208 TYR~? 15.74 CL CL B 226 D 183 LYS B 205 LYS~? 25.67 CL CL B 226 D 278 ASP B 203 ASP~? 25.12 CL CL B 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 52.42 6.76 36.83 50.45 6.61 34.90 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 54.11 5.83 42.26 49.56 6.08 46.56 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 60.54 4.31 43.90 62.00 4.57 45.37 ULMN 3 1do8_c03 MALIC ENZYME user 10 3 # 10 D 112 TYR B 209 TYR~? 20.47 CL CL B 226 D 183 LYS B 205 LYS~? 25.67 CL CL B 226 D 278 ASP B 203 ASP~? 25.12 CL CL B 226 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 50.38 9.38 40.26 48.54 7.35 39.73 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 54.11 5.83 42.26 49.56 6.08 46.56 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 60.54 4.31 43.90 62.00 4.57 45.37 1do8_c03 source 1do8 MALIC ENZYME : 10 hits 1do8_c03 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 176 GLY~? 16.20 CL CL A 226 B 144 GLU A 175 GLU~? 15.88 CL CL A 226 B 164 GLU A 172 GLU~? 15.14 CL CL A 226 coo 88.87 114.43 152.30 88.45 115.15 152.32 20.16 -0.13 2.60 19.89 -0.48 3.28 coo 85.20 111.99 152.05 86.60 110.89 150.91 15.56 2.16 3.91 14.40 0.59 4.79 coo 88.14 113.46 145.73 86.79 113.92 147.30 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY B 176 GLY~? 16.30 CL CL B 226 B 144 GLU B 175 GLU~? 17.14 CL CL B 226 B 164 GLU B 172 GLU~? 15.62 CL CL B 226 coo 88.87 114.43 152.30 88.45 115.15 152.32 55.50 -2.07 38.35 55.76 -2.59 37.82 coo 85.20 111.99 152.05 86.60 110.89 150.91 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 88.14 113.46 145.73 86.79 113.92 147.30 57.49 4.88 36.61 57.44 6.68 35.49 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 176 GLY~? 16.20 CL CL A 226 C 144 GLU A 175 GLU~? 15.88 CL CL A 226 C 164 GLU A 172 GLU~? 15.14 CL CL A 226 coo 56.28 104.55 135.84 56.09 105.34 136.05 20.16 -0.13 2.60 19.89 -0.48 3.28 coo 58.46 103.90 139.48 57.57 102.00 139.16 15.56 2.16 3.91 14.40 0.59 4.79 coo 51.71 102.03 140.09 53.02 103.62 140.54 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 176 GLY~? 16.30 CL CL B 226 C 144 GLU B 175 GLU~? 17.14 CL CL B 226 C 164 GLU B 172 GLU~? 15.62 CL CL B 226 coo 56.28 104.55 135.84 56.09 105.34 136.05 55.50 -2.07 38.35 55.76 -2.59 37.82 coo 58.46 103.90 139.48 57.57 102.00 139.16 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 51.71 102.03 140.09 53.02 103.62 140.54 57.49 4.88 36.61 57.44 6.68 35.49 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 176 GLY~? 16.20 CL CL A 226 D 144 GLU A 175 GLU~? 15.88 CL CL A 226 D 164 GLU A 172 GLU~? 15.14 CL CL A 226 coo 86.19 80.64 132.77 86.38 79.85 132.93 20.16 -0.13 2.60 19.89 -0.48 3.28 coo 84.75 81.24 136.88 85.62 83.14 136.43 15.56 2.16 3.91 14.40 0.59 4.79 coo 91.47 83.05 136.24 90.35 81.38 136.84 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY B 176 GLY~? 16.30 CL CL B 226 D 144 GLU B 175 GLU~? 17.14 CL CL B 226 D 164 GLU B 172 GLU~? 15.62 CL CL B 226 coo 86.19 80.64 132.77 86.38 79.85 132.93 55.50 -2.07 38.35 55.76 -2.59 37.82 coo 84.75 81.24 136.88 85.62 83.14 136.43 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 91.47 83.05 136.24 90.35 81.38 136.84 57.49 4.88 36.61 57.44 6.68 35.49 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 176 GLY~? 16.20 CL CL A 226 E 144 GLU A 175 GLU~? 15.88 CL CL A 226 E 164 GLU A 172 GLU~? 15.14 CL CL A 226 coo 90.07 81.07 170.50 90.23 80.26 170.38 20.16 -0.13 2.60 19.89 -0.48 3.28 coo 87.05 81.30 167.53 86.38 82.74 168.94 15.56 2.16 3.91 14.40 0.59 4.79 coo 84.40 80.02 173.80 85.08 79.06 172.03 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 176 GLY~? 16.30 CL CL B 226 E 144 GLU B 175 GLU~? 17.14 CL CL B 226 E 164 GLU B 172 GLU~? 15.62 CL CL B 226 coo 90.07 81.07 170.50 90.23 80.26 170.38 55.50 -2.07 38.35 55.76 -2.59 37.82 coo 87.05 81.30 167.53 86.38 82.74 168.94 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 84.40 80.02 173.80 85.08 79.06 172.03 57.49 4.88 36.61 57.44 6.68 35.49 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 176 GLY~? 16.20 CL CL A 226 F 144 GLU A 175 GLU~? 15.88 CL CL A 226 F 164 GLU A 172 GLU~? 15.14 CL CL A 226 coo 57.12 70.68 155.10 57.52 69.95 155.02 20.16 -0.13 2.60 19.89 -0.48 3.28 coo 60.62 73.13 154.21 59.05 74.26 153.35 15.56 2.16 3.91 14.40 0.59 4.79 coo 56.75 71.71 148.46 58.44 71.01 149.54 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY B 176 GLY~? 16.30 CL CL B 226 F 144 GLU B 175 GLU~? 17.14 CL CL B 226 F 164 GLU B 172 GLU~? 15.62 CL CL B 226 coo 57.12 70.68 155.10 57.52 69.95 155.02 55.50 -2.07 38.35 55.76 -2.59 37.82 coo 60.62 73.13 154.21 59.05 74.26 153.35 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 56.75 71.71 148.46 58.44 71.01 149.54 57.49 4.88 36.61 57.44 6.68 35.49 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c17 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 29 LYS~? 32.87 CL CL A 226 A 215 LYS B 29 LYS~? 31.47 CL CL B 226 A 277 LYS B 52 LYS^? 28.59 CL CL B 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 27.86 -27.63 18.34 32.94 -28.71 20.74 coo 13.06 30.79 51.73 11.40 35.76 53.48 42.17 -28.64 25.12 38.26 -28.01 22.97 coo 13.04 31.88 60.72 10.57 35.34 57.49 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 29 LYS~? 32.87 CL CL A 226 A 215 LYS B 74 LYS.? 25.46 CL CL A 226 A 277 LYS B 52 LYS^? 28.59 CL CL B 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 27.86 -27.63 18.34 32.94 -28.71 20.74 coo 13.06 30.79 51.73 11.40 35.76 53.48 32.81 -17.40 29.10 28.60 -18.34 31.99 coo 13.04 31.88 60.72 10.57 35.34 57.49 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 36 LYS^? 12.38 CL CL A 226 A 215 LYS A 52 LYS^? 28.69 CL CL A 226 A 277 LYS A 29 LYS~? 32.87 CL CL A 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 13.06 30.79 51.73 11.40 35.76 53.48 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 13.04 31.88 60.72 10.57 35.34 57.49 27.86 -27.63 18.34 32.94 -28.71 20.74 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS A 74 LYS.? 28.20 CL CL B 226 A 215 LYS B 29 LYS~? 31.47 CL CL B 226 A 277 LYS B 52 LYS^? 28.59 CL CL B 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 39.76 -18.88 13.29 42.20 -24.24 11.95 coo 13.06 30.79 51.73 11.40 35.76 53.48 42.17 -28.64 25.12 38.26 -28.01 22.97 coo 13.04 31.88 60.72 10.57 35.34 57.49 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS A 74 LYS.? 28.20 CL CL B 226 A 215 LYS B 52 LYS^? 28.59 CL CL B 226 A 277 LYS B 29 LYS~? 31.47 CL CL B 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 39.76 -18.88 13.29 42.20 -24.24 11.95 coo 13.06 30.79 51.73 11.40 35.76 53.48 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 13.04 31.88 60.72 10.57 35.34 57.49 42.17 -28.64 25.12 38.26 -28.01 22.97 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS A 74 LYS.? 28.20 CL CL B 226 A 215 LYS B 52 LYS^? 28.59 CL CL B 226 A 277 LYS B 74 LYS.? 25.46 CL CL A 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 39.76 -18.88 13.29 42.20 -24.24 11.95 coo 13.06 30.79 51.73 11.40 35.76 53.48 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 13.04 31.88 60.72 10.57 35.34 57.49 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS A 195 LYS~? 35.76 CL CL A 226 A 215 LYS A 205 LYS~? 25.48 CL CL A 226 A 277 LYS A 213 LYS.? 30.41 CL CL A 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 13.04 31.88 60.72 10.57 35.34 57.49 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS A 213 LYS.? 30.41 CL CL A 226 A 215 LYS A 200 LYS~? 23.56 CL CL A 226 A 277 LYS A 195 LYS~? 35.76 CL CL A 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 13.06 30.79 51.73 11.40 35.76 53.48 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 13.04 31.88 60.72 10.57 35.34 57.49 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS B 29 LYS~? 31.47 CL CL B 226 A 215 LYS A 29 LYS~? 32.87 CL CL A 226 A 277 LYS A 52 LYS^? 28.69 CL CL A 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 42.17 -28.64 25.12 38.26 -28.01 22.97 coo 13.06 30.79 51.73 11.40 35.76 53.48 27.86 -27.63 18.34 32.94 -28.71 20.74 coo 13.04 31.88 60.72 10.57 35.34 57.49 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS B 29 LYS~? 31.47 CL CL B 226 A 215 LYS A 74 LYS.? 28.20 CL CL B 226 A 277 LYS A 52 LYS^? 28.69 CL CL A 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 42.17 -28.64 25.12 38.26 -28.01 22.97 coo 13.06 30.79 51.73 11.40 35.76 53.48 39.76 -18.88 13.29 42.20 -24.24 11.95 coo 13.04 31.88 60.72 10.57 35.34 57.49 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS B 36 LYS^? 15.37 CL CL B 226 A 215 LYS B 60 LYS.? 20.89 CL CL B 226 A 277 LYS B 63 LYS.? 30.86 CL CL B 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 13.06 30.79 51.73 11.40 35.76 53.48 65.19 -13.54 33.83 65.46 -10.39 36.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS B 36 LYS^? 15.37 CL CL B 226 A 215 LYS B 60 LYS.? 20.89 CL CL B 226 A 277 LYS B 178 LYS~? 16.76 CL CL B 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 13.06 30.79 51.73 11.40 35.76 53.48 65.19 -13.54 33.83 65.46 -10.39 36.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS B 74 LYS.? 25.46 CL CL A 226 A 215 LYS A 29 LYS~? 32.87 CL CL A 226 A 277 LYS A 52 LYS^? 28.69 CL CL A 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 32.81 -17.40 29.10 28.60 -18.34 31.99 coo 13.06 30.79 51.73 11.40 35.76 53.48 27.86 -27.63 18.34 32.94 -28.71 20.74 coo 13.04 31.88 60.72 10.57 35.34 57.49 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS B 74 LYS.? 25.46 CL CL A 226 A 215 LYS A 52 LYS^? 28.69 CL CL A 226 A 277 LYS A 29 LYS~? 32.87 CL CL A 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 32.81 -17.40 29.10 28.60 -18.34 31.99 coo 13.06 30.79 51.73 11.40 35.76 53.48 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 13.04 31.88 60.72 10.57 35.34 57.49 27.86 -27.63 18.34 32.94 -28.71 20.74 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS B 74 LYS.? 25.46 CL CL A 226 A 215 LYS A 52 LYS^? 28.69 CL CL A 226 A 277 LYS A 74 LYS.? 28.20 CL CL B 226 coo 0.50 24.09 51.68 1.51 29.34 52.35 32.81 -17.40 29.10 28.60 -18.34 31.99 coo 13.06 30.79 51.73 11.40 35.76 53.48 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 13.04 31.88 60.72 10.57 35.34 57.49 39.76 -18.88 13.29 42.20 -24.24 11.95 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 15 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 74 LYS.? 28.20 CL CL B 226 B 215 LYS B 29 LYS~? 31.47 CL CL B 226 B 277 LYS B 52 LYS^? 28.59 CL CL B 226 coo 6.78 45.91 16.15 7.82 40.81 15.84 39.76 -18.88 13.29 42.20 -24.24 11.95 coo 17.88 38.77 19.81 16.38 34.23 17.24 42.17 -28.64 25.12 38.26 -28.01 22.97 coo 20.33 37.78 11.20 16.77 34.53 13.47 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 195 LYS~? 35.76 CL CL A 226 B 215 LYS A 205 LYS~? 25.48 CL CL A 226 B 277 LYS A 213 LYS.? 30.41 CL CL A 226 coo 6.78 45.91 16.15 7.82 40.81 15.84 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 20.33 37.78 11.20 16.77 34.53 13.47 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 213 LYS.? 30.41 CL CL A 226 B 215 LYS A 200 LYS~? 23.56 CL CL A 226 B 277 LYS A 195 LYS~? 35.76 CL CL A 226 coo 6.78 45.91 16.15 7.82 40.81 15.84 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 17.88 38.77 19.81 16.38 34.23 17.24 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 20.33 37.78 11.20 16.77 34.53 13.47 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS B 36 LYS^? 15.37 CL CL B 226 B 215 LYS B 60 LYS.? 20.89 CL CL B 226 B 277 LYS B 63 LYS.? 30.86 CL CL B 226 coo 6.78 45.91 16.15 7.82 40.81 15.84 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 17.88 38.77 19.81 16.38 34.23 17.24 65.19 -13.54 33.83 65.46 -10.39 36.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS B 36 LYS^? 15.37 CL CL B 226 B 215 LYS B 60 LYS.? 20.89 CL CL B 226 B 277 LYS B 178 LYS~? 16.76 CL CL B 226 coo 6.78 45.91 16.15 7.82 40.81 15.84 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 17.88 38.77 19.81 16.38 34.23 17.24 65.19 -13.54 33.83 65.46 -10.39 36.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS B 74 LYS.? 25.46 CL CL A 226 B 215 LYS A 29 LYS~? 32.87 CL CL A 226 B 277 LYS A 52 LYS^? 28.69 CL CL A 226 coo 6.78 45.91 16.15 7.82 40.81 15.84 32.81 -17.40 29.10 28.60 -18.34 31.99 coo 17.88 38.77 19.81 16.38 34.23 17.24 27.86 -27.63 18.34 32.94 -28.71 20.74 coo 20.33 37.78 11.20 16.77 34.53 13.47 30.09 -20.25 13.69 32.70 -23.31 10.81 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 6 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 121 TYR.? 28.41 CL CL A 226 A 40 ASP A 193 ASP~? 30.50 CL CL A 226 A 103 ASP A 186 ASP.? 30.68 CL CL A 226 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 194 TYR~? 29.78 CL CL A 226 A 40 ASP A 186 ASP.? 30.68 CL CL A 226 A 103 ASP A 193 ASP~? 30.50 CL CL A 226 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 12.56 -7.85 -7.87 10.56 -8.42 -7.58 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 121 TYR~? 28.97 CL CL B 226 A 40 ASP B 193 ASP~? 31.47 CL CL B 226 A 103 ASP B 186 ASP.? 30.73 CL CL B 226 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 51.39 -13.47 48.53 51.35 -15.45 46.59 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 56.29 -18.50 46.72 54.94 -17.46 47.93 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 194 TYR~? 30.06 CL CL B 226 A 40 ASP B 186 ASP.? 30.73 CL CL B 226 A 103 ASP B 193 ASP~? 31.47 CL CL B 226 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 60.57 -10.33 49.95 62.16 -11.61 50.53 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 4 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 121 TYR.? 28.41 CL CL A 226 B 40 ASP A 193 ASP~? 30.50 CL CL A 226 B 103 ASP A 186 ASP.? 30.68 CL CL A 226 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 194 TYR~? 29.78 CL CL A 226 B 40 ASP A 186 ASP.? 30.68 CL CL A 226 B 103 ASP A 193 ASP~? 30.50 CL CL A 226 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 12.56 -7.85 -7.87 10.56 -8.42 -7.58 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 121 TYR~? 28.97 CL CL B 226 B 40 ASP B 193 ASP~? 31.47 CL CL B 226 B 103 ASP B 186 ASP.? 30.73 CL CL B 226 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 51.39 -13.47 48.53 51.35 -15.45 46.59 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 56.29 -18.50 46.72 54.94 -17.46 47.93 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 194 TYR~? 30.06 CL CL B 226 B 40 ASP B 186 ASP.? 30.73 CL CL B 226 B 103 ASP B 193 ASP~? 31.47 CL CL B 226 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 60.57 -10.33 49.95 62.16 -11.61 50.53 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 4 hits 1e3v_c03 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 71 ALA^? 20.51 CL CL A 226 A 136 TYR A 21 TYR~? 21.90 CL CL A 226 A 140 LYS A 52 LYS^? 28.69 CL CL A 226 coo 55.90 7.49 23.83 56.71 8.23 22.76 32.71 -15.15 12.56 32.86 -14.68 13.99 coo 59.38 10.02 17.51 59.95 9.89 20.21 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 59.52 3.69 18.67 62.31 6.19 22.58 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA A 105 ALA~? 16.83 CL CL A 226 A 136 TYR A 209 TYR~? 20.76 CL CL A 226 A 140 LYS A 205 LYS~? 25.48 CL CL A 226 coo 55.90 7.49 23.83 56.71 8.23 22.76 28.34 3.47 2.87 28.40 4.99 3.05 coo 59.38 10.02 17.51 59.95 9.89 20.21 27.49 9.87 -0.64 29.01 7.64 0.00 coo 59.52 3.69 18.67 62.31 6.19 22.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA B 71 ALA^? 20.21 CL CL B 226 A 136 TYR B 21 TYR~? 21.81 CL CL B 226 A 140 LYS B 52 LYS^? 28.59 CL CL B 226 coo 55.90 7.49 23.83 56.71 8.23 22.76 40.69 -15.21 29.48 40.79 -14.95 28.00 coo 59.38 10.02 17.51 59.95 9.89 20.21 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 59.52 3.69 18.67 62.31 6.19 22.58 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA B 105 ALA~? 16.52 CL CL B 226 A 136 TYR B 209 TYR~? 20.47 CL CL B 226 A 140 LYS B 205 LYS~? 25.67 CL CL B 226 coo 55.90 7.49 23.83 56.71 8.23 22.76 48.52 2.97 37.54 48.93 4.37 37.10 coo 59.38 10.02 17.51 59.95 9.89 20.21 50.38 9.38 40.26 48.54 7.35 39.73 coo 59.52 3.69 18.67 62.31 6.19 22.58 54.11 5.83 42.26 49.56 6.08 46.56 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 4 hits 1e7q_c01 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS B 195 LYS~? 36.01 CL CL B 226 B 207 LYS B 200 LYS~? 24.54 CL CL B 226 B 366 ASP B 193 ASP~? 31.47 CL CL B 226 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 58.60 -4.05 52.32 60.39 -2.54 57.56 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 60.00 0.23 45.11 63.70 -4.80 44.31 coo -11.13 25.71 4.86 -10.82 24.43 3.24 60.57 -10.33 49.95 62.16 -11.61 50.53 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c05 naa= 3 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 A 66 HIS A 86 HIS~? 10.02 CL CL A 226 A 110 GLY A 85 GLY~? 15.77 CL CL A 226 A 140 TYR B 87 TYR~? 13.52 CL CL B 226 coo 24.53 0.12 1.91 23.47 1.90 2.27 32.84 2.26 17.60 31.66 3.53 18.78 coo 22.96 1.26 5.85 23.32 1.32 6.60 37.09 1.03 13.26 36.82 0.94 14.00 coo 21.28 7.32 1.28 21.07 5.14 3.02 40.26 2.88 20.56 41.63 1.41 18.60 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 A 66 HIS B 86 HIS~? 9.45 CL CL B 226 A 110 GLY B 85 GLY~? 15.33 CL CL B 226 A 140 TYR A 87 TYR~? 13.92 CL CL A 226 coo 24.53 0.12 1.91 23.47 1.90 2.27 44.03 1.12 22.86 45.41 1.90 21.48 coo 22.96 1.26 5.85 23.32 1.32 6.60 39.45 1.04 27.01 39.73 0.94 26.23 coo 21.28 7.32 1.28 21.07 5.14 3.02 36.79 3.26 19.70 35.19 2.19 21.67 1ef8_c00 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 2 hits 1ef8_c00 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 86 HIS~? 10.02 CL CL A 226 B 110 GLY A 85 GLY~? 15.77 CL CL A 226 B 140 TYR B 87 TYR~? 13.52 CL CL B 226 coo 15.25 42.02 9.50 15.08 40.17 8.54 32.84 2.26 17.60 31.66 3.53 18.78 coo 16.54 37.86 10.86 17.07 37.78 11.48 37.09 1.03 13.26 36.82 0.94 14.00 coo 8.70 35.97 10.91 11.44 36.02 10.35 40.26 2.88 20.56 41.63 1.41 18.60 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS B 86 HIS~? 9.45 CL CL B 226 B 110 GLY B 85 GLY~? 15.33 CL CL B 226 B 140 TYR A 87 TYR~? 13.92 CL CL A 226 coo 15.25 42.02 9.50 15.08 40.17 8.54 44.03 1.12 22.86 45.41 1.90 21.48 coo 16.54 37.86 10.86 17.07 37.78 11.48 39.45 1.04 27.01 39.73 0.94 26.23 coo 8.70 35.97 10.91 11.44 36.02 10.35 36.79 3.26 19.70 35.19 2.19 21.67 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 B 66 HIS B 86 HIS~? 9.45 CL CL B 226 B 110 GLY B 165 GLY.? 9.33 CL CL B 226 B 140 TYR B 90 TYR^? 17.17 CL CL B 226 coo 15.25 42.02 9.50 15.08 40.17 8.54 44.03 1.12 22.86 45.41 1.90 21.48 coo 16.54 37.86 10.86 17.07 37.78 11.48 45.52 -2.50 25.89 46.23 -2.42 26.22 coo 8.70 35.97 10.91 11.44 36.02 10.35 38.78 1.99 31.89 40.05 -0.11 30.63 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 86 HIS~? 10.02 CL CL A 226 C 110 GLY A 85 GLY~? 15.77 CL CL A 226 C 140 TYR B 87 TYR~? 13.52 CL CL B 226 coo -9.82 10.01 28.41 -9.17 11.02 26.71 32.84 2.26 17.60 31.66 3.53 18.78 coo -5.73 12.49 27.77 -5.15 12.61 28.37 37.09 1.03 13.26 36.82 0.94 14.00 coo -4.68 8.05 21.05 -4.91 10.19 22.84 40.26 2.88 20.56 41.63 1.41 18.60 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS B 86 HIS~? 9.45 CL CL B 226 C 110 GLY B 85 GLY~? 15.33 CL CL B 226 C 140 TYR A 87 TYR~? 13.92 CL CL A 226 coo -9.82 10.01 28.41 -9.17 11.02 26.71 44.03 1.12 22.86 45.41 1.90 21.48 coo -5.73 12.49 27.77 -5.15 12.61 28.37 39.45 1.04 27.01 39.73 0.94 26.23 coo -4.68 8.05 21.05 -4.91 10.19 22.84 36.79 3.26 19.70 35.19 2.19 21.67 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 C 66 HIS B 86 HIS~? 9.45 CL CL B 226 C 110 GLY B 165 GLY.? 9.33 CL CL B 226 C 140 TYR B 90 TYR^? 17.17 CL CL B 226 coo -9.82 10.01 28.41 -9.17 11.02 26.71 44.03 1.12 22.86 45.41 1.90 21.48 coo -5.73 12.49 27.77 -5.15 12.61 28.37 45.52 -2.50 25.89 46.23 -2.42 26.22 coo -4.68 8.05 21.05 -4.91 10.19 22.84 38.78 1.99 31.89 40.05 -0.11 30.63 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_c02 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 28 SER~? 26.52 CL CL A 226 A 140 TYR A 21 TYR~? 21.90 CL CL A 226 A 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 26.40 -24.33 19.56 28.45 -23.49 18.56 coo 29.60 38.99 53.89 30.10 37.88 51.36 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 32.73 32.94 54.42 29.29 32.83 50.35 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER A 207 SER~? 18.13 CL CL A 226 A 140 TYR A 208 TYR~? 15.64 CL CL A 226 A 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 20.60 11.23 0.64 19.47 10.75 2.68 coo 29.60 38.99 53.89 30.10 37.88 51.36 25.22 8.01 3.41 27.20 7.60 5.36 coo 32.73 32.94 54.42 29.29 32.83 50.35 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 A 116 SER A 207 SER~? 18.13 CL CL A 226 A 140 TYR A 209 TYR~? 20.76 CL CL A 226 A 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 20.60 11.23 0.64 19.47 10.75 2.68 coo 29.60 38.99 53.89 30.10 37.88 51.36 27.49 9.87 -0.64 29.01 7.64 0.00 coo 32.73 32.94 54.42 29.29 32.83 50.35 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 A 116 SER A 210 SER~? 21.09 CL CL A 226 A 140 TYR A 208 TYR~? 15.64 CL CL A 226 A 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 24.15 14.96 0.00 24.37 15.67 2.31 coo 29.60 38.99 53.89 30.10 37.88 51.36 25.22 8.01 3.41 27.20 7.60 5.36 coo 32.73 32.94 54.42 29.29 32.83 50.35 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 A 116 SER A 210 SER~? 21.09 CL CL A 226 A 140 TYR A 209 TYR~? 20.76 CL CL A 226 A 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 24.15 14.96 0.00 24.37 15.67 2.31 coo 29.60 38.99 53.89 30.10 37.88 51.36 27.49 9.87 -0.64 29.01 7.64 0.00 coo 32.73 32.94 54.42 29.29 32.83 50.35 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 A 116 SER B 28 SER~? 26.37 CL CL B 226 A 140 TYR B 21 TYR~? 21.81 CL CL B 226 A 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 29.60 38.99 53.89 30.10 37.88 51.36 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 32.73 32.94 54.42 29.29 32.83 50.35 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 A 116 SER B 72 SER.? 25.86 CL CL B 226 A 140 TYR B 21 TYR~? 21.81 CL CL B 226 A 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 29.60 38.99 53.89 30.10 37.88 51.36 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 32.73 32.94 54.42 29.29 32.83 50.35 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 A 116 SER B 207 SER~? 19.03 CL CL B 226 A 140 TYR B 208 TYR~? 15.74 CL CL B 226 A 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 57.60 9.31 39.27 58.73 7.29 38.76 coo 29.60 38.99 53.89 30.10 37.88 51.36 52.42 6.76 36.83 50.45 6.61 34.90 coo 32.73 32.94 54.42 29.29 32.83 50.35 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 A 116 SER B 207 SER~? 19.03 CL CL B 226 A 140 TYR B 209 TYR~? 20.47 CL CL B 226 A 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 57.60 9.31 39.27 58.73 7.29 38.76 coo 29.60 38.99 53.89 30.10 37.88 51.36 50.38 9.38 40.26 48.54 7.35 39.73 coo 32.73 32.94 54.42 29.29 32.83 50.35 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 A 116 SER B 210 SER~? 23.92 CL CL B 226 A 140 TYR B 209 TYR~? 20.47 CL CL B 226 A 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo 34.67 35.79 48.83 33.57 37.88 49.47 53.28 14.40 40.02 51.53 15.84 39.30 coo 29.60 38.99 53.89 30.10 37.88 51.36 50.38 9.38 40.26 48.54 7.35 39.73 coo 32.73 32.94 54.42 29.29 32.83 50.35 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 28 SER~? 26.52 CL CL A 226 B 140 TYR A 21 TYR~? 21.90 CL CL A 226 B 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 26.40 -24.33 19.56 28.45 -23.49 18.56 coo 24.43 38.83 86.53 27.07 38.03 86.12 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 25.13 32.62 89.49 27.74 32.61 84.91 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER A 207 SER~? 18.13 CL CL A 226 B 140 TYR A 208 TYR~? 15.64 CL CL A 226 B 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 20.60 11.23 0.64 19.47 10.75 2.68 coo 24.43 38.83 86.53 27.07 38.03 86.12 25.22 8.01 3.41 27.20 7.60 5.36 coo 25.13 32.62 89.49 27.74 32.61 84.91 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 B 116 SER A 207 SER~? 18.13 CL CL A 226 B 140 TYR A 209 TYR~? 20.76 CL CL A 226 B 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 20.60 11.23 0.64 19.47 10.75 2.68 coo 24.43 38.83 86.53 27.07 38.03 86.12 27.49 9.87 -0.64 29.01 7.64 0.00 coo 25.13 32.62 89.49 27.74 32.61 84.91 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 B 116 SER A 210 SER~? 21.09 CL CL A 226 B 140 TYR A 208 TYR~? 15.64 CL CL A 226 B 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 24.15 14.96 0.00 24.37 15.67 2.31 coo 24.43 38.83 86.53 27.07 38.03 86.12 25.22 8.01 3.41 27.20 7.60 5.36 coo 25.13 32.62 89.49 27.74 32.61 84.91 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 B 116 SER A 210 SER~? 21.09 CL CL A 226 B 140 TYR A 209 TYR~? 20.76 CL CL A 226 B 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 24.15 14.96 0.00 24.37 15.67 2.31 coo 24.43 38.83 86.53 27.07 38.03 86.12 27.49 9.87 -0.64 29.01 7.64 0.00 coo 25.13 32.62 89.49 27.74 32.61 84.91 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 B 116 SER B 28 SER~? 26.37 CL CL B 226 B 140 TYR B 21 TYR~? 21.81 CL CL B 226 B 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 24.43 38.83 86.53 27.07 38.03 86.12 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 25.13 32.62 89.49 27.74 32.61 84.91 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 B 116 SER B 72 SER.? 25.86 CL CL B 226 B 140 TYR B 21 TYR~? 21.81 CL CL B 226 B 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 24.43 38.83 86.53 27.07 38.03 86.12 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 25.13 32.62 89.49 27.74 32.61 84.91 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 B 116 SER B 207 SER~? 19.03 CL CL B 226 B 140 TYR B 208 TYR~? 15.74 CL CL B 226 B 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 57.60 9.31 39.27 58.73 7.29 38.76 coo 24.43 38.83 86.53 27.07 38.03 86.12 52.42 6.76 36.83 50.45 6.61 34.90 coo 25.13 32.62 89.49 27.74 32.61 84.91 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 B 116 SER B 207 SER~? 19.03 CL CL B 226 B 140 TYR B 209 TYR~? 20.47 CL CL B 226 B 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 57.60 9.31 39.27 58.73 7.29 38.76 coo 24.43 38.83 86.53 27.07 38.03 86.12 50.38 9.38 40.26 48.54 7.35 39.73 coo 25.13 32.62 89.49 27.74 32.61 84.91 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 B 116 SER B 210 SER~? 23.92 CL CL B 226 B 140 TYR B 209 TYR~? 20.47 CL CL B 226 B 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo 30.90 35.65 89.60 29.85 37.72 88.83 53.28 14.40 40.02 51.53 15.84 39.30 coo 24.43 38.83 86.53 27.07 38.03 86.12 50.38 9.38 40.26 48.54 7.35 39.73 coo 25.13 32.62 89.49 27.74 32.61 84.91 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 28 SER~? 26.52 CL CL A 226 C 140 TYR A 21 TYR~? 21.90 CL CL A 226 C 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 26.40 -24.33 19.56 28.45 -23.49 18.56 coo -8.28 37.01 91.79 -6.99 36.16 94.13 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -10.48 30.66 93.19 -5.27 31.07 94.32 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER A 207 SER~? 18.13 CL CL A 226 C 140 TYR A 208 TYR~? 15.64 CL CL A 226 C 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 20.60 11.23 0.64 19.47 10.75 2.68 coo -8.28 37.01 91.79 -6.99 36.16 94.13 25.22 8.01 3.41 27.20 7.60 5.36 coo -10.48 30.66 93.19 -5.27 31.07 94.32 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 C 116 SER A 207 SER~? 18.13 CL CL A 226 C 140 TYR A 209 TYR~? 20.76 CL CL A 226 C 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 20.60 11.23 0.64 19.47 10.75 2.68 coo -8.28 37.01 91.79 -6.99 36.16 94.13 27.49 9.87 -0.64 29.01 7.64 0.00 coo -10.48 30.66 93.19 -5.27 31.07 94.32 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 C 116 SER A 210 SER~? 21.09 CL CL A 226 C 140 TYR A 208 TYR~? 15.64 CL CL A 226 C 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 24.15 14.96 0.00 24.37 15.67 2.31 coo -8.28 37.01 91.79 -6.99 36.16 94.13 25.22 8.01 3.41 27.20 7.60 5.36 coo -10.48 30.66 93.19 -5.27 31.07 94.32 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 C 116 SER A 210 SER~? 21.09 CL CL A 226 C 140 TYR A 209 TYR~? 20.76 CL CL A 226 C 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 24.15 14.96 0.00 24.37 15.67 2.31 coo -8.28 37.01 91.79 -6.99 36.16 94.13 27.49 9.87 -0.64 29.01 7.64 0.00 coo -10.48 30.66 93.19 -5.27 31.07 94.32 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 C 116 SER B 28 SER~? 26.37 CL CL B 226 C 140 TYR B 21 TYR~? 21.81 CL CL B 226 C 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 44.32 -26.04 23.35 42.98 -24.57 24.74 coo -8.28 37.01 91.79 -6.99 36.16 94.13 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -10.48 30.66 93.19 -5.27 31.07 94.32 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 C 116 SER B 72 SER.? 25.86 CL CL B 226 C 140 TYR B 21 TYR~? 21.81 CL CL B 226 C 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 38.31 -18.13 29.75 37.15 -17.87 31.87 coo -8.28 37.01 91.79 -6.99 36.16 94.13 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -10.48 30.66 93.19 -5.27 31.07 94.32 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 C 116 SER B 207 SER~? 19.03 CL CL B 226 C 140 TYR B 208 TYR~? 15.74 CL CL B 226 C 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 57.60 9.31 39.27 58.73 7.29 38.76 coo -8.28 37.01 91.79 -6.99 36.16 94.13 52.42 6.76 36.83 50.45 6.61 34.90 coo -10.48 30.66 93.19 -5.27 31.07 94.32 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 C 116 SER B 207 SER~? 19.03 CL CL B 226 C 140 TYR B 209 TYR~? 20.47 CL CL B 226 C 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 57.60 9.31 39.27 58.73 7.29 38.76 coo -8.28 37.01 91.79 -6.99 36.16 94.13 50.38 9.38 40.26 48.54 7.35 39.73 coo -10.48 30.66 93.19 -5.27 31.07 94.32 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 C 116 SER B 210 SER~? 23.92 CL CL B 226 C 140 TYR B 209 TYR~? 20.47 CL CL B 226 C 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo -8.96 33.70 98.81 -8.96 35.77 97.56 53.28 14.40 40.02 51.53 15.84 39.30 coo -8.28 37.01 91.79 -6.99 36.16 94.13 50.38 9.38 40.26 48.54 7.35 39.73 coo -10.48 30.66 93.19 -5.27 31.07 94.32 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 28 SER~? 26.52 CL CL A 226 D 140 TYR A 21 TYR~? 21.90 CL CL A 226 D 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 26.40 -24.33 19.56 28.45 -23.49 18.56 coo -23.30 35.33 62.20 -25.10 34.24 64.06 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -24.76 28.82 60.31 -24.27 29.01 65.58 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER A 207 SER~? 18.13 CL CL A 226 D 140 TYR A 208 TYR~? 15.64 CL CL A 226 D 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 20.60 11.23 0.64 19.47 10.75 2.68 coo -23.30 35.33 62.20 -25.10 34.24 64.06 25.22 8.01 3.41 27.20 7.60 5.36 coo -24.76 28.82 60.31 -24.27 29.01 65.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 D 116 SER A 207 SER~? 18.13 CL CL A 226 D 140 TYR A 209 TYR~? 20.76 CL CL A 226 D 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 20.60 11.23 0.64 19.47 10.75 2.68 coo -23.30 35.33 62.20 -25.10 34.24 64.06 27.49 9.87 -0.64 29.01 7.64 0.00 coo -24.76 28.82 60.31 -24.27 29.01 65.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 D 116 SER A 210 SER~? 21.09 CL CL A 226 D 140 TYR A 208 TYR~? 15.64 CL CL A 226 D 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 24.15 14.96 0.00 24.37 15.67 2.31 coo -23.30 35.33 62.20 -25.10 34.24 64.06 25.22 8.01 3.41 27.20 7.60 5.36 coo -24.76 28.82 60.31 -24.27 29.01 65.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 D 116 SER A 210 SER~? 21.09 CL CL A 226 D 140 TYR A 209 TYR~? 20.76 CL CL A 226 D 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 24.15 14.96 0.00 24.37 15.67 2.31 coo -23.30 35.33 62.20 -25.10 34.24 64.06 27.49 9.87 -0.64 29.01 7.64 0.00 coo -24.76 28.82 60.31 -24.27 29.01 65.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 D 116 SER B 28 SER~? 26.37 CL CL B 226 D 140 TYR B 21 TYR~? 21.81 CL CL B 226 D 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 44.32 -26.04 23.35 42.98 -24.57 24.74 coo -23.30 35.33 62.20 -25.10 34.24 64.06 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -24.76 28.82 60.31 -24.27 29.01 65.58 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 D 116 SER B 72 SER.? 25.86 CL CL B 226 D 140 TYR B 21 TYR~? 21.81 CL CL B 226 D 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 38.31 -18.13 29.75 37.15 -17.87 31.87 coo -23.30 35.33 62.20 -25.10 34.24 64.06 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -24.76 28.82 60.31 -24.27 29.01 65.58 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 D 116 SER B 207 SER~? 19.03 CL CL B 226 D 140 TYR B 208 TYR~? 15.74 CL CL B 226 D 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 57.60 9.31 39.27 58.73 7.29 38.76 coo -23.30 35.33 62.20 -25.10 34.24 64.06 52.42 6.76 36.83 50.45 6.61 34.90 coo -24.76 28.82 60.31 -24.27 29.01 65.58 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 D 116 SER B 207 SER~? 19.03 CL CL B 226 D 140 TYR B 209 TYR~? 20.47 CL CL B 226 D 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 57.60 9.31 39.27 58.73 7.29 38.76 coo -23.30 35.33 62.20 -25.10 34.24 64.06 50.38 9.38 40.26 48.54 7.35 39.73 coo -24.76 28.82 60.31 -24.27 29.01 65.58 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 D 116 SER B 210 SER~? 23.92 CL CL B 226 D 140 TYR B 209 TYR~? 20.47 CL CL B 226 D 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo -29.80 31.30 63.54 -28.79 33.52 63.37 53.28 14.40 40.02 51.53 15.84 39.30 coo -23.30 35.33 62.20 -25.10 34.24 64.06 50.38 9.38 40.26 48.54 7.35 39.73 coo -24.76 28.82 60.31 -24.27 29.01 65.58 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 28 SER~? 26.52 CL CL A 226 E 140 TYR A 21 TYR~? 21.90 CL CL A 226 E 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 26.40 -24.33 19.56 28.45 -23.49 18.56 coo 0.04 36.70 38.68 -2.21 35.46 37.50 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 1.93 30.52 36.31 -2.84 30.18 38.54 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER A 207 SER~? 18.13 CL CL A 226 E 140 TYR A 208 TYR~? 15.64 CL CL A 226 E 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 20.60 11.23 0.64 19.47 10.75 2.68 coo 0.04 36.70 38.68 -2.21 35.46 37.50 25.22 8.01 3.41 27.20 7.60 5.36 coo 1.93 30.52 36.31 -2.84 30.18 38.54 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 E 116 SER A 207 SER~? 18.13 CL CL A 226 E 140 TYR A 209 TYR~? 20.76 CL CL A 226 E 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 20.60 11.23 0.64 19.47 10.75 2.68 coo 0.04 36.70 38.68 -2.21 35.46 37.50 27.49 9.87 -0.64 29.01 7.64 0.00 coo 1.93 30.52 36.31 -2.84 30.18 38.54 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 E 116 SER A 210 SER~? 21.09 CL CL A 226 E 140 TYR A 208 TYR~? 15.64 CL CL A 226 E 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 24.15 14.96 0.00 24.37 15.67 2.31 coo 0.04 36.70 38.68 -2.21 35.46 37.50 25.22 8.01 3.41 27.20 7.60 5.36 coo 1.93 30.52 36.31 -2.84 30.18 38.54 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 E 116 SER A 210 SER~? 21.09 CL CL A 226 E 140 TYR A 209 TYR~? 20.76 CL CL A 226 E 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 24.15 14.96 0.00 24.37 15.67 2.31 coo 0.04 36.70 38.68 -2.21 35.46 37.50 27.49 9.87 -0.64 29.01 7.64 0.00 coo 1.93 30.52 36.31 -2.84 30.18 38.54 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 E 116 SER B 28 SER~? 26.37 CL CL B 226 E 140 TYR B 21 TYR~? 21.81 CL CL B 226 E 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 0.04 36.70 38.68 -2.21 35.46 37.50 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 1.93 30.52 36.31 -2.84 30.18 38.54 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 E 116 SER B 72 SER.? 25.86 CL CL B 226 E 140 TYR B 21 TYR~? 21.81 CL CL B 226 E 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 0.04 36.70 38.68 -2.21 35.46 37.50 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 1.93 30.52 36.31 -2.84 30.18 38.54 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 E 116 SER B 207 SER~? 19.03 CL CL B 226 E 140 TYR B 208 TYR~? 15.74 CL CL B 226 E 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 57.60 9.31 39.27 58.73 7.29 38.76 coo 0.04 36.70 38.68 -2.21 35.46 37.50 52.42 6.76 36.83 50.45 6.61 34.90 coo 1.93 30.52 36.31 -2.84 30.18 38.54 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 E 116 SER B 207 SER~? 19.03 CL CL B 226 E 140 TYR B 209 TYR~? 20.47 CL CL B 226 E 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 57.60 9.31 39.27 58.73 7.29 38.76 coo 0.04 36.70 38.68 -2.21 35.46 37.50 50.38 9.38 40.26 48.54 7.35 39.73 coo 1.93 30.52 36.31 -2.84 30.18 38.54 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 E 116 SER B 210 SER~? 23.92 CL CL B 226 E 140 TYR B 209 TYR~? 20.47 CL CL B 226 E 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo -3.01 32.72 32.71 -2.80 34.91 33.79 53.28 14.40 40.02 51.53 15.84 39.30 coo 0.04 36.70 38.68 -2.21 35.46 37.50 50.38 9.38 40.26 48.54 7.35 39.73 coo 1.93 30.52 36.31 -2.84 30.18 38.54 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 28 SER~? 26.52 CL CL A 226 F 140 TYR A 21 TYR~? 21.90 CL CL A 226 F 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 26.40 -24.33 19.56 28.45 -23.49 18.56 coo 54.49 89.31 49.65 53.35 90.16 52.06 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 56.78 95.62 51.15 51.59 95.31 52.37 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER A 207 SER~? 18.13 CL CL A 226 F 140 TYR A 208 TYR~? 15.64 CL CL A 226 F 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 20.60 11.23 0.64 19.47 10.75 2.68 coo 54.49 89.31 49.65 53.35 90.16 52.06 25.22 8.01 3.41 27.20 7.60 5.36 coo 56.78 95.62 51.15 51.59 95.31 52.37 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 F 116 SER A 207 SER~? 18.13 CL CL A 226 F 140 TYR A 209 TYR~? 20.76 CL CL A 226 F 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 20.60 11.23 0.64 19.47 10.75 2.68 coo 54.49 89.31 49.65 53.35 90.16 52.06 27.49 9.87 -0.64 29.01 7.64 0.00 coo 56.78 95.62 51.15 51.59 95.31 52.37 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 F 116 SER A 210 SER~? 21.09 CL CL A 226 F 140 TYR A 208 TYR~? 15.64 CL CL A 226 F 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 24.15 14.96 0.00 24.37 15.67 2.31 coo 54.49 89.31 49.65 53.35 90.16 52.06 25.22 8.01 3.41 27.20 7.60 5.36 coo 56.78 95.62 51.15 51.59 95.31 52.37 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 F 116 SER A 210 SER~? 21.09 CL CL A 226 F 140 TYR A 209 TYR~? 20.76 CL CL A 226 F 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 24.15 14.96 0.00 24.37 15.67 2.31 coo 54.49 89.31 49.65 53.35 90.16 52.06 27.49 9.87 -0.64 29.01 7.64 0.00 coo 56.78 95.62 51.15 51.59 95.31 52.37 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 F 116 SER B 28 SER~? 26.37 CL CL B 226 F 140 TYR B 21 TYR~? 21.81 CL CL B 226 F 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 54.49 89.31 49.65 53.35 90.16 52.06 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 56.78 95.62 51.15 51.59 95.31 52.37 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 F 116 SER B 72 SER.? 25.86 CL CL B 226 F 140 TYR B 21 TYR~? 21.81 CL CL B 226 F 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 54.49 89.31 49.65 53.35 90.16 52.06 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 56.78 95.62 51.15 51.59 95.31 52.37 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 F 116 SER B 207 SER~? 19.03 CL CL B 226 F 140 TYR B 208 TYR~? 15.74 CL CL B 226 F 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 57.60 9.31 39.27 58.73 7.29 38.76 coo 54.49 89.31 49.65 53.35 90.16 52.06 52.42 6.76 36.83 50.45 6.61 34.90 coo 56.78 95.62 51.15 51.59 95.31 52.37 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 F 116 SER B 207 SER~? 19.03 CL CL B 226 F 140 TYR B 209 TYR~? 20.47 CL CL B 226 F 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 57.60 9.31 39.27 58.73 7.29 38.76 coo 54.49 89.31 49.65 53.35 90.16 52.06 50.38 9.38 40.26 48.54 7.35 39.73 coo 56.78 95.62 51.15 51.59 95.31 52.37 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 F 116 SER B 210 SER~? 23.92 CL CL B 226 F 140 TYR B 209 TYR~? 20.47 CL CL B 226 F 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo 55.30 92.46 56.72 55.15 90.39 55.38 53.28 14.40 40.02 51.53 15.84 39.30 coo 54.49 89.31 49.65 53.35 90.16 52.06 50.38 9.38 40.26 48.54 7.35 39.73 coo 56.78 95.62 51.15 51.59 95.31 52.37 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 28 SER~? 26.52 CL CL A 226 G 140 TYR A 21 TYR~? 21.90 CL CL A 226 G 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 26.40 -24.33 19.56 28.45 -23.49 18.56 coo 69.78 91.62 20.06 71.51 92.68 22.02 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 71.19 98.21 18.32 70.69 97.75 23.67 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER A 207 SER~? 18.13 CL CL A 226 G 140 TYR A 208 TYR~? 15.64 CL CL A 226 G 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 20.60 11.23 0.64 19.47 10.75 2.68 coo 69.78 91.62 20.06 71.51 92.68 22.02 25.22 8.01 3.41 27.20 7.60 5.36 coo 71.19 98.21 18.32 70.69 97.75 23.67 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 G 116 SER A 207 SER~? 18.13 CL CL A 226 G 140 TYR A 209 TYR~? 20.76 CL CL A 226 G 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 20.60 11.23 0.64 19.47 10.75 2.68 coo 69.78 91.62 20.06 71.51 92.68 22.02 27.49 9.87 -0.64 29.01 7.64 0.00 coo 71.19 98.21 18.32 70.69 97.75 23.67 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 G 116 SER A 210 SER~? 21.09 CL CL A 226 G 140 TYR A 208 TYR~? 15.64 CL CL A 226 G 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 24.15 14.96 0.00 24.37 15.67 2.31 coo 69.78 91.62 20.06 71.51 92.68 22.02 25.22 8.01 3.41 27.20 7.60 5.36 coo 71.19 98.21 18.32 70.69 97.75 23.67 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 G 116 SER A 210 SER~? 21.09 CL CL A 226 G 140 TYR A 209 TYR~? 20.76 CL CL A 226 G 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 24.15 14.96 0.00 24.37 15.67 2.31 coo 69.78 91.62 20.06 71.51 92.68 22.02 27.49 9.87 -0.64 29.01 7.64 0.00 coo 71.19 98.21 18.32 70.69 97.75 23.67 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 G 116 SER B 28 SER~? 26.37 CL CL B 226 G 140 TYR B 21 TYR~? 21.81 CL CL B 226 G 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 69.78 91.62 20.06 71.51 92.68 22.02 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 71.19 98.21 18.32 70.69 97.75 23.67 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 G 116 SER B 72 SER.? 25.86 CL CL B 226 G 140 TYR B 21 TYR~? 21.81 CL CL B 226 G 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 69.78 91.62 20.06 71.51 92.68 22.02 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 71.19 98.21 18.32 70.69 97.75 23.67 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 G 116 SER B 207 SER~? 19.03 CL CL B 226 G 140 TYR B 208 TYR~? 15.74 CL CL B 226 G 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 57.60 9.31 39.27 58.73 7.29 38.76 coo 69.78 91.62 20.06 71.51 92.68 22.02 52.42 6.76 36.83 50.45 6.61 34.90 coo 71.19 98.21 18.32 70.69 97.75 23.67 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 G 116 SER B 207 SER~? 19.03 CL CL B 226 G 140 TYR B 209 TYR~? 20.47 CL CL B 226 G 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 57.60 9.31 39.27 58.73 7.29 38.76 coo 69.78 91.62 20.06 71.51 92.68 22.02 50.38 9.38 40.26 48.54 7.35 39.73 coo 71.19 98.21 18.32 70.69 97.75 23.67 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 G 116 SER B 210 SER~? 23.92 CL CL B 226 G 140 TYR B 209 TYR~? 20.47 CL CL B 226 G 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo 76.25 95.63 21.56 75.29 93.40 21.36 53.28 14.40 40.02 51.53 15.84 39.30 coo 69.78 91.62 20.06 71.51 92.68 22.02 50.38 9.38 40.26 48.54 7.35 39.73 coo 71.19 98.21 18.32 70.69 97.75 23.67 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 28 SER~? 26.52 CL CL A 226 H 140 TYR A 21 TYR~? 21.90 CL CL A 226 H 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 26.40 -24.33 19.56 28.45 -23.49 18.56 coo 21.92 87.58 44.67 19.30 88.41 44.23 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 21.26 93.70 47.67 18.47 93.68 43.08 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER A 207 SER~? 18.13 CL CL A 226 H 140 TYR A 208 TYR~? 15.64 CL CL A 226 H 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 20.60 11.23 0.64 19.47 10.75 2.68 coo 21.92 87.58 44.67 19.30 88.41 44.23 25.22 8.01 3.41 27.20 7.60 5.36 coo 21.26 93.70 47.67 18.47 93.68 43.08 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 H 116 SER A 207 SER~? 18.13 CL CL A 226 H 140 TYR A 209 TYR~? 20.76 CL CL A 226 H 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 20.60 11.23 0.64 19.47 10.75 2.68 coo 21.92 87.58 44.67 19.30 88.41 44.23 27.49 9.87 -0.64 29.01 7.64 0.00 coo 21.26 93.70 47.67 18.47 93.68 43.08 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 H 116 SER A 210 SER~? 21.09 CL CL A 226 H 140 TYR A 208 TYR~? 15.64 CL CL A 226 H 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 24.15 14.96 0.00 24.37 15.67 2.31 coo 21.92 87.58 44.67 19.30 88.41 44.23 25.22 8.01 3.41 27.20 7.60 5.36 coo 21.26 93.70 47.67 18.47 93.68 43.08 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 H 116 SER A 210 SER~? 21.09 CL CL A 226 H 140 TYR A 209 TYR~? 20.76 CL CL A 226 H 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 24.15 14.96 0.00 24.37 15.67 2.31 coo 21.92 87.58 44.67 19.30 88.41 44.23 27.49 9.87 -0.64 29.01 7.64 0.00 coo 21.26 93.70 47.67 18.47 93.68 43.08 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 H 116 SER B 28 SER~? 26.37 CL CL B 226 H 140 TYR B 21 TYR~? 21.81 CL CL B 226 H 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 21.92 87.58 44.67 19.30 88.41 44.23 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 21.26 93.70 47.67 18.47 93.68 43.08 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 H 116 SER B 72 SER.? 25.86 CL CL B 226 H 140 TYR B 21 TYR~? 21.81 CL CL B 226 H 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 21.92 87.58 44.67 19.30 88.41 44.23 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 21.26 93.70 47.67 18.47 93.68 43.08 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 H 116 SER B 207 SER~? 19.03 CL CL B 226 H 140 TYR B 208 TYR~? 15.74 CL CL B 226 H 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 57.60 9.31 39.27 58.73 7.29 38.76 coo 21.92 87.58 44.67 19.30 88.41 44.23 52.42 6.76 36.83 50.45 6.61 34.90 coo 21.26 93.70 47.67 18.47 93.68 43.08 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 H 116 SER B 207 SER~? 19.03 CL CL B 226 H 140 TYR B 209 TYR~? 20.47 CL CL B 226 H 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 57.60 9.31 39.27 58.73 7.29 38.76 coo 21.92 87.58 44.67 19.30 88.41 44.23 50.38 9.38 40.26 48.54 7.35 39.73 coo 21.26 93.70 47.67 18.47 93.68 43.08 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 H 116 SER B 210 SER~? 23.92 CL CL B 226 H 140 TYR B 209 TYR~? 20.47 CL CL B 226 H 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo 15.45 90.62 47.70 16.55 88.57 46.97 53.28 14.40 40.02 51.53 15.84 39.30 coo 21.92 87.58 44.67 19.30 88.41 44.23 50.38 9.38 40.26 48.54 7.35 39.73 coo 21.26 93.70 47.67 18.47 93.68 43.08 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 207 SER~? 18.13 CL CL A 226 I 140 TYR A 208 TYR~? 15.64 CL CL A 226 I 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 20.60 11.23 0.64 19.47 10.75 2.68 coo 16.78 87.76 12.19 16.39 88.69 9.59 25.22 8.01 3.41 27.20 7.60 5.36 coo 13.67 93.83 12.65 17.08 93.94 8.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER A 207 SER~? 18.13 CL CL A 226 I 140 TYR A 209 TYR~? 20.76 CL CL A 226 I 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 20.60 11.23 0.64 19.47 10.75 2.68 coo 16.78 87.76 12.19 16.39 88.69 9.59 27.49 9.87 -0.64 29.01 7.64 0.00 coo 13.67 93.83 12.65 17.08 93.94 8.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 I 116 SER A 210 SER~? 21.09 CL CL A 226 I 140 TYR A 208 TYR~? 15.64 CL CL A 226 I 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 24.15 14.96 0.00 24.37 15.67 2.31 coo 16.78 87.76 12.19 16.39 88.69 9.59 25.22 8.01 3.41 27.20 7.60 5.36 coo 13.67 93.83 12.65 17.08 93.94 8.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 I 116 SER A 210 SER~? 21.09 CL CL A 226 I 140 TYR A 209 TYR~? 20.76 CL CL A 226 I 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 24.15 14.96 0.00 24.37 15.67 2.31 coo 16.78 87.76 12.19 16.39 88.69 9.59 27.49 9.87 -0.64 29.01 7.64 0.00 coo 13.67 93.83 12.65 17.08 93.94 8.58 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 I 116 SER B 28 SER~? 26.37 CL CL B 226 I 140 TYR B 21 TYR~? 21.81 CL CL B 226 I 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 16.78 87.76 12.19 16.39 88.69 9.59 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 13.67 93.83 12.65 17.08 93.94 8.58 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 I 116 SER B 72 SER.? 25.86 CL CL B 226 I 140 TYR B 21 TYR~? 21.81 CL CL B 226 I 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 16.78 87.76 12.19 16.39 88.69 9.59 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 13.67 93.83 12.65 17.08 93.94 8.58 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 I 116 SER B 207 SER~? 19.03 CL CL B 226 I 140 TYR B 208 TYR~? 15.74 CL CL B 226 I 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 57.60 9.31 39.27 58.73 7.29 38.76 coo 16.78 87.76 12.19 16.39 88.69 9.59 52.42 6.76 36.83 50.45 6.61 34.90 coo 13.67 93.83 12.65 17.08 93.94 8.58 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 I 116 SER B 207 SER~? 19.03 CL CL B 226 I 140 TYR B 209 TYR~? 20.47 CL CL B 226 I 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 57.60 9.31 39.27 58.73 7.29 38.76 coo 16.78 87.76 12.19 16.39 88.69 9.59 50.38 9.38 40.26 48.54 7.35 39.73 coo 13.67 93.83 12.65 17.08 93.94 8.58 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 I 116 SER B 210 SER~? 23.92 CL CL B 226 I 140 TYR B 209 TYR~? 20.47 CL CL B 226 I 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo 11.78 90.82 7.18 12.84 88.72 7.93 53.28 14.40 40.02 51.53 15.84 39.30 coo 16.78 87.76 12.19 16.39 88.69 9.59 50.38 9.38 40.26 48.54 7.35 39.73 coo 13.67 93.83 12.65 17.08 93.94 8.58 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 28 SER~? 26.52 CL CL A 226 J 140 TYR A 21 TYR~? 21.90 CL CL A 226 J 144 LYS A 52 LYS^? 28.69 CL CL A 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 26.40 -24.33 19.56 28.45 -23.49 18.56 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER A 207 SER~? 18.13 CL CL A 226 J 140 TYR A 208 TYR~? 15.64 CL CL A 226 J 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 20.60 11.23 0.64 19.47 10.75 2.68 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 25.22 8.01 3.41 27.20 7.60 5.36 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 J 116 SER A 207 SER~? 18.13 CL CL A 226 J 140 TYR A 209 TYR~? 20.76 CL CL A 226 J 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 20.60 11.23 0.64 19.47 10.75 2.68 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 27.49 9.87 -0.64 29.01 7.64 0.00 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 J 116 SER A 210 SER~? 21.09 CL CL A 226 J 140 TYR A 208 TYR~? 15.64 CL CL A 226 J 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 24.15 14.96 0.00 24.37 15.67 2.31 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 25.22 8.01 3.41 27.20 7.60 5.36 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 J 116 SER A 210 SER~? 21.09 CL CL A 226 J 140 TYR A 209 TYR~? 20.76 CL CL A 226 J 144 LYS A 205 LYS~? 25.48 CL CL A 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 24.15 14.96 0.00 24.37 15.67 2.31 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 27.49 9.87 -0.64 29.01 7.64 0.00 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 J 116 SER B 28 SER~? 26.37 CL CL B 226 J 140 TYR B 21 TYR~? 21.81 CL CL B 226 J 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 J 116 SER B 72 SER.? 25.86 CL CL B 226 J 140 TYR B 21 TYR~? 21.81 CL CL B 226 J 144 LYS B 52 LYS^? 28.59 CL CL B 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 J 116 SER B 207 SER~? 19.03 CL CL B 226 J 140 TYR B 208 TYR~? 15.74 CL CL B 226 J 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 57.60 9.31 39.27 58.73 7.29 38.76 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 52.42 6.76 36.83 50.45 6.61 34.90 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 J 116 SER B 207 SER~? 19.03 CL CL B 226 J 140 TYR B 209 TYR~? 20.47 CL CL B 226 J 144 LYS B 205 LYS~? 25.67 CL CL B 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 57.60 9.31 39.27 58.73 7.29 38.76 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 50.38 9.38 40.26 48.54 7.35 39.73 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 J 116 SER B 210 SER~? 23.92 CL CL B 226 J 140 TYR B 209 TYR~? 20.47 CL CL B 226 J 144 LYS B 213 LYS~? 22.42 CL CL B 226 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 53.28 14.40 40.02 51.53 15.84 39.30 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 50.38 9.38 40.26 48.54 7.35 39.73 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 48.60 15.99 42.06 48.42 16.28 35.76 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 10 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 178 LYS~? 16.45 CL CL A 226 A 193 GLU A 172 GLU~? 15.14 CL CL A 226 A 217 VAL A 174 VAL~? 9.86 CL CL A 226 coo 2.10 10.68 61.44 -2.14 13.16 60.61 17.52 -4.22 5.13 11.68 -3.87 7.49 coo -5.33 11.71 69.72 -4.62 11.92 67.73 20.31 7.29 3.53 20.42 8.84 4.96 coo 0.07 12.29 66.53 -0.24 11.95 64.38 19.72 0.69 8.23 18.80 0.95 10.18 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 178 LYS~? 16.76 CL CL B 226 A 193 GLU B 172 GLU~? 15.62 CL CL B 226 A 217 VAL B 174 VAL~? 10.40 CL CL B 226 coo 2.10 10.68 61.44 -2.14 13.16 60.61 57.30 -6.98 36.80 62.98 -8.03 34.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 57.49 4.88 36.61 57.44 6.68 35.49 coo 0.07 12.29 66.53 -0.24 11.95 64.38 56.42 -2.04 33.02 57.43 -1.95 31.09 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR B 22 THR~? 22.16 CL CL B 226 A 159 LYS B 74 LYS.? 25.46 CL CL A 226 A 193 GLU B 69 GLU^? 24.72 CL CL B 226 coo -2.58 16.31 54.79 -4.02 14.93 55.64 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 2.10 10.68 61.44 -2.14 13.16 60.61 32.81 -17.40 29.10 28.60 -18.34 31.99 coo -5.33 11.71 69.72 -4.62 11.92 67.73 42.13 -16.51 33.43 40.68 -17.83 34.16 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 76 THR~? 22.20 CL CL A 226 A 159 LYS B 52 LYS^? 28.59 CL CL B 226 A 193 GLU A 26 GLU~? 31.19 CL CL A 226 coo -2.58 16.31 54.79 -4.02 14.93 55.64 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 42.32 -20.73 28.98 39.02 -22.55 33.10 coo -5.33 11.71 69.72 -4.62 11.92 67.73 31.04 -26.45 25.52 31.42 -26.09 27.62 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 76 THR~? 22.20 CL CL A 226 A 159 LYS B 52 LYS^? 28.59 CL CL B 226 A 193 GLU B 26 GLU~? 28.82 CL CL B 226 coo -2.58 16.31 54.79 -4.02 14.93 55.64 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 42.32 -20.73 28.98 39.02 -22.55 33.10 coo -5.33 11.71 69.72 -4.62 11.92 67.73 37.69 -26.04 19.16 37.25 -23.97 18.66 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 120 THR~? 34.37 CL CL B 226 A 159 LYS B 195 LYS~? 36.01 CL CL B 226 A 193 GLU B 187 GLU.? 29.51 CL CL B 226 coo -2.58 16.31 54.79 -4.02 14.93 55.64 49.53 -10.83 53.77 47.46 -10.98 54.34 coo 2.10 10.68 61.44 -2.14 13.16 60.61 58.60 -4.05 52.32 60.39 -2.54 57.56 coo -5.33 11.71 69.72 -4.62 11.92 67.73 61.43 -15.09 46.94 62.69 -13.43 47.32 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 186 ASP.? 30.68 CL CL A 226 260 GLU A 192 GLU~? 36.97 CL CL A 226 370 TYR A 194 TYR~? 29.78 CL CL A 226 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 9.89 -7.05 -13.47 9.92 -6.07 -15.35 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 18.48 -5.35 -10.35 20.66 -3.63 -10.45 1euu_c00 source 1euu SIALIDASE : 1 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU B 69 GLU^? 24.72 CL CL B 226 A 260 ARG B 81 ARG~? 19.82 CL CL A 226 A 270 LYS B 74 LYS.? 25.46 CL CL A 226 coo 50.99 29.43 12.86 52.11 29.45 14.65 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 39.80 27.50 22.98 42.20 26.56 21.34 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 48.83 21.70 19.50 47.44 24.99 15.25 32.81 -17.40 29.10 28.60 -18.34 31.99 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 1 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 193 ASP~? 30.50 CL CL A 226 A 74 ASP A 186 ASP.? 30.68 CL CL A 226 A 98 GLU A 187 GLU.? 30.59 CL CL A 226 coo 17.19 9.05 25.28 15.77 9.98 26.53 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 15.99 8.54 17.36 14.96 7.80 19.05 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 16.31 12.85 18.11 16.71 11.79 19.90 10.39 -14.82 -4.45 8.65 -14.21 -3.38 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 1 hits 1eyi_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 193 ASP~? 30.50 CL CL A 226 C 117 GLU A 187 GLU.? 30.59 CL CL A 226 C 131 GLU A 192 GLU~? 36.97 CL CL A 226 coo 68.01 56.37 72.57 68.42 56.10 70.51 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 66.59 62.50 67.44 67.57 60.64 67.12 10.39 -14.82 -4.45 8.65 -14.21 -3.38 coo 69.24 52.27 71.96 69.91 50.26 71.89 9.89 -7.05 -13.47 9.92 -6.07 -15.35 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP B 193 ASP~? 31.47 CL CL B 226 C 117 GLU B 192 GLU~? 36.55 CL CL B 226 C 131 GLU B 187 GLU.? 29.51 CL CL B 226 coo 68.01 56.37 72.57 68.42 56.10 70.51 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 66.59 62.50 67.44 67.57 60.64 67.12 63.14 -8.79 55.95 62.53 -7.11 57.12 coo 69.24 52.27 71.96 69.91 50.26 71.89 61.43 -15.09 46.94 62.69 -13.43 47.32 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 2 hits 1f6d_c02 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 109 PHE~? 18.50 CL CL A 226 A 210 ASP A 203 ASP~? 25.03 CL CL A 226 A 244 LYS A 178 LYS~? 16.45 CL CL A 226 coo 9.23 46.77 25.11 11.48 48.39 24.76 24.98 3.58 -0.85 22.97 3.50 1.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -1.20 42.34 17.67 3.19 45.13 19.06 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 109 PHE~? 18.50 CL CL A 226 A 210 ASP A 203 ASP~? 25.03 CL CL A 226 A 244 LYS A 195 LYS~? 35.76 CL CL A 226 coo 9.23 46.77 25.11 11.48 48.39 24.76 24.98 3.58 -0.85 22.97 3.50 1.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -1.20 42.34 17.67 3.19 45.13 19.06 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE B 109 PHE~? 18.73 CL CL B 226 A 210 ASP B 102 ASP~? 16.83 CL CL B 226 A 244 LYS B 213 LYS~? 22.42 CL CL B 226 coo 9.23 46.77 25.11 11.48 48.39 24.76 51.52 2.89 41.40 53.63 2.11 39.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.25 7.06 34.64 46.46 8.64 34.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE B 109 PHE~? 18.73 CL CL B 226 A 210 ASP B 203 ASP~? 25.12 CL CL B 226 A 244 LYS B 178 LYS~? 16.76 CL CL B 226 coo 9.23 46.77 25.11 11.48 48.39 24.76 51.52 2.89 41.40 53.63 2.11 39.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 60.54 4.31 43.90 62.00 4.57 45.37 coo -1.20 42.34 17.67 3.19 45.13 19.06 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE B 109 PHE~? 18.73 CL CL B 226 A 210 ASP B 203 ASP~? 25.12 CL CL B 226 A 244 LYS B 195 LYS~? 36.01 CL CL B 226 coo 9.23 46.77 25.11 11.48 48.39 24.76 51.52 2.89 41.40 53.63 2.11 39.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 60.54 4.31 43.90 62.00 4.57 45.37 coo -1.20 42.34 17.67 3.19 45.13 19.06 58.60 -4.05 52.32 60.39 -2.54 57.56 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 5 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 109 PHE~? 18.50 CL CL A 226 B 210 ASP A 203 ASP~? 25.03 CL CL A 226 B 244 LYS A 178 LYS~? 16.45 CL CL A 226 coo 8.76 47.85 34.91 11.08 46.36 35.41 24.98 3.58 -0.85 22.97 3.50 1.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -2.38 51.82 41.62 2.07 49.19 40.42 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 109 PHE~? 18.50 CL CL A 226 B 210 ASP A 203 ASP~? 25.03 CL CL A 226 B 244 LYS A 195 LYS~? 35.76 CL CL A 226 coo 8.76 47.85 34.91 11.08 46.36 35.41 24.98 3.58 -0.85 22.97 3.50 1.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -2.38 51.82 41.62 2.07 49.19 40.42 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE B 109 PHE~? 18.73 CL CL B 226 B 210 ASP B 102 ASP~? 16.83 CL CL B 226 B 244 LYS B 213 LYS~? 22.42 CL CL B 226 coo 8.76 47.85 34.91 11.08 46.36 35.41 51.52 2.89 41.40 53.63 2.11 39.78 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.25 7.06 34.64 46.46 8.64 34.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE B 109 PHE~? 18.73 CL CL B 226 B 210 ASP B 203 ASP~? 25.12 CL CL B 226 B 244 LYS B 178 LYS~? 16.76 CL CL B 226 coo 8.76 47.85 34.91 11.08 46.36 35.41 51.52 2.89 41.40 53.63 2.11 39.78 coo 9.06 56.85 40.30 7.71 55.27 39.90 60.54 4.31 43.90 62.00 4.57 45.37 coo -2.38 51.82 41.62 2.07 49.19 40.42 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE B 109 PHE~? 18.73 CL CL B 226 B 210 ASP B 203 ASP~? 25.12 CL CL B 226 B 244 LYS B 195 LYS~? 36.01 CL CL B 226 coo 8.76 47.85 34.91 11.08 46.36 35.41 51.52 2.89 41.40 53.63 2.11 39.78 coo 9.06 56.85 40.30 7.71 55.27 39.90 60.54 4.31 43.90 62.00 4.57 45.37 coo -2.38 51.82 41.62 2.07 49.19 40.42 58.60 -4.05 52.32 60.39 -2.54 57.56 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 5 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 21 TYR~? 21.90 CL CL A 226 A 142 LEU A 17 LEU~? 13.21 CL CL A 226 A 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 28.70 -9.89 18.46 26.53 -9.67 18.41 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 21 TYR~? 21.90 CL CL A 226 A 142 LEU A 79 LEU~? 16.20 CL CL A 226 A 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 33.80 -9.42 15.25 31.63 -9.90 15.24 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 21 TYR~? 21.90 CL CL A 226 A 142 LEU B 25 LEU~? 26.04 CL CL B 226 A 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 39.38 -21.98 21.83 38.35 -21.94 23.71 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR A 46 TYR^? 12.99 CL CL A 226 A 142 LEU A 53 LEU^? 18.62 CL CL A 226 A 165 LYS A 36 LYS^? 12.38 CL CL A 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 22.89 -11.80 16.43 23.58 -9.15 16.08 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 28.58 -15.95 15.08 27.62 -14.37 16.15 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR A 46 TYR^? 12.99 CL CL A 226 A 142 LEU A 70 LEU^? 16.48 CL CL A 226 A 165 LYS A 36 LYS^? 12.38 CL CL A 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 22.89 -11.80 16.43 23.58 -9.15 16.08 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 29.18 -12.31 12.09 27.61 -10.79 11.87 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR B 21 TYR~? 21.81 CL CL B 226 A 142 LEU A 25 LEU~? 26.14 CL CL A 226 A 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 32.61 -21.79 21.05 33.45 -21.15 19.19 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR B 21 TYR~? 21.81 CL CL B 226 A 142 LEU B 17 LEU~? 13.17 CL CL B 226 A 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 45.54 -11.42 23.06 47.40 -11.56 24.13 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR B 21 TYR~? 21.81 CL CL B 226 A 142 LEU B 79 LEU~? 16.21 CL CL B 226 A 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 40.62 -9.96 25.88 42.50 -11.06 26.10 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR B 46 TYR^? 12.90 CL CL B 226 A 142 LEU B 24 LEU~? 22.29 CL CL B 226 A 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 44.88 -21.36 19.96 46.64 -21.16 18.72 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR B 46 TYR^? 12.90 CL CL B 226 A 142 LEU B 53 LEU^? 18.36 CL CL B 226 A 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 44.49 -16.82 27.25 45.86 -15.67 25.93 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 A 137 TYR B 46 TYR^? 12.90 CL CL B 226 A 142 LEU B 70 LEU^? 16.29 CL CL B 226 A 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 44.60 -13.30 29.51 46.14 -11.79 29.37 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 55.08 -14.30 22.43 60.90 -14.25 24.08 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 11 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 21 TYR~? 21.90 CL CL A 226 B 142 LEU A 17 LEU~? 13.21 CL CL A 226 B 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 28.70 -9.89 18.46 26.53 -9.67 18.41 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 21 TYR~? 21.90 CL CL A 226 B 142 LEU A 79 LEU~? 16.20 CL CL A 226 B 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 33.80 -9.42 15.25 31.63 -9.90 15.24 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 21 TYR~? 21.90 CL CL A 226 B 142 LEU B 25 LEU~? 26.04 CL CL B 226 B 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 39.38 -21.98 21.83 38.35 -21.94 23.71 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR A 46 TYR^? 12.99 CL CL A 226 B 142 LEU A 53 LEU^? 18.62 CL CL A 226 B 165 LYS A 36 LYS^? 12.38 CL CL A 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 22.89 -11.80 16.43 23.58 -9.15 16.08 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 28.58 -15.95 15.08 27.62 -14.37 16.15 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR A 46 TYR^? 12.99 CL CL A 226 B 142 LEU A 70 LEU^? 16.48 CL CL A 226 B 165 LYS A 36 LYS^? 12.38 CL CL A 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 22.89 -11.80 16.43 23.58 -9.15 16.08 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 29.18 -12.31 12.09 27.61 -10.79 11.87 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR B 21 TYR~? 21.81 CL CL B 226 B 142 LEU A 25 LEU~? 26.14 CL CL A 226 B 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 32.61 -21.79 21.05 33.45 -21.15 19.19 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR B 21 TYR~? 21.81 CL CL B 226 B 142 LEU B 17 LEU~? 13.17 CL CL B 226 B 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 45.54 -11.42 23.06 47.40 -11.56 24.13 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR B 21 TYR~? 21.81 CL CL B 226 B 142 LEU B 79 LEU~? 16.21 CL CL B 226 B 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 40.62 -9.96 25.88 42.50 -11.06 26.10 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 B 137 TYR B 46 TYR^? 12.90 CL CL B 226 B 142 LEU B 24 LEU~? 22.29 CL CL B 226 B 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 44.88 -21.36 19.96 46.64 -21.16 18.72 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 B 137 TYR B 46 TYR^? 12.90 CL CL B 226 B 142 LEU B 53 LEU^? 18.36 CL CL B 226 B 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 44.49 -16.82 27.25 45.86 -15.67 25.93 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 B 137 TYR B 46 TYR^? 12.90 CL CL B 226 B 142 LEU B 70 LEU^? 16.29 CL CL B 226 B 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 44.60 -13.30 29.51 46.14 -11.79 29.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 55.08 -14.30 22.43 60.90 -14.25 24.08 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 11 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 21 TYR~? 21.90 CL CL A 226 C 142 LEU A 17 LEU~? 13.21 CL CL A 226 C 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 28.70 -9.89 18.46 26.53 -9.67 18.41 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 21 TYR~? 21.90 CL CL A 226 C 142 LEU A 79 LEU~? 16.20 CL CL A 226 C 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 33.80 -9.42 15.25 31.63 -9.90 15.24 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 21 TYR~? 21.90 CL CL A 226 C 142 LEU B 25 LEU~? 26.04 CL CL B 226 C 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 39.38 -21.98 21.83 38.35 -21.94 23.71 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR A 46 TYR^? 12.99 CL CL A 226 C 142 LEU A 53 LEU^? 18.62 CL CL A 226 C 165 LYS A 36 LYS^? 12.38 CL CL A 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 22.89 -11.80 16.43 23.58 -9.15 16.08 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 28.58 -15.95 15.08 27.62 -14.37 16.15 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR A 46 TYR^? 12.99 CL CL A 226 C 142 LEU A 70 LEU^? 16.48 CL CL A 226 C 165 LYS A 36 LYS^? 12.38 CL CL A 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 22.89 -11.80 16.43 23.58 -9.15 16.08 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 29.18 -12.31 12.09 27.61 -10.79 11.87 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR B 21 TYR~? 21.81 CL CL B 226 C 142 LEU A 25 LEU~? 26.14 CL CL A 226 C 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 32.61 -21.79 21.05 33.45 -21.15 19.19 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR B 21 TYR~? 21.81 CL CL B 226 C 142 LEU B 17 LEU~? 13.17 CL CL B 226 C 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 45.54 -11.42 23.06 47.40 -11.56 24.13 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR B 21 TYR~? 21.81 CL CL B 226 C 142 LEU B 79 LEU~? 16.21 CL CL B 226 C 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 40.62 -9.96 25.88 42.50 -11.06 26.10 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 C 137 TYR B 46 TYR^? 12.90 CL CL B 226 C 142 LEU B 53 LEU^? 18.36 CL CL B 226 C 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 44.49 -16.82 27.25 45.86 -15.67 25.93 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 C 137 TYR B 46 TYR^? 12.90 CL CL B 226 C 142 LEU B 70 LEU^? 16.29 CL CL B 226 C 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 44.60 -13.30 29.51 46.14 -11.79 29.37 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 55.08 -14.30 22.43 60.90 -14.25 24.08 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 10 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 21 TYR~? 21.90 CL CL A 226 D 142 LEU A 17 LEU~? 13.21 CL CL A 226 D 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 28.70 -9.89 18.46 26.53 -9.67 18.41 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 21 TYR~? 21.90 CL CL A 226 D 142 LEU A 79 LEU~? 16.20 CL CL A 226 D 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 33.80 -9.42 15.25 31.63 -9.90 15.24 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 21 TYR~? 21.90 CL CL A 226 D 142 LEU B 25 LEU~? 26.04 CL CL B 226 D 165 LYS A 52 LYS^? 28.69 CL CL A 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 31.69 -16.23 18.31 32.96 -18.03 16.63 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 39.38 -21.98 21.83 38.35 -21.94 23.71 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR A 46 TYR^? 12.99 CL CL A 226 D 142 LEU A 53 LEU^? 18.62 CL CL A 226 D 165 LYS A 36 LYS^? 12.38 CL CL A 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 22.89 -11.80 16.43 23.58 -9.15 16.08 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 28.58 -15.95 15.08 27.62 -14.37 16.15 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR A 46 TYR^? 12.99 CL CL A 226 D 142 LEU A 70 LEU^? 16.48 CL CL A 226 D 165 LYS A 36 LYS^? 12.38 CL CL A 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 22.89 -11.80 16.43 23.58 -9.15 16.08 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 29.18 -12.31 12.09 27.61 -10.79 11.87 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR B 21 TYR~? 21.81 CL CL B 226 D 142 LEU A 25 LEU~? 26.14 CL CL A 226 D 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 32.61 -21.79 21.05 33.45 -21.15 19.19 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR B 21 TYR~? 21.81 CL CL B 226 D 142 LEU B 17 LEU~? 13.17 CL CL B 226 D 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 45.54 -11.42 23.06 47.40 -11.56 24.13 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR B 21 TYR~? 21.81 CL CL B 226 D 142 LEU B 79 LEU~? 16.21 CL CL B 226 D 165 LYS B 52 LYS^? 28.59 CL CL B 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 41.23 -17.00 23.95 39.78 -18.41 25.81 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 40.62 -9.96 25.88 42.50 -11.06 26.10 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 137 TYR B 46 TYR^? 12.90 CL CL B 226 D 142 LEU B 24 LEU~? 22.29 CL CL B 226 D 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 44.88 -21.36 19.96 46.64 -21.16 18.72 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 D 137 TYR B 46 TYR^? 12.90 CL CL B 226 D 142 LEU B 53 LEU^? 18.36 CL CL B 226 D 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 44.49 -16.82 27.25 45.86 -15.67 25.93 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 D 137 TYR B 46 TYR^? 12.90 CL CL B 226 D 142 LEU B 70 LEU^? 16.29 CL CL B 226 D 165 LYS B 36 LYS^? 15.37 CL CL B 226 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 50.79 -14.19 25.59 51.15 -11.43 25.53 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 44.60 -13.30 29.51 46.14 -11.79 29.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 55.08 -14.30 22.43 60.90 -14.25 24.08 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 11 hits 1fdy_c03 naa= 3 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU A 175 GLU~? 15.88 CL CL A 226 A 198 CYH A 62 CYH.? 23.61 CL CL A 226 A 206 CYH A 34 CYH^? 20.26 CL CL A 226 coo 49.92 26.66 0.19 51.26 25.02 0.19 15.56 2.16 3.91 14.40 0.59 4.79 coo 51.25 11.31 6.04 51.91 8.58 5.83 9.90 -12.74 4.18 12.50 -12.77 3.13 coo 38.98 17.42 20.63 38.42 14.68 20.70 19.64 -17.85 18.93 17.88 -17.43 16.93 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 2 3 # 2 A 94 GLU B 175 GLU~? 17.14 CL CL B 226 A 198 CYH B 62 CYH.? 23.90 CL CL B 226 A 206 CYH B 34 CYH^? 20.64 CL CL B 226 coo 49.92 26.66 0.19 51.26 25.02 0.19 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 51.25 11.31 6.04 51.91 8.58 5.83 63.33 -15.73 38.50 60.87 -15.29 39.80 coo 38.98 17.42 20.63 38.42 14.68 20.70 52.71 -21.09 23.85 54.82 -21.04 25.59 1ff3_c00 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 2 hits 1ff3_c00 naa= 3 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU A 175 GLU~? 15.88 CL CL A 226 A 198 CYH A 62 CYH.? 23.61 CL CL A 226 A 206 CYH A 34 CYH^? 20.26 CL CL A 226 coo 49.92 26.66 0.19 51.26 25.02 0.19 15.56 2.16 3.91 14.40 0.59 4.79 coo 51.25 11.31 6.04 51.91 8.58 5.83 9.90 -12.74 4.18 12.50 -12.77 3.13 coo 38.98 17.42 20.63 38.42 14.68 20.70 19.64 -17.85 18.93 17.88 -17.43 16.93 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 2 3 # 2 A 94 GLU B 175 GLU~? 17.14 CL CL B 226 A 198 CYH B 62 CYH.? 23.90 CL CL B 226 A 206 CYH B 34 CYH^? 20.64 CL CL B 226 coo 49.92 26.66 0.19 51.26 25.02 0.19 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 51.25 11.31 6.04 51.91 8.58 5.83 63.33 -15.73 38.50 60.87 -15.29 39.80 coo 38.98 17.42 20.63 38.42 14.68 20.70 52.71 -21.09 23.85 54.82 -21.04 25.59 1ff3_c01 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 2 hits 1ff3_c01 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 81 ARG~? 19.72 CL CL B 226 A 136 GLU B 9 GLU.? 16.36 CL CL B 226 A 246 GLU A 77 GLU~? 21.84 CL CL B 226 coo 13.48 30.30 107.06 11.75 30.99 109.44 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 9.46 32.37 115.82 8.50 34.20 115.47 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 11.99 34.33 109.92 10.08 34.19 110.77 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 81 ARG~? 19.82 CL CL A 226 A 136 GLU A 9 GLU.? 16.20 CL CL A 226 A 246 GLU B 77 GLU~? 22.22 CL CL A 226 coo 13.48 30.30 107.06 11.75 30.99 109.44 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 9.46 32.37 115.82 8.50 34.20 115.47 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 11.99 34.33 109.92 10.08 34.19 110.77 34.33 -9.48 30.93 34.02 -11.53 31.29 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 2 hits 1fhl_c00 naa= 3 ULMN 3 1fo6_c00 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 A 47 GLU A 4 GLU^? 21.78 CL CL A 226 A 127 LYS A 36 LYS^? 12.38 CL CL A 226 A 172 CYH A 34 CYH^? 20.26 CL CL A 226 coo 14.84 17.73 17.72 12.66 18.02 17.60 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 13.59 13.62 10.66 10.48 17.11 15.01 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 10.73 13.80 18.28 9.65 16.43 18.61 19.64 -17.85 18.93 17.88 -17.43 16.93 ULMN 3 1fo6_c00 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 2 3 # 2 A 47 GLU B 4 GLU^? 21.62 CL CL B 226 A 127 LYS B 36 LYS^? 15.37 CL CL B 226 A 172 CYH B 34 CYH^? 20.64 CL CL B 226 coo 14.84 17.73 17.72 12.66 18.02 17.60 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 13.59 13.62 10.66 10.48 17.11 15.01 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 10.73 13.80 18.28 9.65 16.43 18.61 52.71 -21.09 23.85 54.82 -21.04 25.59 1fo6_c00 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 2 hits 1fo6_c00 naa= 3 ULMN 3 1fo6_c01 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 B 47 GLU A 4 GLU^? 21.78 CL CL A 226 B 127 LYS A 36 LYS^? 12.38 CL CL A 226 B 172 CYH A 34 CYH^? 20.26 CL CL A 226 coo -11.43 -15.11 20.71 -9.41 -15.34 21.12 17.40 -16.82 25.22 19.04 -17.86 26.09 coo -8.59 -13.62 12.98 -6.65 -15.32 18.82 19.01 -10.55 19.77 15.11 -7.69 20.09 coo -7.53 -11.08 20.68 -6.56 -13.38 22.13 19.64 -17.85 18.93 17.88 -17.43 16.93 ULMN 3 1fo6_c01 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 2 3 # 2 B 47 GLU B 4 GLU^? 21.62 CL CL B 226 B 127 LYS B 36 LYS^? 15.37 CL CL B 226 B 172 CYH B 34 CYH^? 20.64 CL CL B 226 coo -11.43 -15.11 20.71 -9.41 -15.34 21.12 55.04 -20.91 16.97 53.22 -21.40 15.95 coo -8.59 -13.62 12.98 -6.65 -15.32 18.82 55.08 -14.30 22.43 60.90 -14.25 24.08 coo -7.53 -11.08 20.68 -6.56 -13.38 22.13 52.71 -21.09 23.85 54.82 -21.04 25.59 1fo6_c01 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 2 hits 1fo6_c01 naa= 3 ULMN 3 1fo6_c02 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 C 47 GLU A 4 GLU^? 21.78 CL CL A 226 C 127 LYS A 36 LYS^? 12.38 CL CL A 226 C 172 CYH A 34 CYH^? 20.26 CL CL A 226 coo -14.75 22.68 45.73 -12.65 22.97 45.86 17.40 -16.82 25.22 19.04 -17.86 26.09 coo -13.46 21.30 53.90 -10.36 22.98 48.58 19.01 -10.55 19.77 15.11 -7.69 20.09 coo -10.67 18.91 46.59 -9.50 21.20 45.39 19.64 -17.85 18.93 17.88 -17.43 16.93 ULMN 3 1fo6_c02 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 2 3 # 2 C 47 GLU B 4 GLU^? 21.62 CL CL B 226 C 127 LYS B 36 LYS^? 15.37 CL CL B 226 C 172 CYH B 34 CYH^? 20.64 CL CL B 226 coo -14.75 22.68 45.73 -12.65 22.97 45.86 55.04 -20.91 16.97 53.22 -21.40 15.95 coo -13.46 21.30 53.90 -10.36 22.98 48.58 55.08 -14.30 22.43 60.90 -14.25 24.08 coo -10.67 18.91 46.59 -9.50 21.20 45.39 52.71 -21.09 23.85 54.82 -21.04 25.59 1fo6_c02 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 2 hits 1fo6_c02 naa= 3 ULMN 3 1fo6_c03 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 D 47 GLU A 4 GLU^? 21.78 CL CL A 226 D 127 LYS A 36 LYS^? 12.38 CL CL A 226 D 172 CYH A 34 CYH^? 20.26 CL CL A 226 coo 11.48 -9.38 54.24 9.40 -9.76 53.86 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 8.59 -5.45 60.90 6.67 -8.84 55.89 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 7.45 -5.79 52.90 6.67 -8.39 52.10 19.64 -17.85 18.93 17.88 -17.43 16.93 ULMN 3 1fo6_c03 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 2 3 # 2 D 47 GLU B 4 GLU^? 21.62 CL CL B 226 D 127 LYS B 36 LYS^? 15.37 CL CL B 226 D 172 CYH B 34 CYH^? 20.64 CL CL B 226 coo 11.48 -9.38 54.24 9.40 -9.76 53.86 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 8.59 -5.45 60.90 6.67 -8.84 55.89 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 7.45 -5.79 52.90 6.67 -8.39 52.10 52.71 -21.09 23.85 54.82 -21.04 25.59 1fo6_c03 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 2 hits 1fo6_c03 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 81 ARG~? 19.72 CL CL B 226 A 136 GLU B 9 GLU.? 16.36 CL CL B 226 A 246 GLU A 77 GLU~? 21.84 CL CL B 226 coo 13.94 29.84 106.80 11.67 30.40 108.79 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 9.52 31.97 115.23 8.45 33.74 114.72 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 11.92 33.82 109.35 10.10 33.50 110.39 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 81 ARG~? 19.82 CL CL A 226 A 136 GLU A 9 GLU.? 16.20 CL CL A 226 A 246 GLU B 77 GLU~? 22.22 CL CL A 226 coo 13.94 29.84 106.80 11.67 30.40 108.79 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 9.52 31.97 115.23 8.45 33.74 114.72 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 11.92 33.82 109.35 10.10 33.50 110.39 34.33 -9.48 30.93 34.02 -11.53 31.29 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 2 hits 1fob_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 40 ASP.? 7.65 CL CL A 226 A 281 ARG A 13 ARG~? 5.03 CL CL A 226 A 289 TYR A 38 TYR.? 10.54 CL CL A 226 coo 54.86 40.00 47.23 55.57 38.60 48.67 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 52.08 40.18 50.14 50.83 38.93 47.73 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 57.82 31.70 50.73 57.94 34.00 49.17 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP A 40 ASP.? 7.65 CL CL A 226 A 281 ARG A 13 ARG~? 5.03 CL CL A 226 A 289 TYR A 46 TYR^? 12.99 CL CL A 226 coo 54.86 40.00 47.23 55.57 38.60 48.67 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 52.08 40.18 50.14 50.83 38.93 47.73 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 57.82 31.70 50.73 57.94 34.00 49.17 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP B 40 ASP.? 7.91 CL CL B 226 A 281 ARG B 13 ARG~? 5.25 CL CL B 226 A 289 TYR B 38 TYR.? 11.29 CL CL B 226 coo 54.86 40.00 47.23 55.57 38.60 48.67 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 52.08 40.18 50.14 50.83 38.93 47.73 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 57.82 31.70 50.73 57.94 34.00 49.17 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 4 3 # 4 A 54 ASP B 40 ASP.? 7.91 CL CL B 226 A 281 ARG B 13 ARG~? 5.25 CL CL B 226 A 289 TYR B 46 TYR^? 12.90 CL CL B 226 coo 54.86 40.00 47.23 55.57 38.60 48.67 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 52.08 40.18 50.14 50.83 38.93 47.73 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 57.82 31.70 50.73 57.94 34.00 49.17 50.79 -14.19 25.59 51.15 -11.43 25.53 1foh_c00 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 40 ASP.? 7.65 CL CL A 226 B 281 ARG A 13 ARG~? 5.03 CL CL A 226 B 289 TYR A 38 TYR.? 10.54 CL CL A 226 coo 90.56 80.24 98.04 90.36 81.53 96.34 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 86.62 80.67 97.51 87.37 82.00 100.10 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 91.83 88.28 92.88 92.60 85.93 94.14 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP A 40 ASP.? 7.65 CL CL A 226 B 281 ARG A 13 ARG~? 5.03 CL CL A 226 B 289 TYR A 46 TYR^? 12.99 CL CL A 226 coo 90.56 80.24 98.04 90.36 81.53 96.34 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 86.62 80.67 97.51 87.37 82.00 100.10 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 91.83 88.28 92.88 92.60 85.93 94.14 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP A 40 ASP.? 7.65 CL CL A 226 B 281 ARG A 13 ARG~? 5.03 CL CL A 226 B 289 TYR A 160 TYR~? 15.52 CL CL A 226 coo 90.56 80.24 98.04 90.36 81.53 96.34 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 86.62 80.67 97.51 87.37 82.00 100.10 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 91.83 88.28 92.88 92.60 85.93 94.14 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 4 3 # 4 B 54 ASP B 40 ASP.? 7.91 CL CL B 226 B 281 ARG B 13 ARG~? 5.25 CL CL B 226 B 289 TYR B 38 TYR.? 11.29 CL CL B 226 coo 90.56 80.24 98.04 90.36 81.53 96.34 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 86.62 80.67 97.51 87.37 82.00 100.10 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 91.83 88.28 92.88 92.60 85.93 94.14 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 5 3 # 5 B 54 ASP B 40 ASP.? 7.91 CL CL B 226 B 281 ARG B 13 ARG~? 5.25 CL CL B 226 B 289 TYR B 46 TYR^? 12.90 CL CL B 226 coo 90.56 80.24 98.04 90.36 81.53 96.34 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 86.62 80.67 97.51 87.37 82.00 100.10 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 91.83 88.28 92.88 92.60 85.93 94.14 50.79 -14.19 25.59 51.15 -11.43 25.53 1foh_c01 source 1foh PHENOL HYDROXYLASE : 5 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 40 ASP.? 7.65 CL CL A 226 C 281 ARG A 13 ARG~? 5.03 CL CL A 226 C 289 TYR A 38 TYR.? 10.54 CL CL A 226 coo 42.34 76.83 49.10 43.06 78.59 50.01 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 46.12 77.15 48.13 44.44 77.61 45.70 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 42.69 86.18 51.69 41.59 83.63 51.54 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP A 40 ASP.? 7.65 CL CL A 226 C 281 ARG A 13 ARG~? 5.03 CL CL A 226 C 289 TYR A 46 TYR^? 12.99 CL CL A 226 coo 42.34 76.83 49.10 43.06 78.59 50.01 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 46.12 77.15 48.13 44.44 77.61 45.70 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 42.69 86.18 51.69 41.59 83.63 51.54 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP A 40 ASP.? 7.65 CL CL A 226 C 281 ARG A 13 ARG~? 5.03 CL CL A 226 C 289 TYR A 160 TYR~? 15.52 CL CL A 226 coo 42.34 76.83 49.10 43.06 78.59 50.01 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 46.12 77.15 48.13 44.44 77.61 45.70 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 42.69 86.18 51.69 41.59 83.63 51.54 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 4 3 # 4 C 54 ASP B 40 ASP.? 7.91 CL CL B 226 C 281 ARG B 13 ARG~? 5.25 CL CL B 226 C 289 TYR B 38 TYR.? 11.29 CL CL B 226 coo 42.34 76.83 49.10 43.06 78.59 50.01 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 46.12 77.15 48.13 44.44 77.61 45.70 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 42.69 86.18 51.69 41.59 83.63 51.54 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 5 3 # 5 C 54 ASP B 40 ASP.? 7.91 CL CL B 226 C 281 ARG B 13 ARG~? 5.25 CL CL B 226 C 289 TYR B 46 TYR^? 12.90 CL CL B 226 coo 42.34 76.83 49.10 43.06 78.59 50.01 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 46.12 77.15 48.13 44.44 77.61 45.70 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 42.69 86.18 51.69 41.59 83.63 51.54 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 6 3 # 6 C 54 ASP B 40 ASP.? 7.91 CL CL B 226 C 281 ARG B 13 ARG~? 5.25 CL CL B 226 C 289 TYR B 160 TYR~? 15.61 CL CL B 226 coo 42.34 76.83 49.10 43.06 78.59 50.01 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 46.12 77.15 48.13 44.44 77.61 45.70 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 42.69 86.18 51.69 41.59 83.63 51.54 49.18 -9.89 33.69 51.74 -10.51 34.51 1foh_c02 source 1foh PHENOL HYDROXYLASE : 6 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 40 ASP.? 7.65 CL CL A 226 D 281 ARG A 13 ARG~? 5.03 CL CL A 226 D 289 TYR A 38 TYR.? 10.54 CL CL A 226 coo 75.05 45.80 106.18 74.73 43.88 105.51 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 78.52 44.93 104.78 78.72 44.49 107.76 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 72.35 36.51 104.82 72.00 39.20 105.46 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP A 40 ASP.? 7.65 CL CL A 226 D 281 ARG A 13 ARG~? 5.03 CL CL A 226 D 289 TYR A 46 TYR^? 12.99 CL CL A 226 coo 75.05 45.80 106.18 74.73 43.88 105.51 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 78.52 44.93 104.78 78.72 44.49 107.76 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 72.35 36.51 104.82 72.00 39.20 105.46 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP A 40 ASP.? 7.65 CL CL A 226 D 281 ARG A 13 ARG~? 5.03 CL CL A 226 D 289 TYR A 160 TYR~? 15.52 CL CL A 226 coo 75.05 45.80 106.18 74.73 43.88 105.51 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 78.52 44.93 104.78 78.72 44.49 107.76 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 72.35 36.51 104.82 72.00 39.20 105.46 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 4 3 # 4 D 54 ASP B 40 ASP.? 7.91 CL CL B 226 D 281 ARG B 13 ARG~? 5.25 CL CL B 226 D 289 TYR B 38 TYR.? 11.29 CL CL B 226 coo 75.05 45.80 106.18 74.73 43.88 105.51 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 78.52 44.93 104.78 78.72 44.49 107.76 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 72.35 36.51 104.82 72.00 39.20 105.46 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 5 3 # 5 D 54 ASP B 40 ASP.? 7.91 CL CL B 226 D 281 ARG B 13 ARG~? 5.25 CL CL B 226 D 289 TYR B 160 TYR~? 15.61 CL CL B 226 coo 75.05 45.80 106.18 74.73 43.88 105.51 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 78.52 44.93 104.78 78.72 44.49 107.76 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 72.35 36.51 104.82 72.00 39.20 105.46 49.18 -9.89 33.69 51.74 -10.51 34.51 1foh_c03 source 1foh PHENOL HYDROXYLASE : 5 hits 1foh_c03 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 182 GLU~? 21.95 CL CL A 226 A 319 ASP A 186 ASP.? 30.68 CL CL A 226 A 359 ARG A 65 ARG.? 31.92 CL CL A 226 coo 14.41 12.40 16.42 12.92 13.74 15.71 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 12.25 13.04 23.85 11.56 15.02 23.93 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 10.89 14.95 28.28 12.39 12.53 29.31 17.05 -18.95 -0.65 15.70 -20.36 -3.04 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 1 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 172 GLU~? 15.14 CL CL A 226 B 319 ASP A 203 ASP~? 25.03 CL CL A 226 B 359 ARG A 199 ARG~? 30.44 CL CL A 226 coo 10.77 13.13 40.94 11.03 14.73 39.51 20.31 7.29 3.53 20.42 8.84 4.96 coo 3.77 12.64 38.21 3.35 14.53 37.39 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -1.16 15.32 35.60 -3.32 13.56 36.98 12.72 2.77 -8.55 10.64 0.77 -9.61 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 175 GLU~? 15.88 CL CL A 226 B 319 ASP A 203 ASP~? 25.03 CL CL A 226 B 359 ARG A 199 ARG~? 30.44 CL CL A 226 coo 10.77 13.13 40.94 11.03 14.73 39.51 15.56 2.16 3.91 14.40 0.59 4.79 coo 3.77 12.64 38.21 3.35 14.53 37.39 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -1.16 15.32 35.60 -3.32 13.56 36.98 12.72 2.77 -8.55 10.64 0.77 -9.61 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU A 182 GLU~? 21.95 CL CL A 226 B 319 ASP A 186 ASP.? 30.68 CL CL A 226 B 359 ARG A 65 ARG.? 31.92 CL CL A 226 coo 10.77 13.13 40.94 11.03 14.73 39.51 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 3.77 12.64 38.21 3.35 14.53 37.39 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo -1.16 15.32 35.60 -3.32 13.56 36.98 17.05 -18.95 -0.65 15.70 -20.36 -3.04 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU B 172 GLU~? 15.62 CL CL B 226 B 319 ASP B 203 ASP~? 25.12 CL CL B 226 B 359 ARG B 199 ARG~? 31.39 CL CL B 226 coo 10.77 13.13 40.94 11.03 14.73 39.51 57.49 4.88 36.61 57.44 6.68 35.49 coo 3.77 12.64 38.21 3.35 14.53 37.39 60.54 4.31 43.90 62.00 4.57 45.37 coo -1.16 15.32 35.60 -3.32 13.56 36.98 62.93 0.56 49.95 63.41 -1.61 52.09 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU B 175 GLU~? 17.14 CL CL B 226 B 319 ASP B 203 ASP~? 25.12 CL CL B 226 B 359 ARG B 199 ARG~? 31.39 CL CL B 226 coo 10.77 13.13 40.94 11.03 14.73 39.51 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 3.77 12.64 38.21 3.35 14.53 37.39 60.54 4.31 43.90 62.00 4.57 45.37 coo -1.16 15.32 35.60 -3.32 13.56 36.98 62.93 0.56 49.95 63.41 -1.61 52.09 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 5 hits 1fr8_c01 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 52 LYS^? 28.69 CL CL A 226 A 331 GLU A 77 GLU~? 21.84 CL CL B 226 B 188 HIS A 75 HIS.? 25.41 CL CL B 226 coo 130.22 155.23 83.49 125.21 153.71 84.04 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 120.90 152.23 75.28 120.94 153.09 77.19 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 122.04 152.80 81.06 120.71 154.37 81.46 38.68 -16.70 9.61 40.32 -17.29 8.43 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS B 52 LYS^? 28.59 CL CL B 226 A 331 GLU B 77 GLU~? 22.22 CL CL A 226 B 188 HIS B 75 HIS.? 25.67 CL CL A 226 coo 130.22 155.23 83.49 125.21 153.71 84.04 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 120.90 152.23 75.28 120.94 153.09 77.19 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 122.04 152.80 81.06 120.71 154.37 81.46 34.50 -15.17 32.63 32.86 -15.45 33.92 1fuq_c00 source 1fuq FUMARASE C : 2 hits 1fuq_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 9 GLU.? 16.20 CL CL A 226 A 47 ASP A 40 ASP.? 7.65 CL CL A 226 A 161 TYR A 20 TYR~? 17.28 CL CL A 226 coo 37.12 18.35 73.76 37.09 16.69 72.44 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 29.81 8.06 73.13 30.21 10.11 72.95 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 37.29 15.56 67.90 37.37 13.79 70.08 26.99 -13.27 24.47 26.16 -12.32 26.98 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 110 GLU~? 23.70 CL CL A 226 A 47 ASP A 203 ASP~? 25.03 CL CL A 226 A 161 TYR A 209 TYR~? 20.76 CL CL A 226 coo 37.12 18.35 73.76 37.09 16.69 72.44 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 29.81 8.06 73.13 30.21 10.11 72.95 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 37.29 15.56 67.90 37.37 13.79 70.08 27.49 9.87 -0.64 29.01 7.64 0.00 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 9 GLU.? 16.36 CL CL B 226 A 47 ASP B 40 ASP.? 7.91 CL CL B 226 A 161 TYR B 20 TYR~? 17.36 CL CL B 226 coo 37.12 18.35 73.76 37.09 16.69 72.44 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 29.81 8.06 73.13 30.21 10.11 72.95 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 37.29 15.56 67.90 37.37 13.79 70.08 46.52 -15.74 17.49 47.60 -15.27 14.94 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU B 110 GLU~? 23.32 CL CL B 226 A 47 ASP B 203 ASP~? 25.12 CL CL B 226 A 161 TYR B 209 TYR~? 20.47 CL CL B 226 coo 37.12 18.35 73.76 37.09 16.69 72.44 46.60 5.74 43.54 45.54 7.20 42.48 coo 29.81 8.06 73.13 30.21 10.11 72.95 60.54 4.31 43.90 62.00 4.57 45.37 coo 37.29 15.56 67.90 37.37 13.79 70.08 50.38 9.38 40.26 48.54 7.35 39.73 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU B 112 GLU~? 31.79 CL CL B 226 A 47 ASP B 151 ASP~? 28.65 CL CL B 226 A 161 TYR B 116 TYR~? 34.40 CL CL B 226 coo 37.12 18.35 73.76 37.09 16.69 72.44 43.43 0.58 50.84 42.60 2.23 51.76 coo 29.81 8.06 73.13 30.21 10.11 72.95 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 37.29 15.56 67.90 37.37 13.79 70.08 45.41 -5.95 53.84 44.74 -7.73 55.90 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU B 198 GLU~? 30.19 CL CL B 226 A 47 ASP B 111 ASP~? 25.68 CL CL B 226 A 161 TYR B 194 TYR~? 30.06 CL CL B 226 coo 37.12 18.35 73.76 37.09 16.69 72.44 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 29.81 8.06 73.13 30.21 10.11 72.95 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 37.29 15.56 67.90 37.37 13.79 70.08 55.14 -6.59 51.91 53.44 -4.41 51.82 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 6 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 9 GLU.? 16.20 CL CL A 226 B 47 ASP A 40 ASP.? 7.65 CL CL A 226 B 161 TYR A 20 TYR~? 17.28 CL CL A 226 coo 53.87 35.49 53.22 55.44 35.72 54.61 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 63.47 43.65 53.95 61.45 43.07 54.06 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 56.38 35.81 59.19 58.25 35.77 57.10 26.99 -13.27 24.47 26.16 -12.32 26.98 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 110 GLU~? 23.70 CL CL A 226 B 47 ASP A 203 ASP~? 25.03 CL CL A 226 B 161 TYR A 209 TYR~? 20.76 CL CL A 226 coo 53.87 35.49 53.22 55.44 35.72 54.61 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 63.47 43.65 53.95 61.45 43.07 54.06 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 56.38 35.81 59.19 58.25 35.77 57.10 27.49 9.87 -0.64 29.01 7.64 0.00 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 9 GLU.? 16.36 CL CL B 226 B 47 ASP B 40 ASP.? 7.91 CL CL B 226 B 161 TYR B 20 TYR~? 17.36 CL CL B 226 coo 53.87 35.49 53.22 55.44 35.72 54.61 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 63.47 43.65 53.95 61.45 43.07 54.06 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 56.38 35.81 59.19 58.25 35.77 57.10 46.52 -15.74 17.49 47.60 -15.27 14.94 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU B 110 GLU~? 23.32 CL CL B 226 B 47 ASP B 203 ASP~? 25.12 CL CL B 226 B 161 TYR B 209 TYR~? 20.47 CL CL B 226 coo 53.87 35.49 53.22 55.44 35.72 54.61 46.60 5.74 43.54 45.54 7.20 42.48 coo 63.47 43.65 53.95 61.45 43.07 54.06 60.54 4.31 43.90 62.00 4.57 45.37 coo 56.38 35.81 59.19 58.25 35.77 57.10 50.38 9.38 40.26 48.54 7.35 39.73 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU B 112 GLU~? 31.79 CL CL B 226 B 47 ASP B 151 ASP~? 28.65 CL CL B 226 B 161 TYR B 116 TYR~? 34.40 CL CL B 226 coo 53.87 35.49 53.22 55.44 35.72 54.61 43.43 0.58 50.84 42.60 2.23 51.76 coo 63.47 43.65 53.95 61.45 43.07 54.06 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 56.38 35.81 59.19 58.25 35.77 57.10 45.41 -5.95 53.84 44.74 -7.73 55.90 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU B 198 GLU~? 30.19 CL CL B 226 B 47 ASP B 111 ASP~? 25.68 CL CL B 226 B 161 TYR B 194 TYR~? 30.06 CL CL B 226 coo 53.87 35.49 53.22 55.44 35.72 54.61 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 63.47 43.65 53.95 61.45 43.07 54.06 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 56.38 35.81 59.19 58.25 35.77 57.10 55.14 -6.59 51.91 53.44 -4.41 51.82 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 6 hits 1geq_c03 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 167 ASN.? 5.51 CL CL A 226 B 108 HIS A 86 HIS~? 10.02 CL CL A 226 B 144 ASP A 102 ASP~? 17.30 CL CL A 226 coo 36.64 101.02 13.15 38.55 101.84 12.78 27.28 3.74 18.20 27.65 2.13 19.59 coo 41.00 107.18 12.86 42.70 107.82 11.96 32.84 2.26 17.60 31.66 3.53 18.78 coo 31.60 110.69 6.14 29.69 109.74 5.94 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN B 167 ASN.? 4.94 CL CL B 226 B 108 HIS B 86 HIS~? 9.45 CL CL B 226 B 144 ASP B 102 ASP~? 16.83 CL CL B 226 coo 36.64 101.02 13.15 38.55 101.84 12.78 50.28 1.34 22.19 49.08 -0.16 21.24 coo 41.00 107.18 12.86 42.70 107.82 11.96 44.03 1.12 22.86 45.41 1.90 21.48 coo 31.60 110.69 6.14 29.69 109.74 5.94 45.25 7.06 34.64 46.46 8.64 34.05 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 2 hits 1grc_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 109 PHE~? 18.50 CL CL A 226 A 298 ASP A 203 ASP~? 25.03 CL CL A 226 A 329 LYS A 213 LYS.? 30.41 CL CL A 226 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 24.98 3.58 -0.85 22.97 3.50 1.05 coo 2.59 0.29 25.55 4.65 0.18 25.07 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 12.42 6.10 23.27 9.95 1.57 20.16 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 109 PHE~? 18.73 CL CL B 226 A 298 ASP B 102 ASP~? 16.83 CL CL B 226 A 329 LYS B 213 LYS~? 22.42 CL CL B 226 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 51.52 2.89 41.40 53.63 2.11 39.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 45.25 7.06 34.64 46.46 8.64 34.05 coo 12.42 6.10 23.27 9.95 1.57 20.16 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE B 183 PHE~? 27.12 CL CL B 226 A 298 ASP B 186 ASP.? 30.73 CL CL B 226 A 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 2.59 0.29 25.55 4.65 0.18 25.07 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 12.42 6.10 23.27 9.95 1.57 20.16 61.77 -19.16 38.03 61.33 -25.31 39.26 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 109 PHE~? 18.50 CL CL A 226 B 298 ASP A 203 ASP~? 25.03 CL CL A 226 B 329 LYS A 213 LYS.? 30.41 CL CL A 226 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 24.98 3.58 -0.85 22.97 3.50 1.05 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 109 PHE~? 18.73 CL CL B 226 B 298 ASP B 102 ASP~? 16.83 CL CL B 226 B 329 LYS B 213 LYS~? 22.42 CL CL B 226 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 51.52 2.89 41.40 53.63 2.11 39.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 45.25 7.06 34.64 46.46 8.64 34.05 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE B 183 PHE~? 27.12 CL CL B 226 B 298 ASP B 186 ASP.? 30.73 CL CL B 226 B 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 61.77 -19.16 38.03 61.33 -25.31 39.26 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 109 PHE~? 18.50 CL CL A 226 C 298 ASP A 203 ASP~? 25.03 CL CL A 226 C 329 LYS A 213 LYS.? 30.41 CL CL A 226 coo 17.41 60.57 64.39 18.40 58.12 65.34 24.98 3.58 -0.85 22.97 3.50 1.05 coo 24.10 66.43 63.33 24.18 64.30 63.40 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 27.64 56.61 58.17 22.18 57.92 60.36 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 109 PHE~? 18.73 CL CL B 226 C 298 ASP B 102 ASP~? 16.83 CL CL B 226 C 329 LYS B 213 LYS~? 22.42 CL CL B 226 coo 17.41 60.57 64.39 18.40 58.12 65.34 51.52 2.89 41.40 53.63 2.11 39.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 45.25 7.06 34.64 46.46 8.64 34.05 coo 27.64 56.61 58.17 22.18 57.92 60.36 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE B 183 PHE~? 27.12 CL CL B 226 C 298 ASP B 186 ASP.? 30.73 CL CL B 226 C 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 17.41 60.57 64.39 18.40 58.12 65.34 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 24.10 66.43 63.33 24.18 64.30 63.40 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 27.64 56.61 58.17 22.18 57.92 60.36 61.77 -19.16 38.03 61.33 -25.31 39.26 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 109 PHE~? 18.50 CL CL A 226 D 298 ASP A 203 ASP~? 25.03 CL CL A 226 D 329 LYS A 213 LYS.? 30.41 CL CL A 226 coo 35.44 53.35 83.81 35.65 54.53 81.28 24.98 3.58 -0.85 22.97 3.50 1.05 coo 29.72 46.46 83.60 30.79 47.36 81.99 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 36.89 44.91 74.55 37.33 48.94 79.01 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 109 PHE~? 18.73 CL CL B 226 D 298 ASP B 102 ASP~? 16.83 CL CL B 226 D 329 LYS B 213 LYS~? 22.42 CL CL B 226 coo 35.44 53.35 83.81 35.65 54.53 81.28 51.52 2.89 41.40 53.63 2.11 39.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 45.25 7.06 34.64 46.46 8.64 34.05 coo 36.89 44.91 74.55 37.33 48.94 79.01 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE B 183 PHE~? 27.12 CL CL B 226 D 298 ASP B 186 ASP.? 30.73 CL CL B 226 D 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 35.44 53.35 83.81 35.65 54.53 81.28 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 29.72 46.46 83.60 30.79 47.36 81.99 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 36.89 44.91 74.55 37.33 48.94 79.01 61.77 -19.16 38.03 61.33 -25.31 39.26 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 72 SER.? 25.76 CL CL A 226 A 164 TYR A 21 TYR~? 21.90 CL CL A 226 A 168 LYS A 52 LYS^? 28.69 CL CL A 226 coo 32.37 52.40 49.35 31.32 53.88 47.74 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 29.69 55.04 42.83 31.98 53.56 43.49 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 26.96 50.99 47.03 31.03 48.83 44.33 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER A 207 SER~? 18.13 CL CL A 226 A 164 TYR A 208 TYR~? 15.64 CL CL A 226 A 168 LYS A 205 LYS~? 25.48 CL CL A 226 coo 32.37 52.40 49.35 31.32 53.88 47.74 20.60 11.23 0.64 19.47 10.75 2.68 coo 29.69 55.04 42.83 31.98 53.56 43.49 25.22 8.01 3.41 27.20 7.60 5.36 coo 26.96 50.99 47.03 31.03 48.83 44.33 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 A 151 SER A 207 SER~? 18.13 CL CL A 226 A 164 TYR A 209 TYR~? 20.76 CL CL A 226 A 168 LYS A 205 LYS~? 25.48 CL CL A 226 coo 32.37 52.40 49.35 31.32 53.88 47.74 20.60 11.23 0.64 19.47 10.75 2.68 coo 29.69 55.04 42.83 31.98 53.56 43.49 27.49 9.87 -0.64 29.01 7.64 0.00 coo 26.96 50.99 47.03 31.03 48.83 44.33 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 A 151 SER B 72 SER.? 25.86 CL CL B 226 A 164 TYR B 21 TYR~? 21.81 CL CL B 226 A 168 LYS B 52 LYS^? 28.59 CL CL B 226 coo 32.37 52.40 49.35 31.32 53.88 47.74 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 29.69 55.04 42.83 31.98 53.56 43.49 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 26.96 50.99 47.03 31.03 48.83 44.33 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 A 151 SER B 207 SER~? 19.03 CL CL B 226 A 164 TYR B 208 TYR~? 15.74 CL CL B 226 A 168 LYS B 205 LYS~? 25.67 CL CL B 226 coo 32.37 52.40 49.35 31.32 53.88 47.74 57.60 9.31 39.27 58.73 7.29 38.76 coo 29.69 55.04 42.83 31.98 53.56 43.49 52.42 6.76 36.83 50.45 6.61 34.90 coo 26.96 50.99 47.03 31.03 48.83 44.33 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 A 151 SER B 207 SER~? 19.03 CL CL B 226 A 164 TYR B 209 TYR~? 20.47 CL CL B 226 A 168 LYS B 205 LYS~? 25.67 CL CL B 226 coo 32.37 52.40 49.35 31.32 53.88 47.74 57.60 9.31 39.27 58.73 7.29 38.76 coo 29.69 55.04 42.83 31.98 53.56 43.49 50.38 9.38 40.26 48.54 7.35 39.73 coo 26.96 50.99 47.03 31.03 48.83 44.33 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 A 151 SER B 210 SER~? 23.92 CL CL B 226 A 164 TYR B 209 TYR~? 20.47 CL CL B 226 A 168 LYS B 213 LYS~? 22.42 CL CL B 226 coo 32.37 52.40 49.35 31.32 53.88 47.74 53.28 14.40 40.02 51.53 15.84 39.30 coo 29.69 55.04 42.83 31.98 53.56 43.49 50.38 9.38 40.26 48.54 7.35 39.73 coo 26.96 50.99 47.03 31.03 48.83 44.33 48.60 15.99 42.06 48.42 16.28 35.76 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 7 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 72 SER.? 25.76 CL CL A 226 B 164 TYR A 21 TYR~? 21.90 CL CL A 226 B 168 LYS A 52 LYS^? 28.69 CL CL A 226 coo 13.08 50.93 56.67 13.12 48.99 55.27 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 11.52 46.03 51.32 10.06 47.90 52.76 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 15.72 50.86 51.22 10.77 52.35 51.39 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER A 207 SER~? 18.13 CL CL A 226 B 164 TYR A 208 TYR~? 15.64 CL CL A 226 B 168 LYS A 205 LYS~? 25.48 CL CL A 226 coo 13.08 50.93 56.67 13.12 48.99 55.27 20.60 11.23 0.64 19.47 10.75 2.68 coo 11.52 46.03 51.32 10.06 47.90 52.76 25.22 8.01 3.41 27.20 7.60 5.36 coo 15.72 50.86 51.22 10.77 52.35 51.39 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 B 151 SER A 207 SER~? 18.13 CL CL A 226 B 164 TYR A 209 TYR~? 20.76 CL CL A 226 B 168 LYS A 205 LYS~? 25.48 CL CL A 226 coo 13.08 50.93 56.67 13.12 48.99 55.27 20.60 11.23 0.64 19.47 10.75 2.68 coo 11.52 46.03 51.32 10.06 47.90 52.76 27.49 9.87 -0.64 29.01 7.64 0.00 coo 15.72 50.86 51.22 10.77 52.35 51.39 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 B 151 SER B 72 SER.? 25.86 CL CL B 226 B 164 TYR B 21 TYR~? 21.81 CL CL B 226 B 168 LYS B 52 LYS^? 28.59 CL CL B 226 coo 13.08 50.93 56.67 13.12 48.99 55.27 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 11.52 46.03 51.32 10.06 47.90 52.76 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 15.72 50.86 51.22 10.77 52.35 51.39 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 B 151 SER B 207 SER~? 19.03 CL CL B 226 B 164 TYR B 208 TYR~? 15.74 CL CL B 226 B 168 LYS B 205 LYS~? 25.67 CL CL B 226 coo 13.08 50.93 56.67 13.12 48.99 55.27 57.60 9.31 39.27 58.73 7.29 38.76 coo 11.52 46.03 51.32 10.06 47.90 52.76 52.42 6.76 36.83 50.45 6.61 34.90 coo 15.72 50.86 51.22 10.77 52.35 51.39 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 B 151 SER B 207 SER~? 19.03 CL CL B 226 B 164 TYR B 209 TYR~? 20.47 CL CL B 226 B 168 LYS B 205 LYS~? 25.67 CL CL B 226 coo 13.08 50.93 56.67 13.12 48.99 55.27 57.60 9.31 39.27 58.73 7.29 38.76 coo 11.52 46.03 51.32 10.06 47.90 52.76 50.38 9.38 40.26 48.54 7.35 39.73 coo 15.72 50.86 51.22 10.77 52.35 51.39 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 B 151 SER B 210 SER~? 23.92 CL CL B 226 B 164 TYR B 209 TYR~? 20.47 CL CL B 226 B 168 LYS B 213 LYS~? 22.42 CL CL B 226 coo 13.08 50.93 56.67 13.12 48.99 55.27 53.28 14.40 40.02 51.53 15.84 39.30 coo 11.52 46.03 51.32 10.06 47.90 52.76 50.38 9.38 40.26 48.54 7.35 39.73 coo 15.72 50.86 51.22 10.77 52.35 51.39 48.60 15.99 42.06 48.42 16.28 35.76 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 7 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 72 SER.? 25.76 CL CL A 226 C 164 TYR A 21 TYR~? 21.90 CL CL A 226 C 168 LYS A 52 LYS^? 28.69 CL CL A 226 coo 11.22 34.38 82.32 11.07 36.29 83.78 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 8.83 39.27 87.38 7.60 37.43 85.69 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 12.98 34.46 88.14 8.11 32.96 87.14 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER A 207 SER~? 18.13 CL CL A 226 C 164 TYR A 208 TYR~? 15.64 CL CL A 226 C 168 LYS A 205 LYS~? 25.48 CL CL A 226 coo 11.22 34.38 82.32 11.07 36.29 83.78 20.60 11.23 0.64 19.47 10.75 2.68 coo 8.83 39.27 87.38 7.60 37.43 85.69 25.22 8.01 3.41 27.20 7.60 5.36 coo 12.98 34.46 88.14 8.11 32.96 87.14 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 C 151 SER A 207 SER~? 18.13 CL CL A 226 C 164 TYR A 209 TYR~? 20.76 CL CL A 226 C 168 LYS A 205 LYS~? 25.48 CL CL A 226 coo 11.22 34.38 82.32 11.07 36.29 83.78 20.60 11.23 0.64 19.47 10.75 2.68 coo 8.83 39.27 87.38 7.60 37.43 85.69 27.49 9.87 -0.64 29.01 7.64 0.00 coo 12.98 34.46 88.14 8.11 32.96 87.14 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 C 151 SER B 72 SER.? 25.86 CL CL B 226 C 164 TYR B 21 TYR~? 21.81 CL CL B 226 C 168 LYS B 52 LYS^? 28.59 CL CL B 226 coo 11.22 34.38 82.32 11.07 36.29 83.78 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 8.83 39.27 87.38 7.60 37.43 85.69 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 12.98 34.46 88.14 8.11 32.96 87.14 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 C 151 SER B 207 SER~? 19.03 CL CL B 226 C 164 TYR B 208 TYR~? 15.74 CL CL B 226 C 168 LYS B 205 LYS~? 25.67 CL CL B 226 coo 11.22 34.38 82.32 11.07 36.29 83.78 57.60 9.31 39.27 58.73 7.29 38.76 coo 8.83 39.27 87.38 7.60 37.43 85.69 52.42 6.76 36.83 50.45 6.61 34.90 coo 12.98 34.46 88.14 8.11 32.96 87.14 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 C 151 SER B 207 SER~? 19.03 CL CL B 226 C 164 TYR B 209 TYR~? 20.47 CL CL B 226 C 168 LYS B 205 LYS~? 25.67 CL CL B 226 coo 11.22 34.38 82.32 11.07 36.29 83.78 57.60 9.31 39.27 58.73 7.29 38.76 coo 8.83 39.27 87.38 7.60 37.43 85.69 50.38 9.38 40.26 48.54 7.35 39.73 coo 12.98 34.46 88.14 8.11 32.96 87.14 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 C 151 SER B 210 SER~? 23.92 CL CL B 226 C 164 TYR B 209 TYR~? 20.47 CL CL B 226 C 168 LYS B 213 LYS~? 22.42 CL CL B 226 coo 11.22 34.38 82.32 11.07 36.29 83.78 53.28 14.40 40.02 51.53 15.84 39.30 coo 8.83 39.27 87.38 7.60 37.43 85.69 50.38 9.38 40.26 48.54 7.35 39.73 coo 12.98 34.46 88.14 8.11 32.96 87.14 48.60 15.99 42.06 48.42 16.28 35.76 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 7 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 72 SER.? 25.76 CL CL A 226 D 164 TYR A 21 TYR~? 21.90 CL CL A 226 D 168 LYS A 52 LYS^? 28.69 CL CL A 226 coo 29.15 32.90 92.57 27.86 31.44 94.02 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 25.49 30.28 98.59 27.88 31.73 98.26 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 23.46 34.31 94.02 27.08 36.46 97.29 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER A 207 SER~? 18.13 CL CL A 226 D 164 TYR A 208 TYR~? 15.64 CL CL A 226 D 168 LYS A 205 LYS~? 25.48 CL CL A 226 coo 29.15 32.90 92.57 27.86 31.44 94.02 20.60 11.23 0.64 19.47 10.75 2.68 coo 25.49 30.28 98.59 27.88 31.73 98.26 25.22 8.01 3.41 27.20 7.60 5.36 coo 23.46 34.31 94.02 27.08 36.46 97.29 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 D 151 SER A 207 SER~? 18.13 CL CL A 226 D 164 TYR A 209 TYR~? 20.76 CL CL A 226 D 168 LYS A 205 LYS~? 25.48 CL CL A 226 coo 29.15 32.90 92.57 27.86 31.44 94.02 20.60 11.23 0.64 19.47 10.75 2.68 coo 25.49 30.28 98.59 27.88 31.73 98.26 27.49 9.87 -0.64 29.01 7.64 0.00 coo 23.46 34.31 94.02 27.08 36.46 97.29 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 D 151 SER B 72 SER.? 25.86 CL CL B 226 D 164 TYR B 21 TYR~? 21.81 CL CL B 226 D 168 LYS B 52 LYS^? 28.59 CL CL B 226 coo 29.15 32.90 92.57 27.86 31.44 94.02 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 25.49 30.28 98.59 27.88 31.73 98.26 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 23.46 34.31 94.02 27.08 36.46 97.29 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 D 151 SER B 207 SER~? 19.03 CL CL B 226 D 164 TYR B 208 TYR~? 15.74 CL CL B 226 D 168 LYS B 205 LYS~? 25.67 CL CL B 226 coo 29.15 32.90 92.57 27.86 31.44 94.02 57.60 9.31 39.27 58.73 7.29 38.76 coo 25.49 30.28 98.59 27.88 31.73 98.26 52.42 6.76 36.83 50.45 6.61 34.90 coo 23.46 34.31 94.02 27.08 36.46 97.29 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 D 151 SER B 207 SER~? 19.03 CL CL B 226 D 164 TYR B 209 TYR~? 20.47 CL CL B 226 D 168 LYS B 205 LYS~? 25.67 CL CL B 226 coo 29.15 32.90 92.57 27.86 31.44 94.02 57.60 9.31 39.27 58.73 7.29 38.76 coo 25.49 30.28 98.59 27.88 31.73 98.26 50.38 9.38 40.26 48.54 7.35 39.73 coo 23.46 34.31 94.02 27.08 36.46 97.29 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 D 151 SER B 210 SER~? 23.92 CL CL B 226 D 164 TYR B 209 TYR~? 20.47 CL CL B 226 D 168 LYS B 213 LYS~? 22.42 CL CL B 226 coo 29.15 32.90 92.57 27.86 31.44 94.02 53.28 14.40 40.02 51.53 15.84 39.30 coo 25.49 30.28 98.59 27.88 31.73 98.26 50.38 9.38 40.26 48.54 7.35 39.73 coo 23.46 34.31 94.02 27.08 36.46 97.29 48.60 15.99 42.06 48.42 16.28 35.76 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 7 hits 1gz6_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 161 GLN~? 19.20 CL CL A 226 A 296 GLU A 69 GLU^? 25.00 CL CL A 226 A 383 TYR A 21 TYR~? 21.90 CL CL A 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 40.93 4.45 2.36 38.91 3.75 2.26 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 30.54 7.22 6.23 31.38 5.79 3.97 31.69 -16.23 18.31 32.96 -18.03 16.63 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN A 161 GLN~? 19.20 CL CL A 226 A 296 GLU A 69 GLU^? 25.00 CL CL A 226 A 383 TYR A 46 TYR^? 12.99 CL CL A 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 40.93 4.45 2.36 38.91 3.75 2.26 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 30.54 7.22 6.23 31.38 5.79 3.97 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN A 161 GLN~? 19.20 CL CL A 226 A 296 GLU A 157 GLU~? 23.07 CL CL A 226 A 383 TYR A 46 TYR^? 12.99 CL CL A 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 31.57 -9.16 9.63 33.31 -10.05 8.78 coo 40.93 4.45 2.36 38.91 3.75 2.26 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 30.54 7.22 6.23 31.38 5.79 3.97 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN A 185 GLN~? 22.98 CL CL A 226 A 296 GLU A 182 GLU~? 21.95 CL CL A 226 A 383 TYR A 58 TYR.? 17.32 CL CL A 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 15.83 -13.17 2.06 17.40 -14.13 3.16 coo 40.93 4.45 2.36 38.91 3.75 2.26 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 30.54 7.22 6.23 31.38 5.79 3.97 12.58 -9.14 12.20 9.89 -9.91 12.27 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN B 161 GLN~? 19.12 CL CL B 226 A 296 GLU B 69 GLU^? 24.72 CL CL B 226 A 383 TYR B 21 TYR~? 21.81 CL CL B 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 40.93 4.45 2.36 38.91 3.75 2.26 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 30.54 7.22 6.23 31.38 5.79 3.97 41.23 -17.00 23.95 39.78 -18.41 25.81 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 6 3 # 6 A 271 GLN B 161 GLN~? 19.12 CL CL B 226 A 296 GLU B 69 GLU^? 24.72 CL CL B 226 A 383 TYR B 46 TYR^? 12.90 CL CL B 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 40.93 4.45 2.36 38.91 3.75 2.26 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 30.54 7.22 6.23 31.38 5.79 3.97 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 7 3 # 7 A 271 GLN B 161 GLN~? 19.12 CL CL B 226 A 296 GLU B 77 GLU~? 22.22 CL CL A 226 A 383 TYR B 21 TYR~? 21.81 CL CL B 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 40.93 4.45 2.36 38.91 3.75 2.26 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 30.54 7.22 6.23 31.38 5.79 3.97 41.23 -17.00 23.95 39.78 -18.41 25.81 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 8 3 # 8 A 271 GLN B 161 GLN~? 19.12 CL CL B 226 A 296 GLU B 77 GLU~? 22.22 CL CL A 226 A 383 TYR B 90 TYR^? 17.17 CL CL B 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 40.93 4.45 2.36 38.91 3.75 2.26 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 30.54 7.22 6.23 31.38 5.79 3.97 38.78 1.99 31.89 40.05 -0.11 30.63 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 9 3 # 9 A 271 GLN B 161 GLN~? 19.12 CL CL B 226 A 296 GLU B 157 GLU~? 23.31 CL CL B 226 A 383 TYR B 46 TYR^? 12.90 CL CL B 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 42.75 -9.18 31.97 40.92 -9.66 32.99 coo 40.93 4.45 2.36 38.91 3.75 2.26 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 30.54 7.22 6.23 31.38 5.79 3.97 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 10 3 # 10 A 271 GLN B 185 GLN~? 23.32 CL CL B 226 A 296 GLU B 182 GLU~? 22.76 CL CL B 226 A 383 TYR B 58 TYR.? 17.22 CL CL B 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 57.03 -15.62 39.97 55.27 -16.55 39.25 coo 40.93 4.45 2.36 38.91 3.75 2.26 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 30.54 7.22 6.23 31.38 5.79 3.97 61.18 -13.09 30.12 63.87 -13.66 29.97 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 11 3 # 11 A 271 GLN B 185 GLN~? 23.32 CL CL B 226 A 296 GLU B 182 GLU~? 22.76 CL CL B 226 A 383 TYR B 121 TYR~? 28.97 CL CL B 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 57.03 -15.62 39.97 55.27 -16.55 39.25 coo 40.93 4.45 2.36 38.91 3.75 2.26 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 30.54 7.22 6.23 31.38 5.79 3.97 51.39 -13.47 48.53 51.35 -15.45 46.59 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 12 3 # 12 A 271 GLN B 185 GLN~? 23.32 CL CL B 226 A 296 GLU B 187 GLU.? 29.51 CL CL B 226 A 383 TYR B 121 TYR~? 28.97 CL CL B 226 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 57.03 -15.62 39.97 55.27 -16.55 39.25 coo 40.93 4.45 2.36 38.91 3.75 2.26 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 30.54 7.22 6.23 31.38 5.79 3.97 51.39 -13.47 48.53 51.35 -15.45 46.59 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 12 hits 1h19_c00 naa= 3 ULMN 3 1h2r_c00 PERIPLASMIC [NIFE] HYDROGENASE LARGEuser 1 3 # 1 S 18 THR A 5 THR^? 14.28 CL CL A 226 L 34 GLU A 4 GLU^? 21.78 CL CL A 226 L 546 CYH A 34 CYH^? 20.26 CL CL A 226 coo 59.66 41.78 78.85 58.82 40.81 80.62 17.44 -11.08 24.10 16.06 -9.50 23.62 coo 58.67 42.52 83.67 60.77 42.68 84.14 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 58.67 44.02 88.31 58.41 45.45 86.02 19.64 -17.85 18.93 17.88 -17.43 16.93 ULMN 3 1h2r_c00 PERIPLASMIC [NIFE] HYDROGENASE LARGEuser 2 3 # 2 S 18 THR A 181 THR~? 17.70 CL CL A 226 L 34 GLU A 182 GLU~? 21.95 CL CL A 226 L 546 CYH A 62 CYH.? 23.61 CL CL A 226 coo 59.66 41.78 78.85 58.82 40.81 80.62 19.07 -8.40 2.64 19.42 -8.54 4.77 coo 58.67 42.52 83.67 60.77 42.68 84.14 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 58.67 44.02 88.31 58.41 45.45 86.02 9.90 -12.74 4.18 12.50 -12.77 3.13 ULMN 3 1h2r_c00 PERIPLASMIC [NIFE] HYDROGENASE LARGEuser 3 3 # 3 S 18 THR B 181 THR~? 17.66 CL CL B 226 L 34 GLU B 182 GLU~? 22.76 CL CL B 226 L 546 CYH B 62 CYH.? 23.90 CL CL B 226 coo 59.66 41.78 78.85 58.82 40.81 80.62 54.63 -10.58 39.28 54.41 -10.04 37.17 coo 58.67 42.52 83.67 60.77 42.68 84.14 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 58.67 44.02 88.31 58.41 45.45 86.02 63.33 -15.73 38.50 60.87 -15.29 39.80 1h2r_c00 source 1h2r PERIPLASMIC [NIFE] HYDROGENASE LARGE SUBUNIT : 3 hits 1h2r_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 64 VAL.? 22.95 CL CL A 226 A 200 ASP A 186 ASP.? 30.68 CL CL A 226 A 226 LYS A 195 LYS~? 35.76 CL CL A 226 coo 19.13 38.05 1.41 19.72 38.80 -0.53 14.87 -16.35 5.29 16.13 -14.91 6.38 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 152 VAL~? 26.34 CL CL A 226 A 200 ASP A 186 ASP.? 30.68 CL CL A 226 A 226 LYS A 60 LYS.? 19.24 CL CL A 226 coo 19.13 38.05 1.41 19.72 38.80 -0.53 27.70 -11.15 -3.43 25.83 -10.57 -4.36 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 34.47 51.09 7.19 28.58 51.18 7.53 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 152 VAL~? 26.34 CL CL A 226 A 200 ASP A 186 ASP.? 30.68 CL CL A 226 A 226 LYS A 63 LYS.? 28.35 CL CL A 226 coo 19.13 38.05 1.41 19.72 38.80 -0.53 27.70 -11.15 -3.43 25.83 -10.57 -4.36 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 34.47 51.09 7.19 28.58 51.18 7.53 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 174 VAL~? 9.86 CL CL A 226 A 200 ASP A 203 ASP~? 25.03 CL CL A 226 A 226 LYS A 195 LYS~? 35.76 CL CL A 226 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.72 0.69 8.23 18.80 0.95 10.18 coo 24.51 43.28 11.18 25.17 44.50 9.58 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 88 VAL~? 16.69 CL CL A 226 A 200 ASP B 102 ASP~? 16.83 CL CL B 226 A 226 LYS B 213 LYS~? 22.42 CL CL B 226 coo 19.13 38.05 1.41 19.72 38.80 -0.53 38.29 5.76 25.33 36.39 5.20 24.42 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.25 7.06 34.64 46.46 8.64 34.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 170 VAL~? 10.93 CL CL B 226 A 200 ASP B 40 ASP.? 7.91 CL CL B 226 A 226 LYS B 60 LYS.? 20.89 CL CL B 226 coo 19.13 38.05 1.41 19.72 38.80 -0.53 55.81 4.52 30.60 55.18 6.39 31.55 coo 24.51 43.28 11.18 25.17 44.50 9.58 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 34.47 51.09 7.19 28.58 51.18 7.53 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 174 VAL~? 10.40 CL CL B 226 A 200 ASP B 203 ASP~? 25.12 CL CL B 226 A 226 LYS B 195 LYS~? 36.01 CL CL B 226 coo 19.13 38.05 1.41 19.72 38.80 -0.53 56.42 -2.04 33.02 57.43 -1.95 31.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 60.54 4.31 43.90 62.00 4.57 45.37 coo 34.47 51.09 7.19 28.58 51.18 7.53 58.60 -4.05 52.32 60.39 -2.54 57.56 1i29_c03 source 1i29 CSDB : 7 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 195 LYS~? 35.76 CL CL A 226 A 74 LYS A 200 LYS~? 23.56 CL CL A 226 A 165 GLU A 182 GLU~? 21.95 CL CL A 226 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 13.02 -8.29 1.26 11.61 -6.76 1.56 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS B 200 LYS~? 24.54 CL CL B 226 A 74 LYS B 195 LYS~? 36.01 CL CL B 226 A 165 GLU B 187 GLU.? 29.51 CL CL B 226 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 60.00 0.23 45.11 63.70 -4.80 44.31 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 61.43 -15.09 46.94 62.69 -13.43 47.32 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 2 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 200 LYS~? 23.56 CL CL A 226 B 74 LYS A 195 LYS~? 35.76 CL CL A 226 B 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 31.64 -0.95 -10.58 32.34 0.04 -12.34 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 200 LYS~? 23.56 CL CL A 226 B 74 LYS A 205 LYS~? 25.48 CL CL A 226 B 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 31.64 -0.95 -10.58 32.34 0.04 -12.34 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 200 LYS~? 24.54 CL CL B 226 B 74 LYS B 195 LYS~? 36.01 CL CL B 226 B 165 GLU B 112 GLU~? 31.79 CL CL B 226 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 60.00 0.23 45.11 63.70 -4.80 44.31 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 58.60 -4.05 52.32 60.39 -2.54 57.56 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 43.43 0.58 50.84 42.60 2.23 51.76 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS B 200 LYS~? 24.54 CL CL B 226 B 74 LYS B 205 LYS~? 25.67 CL CL B 226 B 165 GLU B 112 GLU~? 31.79 CL CL B 226 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 60.00 0.23 45.11 63.70 -4.80 44.31 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 54.11 5.83 42.26 49.56 6.08 46.56 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 43.43 0.58 50.84 42.60 2.23 51.76 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 4 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 99 SER~? 15.47 CL CL A 226 A 173 ARG A 81 ARG~? 19.72 CL CL B 226 A 211 ASP A 102 ASP~? 17.30 CL CL A 226 coo 22.72 76.24 0.23 24.60 76.86 -1.25 34.85 6.30 9.42 33.11 7.76 8.92 coo 18.77 77.82 11.69 20.55 80.22 10.73 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER A 101 SER~? 10.77 CL CL A 226 A 173 ARG A 13 ARG~? 5.03 CL CL A 226 A 211 ASP A 102 ASP~? 17.30 CL CL A 226 coo 22.72 76.24 0.23 24.60 76.86 -1.25 29.86 4.55 8.50 28.44 5.46 10.26 coo 18.77 77.82 11.69 20.55 80.22 10.73 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 32.53 7.12 5.29 31.66 9.04 5.62 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER B 99 SER~? 14.59 CL CL B 226 A 173 ARG B 81 ARG~? 19.82 CL CL A 226 A 211 ASP B 102 ASP~? 16.83 CL CL B 226 coo 22.72 76.24 0.23 24.60 76.86 -1.25 42.80 6.49 30.34 45.08 7.21 30.70 coo 18.77 77.82 11.69 20.55 80.22 10.73 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 45.25 7.06 34.64 46.46 8.64 34.05 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER B 101 SER~? 10.37 CL CL B 226 A 173 ARG B 13 ARG~? 5.25 CL CL B 226 A 211 ASP B 102 ASP~? 16.83 CL CL B 226 coo 22.72 76.24 0.23 24.60 76.86 -1.25 47.36 3.83 31.66 48.67 4.20 29.68 coo 18.77 77.82 11.69 20.55 80.22 10.73 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 45.25 7.06 34.64 46.46 8.64 34.05 1ig8_c00 source 1ig8 HEXOKINASE PII : 4 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 186 ASP.? 30.68 CL CL A 226 158 THR A 120 THR~? 33.80 CL CL A 226 317 ASP A 151 ASP~? 27.89 CL CL A 226 coo -2.63 8.40 35.07 -3.66 9.81 36.17 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo -5.30 12.75 41.86 -4.34 13.05 39.99 22.90 -11.90 -11.33 24.82 -12.79 -11.66 coo -12.63 17.64 33.66 -10.65 17.90 34.40 31.07 -14.15 -4.04 29.86 -14.57 -2.39 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 186 ASP.? 30.68 CL CL A 226 158 THR A 181 THR~? 17.70 CL CL A 226 317 ASP A 61 ASP.? 23.60 CL CL A 226 coo -2.63 8.40 35.07 -3.66 9.81 36.17 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo -5.30 12.75 41.86 -4.34 13.05 39.99 19.07 -8.40 2.64 19.42 -8.54 4.77 coo -12.63 17.64 33.66 -10.65 17.90 34.40 6.80 -9.81 5.25 8.17 -9.51 3.68 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c02 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 151 ASP~? 27.89 CL CL A 226 A1134 ALA A 154 ALA~? 25.49 CL CL A 226 A1137 ASN A 155 ASN~? 24.40 CL CL A 226 coo -27.05 34.58 17.12 -25.81 32.84 17.16 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo -20.53 36.39 15.81 -20.80 35.01 16.40 30.89 -12.05 0.88 32.12 -12.34 0.09 coo -23.72 34.69 12.49 -24.32 32.83 13.34 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP B 186 ASP.? 30.73 CL CL B 226 A1134 ALA B 189 ALA.? 30.31 CL CL B 226 A1137 ASN B 188 ASN.? 35.33 CL CL B 226 coo -27.05 34.58 17.12 -25.81 32.84 17.16 56.29 -18.50 46.72 54.94 -17.46 47.93 coo -20.53 36.39 15.81 -20.80 35.01 16.40 58.37 -14.38 50.46 57.77 -13.39 49.45 coo -23.72 34.69 12.49 -24.32 32.83 13.34 58.21 -19.16 51.65 58.37 -21.08 50.71 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP B 203 ASP~? 25.12 CL CL B 226 A1134 ALA B 206 ALA~? 23.96 CL CL B 226 A1137 ASN B 202 ASN~? 26.89 CL CL B 226 coo -27.05 34.58 17.12 -25.81 32.84 17.16 60.54 4.31 43.90 62.00 4.57 45.37 coo -20.53 36.39 15.81 -20.80 35.01 16.40 56.38 8.90 42.83 57.56 8.97 43.80 coo -23.72 34.69 12.49 -24.32 32.83 13.34 56.47 4.11 47.59 54.90 3.31 48.75 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 3 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 111 ASP~? 26.09 CL CL A 226 A 204 GLU A 110 GLU~? 23.70 CL CL A 226 A 279 TYR A 208 TYR~? 15.64 CL CL A 226 coo 5.85 5.60 30.32 5.00 7.49 29.88 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 7.79 1.83 27.81 9.08 3.25 26.92 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 8.22 7.77 18.64 7.58 8.47 21.28 25.22 8.01 3.41 27.20 7.60 5.36 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP B 186 ASP.? 30.73 CL CL B 226 A 204 GLU B 187 GLU.? 29.51 CL CL B 226 A 279 TYR B 194 TYR~? 30.06 CL CL B 226 coo 5.85 5.60 30.32 5.00 7.49 29.88 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 7.79 1.83 27.81 9.08 3.25 26.92 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 8.22 7.77 18.64 7.58 8.47 21.28 55.14 -6.59 51.91 53.44 -4.41 51.82 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 2 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 77 GLU~? 21.84 CL CL B 226 A 61 GLU A 157 GLU~? 23.07 CL CL A 226 A 162 HIS A 75 HIS.? 25.41 CL CL B 226 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 40.16 -11.08 10.76 40.31 -13.18 10.50 coo -4.89 20.85 5.22 -3.95 21.69 6.91 28.68 -12.57 4.41 29.48 -14.51 4.41 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 38.68 -16.70 9.61 40.32 -17.29 8.43 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU A 84 GLU~? 12.94 CL CL B 226 A 61 GLU A 11 GLU.? 11.48 CL CL A 226 A 162 HIS B 86 HIS~? 9.45 CL CL B 226 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 40.51 -2.33 16.64 42.51 -2.90 16.44 coo -4.89 20.85 5.22 -3.95 21.69 6.91 31.29 2.41 22.91 32.62 4.08 23.08 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 44.03 1.12 22.86 45.41 1.90 21.48 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU B 77 GLU~? 22.22 CL CL A 226 A 61 GLU B 157 GLU~? 23.31 CL CL B 226 A 162 HIS B 75 HIS.? 25.67 CL CL A 226 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 34.33 -9.48 30.93 34.02 -11.53 31.29 coo -4.89 20.85 5.22 -3.95 21.69 6.91 44.83 -13.19 37.20 43.40 -14.70 37.59 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 34.50 -15.17 32.63 32.86 -15.45 33.92 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU B 84 GLU~? 12.79 CL CL A 226 A 61 GLU B 11 GLU.? 11.19 CL CL B 226 A 162 HIS A 86 HIS~? 10.02 CL CL A 226 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 35.35 -1.73 23.75 33.22 -1.55 23.84 coo -4.89 20.85 5.22 -3.95 21.69 6.91 45.62 0.60 17.46 44.46 2.32 17.00 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 32.84 2.26 17.60 31.66 3.53 18.78 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 4 hits 1j53_c00 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 185 GLN~? 22.98 CL CL A 226 A 79 PHE A 68 PHE^? 20.15 CL CL A 226 A 80 THR A 181 THR~? 17.70 CL CL A 226 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 15.83 -13.17 2.06 17.40 -14.13 3.16 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 24.16 -12.52 5.51 22.26 -11.92 3.55 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 19.07 -8.40 2.64 19.42 -8.54 4.77 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN A 185 GLN~? 22.98 CL CL A 226 A 79 PHE A 183 PHE~? 26.67 CL CL A 226 A 80 THR A 181 THR~? 17.70 CL CL A 226 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 15.83 -13.17 2.06 17.40 -14.13 3.16 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 17.50 -8.22 -4.13 17.97 -8.86 -6.81 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 19.07 -8.40 2.64 19.42 -8.54 4.77 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 3 3 # 3 A 78 GLN B 185 GLN~? 23.32 CL CL B 226 A 79 PHE B 68 PHE^? 20.40 CL CL B 226 A 80 THR B 181 THR~? 17.66 CL CL B 226 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 57.03 -15.62 39.97 55.27 -16.55 39.25 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 49.27 -13.62 36.70 51.35 -13.49 38.54 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 54.63 -10.58 39.28 54.41 -10.04 37.17 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 4 3 # 4 A 78 GLN B 185 GLN~? 23.32 CL CL B 226 A 79 PHE B 183 PHE~? 27.12 CL CL B 226 A 80 THR B 181 THR~? 17.66 CL CL B 226 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 57.03 -15.62 39.97 55.27 -16.55 39.25 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 54.63 -10.58 39.28 54.41 -10.04 37.17 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 4 hits 1j7g_c00 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 186 ASP.? 30.68 CL CL A 226 A 58 ASP A 193 ASP~? 30.50 CL CL A 226 A 424 GLU A 182 GLU~? 21.95 CL CL A 226 coo 58.42 47.76 20.67 58.01 49.10 19.12 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 58.59 41.80 18.81 58.94 43.89 18.94 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 52.85 46.34 13.34 54.09 44.97 14.42 13.02 -8.29 1.26 11.61 -6.76 1.56 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 193 ASP~? 30.50 CL CL A 226 A 58 ASP A 186 ASP.? 30.68 CL CL A 226 A 424 GLU A 182 GLU~? 21.95 CL CL A 226 coo 58.42 47.76 20.67 58.01 49.10 19.12 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 58.59 41.80 18.81 58.94 43.89 18.94 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 52.85 46.34 13.34 54.09 44.97 14.42 13.02 -8.29 1.26 11.61 -6.76 1.56 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 2 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 186 ASP.? 30.68 CL CL A 226 B 58 ASP A 193 ASP~? 30.50 CL CL A 226 B 424 GLU A 182 GLU~? 21.95 CL CL A 226 coo 112.10 61.46 19.99 111.82 60.65 18.07 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 117.85 63.62 21.08 115.96 63.25 20.18 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 118.47 57.23 15.57 119.32 58.77 16.73 13.02 -8.29 1.26 11.61 -6.76 1.56 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 193 ASP~? 30.50 CL CL A 226 B 58 ASP A 186 ASP.? 30.68 CL CL A 226 B 424 GLU A 182 GLU~? 21.95 CL CL A 226 coo 112.10 61.46 19.99 111.82 60.65 18.07 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 117.85 63.62 21.08 115.96 63.25 20.18 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 118.47 57.23 15.57 119.32 58.77 16.73 13.02 -8.29 1.26 11.61 -6.76 1.56 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 2 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 4 GLU^? 21.78 CL CL A 226 A 56 LYS A 36 LYS^? 12.38 CL CL A 226 A 258 ARG A 27 ARG~? 25.45 CL CL A 226 coo 42.33 1.56 26.99 42.38 2.91 28.66 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 38.45 -0.44 19.89 37.36 0.90 25.90 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 23.69 -24.29 25.50 21.75 -22.60 23.78 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 175 GLU~? 15.88 CL CL A 226 A 56 LYS A 178 LYS~? 16.45 CL CL A 226 A 258 ARG A 199 ARG~? 30.44 CL CL A 226 coo 42.33 1.56 26.99 42.38 2.91 28.66 15.56 2.16 3.91 14.40 0.59 4.79 coo 38.45 -0.44 19.89 37.36 0.90 25.90 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 12.72 2.77 -8.55 10.64 0.77 -9.61 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU A 182 GLU~? 21.95 CL CL A 226 A 56 LYS A 178 LYS~? 16.45 CL CL A 226 A 258 ARG A 65 ARG.? 31.92 CL CL A 226 coo 42.33 1.56 26.99 42.38 2.91 28.66 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 38.45 -0.44 19.89 37.36 0.90 25.90 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 17.05 -18.95 -0.65 15.70 -20.36 -3.04 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU B 4 GLU^? 21.62 CL CL B 226 A 56 LYS B 36 LYS^? 15.37 CL CL B 226 A 258 ARG B 27 ARG~? 28.79 CL CL B 226 coo 42.33 1.56 26.99 42.38 2.91 28.66 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 38.45 -0.44 19.89 37.36 0.90 25.90 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 46.17 -28.08 18.24 47.24 -27.87 15.37 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU B 175 GLU~? 17.14 CL CL B 226 A 56 LYS B 178 LYS~? 16.76 CL CL B 226 A 258 ARG B 199 ARG~? 31.39 CL CL B 226 coo 42.33 1.56 26.99 42.38 2.91 28.66 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 38.45 -0.44 19.89 37.36 0.90 25.90 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 62.93 0.56 49.95 63.41 -1.61 52.09 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 5 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 4 GLU^? 21.78 CL CL A 226 B 56 LYS A 36 LYS^? 12.38 CL CL A 226 B 258 ARG A 27 ARG~? 25.45 CL CL A 226 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 2.64 1.83 34.81 1.56 1.13 32.02 23.69 -24.29 25.50 21.75 -22.60 23.78 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 175 GLU~? 15.88 CL CL A 226 B 56 LYS A 178 LYS~? 16.45 CL CL A 226 B 258 ARG A 199 ARG~? 30.44 CL CL A 226 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 15.56 2.16 3.91 14.40 0.59 4.79 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 2.64 1.83 34.81 1.56 1.13 32.02 12.72 2.77 -8.55 10.64 0.77 -9.61 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU A 182 GLU~? 21.95 CL CL A 226 B 56 LYS A 178 LYS~? 16.45 CL CL A 226 B 258 ARG A 65 ARG.? 31.92 CL CL A 226 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 2.64 1.83 34.81 1.56 1.13 32.02 17.05 -18.95 -0.65 15.70 -20.36 -3.04 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU B 4 GLU^? 21.62 CL CL B 226 B 56 LYS B 36 LYS^? 15.37 CL CL B 226 B 258 ARG B 27 ARG~? 28.79 CL CL B 226 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 2.64 1.83 34.81 1.56 1.13 32.02 46.17 -28.08 18.24 47.24 -27.87 15.37 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU B 175 GLU~? 17.14 CL CL B 226 B 56 LYS B 178 LYS~? 16.76 CL CL B 226 B 258 ARG B 199 ARG~? 31.39 CL CL B 226 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 2.64 1.83 34.81 1.56 1.13 32.02 62.93 0.56 49.95 63.41 -1.61 52.09 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 5 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 4 GLU^? 21.78 CL CL A 226 C 56 LYS A 36 LYS^? 12.38 CL CL A 226 C 258 ARG A 27 ARG~? 25.45 CL CL A 226 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 23.69 -24.29 25.50 21.75 -22.60 23.78 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 175 GLU~? 15.88 CL CL A 226 C 56 LYS A 178 LYS~? 16.45 CL CL A 226 C 258 ARG A 199 ARG~? 30.44 CL CL A 226 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 15.56 2.16 3.91 14.40 0.59 4.79 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 12.72 2.77 -8.55 10.64 0.77 -9.61 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU A 182 GLU~? 21.95 CL CL A 226 C 56 LYS A 178 LYS~? 16.45 CL CL A 226 C 258 ARG A 65 ARG.? 31.92 CL CL A 226 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 17.05 -18.95 -0.65 15.70 -20.36 -3.04 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU B 4 GLU^? 21.62 CL CL B 226 C 56 LYS B 36 LYS^? 15.37 CL CL B 226 C 258 ARG B 27 ARG~? 28.79 CL CL B 226 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 46.17 -28.08 18.24 47.24 -27.87 15.37 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU B 175 GLU~? 17.14 CL CL B 226 C 56 LYS B 178 LYS~? 16.76 CL CL B 226 C 258 ARG B 199 ARG~? 31.39 CL CL B 226 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 62.93 0.56 49.95 63.41 -1.61 52.09 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 5 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 4 GLU^? 21.78 CL CL A 226 D 56 LYS A 36 LYS^? 12.38 CL CL A 226 D 258 ARG A 27 ARG~? 25.45 CL CL A 226 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 17.40 -16.82 25.22 19.04 -17.86 26.09 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 19.01 -10.55 19.77 15.11 -7.69 20.09 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 23.69 -24.29 25.50 21.75 -22.60 23.78 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 175 GLU~? 15.88 CL CL A 226 D 56 LYS A 178 LYS~? 16.45 CL CL A 226 D 258 ARG A 199 ARG~? 30.44 CL CL A 226 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 15.56 2.16 3.91 14.40 0.59 4.79 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 12.72 2.77 -8.55 10.64 0.77 -9.61 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU A 182 GLU~? 21.95 CL CL A 226 D 56 LYS A 178 LYS~? 16.45 CL CL A 226 D 258 ARG A 65 ARG.? 31.92 CL CL A 226 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 13.02 -8.29 1.26 11.61 -6.76 1.56 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 17.52 -4.22 5.13 11.68 -3.87 7.49 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 17.05 -18.95 -0.65 15.70 -20.36 -3.04 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU B 4 GLU^? 21.62 CL CL B 226 D 56 LYS B 36 LYS^? 15.37 CL CL B 226 D 258 ARG B 27 ARG~? 28.79 CL CL B 226 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 55.04 -20.91 16.97 53.22 -21.40 15.95 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 55.08 -14.30 22.43 60.90 -14.25 24.08 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 46.17 -28.08 18.24 47.24 -27.87 15.37 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU B 175 GLU~? 17.14 CL CL B 226 D 56 LYS B 178 LYS~? 16.76 CL CL B 226 D 258 ARG B 199 ARG~? 31.39 CL CL B 226 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 62.93 0.56 49.95 63.41 -1.61 52.09 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 5 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 77 GLU~? 21.84 CL CL B 226 A 163 ARG A 81 ARG~? 19.72 CL CL B 226 A 222 ARG B 19 ARG~? 20.05 CL CL B 226 coo 51.27 81.34 48.31 51.67 80.79 50.28 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 48.06 78.22 50.94 48.51 78.27 53.98 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 54.85 84.16 52.60 54.26 81.23 53.34 42.78 -12.99 14.20 43.98 -15.00 12.21 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 77 GLU~? 21.84 CL CL B 226 A 163 ARG B 19 ARG~? 20.05 CL CL B 226 A 222 ARG A 81 ARG~? 19.72 CL CL B 226 coo 51.27 81.34 48.31 51.67 80.79 50.28 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 48.06 78.22 50.94 48.51 78.27 53.98 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 54.85 84.16 52.60 54.26 81.23 53.34 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU B 77 GLU~? 22.22 CL CL A 226 A 163 ARG A 19 ARG~? 20.09 CL CL A 226 A 222 ARG B 81 ARG~? 19.82 CL CL A 226 coo 51.27 81.34 48.31 51.67 80.79 50.28 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 48.06 78.22 50.94 48.51 78.27 53.98 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 54.85 84.16 52.60 54.26 81.23 53.34 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU B 77 GLU~? 22.22 CL CL A 226 A 163 ARG B 81 ARG~? 19.82 CL CL A 226 A 222 ARG A 19 ARG~? 20.09 CL CL A 226 coo 51.27 81.34 48.31 51.67 80.79 50.28 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 48.06 78.22 50.94 48.51 78.27 53.98 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 54.85 84.16 52.60 54.26 81.23 53.34 31.00 -11.00 27.75 29.53 -12.56 29.89 1kim_c00 source 1kim THYMIDINE KINASE : 4 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 200 LYS~? 23.56 CL CL A 226 A 74 LYS A 195 LYS~? 35.76 CL CL A 226 A 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo 24.97 5.82 58.78 26.79 1.97 55.46 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 31.64 -0.95 -10.58 32.34 0.04 -12.34 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 200 LYS~? 23.56 CL CL A 226 A 74 LYS A 205 LYS~? 25.48 CL CL A 226 A 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo 24.97 5.82 58.78 26.79 1.97 55.46 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 19.46 3.44 61.93 23.95 1.12 60.13 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 31.64 -0.95 -10.58 32.34 0.04 -12.34 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 200 LYS~? 23.56 CL CL A 226 B 74 LYS A 195 LYS~? 35.76 CL CL A 226 B 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo 4.84 5.09 23.75 3.30 1.39 27.48 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 31.64 -0.95 -10.58 32.34 0.04 -12.34 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 200 LYS~? 23.56 CL CL A 226 B 74 LYS A 205 LYS~? 25.48 CL CL A 226 B 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo 4.84 5.09 23.75 3.30 1.39 27.48 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 10.43 2.88 20.75 5.72 0.41 23.95 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 31.64 -0.95 -10.58 32.34 0.04 -12.34 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 200 LYS~? 23.56 CL CL A 226 C 74 LYS A 205 LYS~? 25.48 CL CL A 226 C 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo 17.59 37.25 25.80 19.64 34.15 21.60 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 12.29 34.52 28.11 16.84 32.47 25.43 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 12.06 27.10 15.56 13.23 27.02 13.80 31.64 -0.95 -10.58 32.34 0.04 -12.34 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 195 LYS~? 35.76 CL CL A 226 D 74 LYS A 200 LYS~? 23.56 CL CL A 226 D 165 GLU A 182 GLU~? 21.95 CL CL A 226 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 13.02 -8.29 1.26 11.61 -6.76 1.56 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 200 LYS~? 23.56 CL CL A 226 D 74 LYS A 195 LYS~? 35.76 CL CL A 226 D 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 31.64 -0.95 -10.58 32.34 0.04 -12.34 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 200 LYS~? 23.56 CL CL A 226 D 74 LYS A 205 LYS~? 25.48 CL CL A 226 D 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 31.64 -0.95 -10.58 32.34 0.04 -12.34 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 3 hits 1kqc_c03 naa= 3 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 60 GLU A 69 GLU^? 25.00 CL CL A 226 198 CYH A 33 CYH^? 23.80 CL CL A 226 229 ASN A 50 ASN.? 30.77 CL CL A 226 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 21.65 -20.96 19.40 23.47 -21.29 21.43 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 28.00 -25.90 12.99 26.73 -27.64 12.92 1lcb_c02 source 1lcb THYMIDYLATE SYNTHASE : 1 hits 1lcb_c02 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 65 ARG.? 31.92 CL CL A 226 245 HIS A 56 HIS^? 18.87 CL CL A 226 343 THR A 181 THR~? 17.70 CL CL A 226 coo 18.11 85.25 41.19 18.04 83.33 43.59 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo 5.34 86.23 43.48 6.16 87.26 45.12 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 9.06 92.76 42.80 7.04 92.63 42.14 19.07 -8.40 2.64 19.42 -8.54 4.77 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG A 81 ARG~? 19.72 CL CL B 226 245 HIS A 86 HIS~? 10.02 CL CL A 226 343 THR A 164 THR~? 11.55 CL CL A 226 coo 18.11 85.25 41.19 18.04 83.33 43.59 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 5.34 86.23 43.48 6.16 87.26 45.12 32.84 2.26 17.60 31.66 3.53 18.78 coo 9.06 92.76 42.80 7.04 92.63 42.14 27.89 -4.17 14.18 28.68 -6.16 13.95 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG A 81 ARG~? 19.72 CL CL B 226 245 HIS B 86 HIS~? 9.45 CL CL B 226 343 THR B 12 THR~? 10.36 CL CL B 226 coo 18.11 85.25 41.19 18.04 83.33 43.59 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 5.34 86.23 43.48 6.16 87.26 45.12 44.03 1.12 22.86 45.41 1.90 21.48 coo 9.06 92.76 42.80 7.04 92.63 42.14 45.94 -3.45 20.21 43.90 -3.11 20.94 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG B 81 ARG~? 19.82 CL CL A 226 245 HIS B 86 HIS~? 9.45 CL CL B 226 343 THR B 164 THR~? 11.43 CL CL B 226 coo 18.11 85.25 41.19 18.04 83.33 43.59 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 5.34 86.23 43.48 6.16 87.26 45.12 44.03 1.12 22.86 45.41 1.90 21.48 coo 9.06 92.76 42.80 7.04 92.63 42.14 47.37 -5.68 26.89 46.28 -7.52 27.30 1lci_c00 source 1lci LUCIFERASE : 4 hits 1lci_c00 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 52 LYS^? 28.69 CL CL A 226 A 202 SER A 55 SER^? 14.68 CL CL A 226 A 226 SER A 67 SER.? 20.77 CL CL A 226 coo 1.62 6.10 69.30 3.81 1.25 65.91 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 4.43 1.89 61.79 4.31 0.09 63.40 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 205 LYS~? 25.48 CL CL A 226 A 202 SER A 210 SER~? 21.09 CL CL A 226 A 226 SER A 212 SER.? 30.23 CL CL A 226 coo 1.62 6.10 69.30 3.81 1.25 65.91 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 4.43 1.89 61.79 4.31 0.09 63.40 24.15 14.96 0.00 24.37 15.67 2.31 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS A 213 LYS.? 30.41 CL CL A 226 A 202 SER A 210 SER~? 21.09 CL CL A 226 A 226 SER A 207 SER~? 18.13 CL CL A 226 coo 1.62 6.10 69.30 3.81 1.25 65.91 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 4.43 1.89 61.79 4.31 0.09 63.40 24.15 14.96 0.00 24.37 15.67 2.31 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS B 52 LYS^? 28.59 CL CL B 226 A 202 SER B 55 SER^? 14.61 CL CL B 226 A 226 SER B 67 SER.? 20.24 CL CL B 226 coo 1.62 6.10 69.30 3.81 1.25 65.91 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 4.43 1.89 61.79 4.31 0.09 63.40 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 5 3 # 5 A 123 LYS B 205 LYS~? 25.67 CL CL B 226 A 202 SER B 210 SER~? 23.92 CL CL B 226 A 226 SER B 212 SER~? 27.82 CL CL B 226 coo 1.62 6.10 69.30 3.81 1.25 65.91 54.11 5.83 42.26 49.56 6.08 46.56 coo 4.43 1.89 61.79 4.31 0.09 63.40 53.28 14.40 40.02 51.53 15.84 39.30 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 51.36 18.00 43.66 51.38 19.12 41.53 1m21_c00 source 1m21 PEPTIDE AMIDASE : 5 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 52 LYS^? 28.69 CL CL A 226 B 202 SER A 55 SER^? 14.68 CL CL A 226 B 226 SER A 67 SER.? 20.77 CL CL A 226 coo 35.67 -0.01 18.11 33.47 4.84 14.73 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 32.81 4.27 10.70 32.87 6.07 12.31 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 28.77 6.36 12.44 30.83 7.25 11.75 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 205 LYS~? 25.48 CL CL A 226 B 202 SER A 210 SER~? 21.09 CL CL A 226 B 226 SER A 212 SER.? 30.23 CL CL A 226 coo 35.67 -0.01 18.11 33.47 4.84 14.73 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 32.81 4.27 10.70 32.87 6.07 12.31 24.15 14.96 0.00 24.37 15.67 2.31 coo 28.77 6.36 12.44 30.83 7.25 11.75 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS A 213 LYS.? 30.41 CL CL A 226 B 202 SER A 210 SER~? 21.09 CL CL A 226 B 226 SER A 207 SER~? 18.13 CL CL A 226 coo 35.67 -0.01 18.11 33.47 4.84 14.73 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 32.81 4.27 10.70 32.87 6.07 12.31 24.15 14.96 0.00 24.37 15.67 2.31 coo 28.77 6.36 12.44 30.83 7.25 11.75 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS B 52 LYS^? 28.59 CL CL B 226 B 202 SER B 55 SER^? 14.61 CL CL B 226 B 226 SER B 67 SER.? 20.24 CL CL B 226 coo 35.67 -0.01 18.11 33.47 4.84 14.73 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 32.81 4.27 10.70 32.87 6.07 12.31 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 28.77 6.36 12.44 30.83 7.25 11.75 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 5 3 # 5 B 123 LYS B 205 LYS~? 25.67 CL CL B 226 B 202 SER B 210 SER~? 23.92 CL CL B 226 B 226 SER B 212 SER~? 27.82 CL CL B 226 coo 35.67 -0.01 18.11 33.47 4.84 14.73 54.11 5.83 42.26 49.56 6.08 46.56 coo 32.81 4.27 10.70 32.87 6.07 12.31 53.28 14.40 40.02 51.53 15.84 39.30 coo 28.77 6.36 12.44 30.83 7.25 11.75 51.36 18.00 43.66 51.38 19.12 41.53 1m21_c01 source 1m21 PEPTIDE AMIDASE : 5 hits 1m21_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 193 ASP~? 31.47 CL CL B 226 A 295 GLU B 187 GLU.? 29.51 CL CL B 226 A 369 ASP B 186 ASP.? 30.73 CL CL B 226 coo 11.74 38.14 80.19 10.63 36.40 80.65 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 16.11 33.72 80.99 14.10 33.54 81.63 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 12.19 31.08 87.29 11.13 32.66 86.38 56.29 -18.50 46.72 54.94 -17.46 47.93 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 111 ASP~? 25.68 CL CL B 226 A 265 GLU B 77 GLU~? 22.22 CL CL A 226 A 369 ASP B 151 ASP~? 28.65 CL CL B 226 coo 11.74 38.14 80.19 10.63 36.40 80.65 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 17.36 23.57 72.04 18.68 21.92 71.98 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 41.86 -11.82 45.74 42.46 -13.70 45.02 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 111 ASP~? 25.68 CL CL B 226 A 265 GLU B 182 GLU~? 22.76 CL CL B 226 A 369 ASP B 151 ASP~? 28.65 CL CL B 226 coo 11.74 38.14 80.19 10.63 36.40 80.65 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 17.36 23.57 72.04 18.68 21.92 71.98 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 12.19 31.08 87.29 11.13 32.66 86.38 41.86 -11.82 45.74 42.46 -13.70 45.02 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 151 ASP~? 28.65 CL CL B 226 A 265 GLU B 77 GLU~? 22.22 CL CL A 226 A 369 ASP B 111 ASP~? 25.68 CL CL B 226 coo 11.74 38.14 80.19 10.63 36.40 80.65 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 17.36 23.57 72.04 18.68 21.92 71.98 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 44.68 -0.98 44.91 42.92 -2.08 45.36 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 151 ASP~? 28.65 CL CL B 226 A 265 GLU B 182 GLU~? 22.76 CL CL B 226 A 369 ASP B 111 ASP~? 25.68 CL CL B 226 coo 11.74 38.14 80.19 10.63 36.40 80.65 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 17.36 23.57 72.04 18.68 21.92 71.98 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 12.19 31.08 87.29 11.13 32.66 86.38 44.68 -0.98 44.91 42.92 -2.08 45.36 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c05 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 60 LYS.? 19.24 CL CL A 226 166 LYS A 63 LYS.? 28.35 CL CL A 226 324 SER A 28 SER~? 26.52 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 27.27 1.43 25.09 29.18 5.25 22.89 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 46.32 14.55 19.93 45.95 12.72 21.27 26.40 -24.33 19.56 28.45 -23.49 18.56 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 63 LYS.? 28.35 CL CL A 226 166 LYS A 60 LYS.? 19.24 CL CL A 226 324 SER A 28 SER~? 26.52 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 27.27 1.43 25.09 29.18 5.25 22.89 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 46.32 14.55 19.93 45.95 12.72 21.27 26.40 -24.33 19.56 28.45 -23.49 18.56 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 63 LYS.? 28.35 CL CL A 226 166 LYS A 60 LYS.? 19.24 CL CL A 226 324 SER A 51 SER.? 28.65 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 27.27 1.43 25.09 29.18 5.25 22.89 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 46.32 14.55 19.93 45.95 12.72 21.27 30.97 -23.17 15.96 32.59 -24.12 14.38 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 195 LYS~? 35.76 CL CL A 226 166 LYS A 200 LYS~? 23.56 CL CL A 226 324 SER A 67 SER.? 20.77 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 27.27 1.43 25.09 29.18 5.25 22.89 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 46.32 14.55 19.93 45.95 12.72 21.27 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS A 200 LYS~? 23.56 CL CL A 226 166 LYS A 195 LYS~? 35.76 CL CL A 226 324 SER A 67 SER.? 20.77 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 27.27 1.43 25.09 29.18 5.25 22.89 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 46.32 14.55 19.93 45.95 12.72 21.27 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS A 200 LYS~? 23.56 CL CL A 226 166 LYS A 205 LYS~? 25.48 CL CL A 226 324 SER A 55 SER^? 14.68 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 27.27 1.43 25.09 29.18 5.25 22.89 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 46.32 14.55 19.93 45.95 12.72 21.27 23.22 -13.07 11.27 22.88 -10.73 11.74 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS A 200 LYS~? 23.56 CL CL A 226 166 LYS A 205 LYS~? 25.48 CL CL A 226 324 SER A 67 SER.? 20.77 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 27.27 1.43 25.09 29.18 5.25 22.89 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 46.32 14.55 19.93 45.95 12.72 21.27 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS A 205 LYS~? 25.48 CL CL A 226 166 LYS A 200 LYS~? 23.56 CL CL A 226 324 SER A 55 SER^? 14.68 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 27.27 1.43 25.09 29.18 5.25 22.89 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 46.32 14.55 19.93 45.95 12.72 21.27 23.22 -13.07 11.27 22.88 -10.73 11.74 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS B 195 LYS~? 36.01 CL CL B 226 166 LYS B 200 LYS~? 24.54 CL CL B 226 324 SER B 67 SER.? 20.24 CL CL B 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 27.27 1.43 25.09 29.18 5.25 22.89 60.00 0.23 45.11 63.70 -4.80 44.31 coo 46.32 14.55 19.93 45.95 12.72 21.27 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS B 195 LYS~? 36.01 CL CL B 226 166 LYS B 200 LYS~? 24.54 CL CL B 226 324 SER B 148 SER.? 30.86 CL CL B 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 27.27 1.43 25.09 29.18 5.25 22.89 60.00 0.23 45.11 63.70 -4.80 44.31 coo 46.32 14.55 19.93 45.95 12.72 21.27 37.61 -3.73 46.12 37.97 -3.44 48.48 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS B 200 LYS~? 24.54 CL CL B 226 166 LYS B 195 LYS~? 36.01 CL CL B 226 324 SER B 55 SER^? 14.61 CL CL B 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 60.00 0.23 45.11 63.70 -4.80 44.31 coo 27.27 1.43 25.09 29.18 5.25 22.89 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 46.32 14.55 19.93 45.95 12.72 21.27 50.30 -14.63 30.79 50.54 -12.31 30.40 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS B 200 LYS~? 24.54 CL CL B 226 166 LYS B 195 LYS~? 36.01 CL CL B 226 324 SER B 67 SER.? 20.24 CL CL B 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 60.00 0.23 45.11 63.70 -4.80 44.31 coo 27.27 1.43 25.09 29.18 5.25 22.89 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 46.32 14.55 19.93 45.95 12.72 21.27 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS B 200 LYS~? 24.54 CL CL B 226 166 LYS B 195 LYS~? 36.01 CL CL B 226 324 SER B 148 SER.? 30.86 CL CL B 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 60.00 0.23 45.11 63.70 -4.80 44.31 coo 27.27 1.43 25.09 29.18 5.25 22.89 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 46.32 14.55 19.93 45.95 12.72 21.27 37.61 -3.73 46.12 37.97 -3.44 48.48 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS B 200 LYS~? 24.54 CL CL B 226 166 LYS B 205 LYS~? 25.67 CL CL B 226 324 SER B 55 SER^? 14.61 CL CL B 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 60.00 0.23 45.11 63.70 -4.80 44.31 coo 27.27 1.43 25.09 29.18 5.25 22.89 54.11 5.83 42.26 49.56 6.08 46.56 coo 46.32 14.55 19.93 45.95 12.72 21.27 50.30 -14.63 30.79 50.54 -12.31 30.40 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 15 3 # 15 164 LYS B 200 LYS~? 24.54 CL CL B 226 166 LYS B 205 LYS~? 25.67 CL CL B 226 324 SER B 67 SER.? 20.24 CL CL B 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 60.00 0.23 45.11 63.70 -4.80 44.31 coo 27.27 1.43 25.09 29.18 5.25 22.89 54.11 5.83 42.26 49.56 6.08 46.56 coo 46.32 14.55 19.93 45.95 12.72 21.27 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 16 3 # 16 164 LYS B 205 LYS~? 25.67 CL CL B 226 166 LYS B 200 LYS~? 24.54 CL CL B 226 324 SER B 55 SER^? 14.61 CL CL B 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 54.11 5.83 42.26 49.56 6.08 46.56 coo 27.27 1.43 25.09 29.18 5.25 22.89 60.00 0.23 45.11 63.70 -4.80 44.31 coo 46.32 14.55 19.93 45.95 12.72 21.27 50.30 -14.63 30.79 50.54 -12.31 30.40 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 17 3 # 17 164 LYS B 205 LYS~? 25.67 CL CL B 226 166 LYS B 200 LYS~? 24.54 CL CL B 226 324 SER B 147 SER.? 29.85 CL CL A 226 coo 25.93 8.11 25.51 26.40 7.80 19.66 54.11 5.83 42.26 49.56 6.08 46.56 coo 27.27 1.43 25.09 29.18 5.25 22.89 60.00 0.23 45.11 63.70 -4.80 44.31 coo 46.32 14.55 19.93 45.95 12.72 21.27 34.91 -3.69 43.41 34.12 -5.63 44.70 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 17 hits 1mdr_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 15 GLY~? 13.48 CL CL A 226 A 501 ASP A 102 ASP~? 17.30 CL CL A 226 B 367 TYR B 208 TYR~? 15.74 CL CL B 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.14 -6.39 21.42 31.45 -6.64 21.14 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 32.53 7.12 5.29 31.66 9.04 5.62 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.42 6.76 36.83 50.45 6.61 34.90 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 89 GLY~? 17.30 CL CL A 226 A 501 ASP A 43 ASP.? 11.79 CL CL A 226 B 367 TYR B 46 TYR^? 12.90 CL CL B 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 37.90 4.36 11.39 38.58 4.02 11.72 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 165 GLY.? 9.73 CL CL A 226 A 501 ASP A 94 ASP.? 26.16 CL CL B 226 B 367 TYR B 46 TYR^? 12.90 CL CL B 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.46 -1.42 14.80 29.77 -1.25 14.46 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 44.86 8.73 -0.50 42.92 8.83 0.44 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 165 GLY.? 9.73 CL CL A 226 A 501 ASP A 151 ASP~? 27.89 CL CL A 226 B 367 TYR B 46 TYR^? 12.90 CL CL B 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.46 -1.42 14.80 29.77 -1.25 14.46 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 15 GLY~? 13.31 CL CL B 226 A 501 ASP B 102 ASP~? 16.83 CL CL B 226 B 367 TYR A 208 TYR~? 15.64 CL CL A 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 42.83 -7.72 19.85 43.46 -8.04 20.13 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 45.25 7.06 34.64 46.46 8.64 34.05 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 25.22 8.01 3.41 27.20 7.60 5.36 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 78 GLY~? 18.96 CL CL B 226 A 501 ASP B 94 ASP.? 27.62 CL CL A 226 B 367 TYR A 160 TYR~? 15.52 CL CL A 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 38.61 -8.60 30.14 38.34 -8.69 29.37 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 32.35 7.85 42.25 31.25 7.59 44.05 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 89 GLY~? 16.64 CL CL B 226 A 501 ASP A 40 ASP.? 7.65 CL CL A 226 B 367 TYR B 38 TYR.? 11.29 CL CL B 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 39.61 4.74 28.75 38.89 4.60 28.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 89 GLY~? 16.64 CL CL B 226 A 501 ASP B 43 ASP.? 11.93 CL CL B 226 B 367 TYR A 46 TYR^? 12.99 CL CL A 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 39.61 4.74 28.75 38.89 4.60 28.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 89 GLY~? 16.64 CL CL B 226 A 501 ASP B 151 ASP~? 28.65 CL CL B 226 B 367 TYR A 46 TYR^? 12.99 CL CL A 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 39.61 4.74 28.75 38.89 4.60 28.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 165 GLY.? 9.33 CL CL B 226 A 501 ASP B 94 ASP.? 27.62 CL CL A 226 B 367 TYR A 160 TYR~? 15.52 CL CL A 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 45.52 -2.50 25.89 46.23 -2.42 26.22 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 32.35 7.85 42.25 31.25 7.59 44.05 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY B 165 GLY.? 9.33 CL CL B 226 A 501 ASP B 151 ASP~? 28.65 CL CL B 226 B 367 TYR A 46 TYR^? 12.99 CL CL A 226 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 45.52 -2.50 25.89 46.23 -2.42 26.22 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 22.89 -11.80 16.43 23.58 -9.15 16.08 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 11 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 15 GLY~? 13.48 CL CL A 226 D 501 ASP A 102 ASP~? 17.30 CL CL A 226 E 367 TYR B 208 TYR~? 15.74 CL CL B 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.14 -6.39 21.42 31.45 -6.64 21.14 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 32.53 7.12 5.29 31.66 9.04 5.62 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.42 6.76 36.83 50.45 6.61 34.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 89 GLY~? 17.30 CL CL A 226 D 501 ASP A 43 ASP.? 11.79 CL CL A 226 E 367 TYR B 46 TYR^? 12.90 CL CL B 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 37.90 4.36 11.39 38.58 4.02 11.72 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 165 GLY.? 9.73 CL CL A 226 D 501 ASP A 94 ASP.? 26.16 CL CL B 226 E 367 TYR B 46 TYR^? 12.90 CL CL B 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.46 -1.42 14.80 29.77 -1.25 14.46 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 44.86 8.73 -0.50 42.92 8.83 0.44 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 165 GLY.? 9.73 CL CL A 226 D 501 ASP A 151 ASP~? 27.89 CL CL A 226 E 367 TYR B 46 TYR^? 12.90 CL CL B 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.46 -1.42 14.80 29.77 -1.25 14.46 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 15 GLY~? 13.31 CL CL B 226 D 501 ASP B 102 ASP~? 16.83 CL CL B 226 E 367 TYR A 208 TYR~? 15.64 CL CL A 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 42.83 -7.72 19.85 43.46 -8.04 20.13 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 45.25 7.06 34.64 46.46 8.64 34.05 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 25.22 8.01 3.41 27.20 7.60 5.36 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 78 GLY~? 18.96 CL CL B 226 D 501 ASP B 94 ASP.? 27.62 CL CL A 226 E 367 TYR A 160 TYR~? 15.52 CL CL A 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 38.61 -8.60 30.14 38.34 -8.69 29.37 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 32.35 7.85 42.25 31.25 7.59 44.05 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 89 GLY~? 16.64 CL CL B 226 D 501 ASP A 40 ASP.? 7.65 CL CL A 226 E 367 TYR B 38 TYR.? 11.29 CL CL B 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 39.61 4.74 28.75 38.89 4.60 28.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 89 GLY~? 16.64 CL CL B 226 D 501 ASP B 43 ASP.? 11.93 CL CL B 226 E 367 TYR A 46 TYR^? 12.99 CL CL A 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 39.61 4.74 28.75 38.89 4.60 28.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 89 GLY~? 16.64 CL CL B 226 D 501 ASP B 151 ASP~? 28.65 CL CL B 226 E 367 TYR A 46 TYR^? 12.99 CL CL A 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 39.61 4.74 28.75 38.89 4.60 28.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 165 GLY.? 9.33 CL CL B 226 D 501 ASP B 94 ASP.? 27.62 CL CL A 226 E 367 TYR A 160 TYR~? 15.52 CL CL A 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 45.52 -2.50 25.89 46.23 -2.42 26.22 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 32.35 7.85 42.25 31.25 7.59 44.05 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 25.03 -8.51 7.95 22.39 -8.85 7.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY B 165 GLY.? 9.33 CL CL B 226 D 501 ASP B 151 ASP~? 28.65 CL CL B 226 E 367 TYR A 46 TYR^? 12.99 CL CL A 226 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 45.52 -2.50 25.89 46.23 -2.42 26.22 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 22.89 -11.80 16.43 23.58 -9.15 16.08 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 11 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 61 ASP.? 23.60 CL CL A 226 A 55 TYR A 58 TYR.? 17.32 CL CL A 226 A 84 LYS A 63 LYS.? 28.35 CL CL A 226 coo 11.09 42.89 24.44 11.32 42.06 22.49 6.80 -9.81 5.25 8.17 -9.51 3.68 coo 4.60 40.33 20.42 7.25 39.50 20.05 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 9.71 44.83 15.47 10.13 41.43 19.93 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 61 ASP.? 23.81 CL CL B 226 A 55 TYR B 58 TYR.? 17.22 CL CL B 226 A 84 LYS B 63 LYS.? 30.86 CL CL B 226 coo 11.09 42.89 24.44 11.32 42.06 22.49 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 4.60 40.33 20.42 7.25 39.50 20.05 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 9.71 44.83 15.47 10.13 41.43 19.93 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 102 ASP~? 16.83 CL CL B 226 A 55 TYR B 90 TYR^? 17.17 CL CL B 226 A 84 LYS B 96 LYS^? 24.51 CL CL B 226 coo 11.09 42.89 24.44 11.32 42.06 22.49 45.25 7.06 34.64 46.46 8.64 34.05 coo 4.60 40.33 20.42 7.25 39.50 20.05 38.78 1.99 31.89 40.05 -0.11 30.63 coo 9.71 44.83 15.47 10.13 41.43 19.93 35.42 10.33 36.63 41.15 11.45 39.22 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 3 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 52 LYS^? 28.69 CL CL A 226 A 217 SER A 55 SER^? 14.68 CL CL A 226 A 241 SER A 67 SER.? 20.77 CL CL A 226 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS A 205 LYS~? 25.48 CL CL A 226 A 217 SER A 210 SER~? 21.09 CL CL A 226 A 241 SER A 212 SER.? 30.23 CL CL A 226 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 24.15 14.96 0.00 24.37 15.67 2.31 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS A 213 LYS.? 30.41 CL CL A 226 A 217 SER A 210 SER~? 21.09 CL CL A 226 A 241 SER A 207 SER~? 18.13 CL CL A 226 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 24.15 14.96 0.00 24.37 15.67 2.31 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 A 142 LYS B 52 LYS^? 28.59 CL CL B 226 A 217 SER B 55 SER^? 14.61 CL CL B 226 A 241 SER B 67 SER.? 20.24 CL CL B 226 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 A 142 LYS B 205 LYS~? 25.67 CL CL B 226 A 217 SER B 210 SER~? 23.92 CL CL B 226 A 241 SER B 212 SER~? 27.82 CL CL B 226 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 54.11 5.83 42.26 49.56 6.08 46.56 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 53.28 14.40 40.02 51.53 15.84 39.30 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 52 LYS^? 28.69 CL CL A 226 B 217 SER A 55 SER^? 14.68 CL CL A 226 B 241 SER A 67 SER.? 20.77 CL CL A 226 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 30.09 -20.25 13.69 32.70 -23.31 10.81 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 23.22 -13.07 11.27 22.88 -10.73 11.74 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS A 205 LYS~? 25.48 CL CL A 226 B 217 SER A 210 SER~? 21.09 CL CL A 226 B 241 SER A 212 SER.? 30.23 CL CL A 226 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 24.15 14.96 0.00 24.37 15.67 2.31 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS A 213 LYS.? 30.41 CL CL A 226 B 217 SER A 210 SER~? 21.09 CL CL A 226 B 241 SER A 207 SER~? 18.13 CL CL A 226 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 20.84 14.61 -7.95 16.28 17.34 -7.27 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 24.15 14.96 0.00 24.37 15.67 2.31 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 B 142 LYS B 52 LYS^? 28.59 CL CL B 226 B 217 SER B 55 SER^? 14.61 CL CL B 226 B 241 SER B 67 SER.? 20.24 CL CL B 226 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 42.32 -20.73 28.98 39.02 -22.55 33.10 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 50.30 -14.63 30.79 50.54 -12.31 30.40 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 B 142 LYS B 205 LYS~? 25.67 CL CL B 226 B 217 SER B 210 SER~? 23.92 CL CL B 226 B 241 SER B 212 SER~? 27.82 CL CL B 226 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 54.11 5.83 42.26 49.56 6.08 46.56 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 53.28 14.40 40.02 51.53 15.84 39.30 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 52 LYS^? 28.69 CL CL A 226 C 217 SER A 55 SER^? 14.68 CL CL A 226 C 241 SER A 67 SER.? 20.77 CL CL A 226 coo -12.07 2.83 63.52 -8.95 7.56 61.01 30.09 -20.25 13.69 32.70 -23.31 10.81 coo -11.64 10.12 58.62 -9.34 9.31 58.79 23.22 -13.07 11.27 22.88 -10.73 11.74 coo -9.31 12.91 61.58 -8.56 11.90 59.50 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS A 205 LYS~? 25.48 CL CL A 226 C 217 SER A 210 SER~? 21.09 CL CL A 226 C 241 SER A 212 SER.? 30.23 CL CL A 226 coo -12.07 2.83 63.52 -8.95 7.56 61.01 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -11.64 10.12 58.62 -9.34 9.31 58.79 24.15 14.96 0.00 24.37 15.67 2.31 coo -9.31 12.91 61.58 -8.56 11.90 59.50 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS A 213 LYS.? 30.41 CL CL A 226 C 217 SER A 207 SER~? 18.13 CL CL A 226 C 241 SER A 210 SER~? 21.09 CL CL A 226 coo -12.07 2.83 63.52 -8.95 7.56 61.01 20.84 14.61 -7.95 16.28 17.34 -7.27 coo -11.64 10.12 58.62 -9.34 9.31 58.79 20.60 11.23 0.64 19.47 10.75 2.68 coo -9.31 12.91 61.58 -8.56 11.90 59.50 24.15 14.96 0.00 24.37 15.67 2.31 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 C 142 LYS A 213 LYS.? 30.41 CL CL A 226 C 217 SER A 210 SER~? 21.09 CL CL A 226 C 241 SER A 207 SER~? 18.13 CL CL A 226 coo -12.07 2.83 63.52 -8.95 7.56 61.01 20.84 14.61 -7.95 16.28 17.34 -7.27 coo -11.64 10.12 58.62 -9.34 9.31 58.79 24.15 14.96 0.00 24.37 15.67 2.31 coo -9.31 12.91 61.58 -8.56 11.90 59.50 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 C 142 LYS B 52 LYS^? 28.59 CL CL B 226 C 217 SER B 55 SER^? 14.61 CL CL B 226 C 241 SER B 67 SER.? 20.24 CL CL B 226 coo -12.07 2.83 63.52 -8.95 7.56 61.01 42.32 -20.73 28.98 39.02 -22.55 33.10 coo -11.64 10.12 58.62 -9.34 9.31 58.79 50.30 -14.63 30.79 50.54 -12.31 30.40 coo -9.31 12.91 61.58 -8.56 11.90 59.50 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 C 142 LYS B 205 LYS~? 25.67 CL CL B 226 C 217 SER B 210 SER~? 23.92 CL CL B 226 C 241 SER B 212 SER~? 27.82 CL CL B 226 coo -12.07 2.83 63.52 -8.95 7.56 61.01 54.11 5.83 42.26 49.56 6.08 46.56 coo -11.64 10.12 58.62 -9.34 9.31 58.79 53.28 14.40 40.02 51.53 15.84 39.30 coo -9.31 12.91 61.58 -8.56 11.90 59.50 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 52 LYS^? 28.69 CL CL A 226 D 217 SER A 55 SER^? 14.68 CL CL A 226 D 241 SER A 67 SER.? 20.77 CL CL A 226 coo 32.93 17.78 71.88 30.89 13.50 67.83 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 34.38 11.17 66.10 32.18 12.14 65.65 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 31.34 7.96 67.74 31.44 9.08 65.62 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS A 205 LYS~? 25.48 CL CL A 226 D 217 SER A 210 SER~? 21.09 CL CL A 226 D 241 SER A 212 SER.? 30.23 CL CL A 226 coo 32.93 17.78 71.88 30.89 13.50 67.83 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 34.38 11.17 66.10 32.18 12.14 65.65 24.15 14.96 0.00 24.37 15.67 2.31 coo 31.34 7.96 67.74 31.44 9.08 65.62 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS A 213 LYS.? 30.41 CL CL A 226 D 217 SER A 210 SER~? 21.09 CL CL A 226 D 241 SER A 207 SER~? 18.13 CL CL A 226 coo 32.93 17.78 71.88 30.89 13.50 67.83 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 34.38 11.17 66.10 32.18 12.14 65.65 24.15 14.96 0.00 24.37 15.67 2.31 coo 31.34 7.96 67.74 31.44 9.08 65.62 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 D 142 LYS B 52 LYS^? 28.59 CL CL B 226 D 217 SER B 55 SER^? 14.61 CL CL B 226 D 241 SER B 67 SER.? 20.24 CL CL B 226 coo 32.93 17.78 71.88 30.89 13.50 67.83 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 34.38 11.17 66.10 32.18 12.14 65.65 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 31.34 7.96 67.74 31.44 9.08 65.62 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 D 142 LYS B 205 LYS~? 25.67 CL CL B 226 D 217 SER B 210 SER~? 23.92 CL CL B 226 D 241 SER B 212 SER~? 27.82 CL CL B 226 coo 32.93 17.78 71.88 30.89 13.50 67.83 54.11 5.83 42.26 49.56 6.08 46.56 coo 34.38 11.17 66.10 32.18 12.14 65.65 53.28 14.40 40.02 51.53 15.84 39.30 coo 31.34 7.96 67.74 31.44 9.08 65.62 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 52 LYS^? 28.69 CL CL A 226 E 217 SER A 55 SER^? 14.68 CL CL A 226 E 241 SER A 67 SER.? 20.77 CL CL A 226 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 205 LYS~? 25.48 CL CL A 226 E 217 SER A 210 SER~? 21.09 CL CL A 226 E 241 SER A 212 SER.? 30.23 CL CL A 226 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 24.15 14.96 0.00 24.37 15.67 2.31 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS A 213 LYS.? 30.41 CL CL A 226 E 217 SER A 210 SER~? 21.09 CL CL A 226 E 241 SER A 207 SER~? 18.13 CL CL A 226 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 24.15 14.96 0.00 24.37 15.67 2.31 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 E 142 LYS B 52 LYS^? 28.59 CL CL B 226 E 217 SER B 55 SER^? 14.61 CL CL B 226 E 241 SER B 67 SER.? 20.24 CL CL B 226 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 E 142 LYS B 205 LYS~? 25.67 CL CL B 226 E 217 SER B 210 SER~? 23.92 CL CL B 226 E 241 SER B 212 SER~? 27.82 CL CL B 226 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 54.11 5.83 42.26 49.56 6.08 46.56 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 53.28 14.40 40.02 51.53 15.84 39.30 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 52 LYS^? 28.69 CL CL A 226 F 217 SER A 55 SER^? 14.68 CL CL A 226 F 241 SER A 67 SER.? 20.77 CL CL A 226 coo 85.78 13.19 64.96 85.47 13.47 58.63 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 87.43 17.13 57.15 85.84 15.39 56.76 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 89.69 13.60 54.86 87.60 14.67 54.46 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 205 LYS~? 25.48 CL CL A 226 F 217 SER A 210 SER~? 21.09 CL CL A 226 F 241 SER A 212 SER.? 30.23 CL CL A 226 coo 85.78 13.19 64.96 85.47 13.47 58.63 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 87.43 17.13 57.15 85.84 15.39 56.76 24.15 14.96 0.00 24.37 15.67 2.31 coo 89.69 13.60 54.86 87.60 14.67 54.46 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS A 213 LYS.? 30.41 CL CL A 226 F 217 SER A 210 SER~? 21.09 CL CL A 226 F 241 SER A 207 SER~? 18.13 CL CL A 226 coo 85.78 13.19 64.96 85.47 13.47 58.63 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 87.43 17.13 57.15 85.84 15.39 56.76 24.15 14.96 0.00 24.37 15.67 2.31 coo 89.69 13.60 54.86 87.60 14.67 54.46 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS B 52 LYS^? 28.59 CL CL B 226 F 217 SER B 55 SER^? 14.61 CL CL B 226 F 241 SER B 67 SER.? 20.24 CL CL B 226 coo 85.78 13.19 64.96 85.47 13.47 58.63 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 87.43 17.13 57.15 85.84 15.39 56.76 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 89.69 13.60 54.86 87.60 14.67 54.46 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 F 142 LYS B 205 LYS~? 25.67 CL CL B 226 F 217 SER B 210 SER~? 23.92 CL CL B 226 F 241 SER B 212 SER~? 27.82 CL CL B 226 coo 85.78 13.19 64.96 85.47 13.47 58.63 54.11 5.83 42.26 49.56 6.08 46.56 coo 87.43 17.13 57.15 85.84 15.39 56.76 53.28 14.40 40.02 51.53 15.84 39.30 coo 89.69 13.60 54.86 87.60 14.67 54.46 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 52 LYS^? 28.69 CL CL A 226 G 217 SER A 55 SER^? 14.68 CL CL A 226 G 241 SER A 67 SER.? 20.77 CL CL A 226 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS A 205 LYS~? 25.48 CL CL A 226 G 217 SER A 210 SER~? 21.09 CL CL A 226 G 241 SER A 212 SER.? 30.23 CL CL A 226 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 24.15 14.96 0.00 24.37 15.67 2.31 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS A 213 LYS.? 30.41 CL CL A 226 G 217 SER A 210 SER~? 21.09 CL CL A 226 G 241 SER A 207 SER~? 18.13 CL CL A 226 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 24.15 14.96 0.00 24.37 15.67 2.31 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 G 142 LYS B 52 LYS^? 28.59 CL CL B 226 G 217 SER B 55 SER^? 14.61 CL CL B 226 G 241 SER B 67 SER.? 20.24 CL CL B 226 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 G 142 LYS B 205 LYS~? 25.67 CL CL B 226 G 217 SER B 210 SER~? 23.92 CL CL B 226 G 241 SER B 212 SER~? 27.82 CL CL B 226 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 54.11 5.83 42.26 49.56 6.08 46.56 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 53.28 14.40 40.02 51.53 15.84 39.30 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 52 LYS^? 28.69 CL CL A 226 H 217 SER A 55 SER^? 14.68 CL CL A 226 H 241 SER A 67 SER.? 20.77 CL CL A 226 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 205 LYS~? 25.48 CL CL A 226 H 217 SER A 210 SER~? 21.09 CL CL A 226 H 241 SER A 212 SER.? 30.23 CL CL A 226 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 24.15 14.96 0.00 24.37 15.67 2.31 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS A 213 LYS.? 30.41 CL CL A 226 H 217 SER A 210 SER~? 21.09 CL CL A 226 H 241 SER A 207 SER~? 18.13 CL CL A 226 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 24.15 14.96 0.00 24.37 15.67 2.31 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 H 142 LYS B 52 LYS^? 28.59 CL CL B 226 H 217 SER B 55 SER^? 14.61 CL CL B 226 H 241 SER B 67 SER.? 20.24 CL CL B 226 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 H 142 LYS B 205 LYS~? 25.67 CL CL B 226 H 217 SER B 210 SER~? 23.92 CL CL B 226 H 241 SER B 212 SER~? 27.82 CL CL B 226 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 54.11 5.83 42.26 49.56 6.08 46.56 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 53.28 14.40 40.02 51.53 15.84 39.30 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 52 LYS^? 28.69 CL CL A 226 I 217 SER A 55 SER^? 14.68 CL CL A 226 I 241 SER A 67 SER.? 20.77 CL CL A 226 coo -5.05 91.11 27.04 -1.24 87.39 30.21 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 2.83 88.63 29.54 1.30 86.82 30.03 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 2.37 88.32 34.25 2.82 86.58 32.61 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 205 LYS~? 25.48 CL CL A 226 I 217 SER A 210 SER~? 21.09 CL CL A 226 I 241 SER A 212 SER.? 30.23 CL CL A 226 coo -5.05 91.11 27.04 -1.24 87.39 30.21 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 2.83 88.63 29.54 1.30 86.82 30.03 24.15 14.96 0.00 24.37 15.67 2.31 coo 2.37 88.32 34.25 2.82 86.58 32.61 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS A 213 LYS.? 30.41 CL CL A 226 I 217 SER A 210 SER~? 21.09 CL CL A 226 I 241 SER A 207 SER~? 18.13 CL CL A 226 coo -5.05 91.11 27.04 -1.24 87.39 30.21 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 2.83 88.63 29.54 1.30 86.82 30.03 24.15 14.96 0.00 24.37 15.67 2.31 coo 2.37 88.32 34.25 2.82 86.58 32.61 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS B 52 LYS^? 28.59 CL CL B 226 I 217 SER B 55 SER^? 14.61 CL CL B 226 I 241 SER B 67 SER.? 20.24 CL CL B 226 coo -5.05 91.11 27.04 -1.24 87.39 30.21 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 2.83 88.63 29.54 1.30 86.82 30.03 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 2.37 88.32 34.25 2.82 86.58 32.61 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 I 142 LYS B 205 LYS~? 25.67 CL CL B 226 I 217 SER B 210 SER~? 23.92 CL CL B 226 I 241 SER B 212 SER~? 27.82 CL CL B 226 coo -5.05 91.11 27.04 -1.24 87.39 30.21 54.11 5.83 42.26 49.56 6.08 46.56 coo 2.83 88.63 29.54 1.30 86.82 30.03 53.28 14.40 40.02 51.53 15.84 39.30 coo 2.37 88.32 34.25 2.82 86.58 32.61 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 52 LYS^? 28.69 CL CL A 226 J 217 SER A 55 SER^? 14.68 CL CL A 226 J 241 SER A 67 SER.? 20.77 CL CL A 226 coo -16.11 59.78 61.53 -15.92 58.68 55.43 30.09 -20.25 13.69 32.70 -23.31 10.81 coo -17.65 54.92 54.17 -15.81 56.46 53.79 23.22 -13.07 11.27 22.88 -10.73 11.74 coo -19.92 58.10 51.57 -17.75 57.08 51.34 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS A 205 LYS~? 25.48 CL CL A 226 J 217 SER A 210 SER~? 21.09 CL CL A 226 J 241 SER A 212 SER.? 30.23 CL CL A 226 coo -16.11 59.78 61.53 -15.92 58.68 55.43 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -17.65 54.92 54.17 -15.81 56.46 53.79 24.15 14.96 0.00 24.37 15.67 2.31 coo -19.92 58.10 51.57 -17.75 57.08 51.34 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS A 213 LYS.? 30.41 CL CL A 226 J 217 SER A 210 SER~? 21.09 CL CL A 226 J 241 SER A 207 SER~? 18.13 CL CL A 226 coo -16.11 59.78 61.53 -15.92 58.68 55.43 20.84 14.61 -7.95 16.28 17.34 -7.27 coo -17.65 54.92 54.17 -15.81 56.46 53.79 24.15 14.96 0.00 24.37 15.67 2.31 coo -19.92 58.10 51.57 -17.75 57.08 51.34 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 J 142 LYS B 52 LYS^? 28.59 CL CL B 226 J 217 SER B 55 SER^? 14.61 CL CL B 226 J 241 SER B 67 SER.? 20.24 CL CL B 226 coo -16.11 59.78 61.53 -15.92 58.68 55.43 42.32 -20.73 28.98 39.02 -22.55 33.10 coo -17.65 54.92 54.17 -15.81 56.46 53.79 50.30 -14.63 30.79 50.54 -12.31 30.40 coo -19.92 58.10 51.57 -17.75 57.08 51.34 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 J 142 LYS B 205 LYS~? 25.67 CL CL B 226 J 217 SER B 210 SER~? 23.92 CL CL B 226 J 241 SER B 212 SER~? 27.82 CL CL B 226 coo -16.11 59.78 61.53 -15.92 58.68 55.43 54.11 5.83 42.26 49.56 6.08 46.56 coo -17.65 54.92 54.17 -15.81 56.46 53.79 53.28 14.40 40.02 51.53 15.84 39.30 coo -19.92 58.10 51.57 -17.75 57.08 51.34 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 52 LYS^? 28.69 CL CL A 226 K 217 SER A 55 SER^? 14.68 CL CL A 226 K 241 SER A 67 SER.? 20.77 CL CL A 226 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 30.09 -20.25 13.69 32.70 -23.31 10.81 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 23.22 -13.07 11.27 22.88 -10.73 11.74 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 205 LYS~? 25.48 CL CL A 226 K 217 SER A 210 SER~? 21.09 CL CL A 226 K 241 SER A 212 SER.? 30.23 CL CL A 226 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 24.15 14.96 0.00 24.37 15.67 2.31 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS A 213 LYS.? 30.41 CL CL A 226 K 217 SER A 210 SER~? 21.09 CL CL A 226 K 241 SER A 207 SER~? 18.13 CL CL A 226 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 20.84 14.61 -7.95 16.28 17.34 -7.27 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 24.15 14.96 0.00 24.37 15.67 2.31 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 K 142 LYS B 52 LYS^? 28.59 CL CL B 226 K 217 SER B 55 SER^? 14.61 CL CL B 226 K 241 SER B 67 SER.? 20.24 CL CL B 226 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 42.32 -20.73 28.98 39.02 -22.55 33.10 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 50.30 -14.63 30.79 50.54 -12.31 30.40 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 K 142 LYS B 205 LYS~? 25.67 CL CL B 226 K 217 SER B 210 SER~? 23.92 CL CL B 226 K 241 SER B 212 SER~? 27.82 CL CL B 226 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 54.11 5.83 42.26 49.56 6.08 46.56 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 53.28 14.40 40.02 51.53 15.84 39.30 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 52 LYS^? 28.69 CL CL A 226 L 217 SER A 55 SER^? 14.68 CL CL A 226 L 241 SER A 67 SER.? 20.77 CL CL A 226 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 205 LYS~? 25.48 CL CL A 226 L 217 SER A 210 SER~? 21.09 CL CL A 226 L 241 SER A 212 SER.? 30.23 CL CL A 226 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 24.15 14.96 0.00 24.37 15.67 2.31 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS A 213 LYS.? 30.41 CL CL A 226 L 217 SER A 210 SER~? 21.09 CL CL A 226 L 241 SER A 207 SER~? 18.13 CL CL A 226 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 24.15 14.96 0.00 24.37 15.67 2.31 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS B 52 LYS^? 28.59 CL CL B 226 L 217 SER B 55 SER^? 14.61 CL CL B 226 L 241 SER B 67 SER.? 20.24 CL CL B 226 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 L 142 LYS B 205 LYS~? 25.67 CL CL B 226 L 217 SER B 210 SER~? 23.92 CL CL B 226 L 241 SER B 212 SER~? 27.82 CL CL B 226 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 54.11 5.83 42.26 49.56 6.08 46.56 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 53.28 14.40 40.02 51.53 15.84 39.30 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 52 LYS^? 28.69 CL CL A 226 M 217 SER A 55 SER^? 14.68 CL CL A 226 M 241 SER A 67 SER.? 20.77 CL CL A 226 coo 57.83 99.61 24.25 54.90 95.14 20.60 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 51.07 94.66 21.52 53.18 93.49 22.20 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 51.67 94.23 16.93 51.60 92.47 18.57 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS A 205 LYS~? 25.48 CL CL A 226 M 217 SER A 210 SER~? 21.09 CL CL A 226 M 241 SER A 212 SER.? 30.23 CL CL A 226 coo 57.83 99.61 24.25 54.90 95.14 20.60 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 51.07 94.66 21.52 53.18 93.49 22.20 24.15 14.96 0.00 24.37 15.67 2.31 coo 51.67 94.23 16.93 51.60 92.47 18.57 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS A 213 LYS.? 30.41 CL CL A 226 M 217 SER A 210 SER~? 21.09 CL CL A 226 M 241 SER A 207 SER~? 18.13 CL CL A 226 coo 57.83 99.61 24.25 54.90 95.14 20.60 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 51.07 94.66 21.52 53.18 93.49 22.20 24.15 14.96 0.00 24.37 15.67 2.31 coo 51.67 94.23 16.93 51.60 92.47 18.57 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 M 142 LYS B 52 LYS^? 28.59 CL CL B 226 M 217 SER B 55 SER^? 14.61 CL CL B 226 M 241 SER B 67 SER.? 20.24 CL CL B 226 coo 57.83 99.61 24.25 54.90 95.14 20.60 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 51.07 94.66 21.52 53.18 93.49 22.20 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 51.67 94.23 16.93 51.60 92.47 18.57 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 M 142 LYS B 205 LYS~? 25.67 CL CL B 226 M 217 SER B 210 SER~? 23.92 CL CL B 226 M 241 SER B 212 SER~? 27.82 CL CL B 226 coo 57.83 99.61 24.25 54.90 95.14 20.60 54.11 5.83 42.26 49.56 6.08 46.56 coo 51.07 94.66 21.52 53.18 93.49 22.20 53.28 14.40 40.02 51.53 15.84 39.30 coo 51.67 94.23 16.93 51.60 92.47 18.57 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 52 LYS^? 28.69 CL CL A 226 N 217 SER A 55 SER^? 14.68 CL CL A 226 N 241 SER A 67 SER.? 20.77 CL CL A 226 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 81.67 67.31 -0.58 79.53 68.28 0.00 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 82.47 71.15 2.07 80.82 69.44 2.28 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS A 205 LYS~? 25.48 CL CL A 226 N 217 SER A 210 SER~? 21.09 CL CL A 226 N 241 SER A 212 SER.? 30.23 CL CL A 226 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 81.67 67.31 -0.58 79.53 68.28 0.00 24.15 14.96 0.00 24.37 15.67 2.31 coo 82.47 71.15 2.07 80.82 69.44 2.28 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS A 213 LYS.? 30.41 CL CL A 226 N 217 SER A 210 SER~? 21.09 CL CL A 226 N 241 SER A 207 SER~? 18.13 CL CL A 226 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 81.67 67.31 -0.58 79.53 68.28 0.00 24.15 14.96 0.00 24.37 15.67 2.31 coo 82.47 71.15 2.07 80.82 69.44 2.28 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 N 142 LYS B 52 LYS^? 28.59 CL CL B 226 N 217 SER B 55 SER^? 14.61 CL CL B 226 N 241 SER B 67 SER.? 20.24 CL CL B 226 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 81.67 67.31 -0.58 79.53 68.28 0.00 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 82.47 71.15 2.07 80.82 69.44 2.28 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 N 142 LYS B 205 LYS~? 25.67 CL CL B 226 N 217 SER B 210 SER~? 23.92 CL CL B 226 N 241 SER B 212 SER~? 27.82 CL CL B 226 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 54.11 5.83 42.26 49.56 6.08 46.56 coo 81.67 67.31 -0.58 79.53 68.28 0.00 53.28 14.40 40.02 51.53 15.84 39.30 coo 82.47 71.15 2.07 80.82 69.44 2.28 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 52 LYS^? 28.69 CL CL A 226 O 217 SER A 55 SER^? 14.68 CL CL A 226 O 241 SER A 67 SER.? 20.77 CL CL A 226 coo 81.67 70.12 58.71 78.82 64.87 57.22 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 81.62 62.23 55.05 79.32 62.93 55.20 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 79.39 59.54 58.42 78.72 60.00 56.11 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 205 LYS~? 25.48 CL CL A 226 O 217 SER A 210 SER~? 21.09 CL CL A 226 O 241 SER A 212 SER.? 30.23 CL CL A 226 coo 81.67 70.12 58.71 78.82 64.87 57.22 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 81.62 62.23 55.05 79.32 62.93 55.20 24.15 14.96 0.00 24.37 15.67 2.31 coo 79.39 59.54 58.42 78.72 60.00 56.11 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS A 213 LYS.? 30.41 CL CL A 226 O 217 SER A 210 SER~? 21.09 CL CL A 226 O 241 SER A 207 SER~? 18.13 CL CL A 226 coo 81.67 70.12 58.71 78.82 64.87 57.22 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 81.62 62.23 55.05 79.32 62.93 55.20 24.15 14.96 0.00 24.37 15.67 2.31 coo 79.39 59.54 58.42 78.72 60.00 56.11 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS B 52 LYS^? 28.59 CL CL B 226 O 217 SER B 55 SER^? 14.61 CL CL B 226 O 241 SER B 67 SER.? 20.24 CL CL B 226 coo 81.67 70.12 58.71 78.82 64.87 57.22 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 81.62 62.23 55.05 79.32 62.93 55.20 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 79.39 59.54 58.42 78.72 60.00 56.11 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 O 142 LYS B 205 LYS~? 25.67 CL CL B 226 O 217 SER B 210 SER~? 23.92 CL CL B 226 O 241 SER B 212 SER~? 27.82 CL CL B 226 coo 81.67 70.12 58.71 78.82 64.87 57.22 54.11 5.83 42.26 49.56 6.08 46.56 coo 81.62 62.23 55.05 79.32 62.93 55.20 53.28 14.40 40.02 51.53 15.84 39.30 coo 79.39 59.54 58.42 78.72 60.00 56.11 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 52 LYS^? 28.69 CL CL A 226 P 217 SER A 55 SER^? 14.68 CL CL A 226 P 241 SER A 67 SER.? 20.77 CL CL A 226 coo 37.29 55.72 69.54 38.73 59.85 65.07 30.09 -20.25 13.69 32.70 -23.31 10.81 coo 35.55 61.40 62.96 37.72 60.41 62.66 23.22 -13.07 11.27 22.88 -10.73 11.74 coo 38.60 64.77 64.10 38.63 63.28 62.26 21.89 -15.85 6.39 21.13 -16.00 8.70 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS A 205 LYS~? 25.48 CL CL A 226 P 217 SER A 210 SER~? 21.09 CL CL A 226 P 241 SER A 212 SER.? 30.23 CL CL A 226 coo 37.29 55.72 69.54 38.73 59.85 65.07 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 35.55 61.40 62.96 37.72 60.41 62.66 24.15 14.96 0.00 24.37 15.67 2.31 coo 38.60 64.77 64.10 38.63 63.28 62.26 22.65 17.11 -5.68 24.22 18.23 -7.14 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS A 213 LYS.? 30.41 CL CL A 226 P 217 SER A 207 SER~? 18.13 CL CL A 226 P 241 SER A 210 SER~? 21.09 CL CL A 226 coo 37.29 55.72 69.54 38.73 59.85 65.07 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 35.55 61.40 62.96 37.72 60.41 62.66 20.60 11.23 0.64 19.47 10.75 2.68 coo 38.60 64.77 64.10 38.63 63.28 62.26 24.15 14.96 0.00 24.37 15.67 2.31 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 P 142 LYS A 213 LYS.? 30.41 CL CL A 226 P 217 SER A 210 SER~? 21.09 CL CL A 226 P 241 SER A 207 SER~? 18.13 CL CL A 226 coo 37.29 55.72 69.54 38.73 59.85 65.07 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 35.55 61.40 62.96 37.72 60.41 62.66 24.15 14.96 0.00 24.37 15.67 2.31 coo 38.60 64.77 64.10 38.63 63.28 62.26 20.60 11.23 0.64 19.47 10.75 2.68 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 P 142 LYS B 52 LYS^? 28.59 CL CL B 226 P 217 SER B 55 SER^? 14.61 CL CL B 226 P 241 SER B 67 SER.? 20.24 CL CL B 226 coo 37.29 55.72 69.54 38.73 59.85 65.07 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 35.55 61.40 62.96 37.72 60.41 62.66 50.30 -14.63 30.79 50.54 -12.31 30.40 coo 38.60 64.77 64.10 38.63 63.28 62.26 51.01 -17.39 35.57 51.85 -17.47 33.34 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 P 142 LYS B 205 LYS~? 25.67 CL CL B 226 P 217 SER B 210 SER~? 23.92 CL CL B 226 P 241 SER B 212 SER~? 27.82 CL CL B 226 coo 37.29 55.72 69.54 38.73 59.85 65.07 54.11 5.83 42.26 49.56 6.08 46.56 coo 35.55 61.40 62.96 37.72 60.41 62.66 53.28 14.40 40.02 51.53 15.84 39.30 coo 38.60 64.77 64.10 38.63 63.28 62.26 51.36 18.00 43.66 51.38 19.12 41.53 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 63 LYS.? 28.35 CL CL A 226 A 169 LYS A 60 LYS.? 19.24 CL CL A 226 A 327 GLU A 187 GLU.? 30.59 CL CL A 226 coo 20.73 15.53 25.54 22.09 15.64 19.40 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 24.31 10.25 23.71 29.02 12.05 20.75 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 21.86 20.40 18.59 22.12 18.33 18.33 10.39 -14.82 -4.45 8.65 -14.21 -3.38 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 200 LYS~? 23.56 CL CL A 226 A 169 LYS A 205 LYS~? 25.48 CL CL A 226 A 327 GLU A 175 GLU~? 15.88 CL CL A 226 coo 20.73 15.53 25.54 22.09 15.64 19.40 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 24.31 10.25 23.71 29.02 12.05 20.75 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 21.86 20.40 18.59 22.12 18.33 18.33 15.56 2.16 3.91 14.40 0.59 4.79 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS A 200 LYS~? 23.56 CL CL A 226 A 169 LYS A 205 LYS~? 25.48 CL CL A 226 A 327 GLU A 198 GLU~? 30.13 CL CL A 226 coo 20.73 15.53 25.54 22.09 15.64 19.40 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 24.31 10.25 23.71 29.02 12.05 20.75 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 21.86 20.40 18.59 22.12 18.33 18.33 19.84 0.58 -9.50 20.29 0.30 -11.52 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 3 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 63 LYS.? 28.35 CL CL A 226 B 169 LYS A 60 LYS.? 19.24 CL CL A 226 B 327 GLU A 187 GLU.? 30.59 CL CL A 226 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 10.39 -14.82 -4.45 8.65 -14.21 -3.38 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 200 LYS~? 23.56 CL CL A 226 B 169 LYS A 205 LYS~? 25.48 CL CL A 226 B 327 GLU A 175 GLU~? 15.88 CL CL A 226 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 15.56 2.16 3.91 14.40 0.59 4.79 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS A 200 LYS~? 23.56 CL CL A 226 B 169 LYS A 205 LYS~? 25.48 CL CL A 226 B 327 GLU A 198 GLU~? 30.13 CL CL A 226 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 19.84 0.58 -9.50 20.29 0.30 -11.52 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 3 hits 1muc_c01 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 56 HIS^? 18.87 CL CL A 226 A 290 LYS A 60 LYS.? 19.24 CL CL A 226 A 405 ARG A 65 ARG.? 31.92 CL CL A 226 coo 41.33 25.99 28.05 41.95 26.95 29.80 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 37.11 33.75 31.82 38.72 27.95 29.90 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 42.28 27.98 41.30 43.16 28.14 38.35 17.05 -18.95 -0.65 15.70 -20.36 -3.04 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 1 hits 1nhx_c00 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 52 LYS^? 28.69 CL CL A 226 631 LYS A 60 LYS.? 19.24 CL CL A 226 708 LYS A 74 LYS.? 28.20 CL CL B 226 coo 8.61 33.06 11.15 10.12 29.19 8.82 30.09 -20.25 13.69 32.70 -23.31 10.81 coo -11.99 27.40 17.14 -13.60 24.52 11.71 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 18.16 32.86 9.85 16.06 28.20 13.56 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 52 LYS^? 28.69 CL CL A 226 631 LYS A 63 LYS.? 28.35 CL CL A 226 708 LYS A 74 LYS.? 28.20 CL CL B 226 coo 8.61 33.06 11.15 10.12 29.19 8.82 30.09 -20.25 13.69 32.70 -23.31 10.81 coo -11.99 27.40 17.14 -13.60 24.52 11.71 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 18.16 32.86 9.85 16.06 28.20 13.56 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS A 178 LYS~? 16.45 CL CL A 226 631 LYS A 213 LYS.? 30.41 CL CL A 226 708 LYS A 60 LYS.? 19.24 CL CL A 226 coo 8.61 33.06 11.15 10.12 29.19 8.82 17.52 -4.22 5.13 11.68 -3.87 7.49 coo -11.99 27.40 17.14 -13.60 24.52 11.71 20.84 14.61 -7.95 16.28 17.34 -7.27 coo 18.16 32.86 9.85 16.06 28.20 13.56 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS B 52 LYS^? 28.59 CL CL B 226 631 LYS B 63 LYS.? 30.86 CL CL B 226 708 LYS B 74 LYS.? 25.46 CL CL A 226 coo 8.61 33.06 11.15 10.12 29.19 8.82 42.32 -20.73 28.98 39.02 -22.55 33.10 coo -11.99 27.40 17.14 -13.60 24.52 11.71 61.77 -19.16 38.03 61.33 -25.31 39.26 coo 18.16 32.86 9.85 16.06 28.20 13.56 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS B 178 LYS~? 16.76 CL CL B 226 631 LYS B 52 LYS^? 28.59 CL CL B 226 708 LYS B 200 LYS~? 24.54 CL CL B 226 coo 8.61 33.06 11.15 10.12 29.19 8.82 57.30 -6.98 36.80 62.98 -8.03 34.22 coo -11.99 27.40 17.14 -13.60 24.52 11.71 42.32 -20.73 28.98 39.02 -22.55 33.10 coo 18.16 32.86 9.85 16.06 28.20 13.56 60.00 0.23 45.11 63.70 -4.80 44.31 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 5 hits 1nsf_c00 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 40 ASP.? 7.65 CL CL A 226 A 146 TYR A 160 TYR~? 15.52 CL CL A 226 A 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -3.50 124.89 25.05 -2.25 124.77 23.26 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 1.87 119.38 16.45 1.41 122.11 16.84 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -2.59 124.07 12.67 -0.91 126.17 18.42 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 111 ASP~? 26.09 CL CL A 226 A 146 TYR A 208 TYR~? 15.64 CL CL A 226 A 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -3.50 124.89 25.05 -2.25 124.77 23.26 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 1.87 119.38 16.45 1.41 122.11 16.84 25.22 8.01 3.41 27.20 7.60 5.36 coo -2.59 124.07 12.67 -0.91 126.17 18.42 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP A 111 ASP~? 26.09 CL CL A 226 A 146 TYR A 209 TYR~? 20.76 CL CL A 226 A 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -3.50 124.89 25.05 -2.25 124.77 23.26 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 1.87 119.38 16.45 1.41 122.11 16.84 27.49 9.87 -0.64 29.01 7.64 0.00 coo -2.59 124.07 12.67 -0.91 126.17 18.42 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP B 40 ASP.? 7.91 CL CL B 226 A 146 TYR B 160 TYR~? 15.61 CL CL B 226 A 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -3.50 124.89 25.05 -2.25 124.77 23.26 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 1.87 119.38 16.45 1.41 122.11 16.84 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -2.59 124.07 12.67 -0.91 126.17 18.42 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP B 111 ASP~? 25.68 CL CL B 226 A 146 TYR B 209 TYR~? 20.47 CL CL B 226 A 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -3.50 124.89 25.05 -2.25 124.77 23.26 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 1.87 119.38 16.45 1.41 122.11 16.84 50.38 9.38 40.26 48.54 7.35 39.73 coo -2.59 124.07 12.67 -0.91 126.17 18.42 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 40 ASP.? 7.65 CL CL A 226 B 146 TYR A 160 TYR~? 15.52 CL CL A 226 B 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -7.43 109.06 51.23 -5.84 110.54 50.86 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 0.22 114.56 44.62 -0.76 115.18 47.18 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -4.18 120.17 46.85 -4.02 115.31 51.00 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 111 ASP~? 26.09 CL CL A 226 B 146 TYR A 208 TYR~? 15.64 CL CL A 226 B 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -7.43 109.06 51.23 -5.84 110.54 50.86 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 0.22 114.56 44.62 -0.76 115.18 47.18 25.22 8.01 3.41 27.20 7.60 5.36 coo -4.18 120.17 46.85 -4.02 115.31 51.00 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP A 111 ASP~? 26.09 CL CL A 226 B 146 TYR A 209 TYR~? 20.76 CL CL A 226 B 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -7.43 109.06 51.23 -5.84 110.54 50.86 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 0.22 114.56 44.62 -0.76 115.18 47.18 27.49 9.87 -0.64 29.01 7.64 0.00 coo -4.18 120.17 46.85 -4.02 115.31 51.00 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP B 40 ASP.? 7.91 CL CL B 226 B 146 TYR B 160 TYR~? 15.61 CL CL B 226 B 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -7.43 109.06 51.23 -5.84 110.54 50.86 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 0.22 114.56 44.62 -0.76 115.18 47.18 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -4.18 120.17 46.85 -4.02 115.31 51.00 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP B 111 ASP~? 25.68 CL CL B 226 B 146 TYR B 209 TYR~? 20.47 CL CL B 226 B 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -7.43 109.06 51.23 -5.84 110.54 50.86 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 0.22 114.56 44.62 -0.76 115.18 47.18 50.38 9.38 40.26 48.54 7.35 39.73 coo -4.18 120.17 46.85 -4.02 115.31 51.00 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 40 ASP.? 7.65 CL CL A 226 C 146 TYR A 160 TYR~? 15.52 CL CL A 226 C 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -13.49 79.65 43.90 -12.13 80.29 45.45 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -5.65 86.78 48.49 -7.16 84.72 49.65 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -11.22 87.18 53.49 -10.94 81.64 50.31 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 111 ASP~? 26.09 CL CL A 226 C 146 TYR A 208 TYR~? 15.64 CL CL A 226 C 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -13.49 79.65 43.90 -12.13 80.29 45.45 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -5.65 86.78 48.49 -7.16 84.72 49.65 25.22 8.01 3.41 27.20 7.60 5.36 coo -11.22 87.18 53.49 -10.94 81.64 50.31 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP A 111 ASP~? 26.09 CL CL A 226 C 146 TYR A 209 TYR~? 20.76 CL CL A 226 C 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -13.49 79.65 43.90 -12.13 80.29 45.45 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -5.65 86.78 48.49 -7.16 84.72 49.65 27.49 9.87 -0.64 29.01 7.64 0.00 coo -11.22 87.18 53.49 -10.94 81.64 50.31 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP B 40 ASP.? 7.91 CL CL B 226 C 146 TYR B 160 TYR~? 15.61 CL CL B 226 C 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -13.49 79.65 43.90 -12.13 80.29 45.45 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -5.65 86.78 48.49 -7.16 84.72 49.65 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -11.22 87.18 53.49 -10.94 81.64 50.31 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP B 111 ASP~? 25.68 CL CL B 226 C 146 TYR B 209 TYR~? 20.47 CL CL B 226 C 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -13.49 79.65 43.90 -12.13 80.29 45.45 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -5.65 86.78 48.49 -7.16 84.72 49.65 50.38 9.38 40.26 48.54 7.35 39.73 coo -11.22 87.18 53.49 -10.94 81.64 50.31 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 40 ASP.? 7.65 CL CL A 226 D 146 TYR A 160 TYR~? 15.52 CL CL A 226 D 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -13.44 77.36 13.12 -12.53 75.97 14.48 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -7.85 74.44 22.75 -9.22 72.86 20.89 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -14.24 70.61 23.48 -12.55 71.73 17.42 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 111 ASP~? 26.09 CL CL A 226 D 146 TYR A 208 TYR~? 15.64 CL CL A 226 D 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -13.44 77.36 13.12 -12.53 75.97 14.48 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -7.85 74.44 22.75 -9.22 72.86 20.89 25.22 8.01 3.41 27.20 7.60 5.36 coo -14.24 70.61 23.48 -12.55 71.73 17.42 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP A 111 ASP~? 26.09 CL CL A 226 D 146 TYR A 209 TYR~? 20.76 CL CL A 226 D 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -13.44 77.36 13.12 -12.53 75.97 14.48 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -7.85 74.44 22.75 -9.22 72.86 20.89 27.49 9.87 -0.64 29.01 7.64 0.00 coo -14.24 70.61 23.48 -12.55 71.73 17.42 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP B 40 ASP.? 7.91 CL CL B 226 D 146 TYR B 160 TYR~? 15.61 CL CL B 226 D 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -13.44 77.36 13.12 -12.53 75.97 14.48 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -7.85 74.44 22.75 -9.22 72.86 20.89 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -14.24 70.61 23.48 -12.55 71.73 17.42 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP B 111 ASP~? 25.68 CL CL B 226 D 146 TYR B 209 TYR~? 20.47 CL CL B 226 D 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -13.44 77.36 13.12 -12.53 75.97 14.48 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -7.85 74.44 22.75 -9.22 72.86 20.89 50.38 9.38 40.26 48.54 7.35 39.73 coo -14.24 70.61 23.48 -12.55 71.73 17.42 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 40 ASP.? 7.65 CL CL A 226 E 146 TYR A 160 TYR~? 15.52 CL CL A 226 E 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -7.12 105.25 1.43 -6.30 103.34 0.77 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -3.11 94.55 3.01 -3.83 95.92 0.66 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 111 ASP~? 26.09 CL CL A 226 E 146 TYR A 208 TYR~? 15.64 CL CL A 226 E 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -7.12 105.25 1.43 -6.30 103.34 0.77 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -3.11 94.55 3.01 -3.83 95.92 0.66 25.22 8.01 3.41 27.20 7.60 5.36 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP A 111 ASP~? 26.09 CL CL A 226 E 146 TYR A 209 TYR~? 20.76 CL CL A 226 E 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -7.12 105.25 1.43 -6.30 103.34 0.77 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -3.11 94.55 3.01 -3.83 95.92 0.66 27.49 9.87 -0.64 29.01 7.64 0.00 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP B 40 ASP.? 7.91 CL CL B 226 E 146 TYR B 160 TYR~? 15.61 CL CL B 226 E 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -7.12 105.25 1.43 -6.30 103.34 0.77 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -3.11 94.55 3.01 -3.83 95.92 0.66 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP B 111 ASP~? 25.68 CL CL B 226 E 146 TYR B 209 TYR~? 20.47 CL CL B 226 E 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -7.12 105.25 1.43 -6.30 103.34 0.77 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -3.11 94.55 3.01 -3.83 95.92 0.66 50.38 9.38 40.26 48.54 7.35 39.73 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 40 ASP.? 7.65 CL CL A 226 F 146 TYR A 160 TYR~? 15.52 CL CL A 226 F 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -44.75 128.15 10.28 -45.68 129.67 11.55 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -50.43 131.90 19.60 -49.04 133.31 17.60 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -44.10 135.86 19.99 -45.67 134.21 14.07 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 111 ASP~? 26.09 CL CL A 226 F 146 TYR A 208 TYR~? 15.64 CL CL A 226 F 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -44.75 128.15 10.28 -45.68 129.67 11.55 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -50.43 131.90 19.60 -49.04 133.31 17.60 25.22 8.01 3.41 27.20 7.60 5.36 coo -44.10 135.86 19.99 -45.67 134.21 14.07 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP A 111 ASP~? 26.09 CL CL A 226 F 146 TYR A 209 TYR~? 20.76 CL CL A 226 F 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -44.75 128.15 10.28 -45.68 129.67 11.55 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -50.43 131.90 19.60 -49.04 133.31 17.60 27.49 9.87 -0.64 29.01 7.64 0.00 coo -44.10 135.86 19.99 -45.67 134.21 14.07 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP B 40 ASP.? 7.91 CL CL B 226 F 146 TYR B 160 TYR~? 15.61 CL CL B 226 F 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -44.75 128.15 10.28 -45.68 129.67 11.55 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -50.43 131.90 19.60 -49.04 133.31 17.60 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -44.10 135.86 19.99 -45.67 134.21 14.07 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP B 111 ASP~? 25.68 CL CL B 226 F 146 TYR B 209 TYR~? 20.47 CL CL B 226 F 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -44.75 128.15 10.28 -45.68 129.67 11.55 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -50.43 131.90 19.60 -49.04 133.31 17.60 50.38 9.38 40.26 48.54 7.35 39.73 coo -44.10 135.86 19.99 -45.67 134.21 14.07 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 40 ASP.? 7.65 CL CL A 226 G 146 TYR A 160 TYR~? 15.52 CL CL A 226 G 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -44.97 128.78 41.20 -46.32 128.26 42.83 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -52.83 122.13 46.42 -51.31 124.30 47.39 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -47.30 122.24 51.49 -47.46 127.44 47.81 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 111 ASP~? 26.09 CL CL A 226 G 146 TYR A 208 TYR~? 15.64 CL CL A 226 G 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -44.97 128.78 41.20 -46.32 128.26 42.83 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -52.83 122.13 46.42 -51.31 124.30 47.39 25.22 8.01 3.41 27.20 7.60 5.36 coo -47.30 122.24 51.49 -47.46 127.44 47.81 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP A 111 ASP~? 26.09 CL CL A 226 G 146 TYR A 209 TYR~? 20.76 CL CL A 226 G 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -44.97 128.78 41.20 -46.32 128.26 42.83 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -52.83 122.13 46.42 -51.31 124.30 47.39 27.49 9.87 -0.64 29.01 7.64 0.00 coo -47.30 122.24 51.49 -47.46 127.44 47.81 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP B 40 ASP.? 7.91 CL CL B 226 G 146 TYR B 160 TYR~? 15.61 CL CL B 226 G 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -44.97 128.78 41.20 -46.32 128.26 42.83 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -52.83 122.13 46.42 -51.31 124.30 47.39 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -47.30 122.24 51.49 -47.46 127.44 47.81 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP B 111 ASP~? 25.68 CL CL B 226 G 146 TYR B 209 TYR~? 20.47 CL CL B 226 G 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -44.97 128.78 41.20 -46.32 128.26 42.83 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -52.83 122.13 46.42 -51.31 124.30 47.39 50.38 9.38 40.26 48.54 7.35 39.73 coo -47.30 122.24 51.49 -47.46 127.44 47.81 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 40 ASP.? 7.65 CL CL A 226 H 146 TYR A 160 TYR~? 15.52 CL CL A 226 H 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -51.11 100.30 51.41 -52.67 98.82 51.12 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -58.70 94.17 45.32 -57.76 93.82 47.92 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -54.32 88.79 48.13 -54.61 94.04 51.74 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 111 ASP~? 26.09 CL CL A 226 H 146 TYR A 208 TYR~? 15.64 CL CL A 226 H 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -51.11 100.30 51.41 -52.67 98.82 51.12 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -58.70 94.17 45.32 -57.76 93.82 47.92 25.22 8.01 3.41 27.20 7.60 5.36 coo -54.32 88.79 48.13 -54.61 94.04 51.74 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP A 111 ASP~? 26.09 CL CL A 226 H 146 TYR A 209 TYR~? 20.76 CL CL A 226 H 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -51.11 100.30 51.41 -52.67 98.82 51.12 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -58.70 94.17 45.32 -57.76 93.82 47.92 27.49 9.87 -0.64 29.01 7.64 0.00 coo -54.32 88.79 48.13 -54.61 94.04 51.74 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP B 40 ASP.? 7.91 CL CL B 226 H 146 TYR B 160 TYR~? 15.61 CL CL B 226 H 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -51.11 100.30 51.41 -52.67 98.82 51.12 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -58.70 94.17 45.32 -57.76 93.82 47.92 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -54.32 88.79 48.13 -54.61 94.04 51.74 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP B 111 ASP~? 25.68 CL CL B 226 H 146 TYR B 209 TYR~? 20.47 CL CL B 226 H 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -51.11 100.30 51.41 -52.67 98.82 51.12 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -58.70 94.17 45.32 -57.76 93.82 47.92 50.38 9.38 40.26 48.54 7.35 39.73 coo -54.32 88.79 48.13 -54.61 94.04 51.74 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 40 ASP.? 7.65 CL CL A 226 I 146 TYR A 160 TYR~? 15.52 CL CL A 226 I 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -54.65 81.97 26.87 -55.88 81.89 25.07 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -59.92 86.62 17.74 -59.42 83.94 18.40 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -55.38 81.61 14.50 -57.11 80.05 20.41 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 111 ASP~? 26.09 CL CL A 226 I 146 TYR A 208 TYR~? 15.64 CL CL A 226 I 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -54.65 81.97 26.87 -55.88 81.89 25.07 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -59.92 86.62 17.74 -59.42 83.94 18.40 25.22 8.01 3.41 27.20 7.60 5.36 coo -55.38 81.61 14.50 -57.11 80.05 20.41 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP A 111 ASP~? 26.09 CL CL A 226 I 146 TYR A 209 TYR~? 20.76 CL CL A 226 I 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -54.65 81.97 26.87 -55.88 81.89 25.07 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -59.92 86.62 17.74 -59.42 83.94 18.40 27.49 9.87 -0.64 29.01 7.64 0.00 coo -55.38 81.61 14.50 -57.11 80.05 20.41 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP B 40 ASP.? 7.91 CL CL B 226 I 146 TYR B 160 TYR~? 15.61 CL CL B 226 I 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -54.65 81.97 26.87 -55.88 81.89 25.07 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -59.92 86.62 17.74 -59.42 83.94 18.40 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -55.38 81.61 14.50 -57.11 80.05 20.41 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP B 111 ASP~? 25.68 CL CL B 226 I 146 TYR B 209 TYR~? 20.47 CL CL B 226 I 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -54.65 81.97 26.87 -55.88 81.89 25.07 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -59.92 86.62 17.74 -59.42 83.94 18.40 50.38 9.38 40.26 48.54 7.35 39.73 coo -55.38 81.61 14.50 -57.11 80.05 20.41 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 40 ASP.? 7.65 CL CL A 226 J 146 TYR A 160 TYR~? 15.52 CL CL A 226 J 177 LYS A 178 LYS~? 16.45 CL CL A 226 coo -50.64 99.08 1.52 -51.52 100.83 0.67 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 25.03 -8.51 7.95 22.39 -8.85 7.25 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 111 ASP~? 26.09 CL CL A 226 J 146 TYR A 208 TYR~? 15.64 CL CL A 226 J 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -50.64 99.08 1.52 -51.52 100.83 0.67 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 25.22 8.01 3.41 27.20 7.60 5.36 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP A 111 ASP~? 26.09 CL CL A 226 J 146 TYR A 209 TYR~? 20.76 CL CL A 226 J 177 LYS A 205 LYS~? 25.48 CL CL A 226 coo -50.64 99.08 1.52 -51.52 100.83 0.67 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 27.49 9.87 -0.64 29.01 7.64 0.00 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP B 40 ASP.? 7.91 CL CL B 226 J 146 TYR B 160 TYR~? 15.61 CL CL B 226 J 177 LYS B 178 LYS~? 16.76 CL CL B 226 coo -50.64 99.08 1.52 -51.52 100.83 0.67 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 49.18 -9.89 33.69 51.74 -10.51 34.51 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP B 111 ASP~? 25.68 CL CL B 226 J 146 TYR B 209 TYR~? 20.47 CL CL B 226 J 177 LYS B 205 LYS~? 25.67 CL CL B 226 coo -50.64 99.08 1.52 -51.52 100.83 0.67 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 50.38 9.38 40.26 48.54 7.35 39.73 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 54.11 5.83 42.26 49.56 6.08 46.56 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 102 ASP~? 17.30 CL CL A 226 A 96 GLU A 172 GLU~? 15.14 CL CL A 226 A 132 LYS A 205 LYS~? 25.48 CL CL A 226 coo 31.23 12.29 16.44 30.82 11.56 18.39 32.53 7.12 5.29 31.66 9.04 5.62 coo 26.82 3.20 24.36 27.99 4.86 24.98 20.31 7.29 3.53 20.42 8.84 4.96 coo 29.99 0.62 22.18 30.38 6.69 20.81 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP B 61 ASP.? 23.81 CL CL B 226 A 96 GLU B 175 GLU~? 17.14 CL CL B 226 A 132 LYS B 178 LYS~? 16.76 CL CL B 226 coo 31.23 12.29 16.44 30.82 11.56 18.39 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 26.82 3.20 24.36 27.99 4.86 24.98 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 29.99 0.62 22.18 30.38 6.69 20.81 57.30 -6.98 36.80 62.98 -8.03 34.22 1onr_c00 source 1onr TRANSALDOLASE B : 2 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 102 ASP~? 17.30 CL CL A 226 B 96 GLU A 172 GLU~? 15.14 CL CL A 226 B 132 LYS A 205 LYS~? 25.48 CL CL A 226 coo 31.16 57.31 -0.94 30.73 56.64 1.01 32.53 7.12 5.29 31.66 9.04 5.62 coo 26.69 48.45 7.18 27.85 50.13 7.74 20.31 7.29 3.53 20.42 8.84 4.96 coo 29.82 45.80 5.07 30.26 51.81 3.56 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP B 61 ASP.? 23.81 CL CL B 226 B 96 GLU B 175 GLU~? 17.14 CL CL B 226 B 132 LYS B 178 LYS~? 16.76 CL CL B 226 coo 31.16 57.31 -0.94 30.73 56.64 1.01 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 26.69 48.45 7.18 27.85 50.13 7.74 60.51 -1.39 37.75 61.84 -2.96 37.21 coo 29.82 45.80 5.07 30.26 51.81 3.56 57.30 -6.98 36.80 62.98 -8.03 34.22 1onr_c01 source 1onr TRANSALDOLASE B : 2 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER B 28 SER~? 26.37 CL CL B 226 A 239 VAL B 30 VAL~? 32.61 CL CL B 226 A 413 ASN B 50 ASN.? 30.91 CL CL B 226 coo 80.14 40.76 52.28 77.73 40.59 51.94 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 75.67 35.37 52.30 76.00 35.96 50.23 44.39 -31.44 23.71 43.54 -32.09 21.77 coo 81.75 35.21 52.13 80.92 37.12 51.69 42.91 -26.63 29.90 43.43 -28.67 30.19 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 1 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER B 28 SER~? 26.37 CL CL B 226 B 239 VAL B 30 VAL~? 32.61 CL CL B 226 B 413 ASN B 50 ASN.? 30.91 CL CL B 226 coo 25.22 6.41 2.90 27.67 6.33 3.11 44.32 -26.04 23.35 42.98 -24.57 24.74 coo 29.71 1.00 2.66 29.43 1.57 4.74 44.39 -31.44 23.71 43.54 -32.09 21.77 coo 23.72 0.88 2.95 24.56 2.79 3.34 42.91 -26.63 29.90 43.43 -28.67 30.19 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 1 hits 1oqz_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 193 ASP~? 30.50 CL CL A 226 A 247 ASP A 186 ASP.? 30.68 CL CL A 226 A 342 GLU A 187 GLU.? 30.59 CL CL A 226 coo 44.36 35.68 9.71 43.29 36.20 11.51 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 41.40 28.81 12.91 40.82 30.90 12.97 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 40.37 33.11 18.06 39.99 34.93 17.06 10.39 -14.82 -4.45 8.65 -14.21 -3.38 1oyg_c00 source 1oyg LEVANSUCRASE : 1 hits 1oyg_c00 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 67 SER.? 20.77 CL CL A 226 A 709 ASP A 43 ASP.? 11.79 CL CL A 226 A 740 HIS A 56 HIS^? 18.87 CL CL A 226 coo -7.09 7.44 6.22 -7.53 5.14 5.59 21.89 -15.85 6.39 21.13 -16.00 8.70 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 16.13 -5.04 13.46 14.39 -5.59 14.60 coo -8.70 2.86 9.96 -8.03 3.92 8.29 18.56 -13.44 9.47 17.41 -14.68 10.72 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 67 SER.? 20.24 CL CL B 226 A 709 ASP B 43 ASP.? 11.93 CL CL B 226 A 740 HIS B 56 HIS^? 18.72 CL CL B 226 coo -7.09 7.44 6.22 -7.53 5.14 5.59 51.01 -17.39 35.57 51.85 -17.47 33.34 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 58.62 -8.54 27.92 60.24 -9.54 27.09 coo -8.70 2.86 9.96 -8.03 3.92 8.29 54.92 -15.50 33.10 56.24 -16.81 32.13 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 67 SER.? 20.77 CL CL A 226 B 709 ASP A 43 ASP.? 11.79 CL CL A 226 B 740 HIS A 56 HIS^? 18.87 CL CL A 226 coo 4.44 13.29 37.64 6.01 11.66 38.49 21.89 -15.85 6.39 21.13 -16.00 8.70 coo 10.26 2.81 31.69 11.64 4.30 32.43 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 8.57 10.09 34.47 7.10 10.73 35.82 18.56 -13.44 9.47 17.41 -14.68 10.72 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 67 SER.? 20.24 CL CL B 226 B 709 ASP B 43 ASP.? 11.93 CL CL B 226 B 740 HIS B 56 HIS^? 18.72 CL CL B 226 coo 4.44 13.29 37.64 6.01 11.66 38.49 51.01 -17.39 35.57 51.85 -17.47 33.34 coo 10.26 2.81 31.69 11.64 4.30 32.43 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 8.57 10.09 34.47 7.10 10.73 35.82 54.92 -15.50 33.10 56.24 -16.81 32.13 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 56 HIS^? 18.87 CL CL A 226 A 259 TYR A 58 TYR.? 17.32 CL CL A 226 A 552 ASP B 94 ASP.? 27.62 CL CL A 226 coo 11.34 95.90 25.54 12.13 96.42 23.67 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 14.91 97.39 18.63 13.39 95.60 20.20 12.58 -9.14 12.20 9.89 -9.91 12.27 coo 46.37 82.54 38.83 45.97 84.66 38.77 32.35 7.85 42.25 31.25 7.59 44.05 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 56 HIS^? 18.87 CL CL A 226 A 259 TYR A 160 TYR~? 15.52 CL CL A 226 A 552 ASP B 94 ASP.? 27.62 CL CL A 226 coo 11.34 95.90 25.54 12.13 96.42 23.67 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 14.91 97.39 18.63 13.39 95.60 20.20 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 46.37 82.54 38.83 45.97 84.66 38.77 32.35 7.85 42.25 31.25 7.59 44.05 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 2 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 105 ALA~? 16.83 CL CL A 226 A 126 LEU A 173 LEU~? 11.61 CL CL A 226 A 158 GLU A 172 GLU~? 15.14 CL CL A 226 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.34 3.47 2.87 28.40 4.99 3.05 coo -4.62 32.83 147.14 -5.50 32.85 149.12 23.57 2.71 7.39 25.45 3.56 6.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 71 ALA^? 20.21 CL CL B 226 A 126 LEU B 70 LEU^? 16.29 CL CL B 226 A 158 GLU B 157 GLU~? 23.31 CL CL B 226 coo -2.29 37.66 144.73 -1.46 37.12 145.87 40.69 -15.21 29.48 40.79 -14.95 28.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 44.60 -13.30 29.51 46.14 -11.79 29.37 coo -0.83 29.57 149.77 -0.39 31.47 148.95 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA B 105 ALA~? 16.52 CL CL B 226 A 126 LEU B 173 LEU~? 11.77 CL CL B 226 A 158 GLU B 172 GLU~? 15.62 CL CL B 226 coo -2.29 37.66 144.73 -1.46 37.12 145.87 48.52 2.97 37.54 48.93 4.37 37.10 coo -4.62 32.83 147.14 -5.50 32.85 149.12 52.88 0.76 33.33 51.47 2.33 33.89 coo -0.83 29.57 149.77 -0.39 31.47 148.95 57.49 4.88 36.61 57.44 6.68 35.49 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA B 206 ALA~? 23.96 CL CL B 226 A 126 LEU B 214 LEU~? 25.82 CL CL B 226 A 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo -2.29 37.66 144.73 -1.46 37.12 145.87 56.38 8.90 42.83 57.56 8.97 43.80 coo -4.62 32.83 147.14 -5.50 32.85 149.12 49.87 12.42 45.08 51.34 11.53 43.79 coo -0.83 29.57 149.77 -0.39 31.47 148.95 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA B 215 ALA~? 31.02 CL CL B 226 A 126 LEU B 214 LEU~? 25.82 CL CL B 226 A 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo -2.29 37.66 144.73 -1.46 37.12 145.87 48.35 16.08 47.03 49.42 17.17 47.15 coo -4.62 32.83 147.14 -5.50 32.85 149.12 49.87 12.42 45.08 51.34 11.53 43.79 coo -0.83 29.57 149.77 -0.39 31.47 148.95 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 217 ALA~? 28.11 CL CL B 226 A 126 LEU B 214 LEU~? 25.82 CL CL B 226 A 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo -2.29 37.66 144.73 -1.46 37.12 145.87 43.69 14.11 45.65 44.11 12.97 44.71 coo -4.62 32.83 147.14 -5.50 32.85 149.12 49.87 12.42 45.08 51.34 11.53 43.79 coo -0.83 29.57 149.77 -0.39 31.47 148.95 46.60 5.74 43.54 45.54 7.20 42.48 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 6 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 105 ALA~? 16.83 CL CL A 226 B 126 LEU A 173 LEU~? 11.61 CL CL A 226 B 158 GLU A 172 GLU~? 15.14 CL CL A 226 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.34 3.47 2.87 28.40 4.99 3.05 coo -34.22 5.06 149.25 -33.65 4.24 151.15 23.57 2.71 7.39 25.45 3.56 6.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 105 ALA~? 16.52 CL CL B 226 B 126 LEU B 173 LEU~? 11.77 CL CL B 226 B 158 GLU B 172 GLU~? 15.62 CL CL B 226 coo -39.79 4.61 147.27 -39.61 5.56 148.47 48.52 2.97 37.54 48.93 4.37 37.10 coo -34.22 5.06 149.25 -33.65 4.24 151.15 52.88 0.76 33.33 51.47 2.33 33.89 coo -33.03 9.93 151.71 -34.98 9.38 151.11 57.49 4.88 36.61 57.44 6.68 35.49 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA B 206 ALA~? 23.96 CL CL B 226 B 126 LEU B 214 LEU~? 25.82 CL CL B 226 B 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo -39.79 4.61 147.27 -39.61 5.56 148.47 56.38 8.90 42.83 57.56 8.97 43.80 coo -34.22 5.06 149.25 -33.65 4.24 151.15 49.87 12.42 45.08 51.34 11.53 43.79 coo -33.03 9.93 151.71 -34.98 9.38 151.11 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 215 ALA~? 31.02 CL CL B 226 B 126 LEU B 214 LEU~? 25.82 CL CL B 226 B 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo -39.79 4.61 147.27 -39.61 5.56 148.47 48.35 16.08 47.03 49.42 17.17 47.15 coo -34.22 5.06 149.25 -33.65 4.24 151.15 49.87 12.42 45.08 51.34 11.53 43.79 coo -33.03 9.93 151.71 -34.98 9.38 151.11 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA B 217 ALA~? 28.11 CL CL B 226 B 126 LEU B 214 LEU~? 25.82 CL CL B 226 B 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo -39.79 4.61 147.27 -39.61 5.56 148.47 43.69 14.11 45.65 44.11 12.97 44.71 coo -34.22 5.06 149.25 -33.65 4.24 151.15 49.87 12.42 45.08 51.34 11.53 43.79 coo -33.03 9.93 151.71 -34.98 9.38 151.11 46.60 5.74 43.54 45.54 7.20 42.48 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 5 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 71 ALA^? 20.51 CL CL A 226 C 126 LEU A 70 LEU^? 16.48 CL CL A 226 C 158 GLU A 157 GLU~? 23.07 CL CL A 226 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 32.71 -15.15 12.56 32.86 -14.68 13.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 29.18 -12.31 12.09 27.61 -10.79 11.87 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 28.68 -12.57 4.41 29.48 -14.51 4.41 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 105 ALA~? 16.83 CL CL A 226 C 126 LEU A 173 LEU~? 11.61 CL CL A 226 C 158 GLU A 172 GLU~? 15.14 CL CL A 226 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.34 3.47 2.87 28.40 4.99 3.05 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 23.57 2.71 7.39 25.45 3.56 6.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 20.31 7.29 3.53 20.42 8.84 4.96 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA B 71 ALA^? 20.21 CL CL B 226 C 126 LEU B 70 LEU^? 16.29 CL CL B 226 C 158 GLU B 157 GLU~? 23.31 CL CL B 226 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 40.69 -15.21 29.48 40.79 -14.95 28.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 44.60 -13.30 29.51 46.14 -11.79 29.37 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 44.83 -13.19 37.20 43.40 -14.70 37.59 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA B 105 ALA~? 16.52 CL CL B 226 C 126 LEU B 173 LEU~? 11.77 CL CL B 226 C 158 GLU B 172 GLU~? 15.62 CL CL B 226 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 48.52 2.97 37.54 48.93 4.37 37.10 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 52.88 0.76 33.33 51.47 2.33 33.89 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 57.49 4.88 36.61 57.44 6.68 35.49 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 206 ALA~? 23.96 CL CL B 226 C 126 LEU B 214 LEU~? 25.82 CL CL B 226 C 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 56.38 8.90 42.83 57.56 8.97 43.80 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 49.87 12.42 45.08 51.34 11.53 43.79 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 215 ALA~? 31.02 CL CL B 226 C 126 LEU B 214 LEU~? 25.82 CL CL B 226 C 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 48.35 16.08 47.03 49.42 17.17 47.15 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 49.87 12.42 45.08 51.34 11.53 43.79 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.60 5.74 43.54 45.54 7.20 42.48 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 217 ALA~? 28.11 CL CL B 226 C 126 LEU B 214 LEU~? 25.82 CL CL B 226 C 158 GLU B 110 GLU~? 23.32 CL CL B 226 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 43.69 14.11 45.65 44.11 12.97 44.71 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 49.87 12.42 45.08 51.34 11.53 43.79 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.60 5.74 43.54 45.54 7.20 42.48 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 7 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 61 ASP.? 23.60 CL CL A 226 B 270 LYS A 63 LYS.? 28.35 CL CL A 226 B 382 MET A 44 MET^? 11.41 CL CL A 226 coo -11.82 154.51 43.38 -12.86 152.74 43.79 6.80 -9.81 5.25 8.17 -9.51 3.68 coo -5.09 158.39 43.41 -0.74 158.80 47.15 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -2.79 145.52 50.38 -5.75 148.14 51.66 19.66 -8.41 13.51 23.56 -7.37 12.56 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP A 203 ASP~? 25.03 CL CL A 226 B 270 LYS A 205 LYS~? 25.48 CL CL A 226 B 382 MET A 115 MET~? 25.25 CL CL A 226 coo -11.82 154.51 43.38 -12.86 152.74 43.79 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -5.09 158.39 43.41 -0.74 158.80 47.15 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -2.79 145.52 50.38 -5.75 148.14 51.66 25.60 -4.05 -8.06 23.94 -1.99 -6.35 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP B 61 ASP.? 23.81 CL CL B 226 B 270 LYS B 63 LYS.? 30.86 CL CL B 226 B 382 MET B 44 MET^? 11.34 CL CL B 226 coo -11.82 154.51 43.38 -12.86 152.74 43.79 66.70 -13.12 38.44 68.10 -11.59 37.89 coo -5.09 158.39 43.41 -0.74 158.80 47.15 61.77 -19.16 38.03 61.33 -25.31 39.26 coo -2.79 145.52 50.38 -5.75 148.14 51.66 54.77 -11.45 28.22 51.23 -9.44 28.91 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP B 203 ASP~? 25.12 CL CL B 226 B 270 LYS B 205 LYS~? 25.67 CL CL B 226 B 382 MET B 115 MET~? 25.65 CL CL B 226 coo -11.82 154.51 43.38 -12.86 152.74 43.79 60.54 4.31 43.90 62.00 4.57 45.37 coo -5.09 158.39 43.41 -0.74 158.80 47.15 54.11 5.83 42.26 49.56 6.08 46.56 coo -2.79 145.52 50.38 -5.75 148.14 51.66 48.77 -3.59 49.15 50.96 -2.07 47.63 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 4 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 66 GLN.? 25.74 CL CL A 226 294 GLU A 69 GLU^? 25.00 CL CL A 226 304 ARG A 65 ARG.? 31.92 CL CL A 226 coo 15.89 18.45 46.53 15.82 16.91 48.02 21.30 -15.42 1.80 22.74 -16.95 1.38 coo 22.84 13.44 52.91 20.84 13.18 52.38 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 8.71 17.11 46.51 7.23 17.64 49.20 17.05 -18.95 -0.65 15.70 -20.36 -3.04 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN B 66 GLN.? 26.19 CL CL B 226 294 GLU B 69 GLU^? 24.72 CL CL B 226 304 ARG B 65 ARG.? 31.41 CL CL B 226 coo 15.89 18.45 46.53 15.82 16.91 48.02 51.36 -17.48 40.20 49.73 -18.74 40.71 coo 22.84 13.44 52.91 20.84 13.18 52.38 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 8.71 17.11 46.51 7.23 17.64 49.20 55.55 -24.03 39.40 53.97 -26.61 39.95 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 2 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 19 ARG~? 20.09 CL CL A 226 A 479 PHE A 10 PHE.? 15.16 CL CL A 226 A 483 GLU A 9 GLU.? 16.20 CL CL A 226 coo 17.33 52.29 2.24 18.71 54.03 0.18 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 20.06 57.44 1.28 18.39 56.19 3.12 31.56 -5.14 25.65 32.44 -7.46 26.93 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 26.61 -7.39 28.28 26.97 -9.45 28.59 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 19 ARG~? 20.09 CL CL A 226 A 479 PHE A 10 PHE.? 15.16 CL CL A 226 A 483 GLU B 77 GLU~? 22.22 CL CL A 226 coo 17.33 52.29 2.24 18.71 54.03 0.18 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 20.06 57.44 1.28 18.39 56.19 3.12 31.56 -5.14 25.65 32.44 -7.46 26.93 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG A 81 ARG~? 19.72 CL CL B 226 A 479 PHE B 10 PHE.? 14.73 CL CL B 226 A 483 GLU A 77 GLU~? 21.84 CL CL B 226 coo 17.33 52.29 2.24 18.71 54.03 0.18 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 20.06 57.44 1.28 18.39 56.19 3.12 43.79 -6.77 15.65 42.42 -8.98 14.72 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG A 81 ARG~? 19.72 CL CL B 226 A 479 PHE B 10 PHE.? 14.73 CL CL B 226 A 483 GLU A 84 GLU~? 12.94 CL CL B 226 coo 17.33 52.29 2.24 18.71 54.03 0.18 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 20.06 57.44 1.28 18.39 56.19 3.12 43.79 -6.77 15.65 42.42 -8.98 14.72 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG B 19 ARG~? 20.05 CL CL B 226 A 479 PHE B 10 PHE.? 14.73 CL CL B 226 A 483 GLU A 77 GLU~? 21.84 CL CL B 226 coo 17.33 52.29 2.24 18.71 54.03 0.18 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 20.06 57.44 1.28 18.39 56.19 3.12 43.79 -6.77 15.65 42.42 -8.98 14.72 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG B 19 ARG~? 20.05 CL CL B 226 A 479 PHE B 10 PHE.? 14.73 CL CL B 226 A 483 GLU B 9 GLU.? 16.36 CL CL B 226 coo 17.33 52.29 2.24 18.71 54.03 0.18 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 20.06 57.44 1.28 18.39 56.19 3.12 43.79 -6.77 15.65 42.42 -8.98 14.72 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 47.73 -10.39 12.99 46.70 -12.24 13.09 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 A 264 ARG B 81 ARG~? 19.82 CL CL A 226 A 479 PHE A 10 PHE.? 15.16 CL CL A 226 A 483 GLU B 77 GLU~? 22.22 CL CL A 226 coo 17.33 52.29 2.24 18.71 54.03 0.18 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 20.06 57.44 1.28 18.39 56.19 3.12 31.56 -5.14 25.65 32.44 -7.46 26.93 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 A 264 ARG B 81 ARG~? 19.82 CL CL A 226 A 479 PHE A 10 PHE.? 15.16 CL CL A 226 A 483 GLU B 84 GLU~? 12.79 CL CL A 226 coo 17.33 52.29 2.24 18.71 54.03 0.18 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 20.06 57.44 1.28 18.39 56.19 3.12 31.56 -5.14 25.65 32.44 -7.46 26.93 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 35.35 -1.73 23.75 33.22 -1.55 23.84 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 8 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 19 ARG~? 20.09 CL CL A 226 B 479 PHE A 10 PHE.? 15.16 CL CL A 226 B 483 GLU A 9 GLU.? 16.20 CL CL A 226 coo -26.72 93.28 20.13 -28.02 93.55 17.39 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -29.34 90.48 15.69 -27.62 89.95 17.80 31.56 -5.14 25.65 32.44 -7.46 26.93 coo -26.63 95.49 14.65 -25.77 93.77 13.77 26.61 -7.39 28.28 26.97 -9.45 28.59 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 19 ARG~? 20.09 CL CL A 226 B 479 PHE A 10 PHE.? 15.16 CL CL A 226 B 483 GLU B 77 GLU~? 22.22 CL CL A 226 coo -26.72 93.28 20.13 -28.02 93.55 17.39 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -29.34 90.48 15.69 -27.62 89.95 17.80 31.56 -5.14 25.65 32.44 -7.46 26.93 coo -26.63 95.49 14.65 -25.77 93.77 13.77 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG A 81 ARG~? 19.72 CL CL B 226 B 479 PHE B 10 PHE.? 14.73 CL CL B 226 B 483 GLU A 77 GLU~? 21.84 CL CL B 226 coo -26.72 93.28 20.13 -28.02 93.55 17.39 40.18 -5.93 10.28 41.49 -8.31 8.89 coo -29.34 90.48 15.69 -27.62 89.95 17.80 43.79 -6.77 15.65 42.42 -8.98 14.72 coo -26.63 95.49 14.65 -25.77 93.77 13.77 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG A 81 ARG~? 19.72 CL CL B 226 B 479 PHE B 10 PHE.? 14.73 CL CL B 226 B 483 GLU A 84 GLU~? 12.94 CL CL B 226 coo -26.72 93.28 20.13 -28.02 93.55 17.39 40.18 -5.93 10.28 41.49 -8.31 8.89 coo -29.34 90.48 15.69 -27.62 89.95 17.80 43.79 -6.77 15.65 42.42 -8.98 14.72 coo -26.63 95.49 14.65 -25.77 93.77 13.77 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG B 19 ARG~? 20.05 CL CL B 226 B 479 PHE B 10 PHE.? 14.73 CL CL B 226 B 483 GLU A 77 GLU~? 21.84 CL CL B 226 coo -26.72 93.28 20.13 -28.02 93.55 17.39 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -29.34 90.48 15.69 -27.62 89.95 17.80 43.79 -6.77 15.65 42.42 -8.98 14.72 coo -26.63 95.49 14.65 -25.77 93.77 13.77 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG B 19 ARG~? 20.05 CL CL B 226 B 479 PHE B 10 PHE.? 14.73 CL CL B 226 B 483 GLU B 9 GLU.? 16.36 CL CL B 226 coo -26.72 93.28 20.13 -28.02 93.55 17.39 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -29.34 90.48 15.69 -27.62 89.95 17.80 43.79 -6.77 15.65 42.42 -8.98 14.72 coo -26.63 95.49 14.65 -25.77 93.77 13.77 47.73 -10.39 12.99 46.70 -12.24 13.09 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 B 264 ARG B 81 ARG~? 19.82 CL CL A 226 B 479 PHE A 10 PHE.? 15.16 CL CL A 226 B 483 GLU B 77 GLU~? 22.22 CL CL A 226 coo -26.72 93.28 20.13 -28.02 93.55 17.39 35.26 -4.61 30.73 33.33 -6.15 32.58 coo -29.34 90.48 15.69 -27.62 89.95 17.80 31.56 -5.14 25.65 32.44 -7.46 26.93 coo -26.63 95.49 14.65 -25.77 93.77 13.77 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 B 264 ARG B 81 ARG~? 19.82 CL CL A 226 B 479 PHE A 10 PHE.? 15.16 CL CL A 226 B 483 GLU B 84 GLU~? 12.79 CL CL A 226 coo -26.72 93.28 20.13 -28.02 93.55 17.39 35.26 -4.61 30.73 33.33 -6.15 32.58 coo -29.34 90.48 15.69 -27.62 89.95 17.80 31.56 -5.14 25.65 32.44 -7.46 26.93 coo -26.63 95.49 14.65 -25.77 93.77 13.77 35.35 -1.73 23.75 33.22 -1.55 23.84 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 8 hits 1pow_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 168 GLU.? -6.12 CL CL A 226s A 67 ARG A 13 ARG~? 5.03 CL CL A 226 A 86 HIS A 86 HIS~? 10.02 CL CL A 226 coo 18.15 3.28 18.56 20.10 2.92 19.20 22.70 6.74 18.04 23.60 8.22 19.21 coo 21.52 6.83 26.64 21.22 5.53 23.85 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 32.84 2.26 17.60 31.66 3.53 18.78 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU B 168 GLU.? -5.97 CL CL B 226s A 67 ARG B 13 ARG~? 5.25 CL CL B 226 A 86 HIS B 86 HIS~? 9.45 CL CL B 226 coo 18.15 3.28 18.56 20.10 2.92 19.20 54.77 3.34 22.36 54.93 5.08 21.18 coo 21.52 6.83 26.64 21.22 5.53 23.85 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 44.03 1.12 22.86 45.41 1.90 21.48 1pyl_c00 source 1pyl RIBONUCLEASE : 2 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 168 GLU.? -6.12 CL CL A 226s B 67 ARG A 13 ARG~? 5.03 CL CL A 226 B 86 HIS A 86 HIS~? 10.02 CL CL A 226 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 22.70 6.74 18.04 23.60 8.22 19.21 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 32.84 2.26 17.60 31.66 3.53 18.78 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU B 9 GLU.? 16.36 CL CL B 226 B 67 ARG A 81 ARG~? 19.72 CL CL B 226 B 86 HIS A 75 HIS.? 25.41 CL CL B 226 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 38.68 -16.70 9.61 40.32 -17.29 8.43 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU B 168 GLU.? -5.97 CL CL B 226s B 67 ARG B 13 ARG~? 5.25 CL CL B 226 B 86 HIS B 86 HIS~? 9.45 CL CL B 226 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 54.77 3.34 22.36 54.93 5.08 21.18 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 44.03 1.12 22.86 45.41 1.90 21.48 1pyl_c01 source 1pyl RIBONUCLEASE : 3 hits 1pyl_c01 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 204 LEU~? 18.22 CL CL A 226 A 58 ASP A 203 ASP~? 25.03 CL CL A 226 A 120 LYS A 213 LYS.? 30.41 CL CL A 226 coo 34.02 69.29 75.26 34.82 67.82 76.74 19.57 4.89 0.19 17.89 4.07 1.29 coo 34.46 72.45 78.57 32.82 72.75 77.28 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 28.96 77.64 81.19 29.05 74.53 77.51 20.84 14.61 -7.95 16.28 17.34 -7.27 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 1 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 204 LEU~? 18.22 CL CL A 226 B 58 ASP A 203 ASP~? 25.03 CL CL A 226 B 120 LYS A 213 LYS.? 30.41 CL CL A 226 coo 54.50 104.32 58.69 55.83 105.69 59.81 19.57 4.89 0.19 17.89 4.07 1.29 coo 57.63 101.19 59.83 56.60 100.89 57.99 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 61.58 95.88 55.22 58.18 99.30 54.71 20.84 14.61 -7.95 16.28 17.34 -7.27 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 1 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 193 ASP~? 30.50 CL CL A 226 A 68 ALA A 196 ALA~? 28.08 CL CL A 226 A 72 LEU A 197 LEU~? 24.34 CL CL A 226 coo 46.76 7.59 18.65 45.27 6.01 18.52 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 48.88 4.35 16.59 48.73 5.09 15.20 13.17 -1.56 -7.76 12.04 -2.43 -7.25 coo 53.89 6.25 15.09 52.88 7.92 14.14 16.90 -3.56 -5.39 18.37 -4.08 -3.85 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP B 102 ASP~? 16.83 CL CL B 226 A 68 ALA B 105 ALA~? 16.52 CL CL B 226 A 72 LEU B 173 LEU~? 11.77 CL CL B 226 coo 46.76 7.59 18.65 45.27 6.01 18.52 45.25 7.06 34.64 46.46 8.64 34.05 coo 48.88 4.35 16.59 48.73 5.09 15.20 48.52 2.97 37.54 48.93 4.37 37.10 coo 53.89 6.25 15.09 52.88 7.92 14.14 52.88 0.76 33.33 51.47 2.33 33.89 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c05 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 72 SER.? 25.76 CL CL A 226 A 310 GLU A 77 GLU~? 21.84 CL CL B 226 A 399 HIS A 75 HIS.? 25.41 CL CL B 226 coo 2.67 37.96 55.23 1.78 40.01 56.16 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 6.61 38.44 63.61 6.69 38.31 61.50 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 4.95 41.82 59.53 3.85 40.70 58.14 38.68 -16.70 9.61 40.32 -17.29 8.43 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER B 72 SER.? 25.86 CL CL B 226 A 310 GLU B 77 GLU~? 22.22 CL CL A 226 A 399 HIS B 75 HIS.? 25.67 CL CL A 226 coo 2.67 37.96 55.23 1.78 40.01 56.16 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 6.61 38.44 63.61 6.69 38.31 61.50 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 4.95 41.82 59.53 3.85 40.70 58.14 34.50 -15.17 32.63 32.86 -15.45 33.92 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 2 hits 1qe3_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 86 HIS~? 10.02 CL CL A 226 A 236 ASP A 43 ASP.? 11.79 CL CL A 226 A 261 LYS A 60 LYS.? 19.24 CL CL A 226 coo 55.45 46.76 42.08 57.34 46.16 42.75 32.84 2.26 17.60 31.66 3.53 18.78 coo 48.87 29.19 44.63 49.10 27.34 43.63 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 47.58 17.35 41.83 51.40 20.85 40.83 9.83 -11.93 8.36 13.65 -13.48 11.58 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 86 HIS~? 10.02 CL CL A 226 B 236 ASP A 43 ASP.? 11.79 CL CL A 226 B 261 LYS A 60 LYS.? 19.24 CL CL A 226 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 32.84 2.26 17.60 31.66 3.53 18.78 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 9.83 -11.93 8.36 13.65 -13.48 11.58 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 86 HIS~? 10.02 CL CL A 226 C 236 ASP A 43 ASP.? 11.79 CL CL A 226 C 261 LYS A 60 LYS.? 19.24 CL CL A 226 coo 55.11 47.10 12.61 53.44 47.85 11.58 32.84 2.26 17.60 31.66 3.53 18.78 coo 45.78 31.11 9.51 44.25 30.06 10.53 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 37.54 22.37 12.10 37.83 27.55 13.24 9.83 -11.93 8.36 13.65 -13.48 11.58 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 86 HIS~? 10.02 CL CL A 226 D 236 ASP A 43 ASP.? 11.79 CL CL A 226 D 261 LYS A 60 LYS.? 19.24 CL CL A 226 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 32.84 2.26 17.60 31.66 3.53 18.78 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 9.83 -11.93 8.36 13.65 -13.48 11.58 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 86 HIS~? 10.02 CL CL A 226 E 236 ASP A 43 ASP.? 11.79 CL CL A 226 E 261 LYS A 60 LYS.? 19.24 CL CL A 226 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 32.84 2.26 17.60 31.66 3.53 18.78 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 9.83 -11.93 8.36 13.65 -13.48 11.58 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 86 HIS~? 10.02 CL CL A 226 F 236 ASP A 43 ASP.? 11.79 CL CL A 226 F 261 LYS A 60 LYS.? 19.24 CL CL A 226 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 32.84 2.26 17.60 31.66 3.53 18.78 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 9.83 -11.93 8.36 13.65 -13.48 11.58 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 86 HIS~? 10.02 CL CL A 226 G 236 ASP A 43 ASP.? 11.79 CL CL A 226 G 261 LYS A 60 LYS.? 19.24 CL CL A 226 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 32.84 2.26 17.60 31.66 3.53 18.78 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 9.83 -11.93 8.36 13.65 -13.48 11.58 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 86 HIS~? 10.02 CL CL A 226 H 236 ASP A 43 ASP.? 11.79 CL CL A 226 H 261 LYS A 60 LYS.? 19.24 CL CL A 226 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 32.84 2.26 17.60 31.66 3.53 18.78 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 9.83 -11.93 8.36 13.65 -13.48 11.58 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 90 TYR^? 17.82 CL CL A 226 A 236 ASP A 102 ASP~? 17.30 CL CL A 226 A 261 LYS A 96 LYS.? 26.69 CL CL B 226 coo 55.48 26.51 40.65 55.39 23.99 39.43 38.12 1.32 8.30 36.38 -0.30 9.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 32.53 7.12 5.29 31.66 9.04 5.62 coo 47.58 17.35 41.83 51.40 20.85 40.83 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 194 TYR~? 29.78 CL CL A 226 A 236 ASP A 193 ASP~? 30.50 CL CL A 226 A 261 LYS A 200 LYS~? 23.56 CL CL A 226 coo 55.48 26.51 40.65 55.39 23.99 39.43 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 48.87 29.19 44.63 49.10 27.34 43.63 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 47.58 17.35 41.83 51.40 20.85 40.83 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 194 TYR~? 30.06 CL CL B 226 A 236 ASP B 193 ASP~? 31.47 CL CL B 226 A 261 LYS B 200 LYS~? 24.54 CL CL B 226 coo 55.48 26.51 40.65 55.39 23.99 39.43 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 47.58 17.35 41.83 51.40 20.85 40.83 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 208 TYR~? 15.74 CL CL B 226 A 236 ASP B 102 ASP~? 16.83 CL CL B 226 A 261 LYS B 213 LYS~? 22.42 CL CL B 226 coo 55.48 26.51 40.65 55.39 23.99 39.43 52.42 6.76 36.83 50.45 6.61 34.90 coo 48.87 29.19 44.63 49.10 27.34 43.63 45.25 7.06 34.64 46.46 8.64 34.05 coo 47.58 17.35 41.83 51.40 20.85 40.83 48.60 15.99 42.06 48.42 16.28 35.76 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 90 TYR^? 17.82 CL CL A 226 B 236 ASP A 102 ASP~? 17.30 CL CL A 226 B 261 LYS A 96 LYS.? 26.69 CL CL B 226 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 38.12 1.32 8.30 36.38 -0.30 9.74 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 32.53 7.12 5.29 31.66 9.04 5.62 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 194 TYR~? 29.78 CL CL A 226 B 236 ASP A 193 ASP~? 30.50 CL CL A 226 B 261 LYS A 200 LYS~? 23.56 CL CL A 226 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 194 TYR~? 30.06 CL CL B 226 B 236 ASP B 193 ASP~? 31.47 CL CL B 226 B 261 LYS B 200 LYS~? 24.54 CL CL B 226 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 208 TYR~? 15.74 CL CL B 226 B 236 ASP B 102 ASP~? 16.83 CL CL B 226 B 261 LYS B 213 LYS~? 22.42 CL CL B 226 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 52.42 6.76 36.83 50.45 6.61 34.90 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 45.25 7.06 34.64 46.46 8.64 34.05 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 48.60 15.99 42.06 48.42 16.28 35.76 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 90 TYR^? 17.82 CL CL A 226 C 236 ASP A 102 ASP~? 17.30 CL CL A 226 C 261 LYS A 96 LYS.? 26.69 CL CL B 226 coo 39.51 34.34 13.63 37.63 32.61 14.79 38.12 1.32 8.30 36.38 -0.30 9.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 32.53 7.12 5.29 31.66 9.04 5.62 coo 37.54 22.37 12.10 37.83 27.55 13.24 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 194 TYR~? 29.78 CL CL A 226 C 236 ASP A 193 ASP~? 30.50 CL CL A 226 C 261 LYS A 200 LYS~? 23.56 CL CL A 226 coo 39.51 34.34 13.63 37.63 32.61 14.79 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 45.78 31.11 9.51 44.25 30.06 10.53 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 37.54 22.37 12.10 37.83 27.55 13.24 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR B 194 TYR~? 30.06 CL CL B 226 C 236 ASP B 193 ASP~? 31.47 CL CL B 226 C 261 LYS B 200 LYS~? 24.54 CL CL B 226 coo 39.51 34.34 13.63 37.63 32.61 14.79 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 37.54 22.37 12.10 37.83 27.55 13.24 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR B 208 TYR~? 15.74 CL CL B 226 C 236 ASP B 102 ASP~? 16.83 CL CL B 226 C 261 LYS B 213 LYS~? 22.42 CL CL B 226 coo 39.51 34.34 13.63 37.63 32.61 14.79 52.42 6.76 36.83 50.45 6.61 34.90 coo 45.78 31.11 9.51 44.25 30.06 10.53 45.25 7.06 34.64 46.46 8.64 34.05 coo 37.54 22.37 12.10 37.83 27.55 13.24 48.60 15.99 42.06 48.42 16.28 35.76 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 90 TYR^? 17.82 CL CL A 226 D 236 ASP A 102 ASP~? 17.30 CL CL A 226 D 261 LYS A 96 LYS.? 26.69 CL CL B 226 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 38.12 1.32 8.30 36.38 -0.30 9.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 32.53 7.12 5.29 31.66 9.04 5.62 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 194 TYR~? 29.78 CL CL A 226 D 236 ASP A 193 ASP~? 30.50 CL CL A 226 D 261 LYS A 200 LYS~? 23.56 CL CL A 226 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR B 194 TYR~? 30.06 CL CL B 226 D 236 ASP B 193 ASP~? 31.47 CL CL B 226 D 261 LYS B 200 LYS~? 24.54 CL CL B 226 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR B 208 TYR~? 15.74 CL CL B 226 D 236 ASP B 102 ASP~? 16.83 CL CL B 226 D 261 LYS B 213 LYS~? 22.42 CL CL B 226 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 52.42 6.76 36.83 50.45 6.61 34.90 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 45.25 7.06 34.64 46.46 8.64 34.05 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 48.60 15.99 42.06 48.42 16.28 35.76 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 90 TYR^? 17.82 CL CL A 226 E 236 ASP A 102 ASP~? 17.30 CL CL A 226 E 261 LYS A 96 LYS.? 26.69 CL CL B 226 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 38.12 1.32 8.30 36.38 -0.30 9.74 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 32.53 7.12 5.29 31.66 9.04 5.62 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 194 TYR~? 29.78 CL CL A 226 E 236 ASP A 193 ASP~? 30.50 CL CL A 226 E 261 LYS A 200 LYS~? 23.56 CL CL A 226 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 90 TYR^? 17.17 CL CL B 226 E 236 ASP B 102 ASP~? 16.83 CL CL B 226 E 261 LYS B 96 LYS^? 24.51 CL CL B 226 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 38.78 1.99 31.89 40.05 -0.11 30.63 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 45.25 7.06 34.64 46.46 8.64 34.05 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 35.42 10.33 36.63 41.15 11.45 39.22 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 194 TYR~? 30.06 CL CL B 226 E 236 ASP B 193 ASP~? 31.47 CL CL B 226 E 261 LYS B 200 LYS~? 24.54 CL CL B 226 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 208 TYR~? 15.74 CL CL B 226 E 236 ASP B 102 ASP~? 16.83 CL CL B 226 E 261 LYS B 213 LYS~? 22.42 CL CL B 226 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 52.42 6.76 36.83 50.45 6.61 34.90 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 45.25 7.06 34.64 46.46 8.64 34.05 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 48.60 15.99 42.06 48.42 16.28 35.76 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 90 TYR^? 17.82 CL CL A 226 F 236 ASP A 102 ASP~? 17.30 CL CL A 226 F 261 LYS A 96 LYS.? 26.69 CL CL B 226 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 38.12 1.32 8.30 36.38 -0.30 9.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 32.53 7.12 5.29 31.66 9.04 5.62 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 194 TYR~? 29.78 CL CL A 226 F 236 ASP A 193 ASP~? 30.50 CL CL A 226 F 261 LYS A 200 LYS~? 23.56 CL CL A 226 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 90 TYR^? 17.17 CL CL B 226 F 236 ASP B 102 ASP~? 16.83 CL CL B 226 F 261 LYS B 96 LYS^? 24.51 CL CL B 226 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 38.78 1.99 31.89 40.05 -0.11 30.63 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 45.25 7.06 34.64 46.46 8.64 34.05 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 35.42 10.33 36.63 41.15 11.45 39.22 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 194 TYR~? 30.06 CL CL B 226 F 236 ASP B 193 ASP~? 31.47 CL CL B 226 F 261 LYS B 200 LYS~? 24.54 CL CL B 226 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 208 TYR~? 15.74 CL CL B 226 F 236 ASP B 102 ASP~? 16.83 CL CL B 226 F 261 LYS B 213 LYS~? 22.42 CL CL B 226 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 52.42 6.76 36.83 50.45 6.61 34.90 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 45.25 7.06 34.64 46.46 8.64 34.05 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 48.60 15.99 42.06 48.42 16.28 35.76 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 90 TYR^? 17.82 CL CL A 226 G 236 ASP A 102 ASP~? 17.30 CL CL A 226 G 261 LYS A 96 LYS.? 26.69 CL CL B 226 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 38.12 1.32 8.30 36.38 -0.30 9.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 32.53 7.12 5.29 31.66 9.04 5.62 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 194 TYR~? 29.78 CL CL A 226 G 236 ASP A 193 ASP~? 30.50 CL CL A 226 G 261 LYS A 200 LYS~? 23.56 CL CL A 226 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR B 194 TYR~? 30.06 CL CL B 226 G 236 ASP B 193 ASP~? 31.47 CL CL B 226 G 261 LYS B 200 LYS~? 24.54 CL CL B 226 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR B 208 TYR~? 15.74 CL CL B 226 G 236 ASP B 102 ASP~? 16.83 CL CL B 226 G 261 LYS B 213 LYS~? 22.42 CL CL B 226 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 52.42 6.76 36.83 50.45 6.61 34.90 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 45.25 7.06 34.64 46.46 8.64 34.05 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 48.60 15.99 42.06 48.42 16.28 35.76 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 90 TYR^? 17.82 CL CL A 226 H 236 ASP A 102 ASP~? 17.30 CL CL A 226 H 261 LYS A 96 LYS.? 26.69 CL CL B 226 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 38.12 1.32 8.30 36.38 -0.30 9.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 32.53 7.12 5.29 31.66 9.04 5.62 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 43.19 9.69 4.63 44.31 14.11 2.17 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 194 TYR~? 29.78 CL CL A 226 H 236 ASP A 193 ASP~? 30.50 CL CL A 226 H 261 LYS A 200 LYS~? 23.56 CL CL A 226 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 194 TYR~? 30.06 CL CL B 226 H 236 ASP B 193 ASP~? 31.47 CL CL B 226 H 261 LYS B 200 LYS~? 24.54 CL CL B 226 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 55.14 -6.59 51.91 53.44 -4.41 51.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR B 208 TYR~? 15.74 CL CL B 226 H 236 ASP B 102 ASP~? 16.83 CL CL B 226 H 261 LYS B 213 LYS~? 22.42 CL CL B 226 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 52.42 6.76 36.83 50.45 6.61 34.90 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 45.25 7.06 34.64 46.46 8.64 34.05 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 48.60 15.99 42.06 48.42 16.28 35.76 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 65 ARG.? 31.92 CL CL A 226 C 163 TYR A 121 TYR.? 28.41 CL CL A 226 C 236 ASP A 151 ASP~? 27.89 CL CL A 226 coo 39.01 29.77 22.02 37.48 31.30 19.84 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo 39.51 34.34 13.63 37.63 32.61 14.79 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 45.78 31.11 9.51 44.25 30.06 10.53 31.07 -14.15 -4.04 29.86 -14.57 -2.39 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 81 ARG~? 19.72 CL CL B 226 C 163 TYR A 90 TYR^? 17.82 CL CL A 226 C 236 ASP A 102 ASP~? 17.30 CL CL A 226 coo 39.01 29.77 22.02 37.48 31.30 19.84 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 39.51 34.34 13.63 37.63 32.61 14.79 38.12 1.32 8.30 36.38 -0.30 9.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 32.53 7.12 5.29 31.66 9.04 5.62 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 65 ARG.? 31.92 CL CL A 226 D 163 TYR A 121 TYR.? 28.41 CL CL A 226 D 236 ASP A 151 ASP~? 27.89 CL CL A 226 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 31.07 -14.15 -4.04 29.86 -14.57 -2.39 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 81 ARG~? 19.72 CL CL B 226 D 163 TYR A 90 TYR^? 17.82 CL CL A 226 D 236 ASP A 102 ASP~? 17.30 CL CL A 226 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 38.12 1.32 8.30 36.38 -0.30 9.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 32.53 7.12 5.29 31.66 9.04 5.62 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 90 TYR^? 17.82 CL CL A 226 A 236 ASP A 102 ASP~? 17.30 CL CL A 226 C 110 ARG A 81 ARG~? 19.72 CL CL B 226 coo 55.48 26.51 40.65 55.39 23.99 39.43 38.12 1.32 8.30 36.38 -0.30 9.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 32.53 7.12 5.29 31.66 9.04 5.62 coo 52.39 23.42 32.10 54.51 23.27 34.29 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 121 TYR.? 28.41 CL CL A 226 A 236 ASP A 151 ASP~? 27.89 CL CL A 226 C 110 ARG A 65 ARG.? 31.92 CL CL A 226 coo 55.48 26.51 40.65 55.39 23.99 39.43 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 48.87 29.19 44.63 49.10 27.34 43.63 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo 52.39 23.42 32.10 54.51 23.27 34.29 17.05 -18.95 -0.65 15.70 -20.36 -3.04 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 90 TYR^? 17.82 CL CL A 226 B 236 ASP A 102 ASP~? 17.30 CL CL A 226 D 110 ARG A 81 ARG~? 19.72 CL CL B 226 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 38.12 1.32 8.30 36.38 -0.30 9.74 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 32.53 7.12 5.29 31.66 9.04 5.62 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 121 TYR.? 28.41 CL CL A 226 B 236 ASP A 151 ASP~? 27.89 CL CL A 226 D 110 ARG A 65 ARG.? 31.92 CL CL A 226 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 17.05 -18.95 -0.65 15.70 -20.36 -3.04 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 65 ARG.? 31.92 CL CL A 226 G 163 TYR A 121 TYR.? 28.41 CL CL A 226 G 236 ASP A 151 ASP~? 27.89 CL CL A 226 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 31.07 -14.15 -4.04 29.86 -14.57 -2.39 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 81 ARG~? 19.72 CL CL B 226 G 163 TYR A 90 TYR^? 17.82 CL CL A 226 G 236 ASP A 102 ASP~? 17.30 CL CL A 226 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 38.12 1.32 8.30 36.38 -0.30 9.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 32.53 7.12 5.29 31.66 9.04 5.62 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 65 ARG.? 31.92 CL CL A 226 H 163 TYR A 121 TYR.? 28.41 CL CL A 226 H 236 ASP A 151 ASP~? 27.89 CL CL A 226 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 31.07 -14.15 -4.04 29.86 -14.57 -2.39 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 81 ARG~? 19.72 CL CL B 226 H 163 TYR A 90 TYR^? 17.82 CL CL A 226 H 236 ASP A 102 ASP~? 17.30 CL CL A 226 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 38.12 1.32 8.30 36.38 -0.30 9.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 32.53 7.12 5.29 31.66 9.04 5.62 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 90 TYR^? 17.82 CL CL A 226 E 236 ASP A 102 ASP~? 17.30 CL CL A 226 G 110 ARG A 81 ARG~? 19.72 CL CL B 226 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 38.12 1.32 8.30 36.38 -0.30 9.74 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 32.53 7.12 5.29 31.66 9.04 5.62 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 121 TYR.? 28.41 CL CL A 226 E 236 ASP A 151 ASP~? 27.89 CL CL A 226 G 110 ARG A 65 ARG.? 31.92 CL CL A 226 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 17.05 -18.95 -0.65 15.70 -20.36 -3.04 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 90 TYR^? 17.17 CL CL B 226 E 236 ASP B 102 ASP~? 16.83 CL CL B 226 G 110 ARG B 81 ARG~? 19.82 CL CL A 226 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 38.78 1.99 31.89 40.05 -0.11 30.63 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 45.25 7.06 34.64 46.46 8.64 34.05 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 35.26 -4.61 30.73 33.33 -6.15 32.58 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 90 TYR^? 17.82 CL CL A 226 F 236 ASP A 102 ASP~? 17.30 CL CL A 226 H 110 ARG A 81 ARG~? 19.72 CL CL B 226 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 38.12 1.32 8.30 36.38 -0.30 9.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 32.53 7.12 5.29 31.66 9.04 5.62 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 121 TYR.? 28.41 CL CL A 226 F 236 ASP A 151 ASP~? 27.89 CL CL A 226 H 110 ARG A 65 ARG.? 31.92 CL CL A 226 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 17.05 -18.95 -0.65 15.70 -20.36 -3.04 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 186 ASP.? 30.73 CL CL B 226 A 256 GLU B 187 GLU.? 29.51 CL CL B 226 A 329 ASP B 193 ASP~? 31.47 CL CL B 226 coo 28.46 69.88 26.74 30.40 70.70 26.53 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 30.54 71.65 32.58 31.73 72.26 30.92 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 37.87 70.12 31.80 36.61 69.74 30.15 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 193 ASP~? 31.47 CL CL B 226 A 256 GLU B 187 GLU.? 29.51 CL CL B 226 A 329 ASP B 186 ASP.? 30.73 CL CL B 226 coo 28.46 69.88 26.74 30.40 70.70 26.53 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 30.54 71.65 32.58 31.73 72.26 30.92 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 37.87 70.12 31.80 36.61 69.74 30.15 56.29 -18.50 46.72 54.94 -17.46 47.93 1qho_c04 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 111 ASP~? 25.68 CL CL B 226 A 261 ASP B 186 ASP.? 30.73 CL CL B 226 A 329 ASP B 151 ASP~? 28.65 CL CL B 226 coo 28.46 69.88 26.74 30.40 70.70 26.53 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 34.02 79.89 42.60 34.73 78.01 41.86 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 41.86 -11.82 45.74 42.46 -13.70 45.02 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 193 ASP~? 31.47 CL CL B 226 A 261 ASP B 151 ASP~? 28.65 CL CL B 226 A 329 ASP B 186 ASP.? 30.73 CL CL B 226 coo 28.46 69.88 26.74 30.40 70.70 26.53 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 34.02 79.89 42.60 34.73 78.01 41.86 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 37.87 70.12 31.80 36.61 69.74 30.15 56.29 -18.50 46.72 54.94 -17.46 47.93 1qho_c05 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 186 ASP.? 30.73 CL CL B 226 A 260 ASP B 61 ASP.? 23.81 CL CL B 226 A 329 ASP B 193 ASP~? 31.47 CL CL B 226 coo 28.46 69.88 26.74 30.40 70.70 26.53 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 30.73 81.29 37.61 31.23 82.07 35.69 66.70 -13.12 38.44 68.10 -11.59 37.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 60.57 -10.33 49.95 62.16 -11.61 50.53 1qho_c07 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 22 THR~? 22.52 CL CL A 226 A 182 TYR A 20 TYR~? 17.28 CL CL A 226 A 186 LYS B 74 LYS.? 25.46 CL CL A 226 coo 69.38 87.38 24.64 71.11 88.47 25.40 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 73.61 90.42 31.12 71.36 89.66 29.64 26.99 -13.27 24.47 26.16 -12.32 26.98 coo 73.54 84.00 28.64 69.01 86.68 29.71 32.81 -17.40 29.10 28.60 -18.34 31.99 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR A 76 THR~? 22.08 CL CL B 226 A 182 TYR B 20 TYR~? 17.36 CL CL B 226 A 186 LYS A 74 LYS.? 28.20 CL CL B 226 coo 69.38 87.38 24.64 71.11 88.47 25.40 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 73.61 90.42 31.12 71.36 89.66 29.64 46.52 -15.74 17.49 47.60 -15.27 14.94 coo 73.54 84.00 28.64 69.01 86.68 29.71 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR B 22 THR~? 22.16 CL CL B 226 A 182 TYR B 20 TYR~? 17.36 CL CL B 226 A 186 LYS A 74 LYS.? 28.20 CL CL B 226 coo 69.38 87.38 24.64 71.11 88.47 25.40 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 73.61 90.42 31.12 71.36 89.66 29.64 46.52 -15.74 17.49 47.60 -15.27 14.94 coo 73.54 84.00 28.64 69.01 86.68 29.71 39.76 -18.88 13.29 42.20 -24.24 11.95 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 3 # 4 A 145 THR B 76 THR~? 22.20 CL CL A 226 A 182 TYR A 20 TYR~? 17.28 CL CL A 226 A 186 LYS B 74 LYS.? 25.46 CL CL A 226 coo 69.38 87.38 24.64 71.11 88.47 25.40 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 73.61 90.42 31.12 71.36 89.66 29.64 26.99 -13.27 24.47 26.16 -12.32 26.98 coo 73.54 84.00 28.64 69.01 86.68 29.71 32.81 -17.40 29.10 28.60 -18.34 31.99 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 4 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 56 HIS^? 18.87 CL CL A 226 A 646 ASP A 43 ASP.? 11.79 CL CL A 226 A 741 SER A 55 SER^? 14.68 CL CL A 226 coo -20.72 2.99 34.37 -21.94 1.82 35.61 18.56 -13.44 9.47 17.41 -14.68 10.72 coo -18.83 7.68 26.86 -20.89 7.78 26.56 16.13 -5.04 13.46 14.39 -5.59 14.60 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 23.22 -13.07 11.27 22.88 -10.73 11.74 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 56 HIS^? 18.72 CL CL B 226 A 646 ASP B 43 ASP.? 11.93 CL CL B 226 A 741 SER B 55 SER^? 14.61 CL CL B 226 coo -20.72 2.99 34.37 -21.94 1.82 35.61 54.92 -15.50 33.10 56.24 -16.81 32.13 coo -18.83 7.68 26.86 -20.89 7.78 26.56 58.62 -8.54 27.92 60.24 -9.54 27.09 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 50.30 -14.63 30.79 50.54 -12.31 30.40 1qrz_c12 source 1qrz PLASMINOGEN : 2 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 56 HIS^? 18.87 CL CL A 226 B 646 ASP A 43 ASP.? 11.79 CL CL A 226 B 741 SER A 55 SER^? 14.68 CL CL A 226 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 18.56 -13.44 9.47 17.41 -14.68 10.72 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 16.13 -5.04 13.46 14.39 -5.59 14.60 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 23.22 -13.07 11.27 22.88 -10.73 11.74 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 56 HIS^? 18.72 CL CL B 226 B 646 ASP B 43 ASP.? 11.93 CL CL B 226 B 741 SER B 55 SER^? 14.61 CL CL B 226 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 54.92 -15.50 33.10 56.24 -16.81 32.13 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 58.62 -8.54 27.92 60.24 -9.54 27.09 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 50.30 -14.63 30.79 50.54 -12.31 30.40 1qrz_c13 source 1qrz PLASMINOGEN : 2 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 56 HIS^? 18.87 CL CL A 226 C 646 ASP A 43 ASP.? 11.79 CL CL A 226 C 741 SER A 55 SER^? 14.68 CL CL A 226 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 23.22 -13.07 11.27 22.88 -10.73 11.74 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 56 HIS^? 18.72 CL CL B 226 C 646 ASP B 43 ASP.? 11.93 CL CL B 226 C 741 SER B 55 SER^? 14.61 CL CL B 226 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 50.30 -14.63 30.79 50.54 -12.31 30.40 1qrz_c14 source 1qrz PLASMINOGEN : 2 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 56 HIS^? 18.87 CL CL A 226 D 646 ASP A 43 ASP.? 11.79 CL CL A 226 D 741 SER A 55 SER^? 14.68 CL CL A 226 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 18.56 -13.44 9.47 17.41 -14.68 10.72 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 16.13 -5.04 13.46 14.39 -5.59 14.60 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 23.22 -13.07 11.27 22.88 -10.73 11.74 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 56 HIS^? 18.72 CL CL B 226 D 646 ASP B 43 ASP.? 11.93 CL CL B 226 D 741 SER B 55 SER^? 14.61 CL CL B 226 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 54.92 -15.50 33.10 56.24 -16.81 32.13 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 58.62 -8.54 27.92 60.24 -9.54 27.09 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 50.30 -14.63 30.79 50.54 -12.31 30.40 1qrz_c15 source 1qrz PLASMINOGEN : 2 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 93 HIS.? 23.56 CL CL B 226 B 646 ASP A 94 ASP.? 26.16 CL CL B 226 B 739 GLY A 89 GLY~? 17.30 CL CL A 226 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 46.12 1.77 -0.18 46.19 -0.30 0.15 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 44.86 8.73 -0.50 42.92 8.83 0.44 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 37.90 4.36 11.39 38.58 4.02 11.72 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS B 93 HIS.? 20.63 CL CL A 226 B 646 ASP B 94 ASP.? 27.62 CL CL A 226 B 739 GLY B 89 GLY~? 16.64 CL CL B 226 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 29.92 2.50 38.47 29.09 1.13 37.10 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 32.35 7.85 42.25 31.25 7.59 44.05 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 39.61 4.74 28.75 38.89 4.60 28.39 1qrz_c21 source 1qrz PLASMINOGEN : 2 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 93 HIS.? 23.56 CL CL B 226 C 646 ASP A 94 ASP.? 26.16 CL CL B 226 C 739 GLY A 89 GLY~? 17.30 CL CL A 226 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 46.12 1.77 -0.18 46.19 -0.30 0.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 44.86 8.73 -0.50 42.92 8.83 0.44 coo 7.82 1.25 3.03 7.30 1.31 3.65 37.90 4.36 11.39 38.58 4.02 11.72 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS B 93 HIS.? 20.63 CL CL A 226 C 646 ASP B 94 ASP.? 27.62 CL CL A 226 C 739 GLY B 85 GLY~? 15.33 CL CL B 226 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 29.92 2.50 38.47 29.09 1.13 37.10 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 32.35 7.85 42.25 31.25 7.59 44.05 coo 7.82 1.25 3.03 7.30 1.31 3.65 39.45 1.04 27.01 39.73 0.94 26.23 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS B 93 HIS.? 20.63 CL CL A 226 C 646 ASP B 94 ASP.? 27.62 CL CL A 226 C 739 GLY B 89 GLY~? 16.64 CL CL B 226 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 29.92 2.50 38.47 29.09 1.13 37.10 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 32.35 7.85 42.25 31.25 7.59 44.05 coo 7.82 1.25 3.03 7.30 1.31 3.65 39.61 4.74 28.75 38.89 4.60 28.39 1qrz_c22 source 1qrz PLASMINOGEN : 3 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 93 HIS.? 23.56 CL CL B 226 D 646 ASP A 94 ASP.? 26.16 CL CL B 226 D 739 GLY A 89 GLY~? 17.30 CL CL A 226 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 46.12 1.77 -0.18 46.19 -0.30 0.15 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 44.86 8.73 -0.50 42.92 8.83 0.44 coo -45.82 1.31 41.67 -46.38 1.39 42.31 37.90 4.36 11.39 38.58 4.02 11.72 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS B 93 HIS.? 20.63 CL CL A 226 D 646 ASP B 94 ASP.? 27.62 CL CL A 226 D 739 GLY B 85 GLY~? 15.33 CL CL B 226 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 29.92 2.50 38.47 29.09 1.13 37.10 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 32.35 7.85 42.25 31.25 7.59 44.05 coo -45.82 1.31 41.67 -46.38 1.39 42.31 39.45 1.04 27.01 39.73 0.94 26.23 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS B 93 HIS.? 20.63 CL CL A 226 D 646 ASP B 94 ASP.? 27.62 CL CL A 226 D 739 GLY B 89 GLY~? 16.64 CL CL B 226 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 29.92 2.50 38.47 29.09 1.13 37.10 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 32.35 7.85 42.25 31.25 7.59 44.05 coo -45.82 1.31 41.67 -46.38 1.39 42.31 39.61 4.74 28.75 38.89 4.60 28.39 1qrz_c23 source 1qrz PLASMINOGEN : 3 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 109 PHE~? 18.50 CL CL A 226 A 201 ASP A 203 ASP~? 25.03 CL CL A 226 A 227 LYS A 178 LYS~? 16.45 CL CL A 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 24.98 3.58 -0.85 22.97 3.50 1.05 coo 25.52 45.12 37.98 23.98 46.65 37.85 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 12.68 46.83 36.69 18.26 48.67 34.51 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 183 PHE~? 26.67 CL CL A 226 A 201 ASP A 186 ASP.? 30.68 CL CL A 226 A 227 LYS A 63 LYS.? 28.35 CL CL A 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 17.50 -8.22 -4.13 17.97 -8.86 -6.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 12.68 46.83 36.69 18.26 48.67 34.51 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 183 PHE~? 26.67 CL CL A 226 A 201 ASP A 186 ASP.? 30.68 CL CL A 226 A 227 LYS A 178 LYS~? 16.45 CL CL A 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 17.50 -8.22 -4.13 17.97 -8.86 -6.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 12.68 46.83 36.69 18.26 48.67 34.51 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE A 183 PHE~? 26.67 CL CL A 226 A 201 ASP A 193 ASP~? 30.50 CL CL A 226 A 227 LYS A 178 LYS~? 16.45 CL CL A 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 17.50 -8.22 -4.13 17.97 -8.86 -6.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 12.68 46.83 36.69 18.26 48.67 34.51 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE A 183 PHE~? 26.67 CL CL A 226 A 201 ASP A 193 ASP~? 30.50 CL CL A 226 A 227 LYS A 200 LYS~? 23.56 CL CL A 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 17.50 -8.22 -4.13 17.97 -8.86 -6.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 12.68 46.83 36.69 18.26 48.67 34.51 16.08 2.95 -3.95 11.11 -0.40 -2.10 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 109 PHE~? 18.73 CL CL B 226 A 201 ASP B 203 ASP~? 25.12 CL CL B 226 A 227 LYS B 178 LYS~? 16.76 CL CL B 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 51.52 2.89 41.40 53.63 2.11 39.78 coo 25.52 45.12 37.98 23.98 46.65 37.85 60.54 4.31 43.90 62.00 4.57 45.37 coo 12.68 46.83 36.69 18.26 48.67 34.51 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE B 183 PHE~? 27.12 CL CL B 226 A 201 ASP B 193 ASP~? 31.47 CL CL B 226 A 227 LYS B 63 LYS.? 30.86 CL CL B 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 25.52 45.12 37.98 23.98 46.65 37.85 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 12.68 46.83 36.69 18.26 48.67 34.51 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE B 183 PHE~? 27.12 CL CL B 226 A 201 ASP B 193 ASP~? 31.47 CL CL B 226 A 227 LYS B 178 LYS~? 16.76 CL CL B 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 25.52 45.12 37.98 23.98 46.65 37.85 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 12.68 46.83 36.69 18.26 48.67 34.51 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE B 183 PHE~? 27.12 CL CL B 226 A 201 ASP B 193 ASP~? 31.47 CL CL B 226 A 227 LYS B 200 LYS~? 24.54 CL CL B 226 coo 23.39 49.81 32.16 21.33 51.68 32.26 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 25.52 45.12 37.98 23.98 46.65 37.85 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 12.68 46.83 36.69 18.26 48.67 34.51 60.00 0.23 45.11 63.70 -4.80 44.31 1qz9_c02 source 1qz9 KYNURENINASE : 9 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP B 40 ASP.? 7.91 CL CL B 226 A 186 ASN B 8 ASN.? 7.79 CL CL B 226 A 260 ALA B 14 ALA~? 12.02 CL CL B 226 coo 11.81 33.10 11.71 13.07 31.45 11.40 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 11.43 26.53 7.41 13.01 27.56 8.43 51.02 -6.75 16.28 50.85 -6.79 18.40 coo 21.53 26.33 6.96 20.26 25.69 7.52 44.33 -7.28 23.33 43.44 -6.30 24.13 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 1 hits 1r4f_c00 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 9 GLU.? 16.20 CL CL A 226 A 288 HIS A 56 HIS^? 18.87 CL CL A 226 A 329 LYS A 63 LYS.? 28.35 CL CL A 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 49.52 10.06 10.36 50.99 9.65 8.92 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 11 GLU.? 11.48 CL CL A 226 A 288 HIS A 56 HIS^? 18.87 CL CL A 226 A 329 LYS A 60 LYS.? 19.24 CL CL A 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 31.29 2.41 22.91 32.62 4.08 23.08 coo 49.52 10.06 10.36 50.99 9.65 8.92 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 26 GLU~? 31.19 CL CL A 226 A 288 HIS A 56 HIS^? 18.87 CL CL A 226 A 329 LYS A 60 LYS.? 19.24 CL CL A 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 49.52 10.06 10.36 50.99 9.65 8.92 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU A 26 GLU~? 31.19 CL CL A 226 A 288 HIS A 56 HIS^? 18.87 CL CL A 226 A 329 LYS A 63 LYS.? 28.35 CL CL A 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 49.52 10.06 10.36 50.99 9.65 8.92 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU A 77 GLU~? 21.84 CL CL B 226 A 288 HIS A 56 HIS^? 18.87 CL CL A 226 A 329 LYS A 60 LYS.? 19.24 CL CL A 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 49.52 10.06 10.36 50.99 9.65 8.92 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU A 77 GLU~? 21.84 CL CL B 226 A 288 HIS A 56 HIS^? 18.87 CL CL A 226 A 329 LYS A 63 LYS.? 28.35 CL CL A 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 49.52 10.06 10.36 50.99 9.65 8.92 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU A 91 GLU^? 16.38 CL CL B 226 A 288 HIS A 75 HIS.? 25.41 CL CL B 226 A 329 LYS A 52 LYS^? 28.69 CL CL A 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 45.65 4.89 7.15 47.54 4.63 8.07 coo 49.52 10.06 10.36 50.99 9.65 8.92 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 57.80 12.92 13.83 53.77 8.42 12.15 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU A 168 GLU.? -6.12 CL CL A 226s A 288 HIS A 56 HIS^? 18.87 CL CL A 226 A 329 LYS A 63 LYS.? 28.35 CL CL A 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 22.70 6.74 18.04 23.60 8.22 19.21 coo 49.52 10.06 10.36 50.99 9.65 8.92 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU B 9 GLU.? 16.36 CL CL B 226 A 288 HIS B 56 HIS^? 18.72 CL CL B 226 A 329 LYS B 60 LYS.? 20.89 CL CL B 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 49.52 10.06 10.36 50.99 9.65 8.92 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU B 9 GLU.? 16.36 CL CL B 226 A 288 HIS B 56 HIS^? 18.72 CL CL B 226 A 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 49.52 10.06 10.36 50.99 9.65 8.92 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 A 137 GLU B 11 GLU.? 11.19 CL CL B 226 A 288 HIS B 56 HIS^? 18.72 CL CL B 226 A 329 LYS B 60 LYS.? 20.89 CL CL B 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 45.62 0.60 17.46 44.46 2.32 17.00 coo 49.52 10.06 10.36 50.99 9.65 8.92 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 A 137 GLU B 69 GLU^? 24.72 CL CL B 226 A 288 HIS B 93 HIS.? 20.63 CL CL A 226 A 329 LYS B 96 LYS^? 24.51 CL CL B 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 49.52 10.06 10.36 50.99 9.65 8.92 29.92 2.50 38.47 29.09 1.13 37.10 coo 57.80 12.92 13.83 53.77 8.42 12.15 35.42 10.33 36.63 41.15 11.45 39.22 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 A 137 GLU B 77 GLU~? 22.22 CL CL A 226 A 288 HIS B 56 HIS^? 18.72 CL CL B 226 A 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 49.52 10.06 10.36 50.99 9.65 8.92 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 A 137 GLU B 91 GLU^? 18.27 CL CL A 226 A 288 HIS B 75 HIS.? 25.67 CL CL A 226 A 329 LYS B 52 LYS^? 28.59 CL CL B 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 32.79 7.55 33.87 31.17 8.67 33.09 coo 49.52 10.06 10.36 50.99 9.65 8.92 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 57.80 12.92 13.83 53.77 8.42 12.15 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 A 137 GLU B 168 GLU.? -5.97 CL CL B 226s A 288 HIS B 56 HIS^? 18.72 CL CL B 226 A 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 29.27 18.78 14.99 27.16 18.62 14.76 54.77 3.34 22.36 54.93 5.08 21.18 coo 49.52 10.06 10.36 50.99 9.65 8.92 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 61.77 -19.16 38.03 61.33 -25.31 39.26 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 15 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 9 GLU.? 16.20 CL CL A 226 B 288 HIS A 56 HIS^? 18.87 CL CL A 226 B 329 LYS A 63 LYS.? 28.35 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 11 GLU.? 11.48 CL CL A 226 B 288 HIS A 56 HIS^? 18.87 CL CL A 226 B 329 LYS A 60 LYS.? 19.24 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 31.29 2.41 22.91 32.62 4.08 23.08 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU A 26 GLU~? 31.19 CL CL A 226 B 288 HIS A 56 HIS^? 18.87 CL CL A 226 B 329 LYS A 60 LYS.? 19.24 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU A 26 GLU~? 31.19 CL CL A 226 B 288 HIS A 56 HIS^? 18.87 CL CL A 226 B 329 LYS A 63 LYS.? 28.35 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU A 77 GLU~? 21.84 CL CL B 226 B 288 HIS A 56 HIS^? 18.87 CL CL A 226 B 329 LYS A 60 LYS.? 19.24 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU A 77 GLU~? 21.84 CL CL B 226 B 288 HIS A 56 HIS^? 18.87 CL CL A 226 B 329 LYS A 63 LYS.? 28.35 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU A 91 GLU^? 16.38 CL CL B 226 B 288 HIS A 75 HIS.? 25.41 CL CL B 226 B 329 LYS A 52 LYS^? 28.69 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 45.65 4.89 7.15 47.54 4.63 8.07 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU A 168 GLU.? -6.12 CL CL A 226s B 288 HIS A 56 HIS^? 18.87 CL CL A 226 B 329 LYS A 63 LYS.? 28.35 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 22.70 6.74 18.04 23.60 8.22 19.21 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU A 198 GLU~? 30.13 CL CL A 226 B 288 HIS A 56 HIS^? 18.87 CL CL A 226 B 329 LYS A 36 LYS^? 12.38 CL CL A 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 19.84 0.58 -9.50 20.29 0.30 -11.52 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU B 9 GLU.? 16.36 CL CL B 226 B 288 HIS B 56 HIS^? 18.72 CL CL B 226 B 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 B 137 GLU B 11 GLU.? 11.19 CL CL B 226 B 288 HIS B 56 HIS^? 18.72 CL CL B 226 B 329 LYS B 60 LYS.? 20.89 CL CL B 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 45.62 0.60 17.46 44.46 2.32 17.00 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 B 137 GLU B 26 GLU~? 28.82 CL CL B 226 B 288 HIS B 56 HIS^? 18.72 CL CL B 226 B 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 B 137 GLU B 69 GLU^? 24.72 CL CL B 226 B 288 HIS B 93 HIS.? 20.63 CL CL A 226 B 329 LYS B 96 LYS^? 24.51 CL CL B 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 29.92 2.50 38.47 29.09 1.13 37.10 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 35.42 10.33 36.63 41.15 11.45 39.22 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 B 137 GLU B 77 GLU~? 22.22 CL CL A 226 B 288 HIS B 56 HIS^? 18.72 CL CL B 226 B 329 LYS B 60 LYS.? 20.89 CL CL B 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 B 137 GLU B 77 GLU~? 22.22 CL CL A 226 B 288 HIS B 56 HIS^? 18.72 CL CL B 226 B 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 61.77 -19.16 38.03 61.33 -25.31 39.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 16 3 # 16 B 137 GLU B 91 GLU^? 18.27 CL CL A 226 B 288 HIS B 75 HIS.? 25.67 CL CL A 226 B 329 LYS B 52 LYS^? 28.59 CL CL B 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 32.79 7.55 33.87 31.17 8.67 33.09 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 17 3 # 17 B 137 GLU B 168 GLU.? -5.97 CL CL B 226s B 288 HIS B 56 HIS^? 18.72 CL CL B 226 B 329 LYS B 63 LYS.? 30.86 CL CL B 226 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 54.77 3.34 22.36 54.93 5.08 21.18 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 61.77 -19.16 38.03 61.33 -25.31 39.26 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 17 hits 1roz_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP B 102 ASP~? 16.83 CL CL B 226 595 GLU B 91 GLU^? 18.27 CL CL A 226 713 TYR B 90 TYR^? 17.17 CL CL B 226 coo 5.64 2.82 38.49 4.59 4.19 37.25 45.25 7.06 34.64 46.46 8.64 34.05 coo 4.35 13.73 37.63 3.39 12.18 36.55 32.79 7.55 33.87 31.17 8.67 33.09 coo 3.76 10.25 31.38 3.16 9.87 34.10 38.78 1.99 31.89 40.05 -0.11 30.63 1sll_c00 source 1sll SIALIDASE L : 1 hits 1sll_c00 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 203 ASP~? 25.03 CL CL A 226 E 168 LYS A 205 LYS~? 25.48 CL CL A 226 E 171 ASN A 202 ASN~? 26.54 CL CL A 226 coo 5.36 16.20 22.10 3.88 17.00 23.31 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 5.06 22.32 18.11 1.02 22.08 22.74 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 6.68 21.78 22.39 5.28 20.74 23.60 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 203 ASP~? 25.12 CL CL B 226 E 168 LYS B 205 LYS~? 25.67 CL CL B 226 E 171 ASN B 202 ASN~? 26.89 CL CL B 226 coo 5.36 16.20 22.10 3.88 17.00 23.31 60.54 4.31 43.90 62.00 4.57 45.37 coo 5.06 22.32 18.11 1.02 22.08 22.74 54.11 5.83 42.26 49.56 6.08 46.56 coo 6.68 21.78 22.39 5.28 20.74 23.60 56.47 4.11 47.59 54.90 3.31 48.75 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 2 hits 1stc_c03 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 86 HIS~? 10.02 CL CL A 226 B 80 GLU A 11 GLU.? 11.48 CL CL A 226 B 223 ARG B 27 ARG~? 28.79 CL CL B 226 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 32.84 2.26 17.60 31.66 3.53 18.78 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 31.29 2.41 22.91 32.62 4.08 23.08 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 46.17 -28.08 18.24 47.24 -27.87 15.37 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS B 86 HIS~? 9.45 CL CL B 226 B 80 GLU B 11 GLU.? 11.19 CL CL B 226 B 223 ARG A 27 ARG~? 25.45 CL CL A 226 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 44.03 1.12 22.86 45.41 1.90 21.48 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 45.62 0.60 17.46 44.46 2.32 17.00 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 23.69 -24.29 25.50 21.75 -22.60 23.78 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 86 HIS~? 9.45 CL CL B 226 B 80 GLU B 11 GLU.? 11.19 CL CL B 226 B 223 ARG B 65 ARG.? 31.41 CL CL B 226 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 44.03 1.12 22.86 45.41 1.90 21.48 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 45.62 0.60 17.46 44.46 2.32 17.00 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 55.55 -24.03 39.40 53.97 -26.61 39.95 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 93 HIS.? 20.63 CL CL A 226 B 80 GLU B 91 GLU^? 18.27 CL CL A 226 B 223 ARG A 27 ARG~? 25.45 CL CL A 226 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 29.92 2.50 38.47 29.09 1.13 37.10 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 32.79 7.55 33.87 31.17 8.67 33.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 23.69 -24.29 25.50 21.75 -22.60 23.78 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 4 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 95 GLY.? 21.62 CL CL B 226 B 17 GLN A 97 GLN^? 17.74 CL CL B 226 B 140 GLU A 91 GLU^? 16.38 CL CL B 226 coo 61.49 19.86 5.96 61.52 19.46 5.16 46.76 8.51 3.98 46.00 8.53 3.69 coo 63.76 11.90 7.93 65.18 13.07 6.77 41.33 7.73 10.04 42.82 6.16 10.16 coo 66.44 19.00 7.38 67.69 17.67 8.37 45.65 4.89 7.15 47.54 4.63 8.07 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 1 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 72 SER.? 25.76 CL CL A 226 A 90 SER A 51 SER.? 28.65 CL CL A 226 A 145 LYS A 29 LYS~? 32.87 CL CL A 226 coo -3.31 40.95 15.56 -0.94 40.79 14.97 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 1.47 40.03 18.48 2.45 41.37 16.68 30.97 -23.17 15.96 32.59 -24.12 14.38 coo 7.35 44.71 16.29 4.71 40.98 14.52 27.86 -27.63 18.34 32.94 -28.71 20.74 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 212 SER.? 30.23 CL CL A 226 A 90 SER A 210 SER~? 21.09 CL CL A 226 A 145 LYS A 205 LYS~? 25.48 CL CL A 226 coo -3.31 40.95 15.56 -0.94 40.79 14.97 22.65 17.11 -5.68 24.22 18.23 -7.14 coo 1.47 40.03 18.48 2.45 41.37 16.68 24.15 14.96 0.00 24.37 15.67 2.31 coo 7.35 44.71 16.29 4.71 40.98 14.52 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER B 212 SER~? 27.82 CL CL B 226 A 90 SER B 210 SER~? 23.92 CL CL B 226 A 145 LYS B 205 LYS~? 25.67 CL CL B 226 coo -3.31 40.95 15.56 -0.94 40.79 14.97 51.36 18.00 43.66 51.38 19.12 41.53 coo 1.47 40.03 18.48 2.45 41.37 16.68 53.28 14.40 40.02 51.53 15.84 39.30 coo 7.35 44.71 16.29 4.71 40.98 14.52 54.11 5.83 42.26 49.56 6.08 46.56 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 3 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 72 SER.? 25.76 CL CL A 226 B 90 SER A 51 SER.? 28.65 CL CL A 226 B 145 LYS A 29 LYS~? 32.87 CL CL A 226 coo 61.01 10.03 12.97 58.78 10.97 12.69 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 56.85 12.22 16.37 55.62 11.34 14.45 30.97 -23.17 15.96 32.59 -24.12 14.38 coo 49.80 9.51 14.88 53.14 11.99 12.77 27.86 -27.63 18.34 32.94 -28.71 20.74 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER A 212 SER.? 30.23 CL CL A 226 B 90 SER A 210 SER~? 21.09 CL CL A 226 B 145 LYS A 205 LYS~? 25.48 CL CL A 226 coo 61.01 10.03 12.97 58.78 10.97 12.69 22.65 17.11 -5.68 24.22 18.23 -7.14 coo 56.85 12.22 16.37 55.62 11.34 14.45 24.15 14.96 0.00 24.37 15.67 2.31 coo 49.80 9.51 14.88 53.14 11.99 12.77 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER B 212 SER~? 27.82 CL CL B 226 B 90 SER B 210 SER~? 23.92 CL CL B 226 B 145 LYS B 205 LYS~? 25.67 CL CL B 226 coo 61.01 10.03 12.97 58.78 10.97 12.69 51.36 18.00 43.66 51.38 19.12 41.53 coo 56.85 12.22 16.37 55.62 11.34 14.45 53.28 14.40 40.02 51.53 15.84 39.30 coo 49.80 9.51 14.88 53.14 11.99 12.77 54.11 5.83 42.26 49.56 6.08 46.56 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 3 hits 1t7d_c01 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 72 SER.? 25.76 CL CL A 226 354 GLU A 77 GLU~? 21.84 CL CL B 226 463 HIS A 75 HIS.? 25.41 CL CL B 226 coo 48.87 13.74 2.81 48.49 11.54 3.93 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 39.95 14.43 3.01 41.55 14.10 1.63 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 43.90 10.50 2.81 45.63 11.48 3.27 38.68 -16.70 9.61 40.32 -17.29 8.43 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 72 SER.? 25.86 CL CL B 226 354 GLU B 77 GLU~? 22.22 CL CL A 226 463 HIS B 75 HIS.? 25.67 CL CL A 226 coo 48.87 13.74 2.81 48.49 11.54 3.93 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 39.95 14.43 3.01 41.55 14.10 1.63 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 43.90 10.50 2.81 45.63 11.48 3.27 34.50 -15.17 32.63 32.86 -15.45 33.92 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 2 hits 1thg_c00 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 110 GLU~? 23.70 CL CL A 226 A 126 LYS A 205 LYS~? 25.48 CL CL A 226 A 171 ALA A 105 ALA~? 16.83 CL CL A 226 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 28.34 3.47 2.87 28.40 4.99 3.05 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 172 GLU~? 15.14 CL CL A 226 A 126 LYS A 200 LYS~? 23.56 CL CL A 226 A 171 ALA A 206 ALA~? 24.00 CL CL A 226 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 20.31 7.29 3.53 20.42 8.84 4.96 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 22.02 10.53 -2.80 20.97 10.90 -3.89 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU A 198 GLU~? 30.13 CL CL A 226 A 126 LYS A 200 LYS~? 23.56 CL CL A 226 A 171 ALA A 196 ALA~? 28.08 CL CL A 226 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 19.84 0.58 -9.50 20.29 0.30 -11.52 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 13.17 -1.56 -7.76 12.04 -2.43 -7.25 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU B 110 GLU~? 23.32 CL CL B 226 A 126 LYS B 205 LYS~? 25.67 CL CL B 226 A 171 ALA B 105 ALA~? 16.52 CL CL B 226 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 46.60 5.74 43.54 45.54 7.20 42.48 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 54.11 5.83 42.26 49.56 6.08 46.56 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 48.52 2.97 37.54 48.93 4.37 37.10 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU B 172 GLU~? 15.62 CL CL B 226 A 126 LYS B 200 LYS~? 24.54 CL CL B 226 A 171 ALA B 206 ALA~? 23.96 CL CL B 226 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 57.49 4.88 36.61 57.44 6.68 35.49 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 60.00 0.23 45.11 63.70 -4.80 44.31 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 56.38 8.90 42.83 57.56 8.97 43.80 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU B 198 GLU~? 30.19 CL CL B 226 A 126 LYS B 200 LYS~? 24.54 CL CL B 226 A 171 ALA B 196 ALA~? 28.88 CL CL B 226 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 60.00 0.23 45.11 63.70 -4.80 44.31 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 61.41 -3.92 49.78 62.39 -5.06 49.44 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 6 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 69 GLU^? 25.00 CL CL A 226 B 126 LYS A 74 LYS.? 28.20 CL CL B 226 B 171 ALA A 71 ALA^? 20.51 CL CL A 226 coo 20.47 87.42 16.54 20.16 87.17 14.45 30.56 -16.89 8.89 31.90 -18.26 8.02 coo 24.73 94.37 14.59 21.08 89.84 11.98 39.76 -18.88 13.29 42.20 -24.24 11.95 coo 24.38 86.32 12.71 22.88 86.54 12.71 32.71 -15.15 12.56 32.86 -14.68 13.99 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 110 GLU~? 23.70 CL CL A 226 B 126 LYS A 205 LYS~? 25.48 CL CL A 226 B 171 ALA A 105 ALA~? 16.83 CL CL A 226 coo 20.47 87.42 16.54 20.16 87.17 14.45 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 24.73 94.37 14.59 21.08 89.84 11.98 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 24.38 86.32 12.71 22.88 86.54 12.71 28.34 3.47 2.87 28.40 4.99 3.05 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU A 172 GLU~? 15.14 CL CL A 226 B 126 LYS A 200 LYS~? 23.56 CL CL A 226 B 171 ALA A 206 ALA~? 24.00 CL CL A 226 coo 20.47 87.42 16.54 20.16 87.17 14.45 20.31 7.29 3.53 20.42 8.84 4.96 coo 24.73 94.37 14.59 21.08 89.84 11.98 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 24.38 86.32 12.71 22.88 86.54 12.71 22.02 10.53 -2.80 20.97 10.90 -3.89 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU A 198 GLU~? 30.13 CL CL A 226 B 126 LYS A 200 LYS~? 23.56 CL CL A 226 B 171 ALA A 196 ALA~? 28.08 CL CL A 226 coo 20.47 87.42 16.54 20.16 87.17 14.45 19.84 0.58 -9.50 20.29 0.30 -11.52 coo 24.73 94.37 14.59 21.08 89.84 11.98 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 24.38 86.32 12.71 22.88 86.54 12.71 13.17 -1.56 -7.76 12.04 -2.43 -7.25 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU B 69 GLU^? 24.72 CL CL B 226 B 126 LYS B 74 LYS.? 25.46 CL CL A 226 B 171 ALA B 71 ALA^? 20.21 CL CL B 226 coo 20.47 87.42 16.54 20.16 87.17 14.45 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 24.73 94.37 14.59 21.08 89.84 11.98 32.81 -17.40 29.10 28.60 -18.34 31.99 coo 24.38 86.32 12.71 22.88 86.54 12.71 40.69 -15.21 29.48 40.79 -14.95 28.00 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU B 110 GLU~? 23.32 CL CL B 226 B 126 LYS B 205 LYS~? 25.67 CL CL B 226 B 171 ALA B 105 ALA~? 16.52 CL CL B 226 coo 20.47 87.42 16.54 20.16 87.17 14.45 46.60 5.74 43.54 45.54 7.20 42.48 coo 24.73 94.37 14.59 21.08 89.84 11.98 54.11 5.83 42.26 49.56 6.08 46.56 coo 24.38 86.32 12.71 22.88 86.54 12.71 48.52 2.97 37.54 48.93 4.37 37.10 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 B 46 GLU B 172 GLU~? 15.62 CL CL B 226 B 126 LYS B 200 LYS~? 24.54 CL CL B 226 B 171 ALA B 206 ALA~? 23.96 CL CL B 226 coo 20.47 87.42 16.54 20.16 87.17 14.45 57.49 4.88 36.61 57.44 6.68 35.49 coo 24.73 94.37 14.59 21.08 89.84 11.98 60.00 0.23 45.11 63.70 -4.80 44.31 coo 24.38 86.32 12.71 22.88 86.54 12.71 56.38 8.90 42.83 57.56 8.97 43.80 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 B 46 GLU B 198 GLU~? 30.19 CL CL B 226 B 126 LYS B 200 LYS~? 24.54 CL CL B 226 B 171 ALA B 196 ALA~? 28.88 CL CL B 226 coo 20.47 87.42 16.54 20.16 87.17 14.45 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 24.73 94.37 14.59 21.08 89.84 11.98 60.00 0.23 45.11 63.70 -4.80 44.31 coo 24.38 86.32 12.71 22.88 86.54 12.71 61.41 -3.92 49.78 62.39 -5.06 49.44 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 8 hits 1uf7_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 75 HIS.? 25.41 CL CL B 226 89 GLU A 77 GLU~? 21.84 CL CL B 226 243 ASN A 50 ASN.? 30.77 CL CL A 226 coo 5.83 15.74 17.38 6.41 17.70 17.86 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 3.11 16.19 13.44 4.96 17.09 13.42 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 0.53 21.81 31.33 1.05 20.47 29.70 28.00 -25.90 12.99 26.73 -27.64 12.92 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS A 86 HIS~? 10.02 CL CL A 226 89 GLU A 11 GLU.? 11.48 CL CL A 226 243 ASN B 167 ASN.? 4.94 CL CL B 226 coo 5.83 15.74 17.38 6.41 17.70 17.86 32.84 2.26 17.60 31.66 3.53 18.78 coo 3.11 16.19 13.44 4.96 17.09 13.42 31.29 2.41 22.91 32.62 4.08 23.08 coo 0.53 21.81 31.33 1.05 20.47 29.70 50.28 1.34 22.19 49.08 -0.16 21.24 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS B 75 HIS.? 25.67 CL CL A 226 89 GLU B 77 GLU~? 22.22 CL CL A 226 243 ASN B 50 ASN.? 30.91 CL CL B 226 coo 5.83 15.74 17.38 6.41 17.70 17.86 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 3.11 16.19 13.44 4.96 17.09 13.42 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 0.53 21.81 31.33 1.05 20.47 29.70 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS B 86 HIS~? 9.45 CL CL B 226 89 GLU B 11 GLU.? 11.19 CL CL B 226 243 ASN A 167 ASN.? 5.51 CL CL A 226 coo 5.83 15.74 17.38 6.41 17.70 17.86 44.03 1.12 22.86 45.41 1.90 21.48 coo 3.11 16.19 13.44 4.96 17.09 13.42 45.62 0.60 17.46 44.46 2.32 17.00 coo 0.53 21.81 31.33 1.05 20.47 29.70 27.28 3.74 18.20 27.65 2.13 19.59 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 4 hits 1ula_c00 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU A 110 GLU~? 23.70 CL CL A 226 A 87 ASP A 111 ASP~? 26.09 CL CL A 226 A 89 GLU A 112 GLU~? 32.50 CL CL A 226 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 31.64 -0.95 -10.58 32.34 0.04 -12.34 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 1 hits 1un1_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 186 ASP.? 30.73 CL CL B 226 255 GLU B 187 GLU.? 29.51 CL CL B 226 329 ASP B 193 ASP~? 31.47 CL CL B 226 coo 49.16 35.16 15.19 51.08 34.43 15.65 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 52.57 37.12 10.17 53.37 35.95 11.75 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 59.16 37.82 13.95 57.63 37.03 15.12 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 193 ASP~? 31.47 CL CL B 226 255 GLU B 187 GLU.? 29.51 CL CL B 226 329 ASP B 186 ASP.? 30.73 CL CL B 226 coo 49.16 35.16 15.19 51.08 34.43 15.65 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 52.57 37.12 10.17 53.37 35.95 11.75 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 59.16 37.82 13.95 57.63 37.03 15.12 56.29 -18.50 46.72 54.94 -17.46 47.93 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 151 ASP~? 28.65 CL CL B 226 218 GLU A 84 GLU~? 12.94 CL CL B 226 329 ASP B 111 ASP~? 25.68 CL CL B 226 coo 49.16 35.16 15.19 51.08 34.43 15.65 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 70.09 11.71 8.46 70.56 12.89 6.77 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 59.16 37.82 13.95 57.63 37.03 15.12 44.68 -0.98 44.91 42.92 -2.08 45.36 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 151 ASP~? 28.65 CL CL B 226 218 GLU B 11 GLU.? 11.19 CL CL B 226 329 ASP B 111 ASP~? 25.68 CL CL B 226 coo 49.16 35.16 15.19 51.08 34.43 15.65 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 70.09 11.71 8.46 70.56 12.89 6.77 45.62 0.60 17.46 44.46 2.32 17.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 44.68 -0.98 44.91 42.92 -2.08 45.36 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 193 ASP~? 31.47 CL CL B 226 218 GLU B 77 GLU~? 22.22 CL CL A 226 329 ASP B 186 ASP.? 30.73 CL CL B 226 coo 49.16 35.16 15.19 51.08 34.43 15.65 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 70.09 11.71 8.46 70.56 12.89 6.77 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 59.16 37.82 13.95 57.63 37.03 15.12 56.29 -18.50 46.72 54.94 -17.46 47.93 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c04 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 9 GLU.? 16.20 CL CL A 226 A 596 ARG A 19 ARG~? 20.09 CL CL A 226 A 647 ARG B 81 ARG~? 19.82 CL CL A 226 coo 69.13 32.20 28.58 68.39 32.96 30.44 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 70.89 37.31 29.70 69.54 36.29 32.39 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 66.09 40.54 34.70 66.92 37.69 35.49 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 84 GLU~? 12.94 CL CL B 226 A 596 ARG A 81 ARG~? 19.72 CL CL B 226 A 647 ARG B 19 ARG~? 20.05 CL CL B 226 coo 69.13 32.20 28.58 68.39 32.96 30.44 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 70.89 37.31 29.70 69.54 36.29 32.39 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 66.09 40.54 34.70 66.92 37.69 35.49 42.78 -12.99 14.20 43.98 -15.00 12.21 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU B 9 GLU.? 16.36 CL CL B 226 A 596 ARG B 19 ARG~? 20.05 CL CL B 226 A 647 ARG A 81 ARG~? 19.72 CL CL B 226 coo 69.13 32.20 28.58 68.39 32.96 30.44 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 70.89 37.31 29.70 69.54 36.29 32.39 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 66.09 40.54 34.70 66.92 37.69 35.49 40.18 -5.93 10.28 41.49 -8.31 8.89 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 9 GLU.? 16.20 CL CL A 226 B 596 ARG A 19 ARG~? 20.09 CL CL A 226 B 647 ARG B 81 ARG~? 19.82 CL CL A 226 coo 38.22 57.83 70.36 36.82 56.74 69.18 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 34.24 60.89 68.08 33.31 57.93 67.63 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 31.43 57.38 61.97 31.90 55.58 64.41 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 84 GLU~? 12.94 CL CL B 226 B 596 ARG A 81 ARG~? 19.72 CL CL B 226 B 647 ARG B 19 ARG~? 20.05 CL CL B 226 coo 38.22 57.83 70.36 36.82 56.74 69.18 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 34.24 60.89 68.08 33.31 57.93 67.63 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 31.43 57.38 61.97 31.90 55.58 64.41 42.78 -12.99 14.20 43.98 -15.00 12.21 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU B 9 GLU.? 16.36 CL CL B 226 B 596 ARG B 19 ARG~? 20.05 CL CL B 226 B 647 ARG A 81 ARG~? 19.72 CL CL B 226 coo 38.22 57.83 70.36 36.82 56.74 69.18 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 34.24 60.89 68.08 33.31 57.93 67.63 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 31.43 57.38 61.97 31.90 55.58 64.41 40.18 -5.93 10.28 41.49 -8.31 8.89 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 9 GLU.? 16.20 CL CL A 226 C 596 ARG A 19 ARG~? 20.09 CL CL A 226 C 647 ARG B 81 ARG~? 19.82 CL CL A 226 coo 11.31 31.26 27.00 13.31 30.71 26.58 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 13.44 32.78 22.07 15.56 30.91 23.37 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 21.00 33.35 22.82 19.83 30.82 24.09 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 84 GLU~? 12.94 CL CL B 226 C 596 ARG A 81 ARG~? 19.72 CL CL B 226 C 647 ARG B 19 ARG~? 20.05 CL CL B 226 coo 11.31 31.26 27.00 13.31 30.71 26.58 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 13.44 32.78 22.07 15.56 30.91 23.37 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 21.00 33.35 22.82 19.83 30.82 24.09 42.78 -12.99 14.20 43.98 -15.00 12.21 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU B 9 GLU.? 16.36 CL CL B 226 C 596 ARG B 19 ARG~? 20.05 CL CL B 226 C 647 ARG A 81 ARG~? 19.72 CL CL B 226 coo 11.31 31.26 27.00 13.31 30.71 26.58 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 13.44 32.78 22.07 15.56 30.91 23.37 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 21.00 33.35 22.82 19.83 30.82 24.09 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU B 84 GLU~? 12.79 CL CL A 226 C 596 ARG B 81 ARG~? 19.82 CL CL A 226 C 647 ARG A 19 ARG~? 20.09 CL CL A 226 coo 11.31 31.26 27.00 13.31 30.71 26.58 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 13.44 32.78 22.07 15.56 30.91 23.37 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 21.00 33.35 22.82 19.83 30.82 24.09 31.00 -11.00 27.75 29.53 -12.56 29.89 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 4 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 9 GLU.? 16.20 CL CL A 226 D 596 ARG A 19 ARG~? 20.09 CL CL A 226 D 647 ARG B 81 ARG~? 19.82 CL CL A 226 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 26.61 -7.39 28.28 26.97 -9.45 28.59 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 84 GLU~? 12.94 CL CL B 226 D 596 ARG A 81 ARG~? 19.72 CL CL B 226 D 647 ARG B 19 ARG~? 20.05 CL CL B 226 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 40.51 -2.33 16.64 42.51 -2.90 16.44 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 40.18 -5.93 10.28 41.49 -8.31 8.89 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 42.78 -12.99 14.20 43.98 -15.00 12.21 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU B 9 GLU.? 16.36 CL CL B 226 D 596 ARG B 19 ARG~? 20.05 CL CL B 226 D 647 ARG A 81 ARG~? 19.72 CL CL B 226 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 47.73 -10.39 12.99 46.70 -12.24 13.09 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 40.18 -5.93 10.28 41.49 -8.31 8.89 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 9 GLU.? 16.20 CL CL A 226 E 596 ARG A 19 ARG~? 20.09 CL CL A 226 E 647 ARG B 81 ARG~? 19.82 CL CL A 226 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 84 GLU~? 12.94 CL CL B 226 E 596 ARG A 81 ARG~? 19.72 CL CL B 226 E 647 ARG B 19 ARG~? 20.05 CL CL B 226 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 42.78 -12.99 14.20 43.98 -15.00 12.21 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU B 9 GLU.? 16.36 CL CL B 226 E 596 ARG B 19 ARG~? 20.05 CL CL B 226 E 647 ARG A 81 ARG~? 19.72 CL CL B 226 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 40.18 -5.93 10.28 41.49 -8.31 8.89 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 9 GLU.? 16.20 CL CL A 226 F 596 ARG A 19 ARG~? 20.09 CL CL A 226 F 647 ARG B 81 ARG~? 19.82 CL CL A 226 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 26.61 -7.39 28.28 26.97 -9.45 28.59 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU B 9 GLU.? 16.36 CL CL B 226 F 596 ARG B 19 ARG~? 20.05 CL CL B 226 F 647 ARG A 81 ARG~? 19.72 CL CL B 226 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 47.73 -10.39 12.99 46.70 -12.24 13.09 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 40.18 -5.93 10.28 41.49 -8.31 8.89 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 8 ASN.? 6.94 CL CL A 226 457 GLY A 15 GLY~? 13.48 CL CL A 226 459 GLU B 84 GLU~? 12.79 CL CL A 226 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 24.44 -3.01 24.75 23.45 -2.96 22.86 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 32.14 -6.39 21.42 31.45 -6.64 21.14 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 35.35 -1.73 23.75 33.22 -1.55 23.84 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 202 ASN~? 26.54 CL CL A 226 457 GLY A 176 GLY~? 16.20 CL CL A 226 459 GLU A 172 GLU~? 15.14 CL CL A 226 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 20.33 4.95 -7.07 21.62 3.54 -8.03 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 20.16 -0.13 2.60 19.89 -0.48 3.28 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 20.31 7.29 3.53 20.42 8.84 4.96 1vom_c00 source 1vom MYOSIN : 2 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE B 54 PHE^? 23.35 CL CL B 226 A 197 ASN B 50 ASN.? 30.91 CL CL B 226 A 198 PRO B 32 PRO.? 27.52 CL CL B 226 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 47.05 -19.25 32.15 45.09 -20.88 33.13 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 42.91 -26.63 29.90 43.43 -28.67 30.19 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 49.40 -27.99 26.91 48.79 -27.10 24.95 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 1 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE B 54 PHE^? 23.35 CL CL B 226 B 197 ASN B 50 ASN.? 30.91 CL CL B 226 B 198 PRO B 32 PRO.? 27.52 CL CL B 226 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 47.05 -19.25 32.15 45.09 -20.88 33.13 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 42.91 -26.63 29.90 43.43 -28.67 30.19 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 49.40 -27.99 26.91 48.79 -27.10 24.95 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 1 hits 1vq1_c01 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 87 TYR~? 13.92 CL CL A 226 A 317 GLU A 84 GLU~? 12.94 CL CL B 226 A 365 ARG A 13 ARG~? 5.03 CL CL A 226 coo 1.77 6.56 57.05 3.05 7.44 59.37 36.79 3.26 19.70 35.19 2.19 21.67 coo 3.06 2.85 52.79 4.83 3.89 53.24 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 24.18 -3.56 18.28 25.11 -1.28 16.40 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 87 TYR~? 13.92 CL CL A 226 A 317 GLU A 84 GLU~? 12.94 CL CL B 226 A 365 ARG B 81 ARG~? 19.82 CL CL A 226 coo 1.77 6.56 57.05 3.05 7.44 59.37 36.79 3.26 19.70 35.19 2.19 21.67 coo 3.06 2.85 52.79 4.83 3.89 53.24 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR A 87 TYR~? 13.92 CL CL A 226 A 317 GLU B 84 GLU~? 12.79 CL CL A 226 A 365 ARG A 81 ARG~? 19.72 CL CL B 226 coo 1.77 6.56 57.05 3.05 7.44 59.37 36.79 3.26 19.70 35.19 2.19 21.67 coo 3.06 2.85 52.79 4.83 3.89 53.24 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 3.82 17.09 49.56 4.09 14.32 50.84 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR B 87 TYR~? 13.52 CL CL B 226 A 317 GLU A 84 GLU~? 12.94 CL CL B 226 A 365 ARG B 13 ARG~? 5.25 CL CL B 226 coo 1.77 6.56 57.05 3.05 7.44 59.37 40.26 2.88 20.56 41.63 1.41 18.60 coo 3.06 2.85 52.79 4.83 3.89 53.24 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 51.04 -6.15 23.43 50.81 -3.67 25.23 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR B 87 TYR~? 13.52 CL CL B 226 A 317 GLU A 84 GLU~? 12.94 CL CL B 226 A 365 ARG B 81 ARG~? 19.82 CL CL A 226 coo 1.77 6.56 57.05 3.05 7.44 59.37 40.26 2.88 20.56 41.63 1.41 18.60 coo 3.06 2.85 52.79 4.83 3.89 53.24 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR B 87 TYR~? 13.52 CL CL B 226 A 317 GLU B 84 GLU~? 12.79 CL CL A 226 A 365 ARG A 81 ARG~? 19.72 CL CL B 226 coo 1.77 6.56 57.05 3.05 7.44 59.37 40.26 2.88 20.56 41.63 1.41 18.60 coo 3.06 2.85 52.79 4.83 3.89 53.24 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 3.82 17.09 49.56 4.09 14.32 50.84 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1vzx_c02 2.04.01.0087 user 7 3 # 7 A 314 TYR B 87 TYR~? 13.52 CL CL B 226 A 317 GLU B 84 GLU~? 12.79 CL CL A 226 A 365 ARG B 13 ARG~? 5.25 CL CL B 226 coo 1.77 6.56 57.05 3.05 7.44 59.37 40.26 2.88 20.56 41.63 1.41 18.60 coo 3.06 2.85 52.79 4.83 3.89 53.24 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 3.82 17.09 49.56 4.09 14.32 50.84 51.04 -6.15 23.43 50.81 -3.67 25.23 1vzx_c02 source 1vzx 2.04.01.0087 : 7 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 87 TYR~? 13.92 CL CL A 226 B1317 GLU A 84 GLU~? 12.94 CL CL B 226 B1365 ARG A 13 ARG~? 5.03 CL CL A 226 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 36.79 3.26 19.70 35.19 2.19 21.67 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 24.18 -3.56 18.28 25.11 -1.28 16.40 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 87 TYR~? 13.92 CL CL A 226 B1317 GLU A 84 GLU~? 12.94 CL CL B 226 B1365 ARG B 81 ARG~? 19.82 CL CL A 226 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 36.79 3.26 19.70 35.19 2.19 21.67 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR A 87 TYR~? 13.92 CL CL A 226 B1317 GLU B 84 GLU~? 12.79 CL CL A 226 B1365 ARG A 81 ARG~? 19.72 CL CL B 226 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 36.79 3.26 19.70 35.19 2.19 21.67 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR B 87 TYR~? 13.52 CL CL B 226 B1317 GLU A 84 GLU~? 12.94 CL CL B 226 B1365 ARG B 13 ARG~? 5.25 CL CL B 226 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 40.26 2.88 20.56 41.63 1.41 18.60 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 51.04 -6.15 23.43 50.81 -3.67 25.23 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR B 87 TYR~? 13.52 CL CL B 226 B1317 GLU A 84 GLU~? 12.94 CL CL B 226 B1365 ARG B 81 ARG~? 19.82 CL CL A 226 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 40.26 2.88 20.56 41.63 1.41 18.60 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 35.26 -4.61 30.73 33.33 -6.15 32.58 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR B 87 TYR~? 13.52 CL CL B 226 B1317 GLU B 84 GLU~? 12.79 CL CL A 226 B1365 ARG A 81 ARG~? 19.72 CL CL B 226 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 40.26 2.88 20.56 41.63 1.41 18.60 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 40.18 -5.93 10.28 41.49 -8.31 8.89 ULMN 3 1vzx_c03 2.04.01.0087 user 7 3 # 7 B1314 TYR B 87 TYR~? 13.52 CL CL B 226 B1317 GLU B 84 GLU~? 12.79 CL CL A 226 B1365 ARG B 13 ARG~? 5.25 CL CL B 226 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 40.26 2.88 20.56 41.63 1.41 18.60 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 51.04 -6.15 23.43 50.81 -3.67 25.23 ULMN 3 1vzx_c03 2.04.01.0087 user 8 3 # 8 B1314 TYR B 160 TYR~? 15.61 CL CL B 226 B1317 GLU B 157 GLU~? 23.31 CL CL B 226 B1365 ARG B 13 ARG~? 5.25 CL CL B 226 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 51.04 -6.15 23.43 50.81 -3.67 25.23 1vzx_c03 source 1vzx 2.04.01.0087 : 8 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 38 TYR.? 10.54 CL CL A 226 A 40 ASP A 43 ASP.? 11.79 CL CL A 226 A 103 LEU A 37 LEU^? 9.80 CL CL A 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 17.27 -3.90 25.00 15.42 -2.03 25.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.90 -6.76 20.72 23.88 -7.62 21.01 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 46 TYR^? 12.99 CL CL A 226 A 40 ASP A 43 ASP.? 11.79 CL CL A 226 A 103 LEU A 37 LEU^? 9.80 CL CL A 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 7.55 25.51 14.34 9.65 25.73 14.24 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.90 -6.76 20.72 23.88 -7.62 21.01 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 121 TYR.? 28.41 CL CL A 226 A 40 ASP A 193 ASP~? 30.50 CL CL A 226 A 103 LEU A 118 LEU~? 25.85 CL CL A 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 7.55 25.51 14.34 9.65 25.73 14.24 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 11.83 18.73 16.99 10.99 19.71 15.26 22.61 -7.03 -6.79 22.70 -6.57 -4.65 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR A 160 TYR~? 15.52 CL CL A 226 A 40 ASP A 43 ASP.? 11.79 CL CL A 226 A 103 LEU A 177 LEU~? 13.61 CL CL A 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 7.55 25.51 14.34 9.65 25.73 14.24 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.89 -3.14 5.96 23.23 -4.67 6.76 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR A 194 TYR~? 29.78 CL CL A 226 A 40 ASP A 186 ASP.? 30.68 CL CL A 226 A 103 LEU A 118 LEU~? 25.85 CL CL A 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 7.55 25.51 14.34 9.65 25.73 14.24 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 11.83 18.73 16.99 10.99 19.71 15.26 22.61 -7.03 -6.79 22.70 -6.57 -4.65 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR A 194 TYR~? 29.78 CL CL A 226 A 40 ASP A 186 ASP.? 30.68 CL CL A 226 A 103 LEU A 197 LEU~? 24.34 CL CL A 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 7.55 25.51 14.34 9.65 25.73 14.24 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 11.83 18.73 16.99 10.99 19.71 15.26 16.90 -3.56 -5.39 18.37 -4.08 -3.85 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR A 209 TYR~? 20.76 CL CL A 226 A 40 ASP A 203 ASP~? 25.03 CL CL A 226 A 103 LEU A 211 LEU.? 25.23 CL CL A 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 27.49 9.87 -0.64 29.01 7.64 0.00 coo 7.55 25.51 14.34 9.65 25.73 14.24 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 11.83 18.73 16.99 10.99 19.71 15.26 24.28 13.19 -4.47 25.75 11.46 -4.53 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR B 38 TYR.? 11.29 CL CL B 226 A 40 ASP B 43 ASP.? 11.93 CL CL B 226 A 103 LEU B 37 LEU^? 10.28 CL CL B 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 58.26 -9.06 16.81 60.90 -8.31 16.35 coo 7.55 25.51 14.34 9.65 25.73 14.24 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 11.83 18.73 16.99 10.99 19.71 15.26 52.97 -10.13 21.12 51.34 -11.38 20.62 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR B 46 TYR^? 12.90 CL CL B 226 A 40 ASP B 43 ASP.? 11.93 CL CL B 226 A 103 LEU B 37 LEU^? 10.28 CL CL B 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 7.55 25.51 14.34 9.65 25.73 14.24 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 11.83 18.73 16.99 10.99 19.71 15.26 52.97 -10.13 21.12 51.34 -11.38 20.62 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR B 116 TYR~? 34.40 CL CL B 226 A 40 ASP B 111 ASP~? 25.68 CL CL B 226 A 103 LEU B 118 LEU~? 26.00 CL CL B 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 45.41 -5.95 53.84 44.74 -7.73 55.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 11.83 18.73 16.99 10.99 19.71 15.26 51.19 -7.22 48.32 51.33 -7.18 46.14 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR B 121 TYR~? 28.97 CL CL B 226 A 40 ASP B 193 ASP~? 31.47 CL CL B 226 A 103 LEU B 118 LEU~? 26.00 CL CL B 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 51.39 -13.47 48.53 51.35 -15.45 46.59 coo 7.55 25.51 14.34 9.65 25.73 14.24 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 11.83 18.73 16.99 10.99 19.71 15.26 51.19 -7.22 48.32 51.33 -7.18 46.14 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR B 160 TYR~? 15.61 CL CL B 226 A 40 ASP B 43 ASP.? 11.93 CL CL B 226 A 103 LEU B 177 LEU~? 14.04 CL CL B 226 coo 12.09 16.13 10.57 11.28 18.80 10.73 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 7.55 25.51 14.34 9.65 25.73 14.24 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 11.83 18.73 16.99 10.99 19.71 15.26 53.33 -5.23 35.37 51.75 -6.67 34.92 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 12 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 38 TYR.? 10.54 CL CL A 226 B 40 ASP A 43 ASP.? 11.79 CL CL A 226 B 103 LEU A 37 LEU^? 9.80 CL CL A 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 17.27 -3.90 25.00 15.42 -2.03 25.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.90 -6.76 20.72 23.88 -7.62 21.01 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 46 TYR^? 12.99 CL CL A 226 B 40 ASP A 43 ASP.? 11.79 CL CL A 226 B 103 LEU A 37 LEU^? 9.80 CL CL A 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 9.39 10.77 34.53 11.50 10.63 34.41 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.90 -6.76 20.72 23.88 -7.62 21.01 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 121 TYR.? 28.41 CL CL A 226 B 40 ASP A 193 ASP~? 30.50 CL CL A 226 B 103 LEU A 118 LEU~? 25.85 CL CL A 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 9.39 10.77 34.53 11.50 10.63 34.41 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 12.89 17.60 31.13 12.34 16.51 32.90 22.61 -7.03 -6.79 22.70 -6.57 -4.65 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR A 160 TYR~? 15.52 CL CL A 226 B 40 ASP A 43 ASP.? 11.79 CL CL A 226 B 103 LEU A 177 LEU~? 13.61 CL CL A 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 9.39 10.77 34.53 11.50 10.63 34.41 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.89 -3.14 5.96 23.23 -4.67 6.76 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR A 194 TYR~? 29.78 CL CL A 226 B 40 ASP A 186 ASP.? 30.68 CL CL A 226 B 103 LEU A 118 LEU~? 25.85 CL CL A 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo 9.39 10.77 34.53 11.50 10.63 34.41 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo 12.89 17.60 31.13 12.34 16.51 32.90 22.61 -7.03 -6.79 22.70 -6.57 -4.65 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR A 209 TYR~? 20.76 CL CL A 226 B 40 ASP A 203 ASP~? 25.03 CL CL A 226 B 103 LEU A 211 LEU.? 25.23 CL CL A 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 27.49 9.87 -0.64 29.01 7.64 0.00 coo 9.39 10.77 34.53 11.50 10.63 34.41 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 12.89 17.60 31.13 12.34 16.51 32.90 24.28 13.19 -4.47 25.75 11.46 -4.53 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR B 38 TYR.? 11.29 CL CL B 226 B 40 ASP B 43 ASP.? 11.93 CL CL B 226 B 103 LEU B 37 LEU^? 10.28 CL CL B 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 58.26 -9.06 16.81 60.90 -8.31 16.35 coo 9.39 10.77 34.53 11.50 10.63 34.41 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 12.89 17.60 31.13 12.34 16.51 32.90 52.97 -10.13 21.12 51.34 -11.38 20.62 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR B 46 TYR^? 12.90 CL CL B 226 B 40 ASP B 43 ASP.? 11.93 CL CL B 226 B 103 LEU B 37 LEU^? 10.28 CL CL B 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 9.39 10.77 34.53 11.50 10.63 34.41 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 12.89 17.60 31.13 12.34 16.51 32.90 52.97 -10.13 21.12 51.34 -11.38 20.62 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR B 116 TYR~? 34.40 CL CL B 226 B 40 ASP B 111 ASP~? 25.68 CL CL B 226 B 103 LEU B 118 LEU~? 26.00 CL CL B 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 45.41 -5.95 53.84 44.74 -7.73 55.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 12.89 17.60 31.13 12.34 16.51 32.90 51.19 -7.22 48.32 51.33 -7.18 46.14 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR B 121 TYR~? 28.97 CL CL B 226 B 40 ASP B 193 ASP~? 31.47 CL CL B 226 B 103 LEU B 118 LEU~? 26.00 CL CL B 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 51.39 -13.47 48.53 51.35 -15.45 46.59 coo 9.39 10.77 34.53 11.50 10.63 34.41 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 12.89 17.60 31.13 12.34 16.51 32.90 51.19 -7.22 48.32 51.33 -7.18 46.14 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR B 160 TYR~? 15.61 CL CL B 226 B 40 ASP B 43 ASP.? 11.93 CL CL B 226 B 103 LEU B 177 LEU~? 14.04 CL CL B 226 coo 14.25 20.09 37.35 13.48 17.40 37.38 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 9.39 10.77 34.53 11.50 10.63 34.41 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 12.89 17.60 31.13 12.34 16.51 32.90 53.33 -5.23 35.37 51.75 -6.67 34.92 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 11 hits 1vzz_c01 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 22 THR~? 22.52 CL CL A 226 A 345 PHE A 35 PHE^? 16.62 CL CL A 226 A 352 CYH A 33 CYH^? 23.80 CL CL A 226 coo 9.58 21.79 21.50 11.25 23.03 20.90 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 19.40 19.75 18.58 17.39 17.81 18.80 21.81 -14.26 20.74 24.44 -14.15 19.85 coo 21.57 22.52 22.79 19.20 21.13 23.26 21.65 -20.96 19.40 23.47 -21.29 21.43 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR A 22 THR~? 22.52 CL CL A 226 A 345 PHE A 35 PHE^? 16.62 CL CL A 226 A 352 CYH A 34 CYH^? 20.26 CL CL A 226 coo 9.58 21.79 21.50 11.25 23.03 20.90 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 19.40 19.75 18.58 17.39 17.81 18.80 21.81 -14.26 20.74 24.44 -14.15 19.85 coo 21.57 22.52 22.79 19.20 21.13 23.26 19.64 -17.85 18.93 17.88 -17.43 16.93 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 3 3 # 3 A 243 THR B 22 THR~? 22.16 CL CL B 226 A 345 PHE B 35 PHE^? 16.36 CL CL B 226 A 352 CYH B 33 CYH^? 24.15 CL CL B 226 coo 9.58 21.79 21.50 11.25 23.03 20.90 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 19.40 19.75 18.58 17.39 17.81 18.80 51.45 -17.11 21.55 48.96 -16.17 22.31 coo 21.57 22.52 22.79 19.20 21.13 23.26 50.19 -23.62 22.85 47.96 -24.10 21.26 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 3 hits 1xqd_c02 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA B 14 ALA~? 12.02 CL CL B 226 B 126 ARG B 13 ARG~? 5.25 CL CL B 226 B 138 GLU A 84 GLU~? 12.94 CL CL B 226 coo 2.11 4.00 19.31 3.14 4.86 19.99 44.33 -7.28 23.33 43.44 -6.30 24.13 coo 2.45 5.53 11.28 3.59 7.56 13.29 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 6.10 2.00 25.24 6.12 1.84 23.13 40.51 -2.33 16.64 42.51 -2.90 16.44 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA B 14 ALA~? 12.02 CL CL B 226 C 126 ARG B 13 ARG~? 5.25 CL CL B 226 C 138 GLU A 84 GLU~? 12.94 CL CL B 226 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 44.33 -7.28 23.33 43.44 -6.30 24.13 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 51.04 -6.15 23.43 50.81 -3.67 25.23 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 40.51 -2.33 16.64 42.51 -2.90 16.44 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA B 14 ALA~? 12.02 CL CL B 226 D 126 ARG B 13 ARG~? 5.25 CL CL B 226 D 138 GLU A 84 GLU~? 12.94 CL CL B 226 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 44.33 -7.28 23.33 43.44 -6.30 24.13 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 6.23 0.50 57.10 5.93 0.72 59.19 40.51 -2.33 16.64 42.51 -2.90 16.44 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA B 14 ALA~? 12.02 CL CL B 226 E 126 ARG B 13 ARG~? 5.25 CL CL B 226 E 138 GLU A 84 GLU~? 12.94 CL CL B 226 coo -4.56 10.03 62.36 -4.38 11.31 61.55 44.33 -7.28 23.33 43.44 -6.30 24.13 coo -3.02 12.00 70.07 -1.94 13.84 67.82 51.04 -6.15 23.43 50.81 -3.67 25.23 coo -8.67 12.22 56.54 -8.68 12.09 58.65 40.51 -2.33 16.64 42.51 -2.90 16.44 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA B 14 ALA~? 12.02 CL CL B 226 F 126 ARG B 13 ARG~? 5.25 CL CL B 226 F 138 GLU A 84 GLU~? 12.94 CL CL B 226 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 44.33 -7.28 23.33 43.44 -6.30 24.13 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 51.04 -6.15 23.43 50.81 -3.67 25.23 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 40.51 -2.33 16.64 42.51 -2.90 16.44 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 15 GLY~? 13.48 CL CL A 226 B 175 ARG A 13 ARG~? 5.03 CL CL A 226 B 242 TYR A 46 TYR^? 12.99 CL CL A 226 coo 99.45 58.28 3.33 99.57 58.61 4.10 32.14 -6.39 21.42 31.45 -6.64 21.14 coo 106.37 63.53 0.89 108.02 63.40 -1.62 24.18 -3.56 18.28 25.11 -1.28 16.40 coo 100.93 69.04 4.38 99.52 68.48 2.09 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY B 15 GLY~? 13.31 CL CL B 226 B 175 ARG B 13 ARG~? 5.25 CL CL B 226 B 242 TYR B 46 TYR^? 12.90 CL CL B 226 coo 99.45 58.28 3.33 99.57 58.61 4.10 42.83 -7.72 19.85 43.46 -8.04 20.13 coo 106.37 63.53 0.89 108.02 63.40 -1.62 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 100.93 69.04 4.38 99.52 68.48 2.09 50.79 -14.19 25.59 51.15 -11.43 25.53 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 165 GLY.? 9.33 CL CL B 226 B 175 ARG B 13 ARG~? 5.25 CL CL B 226 B 242 TYR B 46 TYR^? 12.90 CL CL B 226 coo 99.45 58.28 3.33 99.57 58.61 4.10 45.52 -2.50 25.89 46.23 -2.42 26.22 coo 106.37 63.53 0.89 108.02 63.40 -1.62 51.04 -6.15 23.43 50.81 -3.67 25.23 coo 100.93 69.04 4.38 99.52 68.48 2.09 50.79 -14.19 25.59 51.15 -11.43 25.53 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 3 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 72 SER.? 25.76 CL CL A 226 A 178 TYR A 21 TYR~? 21.90 CL CL A 226 A 182 LYS A 52 LYS^? 28.69 CL CL A 226 coo 81.46 10.53 21.66 82.20 10.82 19.39 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 87.67 8.69 17.10 86.62 10.83 18.52 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 85.30 6.17 22.83 87.26 11.02 23.50 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER A 207 SER~? 18.13 CL CL A 226 A 178 TYR A 208 TYR~? 15.64 CL CL A 226 A 182 LYS A 205 LYS~? 25.48 CL CL A 226 coo 81.46 10.53 21.66 82.20 10.82 19.39 20.60 11.23 0.64 19.47 10.75 2.68 coo 87.67 8.69 17.10 86.62 10.83 18.52 25.22 8.01 3.41 27.20 7.60 5.36 coo 85.30 6.17 22.83 87.26 11.02 23.50 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 A 164 SER A 207 SER~? 18.13 CL CL A 226 A 178 TYR A 209 TYR~? 20.76 CL CL A 226 A 182 LYS A 205 LYS~? 25.48 CL CL A 226 coo 81.46 10.53 21.66 82.20 10.82 19.39 20.60 11.23 0.64 19.47 10.75 2.68 coo 87.67 8.69 17.10 86.62 10.83 18.52 27.49 9.87 -0.64 29.01 7.64 0.00 coo 85.30 6.17 22.83 87.26 11.02 23.50 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 3 # 4 A 164 SER B 72 SER.? 25.86 CL CL B 226 A 178 TYR B 21 TYR~? 21.81 CL CL B 226 A 182 LYS B 52 LYS^? 28.59 CL CL B 226 coo 81.46 10.53 21.66 82.20 10.82 19.39 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 87.67 8.69 17.10 86.62 10.83 18.52 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 85.30 6.17 22.83 87.26 11.02 23.50 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 3 # 5 A 164 SER B 207 SER~? 19.03 CL CL B 226 A 178 TYR B 208 TYR~? 15.74 CL CL B 226 A 182 LYS B 205 LYS~? 25.67 CL CL B 226 coo 81.46 10.53 21.66 82.20 10.82 19.39 57.60 9.31 39.27 58.73 7.29 38.76 coo 87.67 8.69 17.10 86.62 10.83 18.52 52.42 6.76 36.83 50.45 6.61 34.90 coo 85.30 6.17 22.83 87.26 11.02 23.50 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 3 # 6 A 164 SER B 207 SER~? 19.03 CL CL B 226 A 178 TYR B 209 TYR~? 20.47 CL CL B 226 A 182 LYS B 205 LYS~? 25.67 CL CL B 226 coo 81.46 10.53 21.66 82.20 10.82 19.39 57.60 9.31 39.27 58.73 7.29 38.76 coo 87.67 8.69 17.10 86.62 10.83 18.52 50.38 9.38 40.26 48.54 7.35 39.73 coo 85.30 6.17 22.83 87.26 11.02 23.50 54.11 5.83 42.26 49.56 6.08 46.56 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 6 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 72 SER.? 25.76 CL CL A 226 B 178 TYR A 21 TYR~? 21.90 CL CL A 226 B 182 LYS A 52 LYS^? 28.69 CL CL A 226 coo 61.22 3.61 34.51 60.46 1.86 35.98 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 54.99 -1.20 35.40 56.04 1.15 36.44 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 57.40 2.23 30.19 55.43 5.44 33.87 30.09 -20.25 13.69 32.70 -23.31 10.81 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER A 207 SER~? 18.13 CL CL A 226 B 178 TYR A 208 TYR~? 15.64 CL CL A 226 B 182 LYS A 205 LYS~? 25.48 CL CL A 226 coo 61.22 3.61 34.51 60.46 1.86 35.98 20.60 11.23 0.64 19.47 10.75 2.68 coo 54.99 -1.20 35.40 56.04 1.15 36.44 25.22 8.01 3.41 27.20 7.60 5.36 coo 57.40 2.23 30.19 55.43 5.44 33.87 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 B 164 SER A 207 SER~? 18.13 CL CL A 226 B 178 TYR A 209 TYR~? 20.76 CL CL A 226 B 182 LYS A 205 LYS~? 25.48 CL CL A 226 coo 61.22 3.61 34.51 60.46 1.86 35.98 20.60 11.23 0.64 19.47 10.75 2.68 coo 54.99 -1.20 35.40 56.04 1.15 36.44 27.49 9.87 -0.64 29.01 7.64 0.00 coo 57.40 2.23 30.19 55.43 5.44 33.87 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 3 # 4 B 164 SER B 72 SER.? 25.86 CL CL B 226 B 178 TYR B 21 TYR~? 21.81 CL CL B 226 B 182 LYS B 52 LYS^? 28.59 CL CL B 226 coo 61.22 3.61 34.51 60.46 1.86 35.98 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 54.99 -1.20 35.40 56.04 1.15 36.44 41.23 -17.00 23.95 39.78 -18.41 25.81 coo 57.40 2.23 30.19 55.43 5.44 33.87 42.32 -20.73 28.98 39.02 -22.55 33.10 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 3 # 5 B 164 SER B 207 SER~? 19.03 CL CL B 226 B 178 TYR B 208 TYR~? 15.74 CL CL B 226 B 182 LYS B 205 LYS~? 25.67 CL CL B 226 coo 61.22 3.61 34.51 60.46 1.86 35.98 57.60 9.31 39.27 58.73 7.29 38.76 coo 54.99 -1.20 35.40 56.04 1.15 36.44 52.42 6.76 36.83 50.45 6.61 34.90 coo 57.40 2.23 30.19 55.43 5.44 33.87 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 3 # 6 B 164 SER B 207 SER~? 19.03 CL CL B 226 B 178 TYR B 209 TYR~? 20.47 CL CL B 226 B 182 LYS B 205 LYS~? 25.67 CL CL B 226 coo 61.22 3.61 34.51 60.46 1.86 35.98 57.60 9.31 39.27 58.73 7.29 38.76 coo 54.99 -1.20 35.40 56.04 1.15 36.44 50.38 9.38 40.26 48.54 7.35 39.73 coo 57.40 2.23 30.19 55.43 5.44 33.87 54.11 5.83 42.26 49.56 6.08 46.56 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 6 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 195 LYS~? 35.76 CL CL A 226 A 74 LYS A 200 LYS~? 23.56 CL CL A 226 A 165 GLU A 182 GLU~? 21.95 CL CL A 226 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 22.22 16.06 48.76 23.94 15.33 49.78 13.02 -8.29 1.26 11.61 -6.76 1.56 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 200 LYS~? 23.56 CL CL A 226 A 74 LYS A 195 LYS~? 35.76 CL CL A 226 A 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo 18.28 7.83 36.39 22.82 8.75 39.52 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 31.64 -0.95 -10.58 32.34 0.04 -12.34 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 200 LYS~? 23.56 CL CL A 226 A 74 LYS A 205 LYS~? 25.48 CL CL A 226 A 165 GLU A 112 GLU~? 32.50 CL CL A 226 coo 18.28 7.83 36.39 22.82 8.75 39.52 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 14.16 13.09 37.03 20.00 12.44 37.49 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 22.22 16.06 48.76 23.94 15.33 49.78 31.64 -0.95 -10.58 32.34 0.04 -12.34 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 200 LYS~? 24.54 CL CL B 226 A 74 LYS B 195 LYS~? 36.01 CL CL B 226 A 165 GLU B 187 GLU.? 29.51 CL CL B 226 coo 18.28 7.83 36.39 22.82 8.75 39.52 60.00 0.23 45.11 63.70 -4.80 44.31 coo 14.16 13.09 37.03 20.00 12.44 37.49 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 22.22 16.06 48.76 23.94 15.33 49.78 61.43 -15.09 46.94 62.69 -13.43 47.32 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS B 200 LYS~? 24.54 CL CL B 226 B 74 LYS B 195 LYS~? 36.01 CL CL B 226 B 165 GLU B 187 GLU.? 29.51 CL CL B 226 coo 13.51 0.92 76.10 12.98 6.13 74.68 60.00 0.23 45.11 63.70 -4.80 44.31 coo 19.89 -0.55 76.51 17.10 4.32 77.43 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 21.39 11.56 68.52 20.24 13.13 67.73 61.43 -15.09 46.94 62.69 -13.43 47.32 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 203 ASP~? 25.03 CL CL A 226 A 371 LYS A 205 LYS~? 25.48 CL CL A 226 A 374 ASN A 202 ASN~? 26.54 CL CL A 226 coo -5.17 31.09 15.73 -7.07 31.12 16.73 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -4.43 30.92 22.89 -6.61 31.91 19.71 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -4.84 27.04 20.49 -6.40 27.76 19.26 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 203 ASP~? 25.12 CL CL B 226 A 371 LYS B 205 LYS~? 25.67 CL CL B 226 A 374 ASN B 202 ASN~? 26.89 CL CL B 226 coo -5.17 31.09 15.73 -7.07 31.12 16.73 60.54 4.31 43.90 62.00 4.57 45.37 coo -4.43 30.92 22.89 -6.61 31.91 19.71 54.11 5.83 42.26 49.56 6.08 46.56 coo -4.84 27.04 20.49 -6.40 27.76 19.26 56.47 4.11 47.59 54.90 3.31 48.75 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c03 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 72 SER.? 25.76 CL CL A 226 327 GLU A 77 GLU~? 21.84 CL CL B 226 440 HIS A 75 HIS.? 25.41 CL CL B 226 coo 6.96 64.04 57.84 6.74 63.69 60.26 34.13 -18.66 12.80 35.17 -18.58 10.66 coo 14.82 64.63 62.37 13.47 65.72 61.17 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 9.52 66.51 63.07 8.75 65.02 61.81 38.68 -16.70 9.61 40.32 -17.29 8.43 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 72 SER.? 25.86 CL CL B 226 327 GLU B 77 GLU~? 22.22 CL CL A 226 440 HIS B 75 HIS.? 25.67 CL CL A 226 coo 6.96 64.04 57.84 6.74 63.69 60.26 38.31 -18.13 29.75 37.15 -17.87 31.87 coo 14.82 64.63 62.37 13.47 65.72 61.17 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 9.52 66.51 63.07 8.75 65.02 61.81 34.50 -15.17 32.63 32.86 -15.45 33.92 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 2 hits 2ace_c00 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP A 43 ASP.? 11.79 CL CL A 226 A 48 HIS A 56 HIS^? 18.87 CL CL A 226 A 77 LYS A 36 LYS^? 12.38 CL CL A 226 coo 13.04 30.41 72.50 12.95 30.65 70.36 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 12.77 23.50 68.33 13.58 25.42 68.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 7.53 29.84 65.06 12.29 29.41 67.79 19.01 -10.55 19.77 15.11 -7.69 20.09 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP A 43 ASP.? 11.79 CL CL A 226 A 48 HIS A 56 HIS^? 18.87 CL CL A 226 A 77 LYS A 60 LYS.? 19.24 CL CL A 226 coo 13.04 30.41 72.50 12.95 30.65 70.36 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 12.77 23.50 68.33 13.58 25.42 68.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 7.53 29.84 65.06 12.29 29.41 67.79 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 3 3 # 3 A 43 ASP A 43 ASP.? 11.79 CL CL A 226 A 48 HIS A 56 HIS^? 18.87 CL CL A 226 A 77 LYS A 178 LYS~? 16.45 CL CL A 226 coo 13.04 30.41 72.50 12.95 30.65 70.36 16.13 -5.04 13.46 14.39 -5.59 14.60 coo 12.77 23.50 68.33 13.58 25.42 68.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 7.53 29.84 65.06 12.29 29.41 67.79 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 4 3 # 4 A 43 ASP B 43 ASP.? 11.93 CL CL B 226 A 48 HIS B 56 HIS^? 18.72 CL CL B 226 A 77 LYS B 36 LYS^? 15.37 CL CL B 226 coo 13.04 30.41 72.50 12.95 30.65 70.36 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 12.77 23.50 68.33 13.58 25.42 68.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 7.53 29.84 65.06 12.29 29.41 67.79 55.08 -14.30 22.43 60.90 -14.25 24.08 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 5 3 # 5 A 43 ASP B 43 ASP.? 11.93 CL CL B 226 A 48 HIS B 56 HIS^? 18.72 CL CL B 226 A 77 LYS B 60 LYS.? 20.89 CL CL B 226 coo 13.04 30.41 72.50 12.95 30.65 70.36 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 12.77 23.50 68.33 13.58 25.42 68.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 7.53 29.84 65.06 12.29 29.41 67.79 65.19 -13.54 33.83 65.46 -10.39 36.65 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 6 3 # 6 A 43 ASP B 43 ASP.? 11.93 CL CL B 226 A 48 HIS B 56 HIS^? 18.72 CL CL B 226 A 77 LYS B 178 LYS~? 16.76 CL CL B 226 coo 13.04 30.41 72.50 12.95 30.65 70.36 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 12.77 23.50 68.33 13.58 25.42 68.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 7.53 29.84 65.06 12.29 29.41 67.79 57.30 -6.98 36.80 62.98 -8.03 34.22 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 6 hits 2acu_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 56 HIS^? 18.87 CL CL A 226 B 50 GLU A 157 GLU~? 23.07 CL CL A 226 B 113 GLN A 185 GLN~? 22.98 CL CL A 226 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 15.83 -13.17 2.06 17.40 -14.13 3.16 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 56 HIS^? 18.72 CL CL B 226 B 50 GLU B 69 GLU^? 24.72 CL CL B 226 B 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 51.36 -17.48 40.20 49.73 -18.74 40.71 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS B 56 HIS^? 18.72 CL CL B 226 B 50 GLU B 157 GLU~? 23.31 CL CL B 226 B 113 GLN B 185 GLN~? 23.32 CL CL B 226 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 57.03 -15.62 39.97 55.27 -16.55 39.25 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS B 56 HIS^? 18.72 CL CL B 226 B 50 GLU B 182 GLU~? 22.76 CL CL B 226 B 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 51.36 -17.48 40.20 49.73 -18.74 40.71 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 56 HIS^? 18.87 CL CL A 226 B 50 GLU A 157 GLU~? 23.07 CL CL A 226 B 113 GLN A 185 GLN~? 22.98 CL CL A 226 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 15.83 -13.17 2.06 17.40 -14.13 3.16 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 56 HIS^? 18.72 CL CL B 226 B 50 GLU B 69 GLU^? 24.72 CL CL B 226 B 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 51.36 -17.48 40.20 49.73 -18.74 40.71 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS B 56 HIS^? 18.72 CL CL B 226 B 50 GLU B 157 GLU~? 23.31 CL CL B 226 B 113 GLN B 185 GLN~? 23.32 CL CL B 226 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 57.03 -15.62 39.97 55.27 -16.55 39.25 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS B 56 HIS^? 18.72 CL CL B 226 B 50 GLU B 182 GLU~? 22.76 CL CL B 226 B 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 51.36 -17.48 40.20 49.73 -18.74 40.71 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 56 HIS^? 18.87 CL CL A 226 A 50 GLU A 157 GLU~? 23.07 CL CL A 226 A 113 GLN A 185 GLN~? 22.98 CL CL A 226 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 15.83 -13.17 2.06 17.40 -14.13 3.16 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS B 56 HIS^? 18.72 CL CL B 226 A 50 GLU B 69 GLU^? 24.72 CL CL B 226 A 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 51.36 -17.48 40.20 49.73 -18.74 40.71 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS B 56 HIS^? 18.72 CL CL B 226 A 50 GLU B 157 GLU~? 23.31 CL CL B 226 A 113 GLN B 185 GLN~? 23.32 CL CL B 226 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 57.03 -15.62 39.97 55.27 -16.55 39.25 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS B 56 HIS^? 18.72 CL CL B 226 A 50 GLU B 182 GLU~? 22.76 CL CL B 226 A 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 51.36 -17.48 40.20 49.73 -18.74 40.71 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 56 HIS^? 18.87 CL CL A 226 C 50 GLU A 157 GLU~? 23.07 CL CL A 226 C 113 GLN A 185 GLN~? 22.98 CL CL A 226 coo 74.92 8.52 28.42 74.88 6.86 29.70 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 65.25 15.95 28.73 65.73 15.63 30.78 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 70.80 6.73 32.72 71.88 8.55 32.53 15.83 -13.17 2.06 17.40 -14.13 3.16 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS B 56 HIS^? 18.72 CL CL B 226 C 50 GLU B 69 GLU^? 24.72 CL CL B 226 C 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 74.92 8.52 28.42 74.88 6.86 29.70 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 65.25 15.95 28.73 65.73 15.63 30.78 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 70.80 6.73 32.72 71.88 8.55 32.53 51.36 -17.48 40.20 49.73 -18.74 40.71 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS B 56 HIS^? 18.72 CL CL B 226 C 50 GLU B 157 GLU~? 23.31 CL CL B 226 C 113 GLN B 185 GLN~? 23.32 CL CL B 226 coo 74.92 8.52 28.42 74.88 6.86 29.70 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 65.25 15.95 28.73 65.73 15.63 30.78 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 70.80 6.73 32.72 71.88 8.55 32.53 57.03 -15.62 39.97 55.27 -16.55 39.25 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS B 56 HIS^? 18.72 CL CL B 226 C 50 GLU B 182 GLU~? 22.76 CL CL B 226 C 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 74.92 8.52 28.42 74.88 6.86 29.70 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 65.25 15.95 28.73 65.73 15.63 30.78 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 70.80 6.73 32.72 71.88 8.55 32.53 51.36 -17.48 40.20 49.73 -18.74 40.71 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 56 HIS^? 18.87 CL CL A 226 D 50 GLU A 157 GLU~? 23.07 CL CL A 226 D 113 GLN A 185 GLN~? 22.98 CL CL A 226 coo 38.66 11.31 27.15 38.67 12.13 25.22 18.56 -13.44 9.47 17.41 -14.68 10.72 coo 48.72 12.85 33.83 48.36 14.77 32.95 28.68 -12.57 4.41 29.48 -14.51 4.41 coo 42.85 14.77 24.15 41.85 15.11 26.02 15.83 -13.17 2.06 17.40 -14.13 3.16 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS B 56 HIS^? 18.72 CL CL B 226 D 50 GLU B 69 GLU^? 24.72 CL CL B 226 D 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 38.66 11.31 27.15 38.67 12.13 25.22 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 48.72 12.85 33.83 48.36 14.77 32.95 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 42.85 14.77 24.15 41.85 15.11 26.02 51.36 -17.48 40.20 49.73 -18.74 40.71 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS B 56 HIS^? 18.72 CL CL B 226 D 50 GLU B 157 GLU~? 23.31 CL CL B 226 D 113 GLN B 185 GLN~? 23.32 CL CL B 226 coo 38.66 11.31 27.15 38.67 12.13 25.22 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 48.72 12.85 33.83 48.36 14.77 32.95 44.83 -13.19 37.20 43.40 -14.70 37.59 coo 42.85 14.77 24.15 41.85 15.11 26.02 57.03 -15.62 39.97 55.27 -16.55 39.25 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS B 56 HIS^? 18.72 CL CL B 226 D 50 GLU B 182 GLU~? 22.76 CL CL B 226 D 113 GLN B 66 GLN.? 26.19 CL CL B 226 coo 38.66 11.31 27.15 38.67 12.13 25.22 54.92 -15.50 33.10 56.24 -16.81 32.13 coo 48.72 12.85 33.83 48.36 14.77 32.95 60.53 -11.37 41.12 62.33 -10.24 41.06 coo 42.85 14.77 24.15 41.85 15.11 26.02 51.36 -17.48 40.20 49.73 -18.74 40.71 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 186 ASP.? 30.73 CL CL B 226 219 GLU B 187 GLU.? 29.51 CL CL B 226 294 ASP B 193 ASP~? 31.47 CL CL B 226 coo 27.89 102.52 14.98 29.35 101.92 13.57 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 25.84 105.87 9.06 27.86 105.55 8.74 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 33.16 106.80 7.72 33.34 104.87 6.92 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 193 ASP~? 31.47 CL CL B 226 219 GLU B 187 GLU.? 29.51 CL CL B 226 294 ASP B 186 ASP.? 30.73 CL CL B 226 coo 27.89 102.52 14.98 29.35 101.92 13.57 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 25.84 105.87 9.06 27.86 105.55 8.74 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 33.16 106.80 7.72 33.34 104.87 6.92 56.29 -18.50 46.72 54.94 -17.46 47.93 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 2 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 111 ASP~? 25.68 CL CL B 226 231 ASP B 40 ASP.? 7.91 CL CL B 226 294 ASP B 151 ASP~? 28.65 CL CL B 226 coo 27.89 102.52 14.98 29.35 101.92 13.57 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 14.74 93.05 -1.00 14.30 94.22 0.73 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 33.16 106.80 7.72 33.34 104.87 6.92 41.86 -11.82 45.74 42.46 -13.70 45.02 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 111 ASP~? 25.68 CL CL B 226 231 ASP B 43 ASP.? 11.93 CL CL B 226 294 ASP B 151 ASP~? 28.65 CL CL B 226 coo 27.89 102.52 14.98 29.35 101.92 13.57 44.68 -0.98 44.91 42.92 -2.08 45.36 coo 14.74 93.05 -1.00 14.30 94.22 0.73 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 33.16 106.80 7.72 33.34 104.87 6.92 41.86 -11.82 45.74 42.46 -13.70 45.02 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 151 ASP~? 28.65 CL CL B 226 231 ASP B 43 ASP.? 11.93 CL CL B 226 294 ASP B 111 ASP~? 25.68 CL CL B 226 coo 27.89 102.52 14.98 29.35 101.92 13.57 41.86 -11.82 45.74 42.46 -13.70 45.02 coo 14.74 93.05 -1.00 14.30 94.22 0.73 58.62 -8.54 27.92 60.24 -9.54 27.09 coo 33.16 106.80 7.72 33.34 104.87 6.92 44.68 -0.98 44.91 42.92 -2.08 45.36 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 3 hits 2amg_c06 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 75 HIS.? 25.41 CL CL B 226 B 163 ALA A 71 ALA^? 20.51 CL CL A 226 B 182 SER A 72 SER.? 25.76 CL CL A 226 coo 30.42 1.98 4.36 29.07 0.41 4.68 38.68 -16.70 9.61 40.32 -17.29 8.43 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 32.71 -15.15 12.56 32.86 -14.68 13.99 coo 24.00 -0.17 2.07 24.51 1.00 0.04 34.13 -18.66 12.80 35.17 -18.58 10.66 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 86 HIS~? 10.02 CL CL A 226 B 163 ALA A 14 ALA~? 12.29 CL CL A 226 B 182 SER A 82 SER~? 14.07 CL CL A 226 coo 30.42 1.98 4.36 29.07 0.41 4.68 32.84 2.26 17.60 31.66 3.53 18.78 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 30.79 -6.03 17.88 31.85 -5.27 17.14 coo 24.00 -0.17 2.07 24.51 1.00 0.04 34.77 -3.21 13.72 33.13 -4.11 12.24 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS B 75 HIS.? 25.67 CL CL A 226 B 163 ALA B 71 ALA^? 20.21 CL CL B 226 B 182 SER B 72 SER.? 25.86 CL CL B 226 coo 30.42 1.98 4.36 29.07 0.41 4.68 34.50 -15.17 32.63 32.86 -15.45 33.92 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 40.69 -15.21 29.48 40.79 -14.95 28.00 coo 24.00 -0.17 2.07 24.51 1.00 0.04 38.31 -18.13 29.75 37.15 -17.87 31.87 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS B 86 HIS~? 9.45 CL CL B 226 B 163 ALA B 14 ALA~? 12.02 CL CL B 226 B 182 SER B 82 SER~? 13.78 CL CL B 226 coo 30.42 1.98 4.36 29.07 0.41 4.68 44.03 1.12 22.86 45.41 1.90 21.48 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 44.33 -7.28 23.33 43.44 -6.30 24.13 coo 24.00 -0.17 2.07 24.51 1.00 0.04 41.03 -3.36 27.11 42.38 -4.54 28.72 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 4 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 19 ARG~? 20.09 CL CL A 226 A 161 ASP A 40 ASP.? 7.65 CL CL A 226 A 174 TYR A 38 TYR.? 10.54 CL CL A 226 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 19 ARG~? 20.09 CL CL A 226 A 161 ASP A 40 ASP.? 7.65 CL CL A 226 A 174 TYR A 46 TYR^? 12.99 CL CL A 226 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG B 19 ARG~? 20.05 CL CL B 226 A 161 ASP B 40 ASP.? 7.91 CL CL B 226 A 174 TYR B 38 TYR.? 11.29 CL CL B 226 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 19 ARG~? 20.05 CL CL B 226 A 161 ASP B 40 ASP.? 7.91 CL CL B 226 A 174 TYR B 46 TYR^? 12.90 CL CL B 226 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 50.79 -14.19 25.59 51.15 -11.43 25.53 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 19 ARG~? 20.09 CL CL A 226 B 161 ASP A 40 ASP.? 7.65 CL CL A 226 B 174 TYR A 38 TYR.? 10.54 CL CL A 226 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -14.86 10.19 8.14 -14.82 12.31 8.42 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -21.46 12.70 8.53 -19.04 12.30 7.24 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 19 ARG~? 20.09 CL CL A 226 B 161 ASP A 40 ASP.? 7.65 CL CL A 226 B 174 TYR A 46 TYR^? 12.99 CL CL A 226 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -14.86 10.19 8.14 -14.82 12.31 8.42 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -21.46 12.70 8.53 -19.04 12.30 7.24 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG B 19 ARG~? 20.05 CL CL B 226 B 161 ASP B 40 ASP.? 7.91 CL CL B 226 B 174 TYR B 38 TYR.? 11.29 CL CL B 226 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -14.86 10.19 8.14 -14.82 12.31 8.42 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -21.46 12.70 8.53 -19.04 12.30 7.24 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 19 ARG~? 20.05 CL CL B 226 B 161 ASP B 40 ASP.? 7.91 CL CL B 226 B 174 TYR B 46 TYR^? 12.90 CL CL B 226 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -14.86 10.19 8.14 -14.82 12.31 8.42 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -21.46 12.70 8.53 -19.04 12.30 7.24 50.79 -14.19 25.59 51.15 -11.43 25.53 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 19 ARG~? 20.09 CL CL A 226 C 161 ASP A 40 ASP.? 7.65 CL CL A 226 C 174 TYR A 38 TYR.? 10.54 CL CL A 226 coo 2.84 19.43 40.34 1.59 20.35 37.65 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -0.62 11.10 28.05 -0.65 13.15 27.46 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 5.94 13.28 27.17 3.53 13.05 28.58 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 19 ARG~? 20.09 CL CL A 226 C 161 ASP A 40 ASP.? 7.65 CL CL A 226 C 174 TYR A 46 TYR^? 12.99 CL CL A 226 coo 2.84 19.43 40.34 1.59 20.35 37.65 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -0.62 11.10 28.05 -0.65 13.15 27.46 20.12 -4.48 17.55 21.44 -4.89 15.96 coo 5.94 13.28 27.17 3.53 13.05 28.58 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 65 ARG.? 31.92 CL CL A 226 C 161 ASP A 193 ASP~? 30.50 CL CL A 226 C 174 TYR A 194 TYR~? 29.78 CL CL A 226 coo 2.84 19.43 40.34 1.59 20.35 37.65 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo -0.62 11.10 28.05 -0.65 13.15 27.46 12.56 -7.85 -7.87 10.56 -8.42 -7.58 coo 5.94 13.28 27.17 3.53 13.05 28.58 18.48 -5.35 -10.35 20.66 -3.63 -10.45 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG B 19 ARG~? 20.05 CL CL B 226 C 161 ASP B 40 ASP.? 7.91 CL CL B 226 C 174 TYR B 38 TYR.? 11.29 CL CL B 226 coo 2.84 19.43 40.34 1.59 20.35 37.65 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -0.62 11.10 28.05 -0.65 13.15 27.46 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 5.94 13.28 27.17 3.53 13.05 28.58 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG B 19 ARG~? 20.05 CL CL B 226 C 161 ASP B 40 ASP.? 7.91 CL CL B 226 C 174 TYR B 46 TYR^? 12.90 CL CL B 226 coo 2.84 19.43 40.34 1.59 20.35 37.65 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -0.62 11.10 28.05 -0.65 13.15 27.46 55.19 -7.93 23.91 53.71 -7.92 25.42 coo 5.94 13.28 27.17 3.53 13.05 28.58 50.79 -14.19 25.59 51.15 -11.43 25.53 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 5 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 19 ARG~? 20.09 CL CL A 226 D 161 ASP A 40 ASP.? 7.65 CL CL A 226 D 174 TYR A 38 TYR.? 10.54 CL CL A 226 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 17.27 -3.90 25.00 15.42 -2.03 25.90 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 19 ARG~? 20.09 CL CL A 226 D 161 ASP A 40 ASP.? 7.65 CL CL A 226 D 174 TYR A 46 TYR^? 12.99 CL CL A 226 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 31.00 -11.00 27.75 29.53 -12.56 29.89 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 22.89 -11.80 16.43 23.58 -9.15 16.08 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG B 19 ARG~? 20.05 CL CL B 226 D 161 ASP B 40 ASP.? 7.91 CL CL B 226 D 174 TYR B 38 TYR.? 11.29 CL CL B 226 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 58.26 -9.06 16.81 60.90 -8.31 16.35 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG B 19 ARG~? 20.05 CL CL B 226 D 161 ASP B 40 ASP.? 7.91 CL CL B 226 D 174 TYR B 46 TYR^? 12.90 CL CL B 226 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 42.78 -12.99 14.20 43.98 -15.00 12.21 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 50.79 -14.19 25.59 51.15 -11.43 25.53 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP B 193 ASP~? 31.47 CL CL B 226 A 233 GLU B 187 GLU.? 29.51 CL CL B 226 A 300 ASN B 188 ASN.? 35.33 CL CL B 226 coo 12.51 17.07 49.46 12.44 16.89 47.35 60.57 -10.33 49.95 62.16 -11.61 50.53 coo 6.52 19.14 48.16 7.77 18.42 46.61 61.43 -15.09 46.94 62.69 -13.43 47.32 coo 9.30 22.40 41.76 10.10 20.96 40.36 58.21 -19.16 51.65 58.37 -21.08 50.71 2cpu_c01 source 2cpu ALPHA-AMYLASE : 1 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 9 GLU.? 16.20 CL CL A 226 A 156 GLU A 11 GLU.? 11.48 CL CL A 226 A 194 ASN A 39 ASN.? 7.49 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 67.47 20.07 1.34 65.99 20.06 2.88 31.29 2.41 22.91 32.62 4.08 23.08 coo 67.44 25.26 13.91 67.54 23.65 15.28 17.97 -0.91 21.86 16.15 0.14 22.24 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 11 GLU.? 11.48 CL CL A 226 A 156 GLU A 9 GLU.? 16.20 CL CL A 226 A 194 ASN A 39 ASN.? 7.49 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 31.29 2.41 22.91 32.62 4.08 23.08 coo 67.47 20.07 1.34 65.99 20.06 2.88 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 67.44 25.26 13.91 67.54 23.65 15.28 17.97 -0.91 21.86 16.15 0.14 22.24 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 26 GLU~? 31.19 CL CL A 226 A 156 GLU B 26 GLU~? 28.82 CL CL B 226 A 194 ASN B 50 ASN.? 30.91 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 67.47 20.07 1.34 65.99 20.06 2.88 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 67.44 25.26 13.91 67.54 23.65 15.28 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 84 GLU~? 12.94 CL CL B 226 A 156 GLU A 77 GLU~? 21.84 CL CL B 226 A 194 ASN B 8 ASN.? 7.79 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 67.47 20.07 1.34 65.99 20.06 2.88 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 67.44 25.26 13.91 67.54 23.65 15.28 51.02 -6.75 16.28 50.85 -6.79 18.40 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 84 GLU~? 12.94 CL CL B 226 A 156 GLU B 9 GLU.? 16.36 CL CL B 226 A 194 ASN B 167 ASN.? 4.94 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 67.47 20.07 1.34 65.99 20.06 2.88 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 67.44 25.26 13.91 67.54 23.65 15.28 50.28 1.34 22.19 49.08 -0.16 21.24 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU A 84 GLU~? 12.94 CL CL B 226 A 156 GLU B 84 GLU~? 12.79 CL CL A 226 A 194 ASN B 167 ASN.? 4.94 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 67.47 20.07 1.34 65.99 20.06 2.88 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 67.44 25.26 13.91 67.54 23.65 15.28 50.28 1.34 22.19 49.08 -0.16 21.24 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU A 110 GLU~? 23.70 CL CL A 226 A 156 GLU A 112 GLU~? 32.50 CL CL A 226 A 194 ASN A 155 ASN~? 24.40 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 67.47 20.07 1.34 65.99 20.06 2.88 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 67.44 25.26 13.91 67.54 23.65 15.28 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU A 110 GLU~? 23.70 CL CL A 226 A 156 GLU A 112 GLU~? 32.50 CL CL A 226 A 194 ASN A 202 ASN~? 26.54 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 67.47 20.07 1.34 65.99 20.06 2.88 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 67.44 25.26 13.91 67.54 23.65 15.28 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU A 112 GLU~? 32.50 CL CL A 226 A 156 GLU A 110 GLU~? 23.70 CL CL A 226 A 194 ASN A 155 ASN~? 24.40 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 67.47 20.07 1.34 65.99 20.06 2.88 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 67.44 25.26 13.91 67.54 23.65 15.28 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU A 112 GLU~? 32.50 CL CL A 226 A 156 GLU A 198 GLU~? 30.13 CL CL A 226 A 194 ASN A 155 ASN~? 24.40 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 67.47 20.07 1.34 65.99 20.06 2.88 19.84 0.58 -9.50 20.29 0.30 -11.52 coo 67.44 25.26 13.91 67.54 23.65 15.28 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU B 9 GLU.? 16.36 CL CL B 226 A 156 GLU B 11 GLU.? 11.19 CL CL B 226 A 194 ASN B 39 ASN.? 7.81 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 67.47 20.07 1.34 65.99 20.06 2.88 45.62 0.60 17.46 44.46 2.32 17.00 coo 67.44 25.26 13.91 67.54 23.65 15.28 58.04 -5.16 19.24 60.05 -4.37 19.05 ULMN 3 2dbt_c00 CHITINASE C user 12 3 # 12 A 147 GLU B 11 GLU.? 11.19 CL CL B 226 A 156 GLU B 9 GLU.? 16.36 CL CL B 226 A 194 ASN B 39 ASN.? 7.81 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 45.62 0.60 17.46 44.46 2.32 17.00 coo 67.47 20.07 1.34 65.99 20.06 2.88 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 67.44 25.26 13.91 67.54 23.65 15.28 58.04 -5.16 19.24 60.05 -4.37 19.05 ULMN 3 2dbt_c00 CHITINASE C user 13 3 # 13 A 147 GLU B 26 GLU~? 28.82 CL CL B 226 A 156 GLU A 26 GLU~? 31.19 CL CL A 226 A 194 ASN A 50 ASN.? 30.77 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 67.47 20.07 1.34 65.99 20.06 2.88 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 67.44 25.26 13.91 67.54 23.65 15.28 28.00 -25.90 12.99 26.73 -27.64 12.92 ULMN 3 2dbt_c00 CHITINASE C user 14 3 # 14 A 147 GLU B 26 GLU~? 28.82 CL CL B 226 A 156 GLU A 26 GLU~? 31.19 CL CL A 226 A 194 ASN B 50 ASN.? 30.91 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 67.47 20.07 1.34 65.99 20.06 2.88 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 67.44 25.26 13.91 67.54 23.65 15.28 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 3 2dbt_c00 CHITINASE C user 15 3 # 15 A 147 GLU B 84 GLU~? 12.79 CL CL A 226 A 156 GLU A 9 GLU.? 16.20 CL CL A 226 A 194 ASN A 167 ASN.? 5.51 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 67.47 20.07 1.34 65.99 20.06 2.88 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 67.44 25.26 13.91 67.54 23.65 15.28 27.28 3.74 18.20 27.65 2.13 19.59 ULMN 3 2dbt_c00 CHITINASE C user 16 3 # 16 A 147 GLU B 84 GLU~? 12.79 CL CL A 226 A 156 GLU A 84 GLU~? 12.94 CL CL B 226 A 194 ASN A 167 ASN.? 5.51 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 67.47 20.07 1.34 65.99 20.06 2.88 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 67.44 25.26 13.91 67.54 23.65 15.28 27.28 3.74 18.20 27.65 2.13 19.59 ULMN 3 2dbt_c00 CHITINASE C user 17 3 # 17 A 147 GLU B 84 GLU~? 12.79 CL CL A 226 A 156 GLU B 77 GLU~? 22.22 CL CL A 226 A 194 ASN A 8 ASN.? 6.94 CL CL A 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 67.47 20.07 1.34 65.99 20.06 2.88 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 67.44 25.26 13.91 67.54 23.65 15.28 24.44 -3.01 24.75 23.45 -2.96 22.86 ULMN 3 2dbt_c00 CHITINASE C user 18 3 # 18 A 147 GLU B 110 GLU~? 23.32 CL CL B 226 A 156 GLU B 112 GLU~? 31.79 CL CL B 226 A 194 ASN B 155 ASN~? 24.46 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 46.60 5.74 43.54 45.54 7.20 42.48 coo 67.47 20.07 1.34 65.99 20.06 2.88 43.43 0.58 50.84 42.60 2.23 51.76 coo 67.44 25.26 13.91 67.54 23.65 15.28 44.94 -7.51 42.45 43.54 -6.44 43.59 ULMN 3 2dbt_c00 CHITINASE C user 19 3 # 19 A 147 GLU B 110 GLU~? 23.32 CL CL B 226 A 156 GLU B 112 GLU~? 31.79 CL CL B 226 A 194 ASN B 202 ASN~? 26.89 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 46.60 5.74 43.54 45.54 7.20 42.48 coo 67.47 20.07 1.34 65.99 20.06 2.88 43.43 0.58 50.84 42.60 2.23 51.76 coo 67.44 25.26 13.91 67.54 23.65 15.28 56.47 4.11 47.59 54.90 3.31 48.75 ULMN 3 2dbt_c00 CHITINASE C user 20 3 # 20 A 147 GLU B 112 GLU~? 31.79 CL CL B 226 A 156 GLU B 110 GLU~? 23.32 CL CL B 226 A 194 ASN B 149 ASN.? 28.07 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 43.43 0.58 50.84 42.60 2.23 51.76 coo 67.47 20.07 1.34 65.99 20.06 2.88 46.60 5.74 43.54 45.54 7.20 42.48 coo 67.44 25.26 13.91 67.54 23.65 15.28 39.68 -7.57 44.84 39.54 -9.68 44.58 ULMN 3 2dbt_c00 CHITINASE C user 21 3 # 21 A 147 GLU B 112 GLU~? 31.79 CL CL B 226 A 156 GLU B 110 GLU~? 23.32 CL CL B 226 A 194 ASN B 155 ASN~? 24.46 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 43.43 0.58 50.84 42.60 2.23 51.76 coo 67.47 20.07 1.34 65.99 20.06 2.88 46.60 5.74 43.54 45.54 7.20 42.48 coo 67.44 25.26 13.91 67.54 23.65 15.28 44.94 -7.51 42.45 43.54 -6.44 43.59 ULMN 3 2dbt_c00 CHITINASE C user 22 3 # 22 A 147 GLU B 112 GLU~? 31.79 CL CL B 226 A 156 GLU B 198 GLU~? 30.19 CL CL B 226 A 194 ASN B 155 ASN~? 24.46 CL CL B 226 coo 74.14 15.91 8.55 72.08 15.36 8.63 43.43 0.58 50.84 42.60 2.23 51.76 coo 67.47 20.07 1.34 65.99 20.06 2.88 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 67.44 25.26 13.91 67.54 23.65 15.28 44.94 -7.51 42.45 43.54 -6.44 43.59 2dbt_c00 source 2dbt CHITINASE C : 22 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 9 GLU.? 16.20 CL CL A 226 B 156 GLU A 11 GLU.? 11.48 CL CL A 226 B 194 ASN A 39 ASN.? 7.49 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 54.43 67.89 19.82 55.62 67.90 18.07 31.29 2.41 22.91 32.62 4.08 23.08 coo 49.79 70.75 7.78 50.10 68.90 6.86 17.97 -0.91 21.86 16.15 0.14 22.24 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 11 GLU.? 11.48 CL CL A 226 B 156 GLU A 9 GLU.? 16.20 CL CL A 226 B 194 ASN A 39 ASN.? 7.49 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 31.29 2.41 22.91 32.62 4.08 23.08 coo 54.43 67.89 19.82 55.62 67.90 18.07 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 49.79 70.75 7.78 50.10 68.90 6.86 17.97 -0.91 21.86 16.15 0.14 22.24 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 26 GLU~? 31.19 CL CL A 226 B 156 GLU B 26 GLU~? 28.82 CL CL B 226 B 194 ASN A 50 ASN.? 30.77 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 54.43 67.89 19.82 55.62 67.90 18.07 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 49.79 70.75 7.78 50.10 68.90 6.86 28.00 -25.90 12.99 26.73 -27.64 12.92 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 26 GLU~? 31.19 CL CL A 226 B 156 GLU B 26 GLU~? 28.82 CL CL B 226 B 194 ASN B 50 ASN.? 30.91 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 54.43 67.89 19.82 55.62 67.90 18.07 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 49.79 70.75 7.78 50.10 68.90 6.86 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 77 GLU~? 21.84 CL CL B 226 B 156 GLU A 84 GLU~? 12.94 CL CL B 226 B 194 ASN B 8 ASN.? 7.79 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 54.43 67.89 19.82 55.62 67.90 18.07 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 49.79 70.75 7.78 50.10 68.90 6.86 51.02 -6.75 16.28 50.85 -6.79 18.40 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU A 84 GLU~? 12.94 CL CL B 226 B 156 GLU A 77 GLU~? 21.84 CL CL B 226 B 194 ASN B 8 ASN.? 7.79 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 54.43 67.89 19.82 55.62 67.90 18.07 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 49.79 70.75 7.78 50.10 68.90 6.86 51.02 -6.75 16.28 50.85 -6.79 18.40 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU A 84 GLU~? 12.94 CL CL B 226 B 156 GLU B 9 GLU.? 16.36 CL CL B 226 B 194 ASN B 167 ASN.? 4.94 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 54.43 67.89 19.82 55.62 67.90 18.07 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 49.79 70.75 7.78 50.10 68.90 6.86 50.28 1.34 22.19 49.08 -0.16 21.24 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU A 84 GLU~? 12.94 CL CL B 226 B 156 GLU B 84 GLU~? 12.79 CL CL A 226 B 194 ASN A 167 ASN.? 5.51 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 54.43 67.89 19.82 55.62 67.90 18.07 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 49.79 70.75 7.78 50.10 68.90 6.86 27.28 3.74 18.20 27.65 2.13 19.59 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU A 110 GLU~? 23.70 CL CL A 226 B 156 GLU A 112 GLU~? 32.50 CL CL A 226 B 194 ASN A 155 ASN~? 24.40 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 54.43 67.89 19.82 55.62 67.90 18.07 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 49.79 70.75 7.78 50.10 68.90 6.86 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU A 110 GLU~? 23.70 CL CL A 226 B 156 GLU A 112 GLU~? 32.50 CL CL A 226 B 194 ASN A 202 ASN~? 26.54 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 54.43 67.89 19.82 55.62 67.90 18.07 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 49.79 70.75 7.78 50.10 68.90 6.86 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU A 112 GLU~? 32.50 CL CL A 226 B 156 GLU A 110 GLU~? 23.70 CL CL A 226 B 194 ASN A 155 ASN~? 24.40 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 54.43 67.89 19.82 55.62 67.90 18.07 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 49.79 70.75 7.78 50.10 68.90 6.86 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU B 9 GLU.? 16.36 CL CL B 226 B 156 GLU B 11 GLU.? 11.19 CL CL B 226 B 194 ASN B 39 ASN.? 7.81 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 54.43 67.89 19.82 55.62 67.90 18.07 45.62 0.60 17.46 44.46 2.32 17.00 coo 49.79 70.75 7.78 50.10 68.90 6.86 58.04 -5.16 19.24 60.05 -4.37 19.05 ULMN 3 2dbt_c01 CHITINASE C user 13 3 # 13 B 147 GLU B 11 GLU.? 11.19 CL CL B 226 B 156 GLU B 9 GLU.? 16.36 CL CL B 226 B 194 ASN B 39 ASN.? 7.81 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 45.62 0.60 17.46 44.46 2.32 17.00 coo 54.43 67.89 19.82 55.62 67.90 18.07 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 49.79 70.75 7.78 50.10 68.90 6.86 58.04 -5.16 19.24 60.05 -4.37 19.05 ULMN 3 2dbt_c01 CHITINASE C user 14 3 # 14 B 147 GLU B 26 GLU~? 28.82 CL CL B 226 B 156 GLU A 26 GLU~? 31.19 CL CL A 226 B 194 ASN A 50 ASN.? 30.77 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 54.43 67.89 19.82 55.62 67.90 18.07 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 49.79 70.75 7.78 50.10 68.90 6.86 28.00 -25.90 12.99 26.73 -27.64 12.92 ULMN 3 2dbt_c01 CHITINASE C user 15 3 # 15 B 147 GLU B 26 GLU~? 28.82 CL CL B 226 B 156 GLU A 26 GLU~? 31.19 CL CL A 226 B 194 ASN B 50 ASN.? 30.91 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 54.43 67.89 19.82 55.62 67.90 18.07 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 49.79 70.75 7.78 50.10 68.90 6.86 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 3 2dbt_c01 CHITINASE C user 16 3 # 16 B 147 GLU B 69 GLU^? 24.72 CL CL B 226 B 156 GLU B 77 GLU~? 22.22 CL CL A 226 B 194 ASN B 149 ASN.? 28.07 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 54.43 67.89 19.82 55.62 67.90 18.07 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 49.79 70.75 7.78 50.10 68.90 6.86 39.68 -7.57 44.84 39.54 -9.68 44.58 ULMN 3 2dbt_c01 CHITINASE C user 17 3 # 17 B 147 GLU B 84 GLU~? 12.79 CL CL A 226 B 156 GLU A 9 GLU.? 16.20 CL CL A 226 B 194 ASN A 167 ASN.? 5.51 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 54.43 67.89 19.82 55.62 67.90 18.07 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 49.79 70.75 7.78 50.10 68.90 6.86 27.28 3.74 18.20 27.65 2.13 19.59 ULMN 3 2dbt_c01 CHITINASE C user 18 3 # 18 B 147 GLU B 84 GLU~? 12.79 CL CL A 226 B 156 GLU A 84 GLU~? 12.94 CL CL B 226 B 194 ASN A 167 ASN.? 5.51 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 54.43 67.89 19.82 55.62 67.90 18.07 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 49.79 70.75 7.78 50.10 68.90 6.86 27.28 3.74 18.20 27.65 2.13 19.59 ULMN 3 2dbt_c01 CHITINASE C user 19 3 # 19 B 147 GLU B 84 GLU~? 12.79 CL CL A 226 B 156 GLU B 77 GLU~? 22.22 CL CL A 226 B 194 ASN A 8 ASN.? 6.94 CL CL A 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 54.43 67.89 19.82 55.62 67.90 18.07 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 49.79 70.75 7.78 50.10 68.90 6.86 24.44 -3.01 24.75 23.45 -2.96 22.86 ULMN 3 2dbt_c01 CHITINASE C user 20 3 # 20 B 147 GLU B 110 GLU~? 23.32 CL CL B 226 B 156 GLU B 112 GLU~? 31.79 CL CL B 226 B 194 ASN B 155 ASN~? 24.46 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 46.60 5.74 43.54 45.54 7.20 42.48 coo 54.43 67.89 19.82 55.62 67.90 18.07 43.43 0.58 50.84 42.60 2.23 51.76 coo 49.79 70.75 7.78 50.10 68.90 6.86 44.94 -7.51 42.45 43.54 -6.44 43.59 ULMN 3 2dbt_c01 CHITINASE C user 21 3 # 21 B 147 GLU B 112 GLU~? 31.79 CL CL B 226 B 156 GLU B 110 GLU~? 23.32 CL CL B 226 B 194 ASN B 155 ASN~? 24.46 CL CL B 226 coo 45.64 63.11 17.20 47.48 62.43 16.45 43.43 0.58 50.84 42.60 2.23 51.76 coo 54.43 67.89 19.82 55.62 67.90 18.07 46.60 5.74 43.54 45.54 7.20 42.48 coo 49.79 70.75 7.78 50.10 68.90 6.86 44.94 -7.51 42.45 43.54 -6.44 43.59 2dbt_c01 source 2dbt CHITINASE C : 21 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 9 GLU.? 16.20 CL CL A 226 C 156 GLU A 11 GLU.? 11.48 CL CL A 226 C 194 ASN A 39 ASN.? 7.49 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 44.75 23.09 5.51 46.77 22.91 6.12 31.29 2.41 22.91 32.62 4.08 23.08 coo 49.75 21.00 18.12 50.45 23.02 18.26 17.97 -0.91 21.86 16.15 0.14 22.24 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 11 GLU.? 11.48 CL CL A 226 C 156 GLU A 9 GLU.? 16.20 CL CL A 226 C 194 ASN A 39 ASN.? 7.49 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 31.29 2.41 22.91 32.62 4.08 23.08 coo 44.75 23.09 5.51 46.77 22.91 6.12 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 49.75 21.00 18.12 50.45 23.02 18.26 17.97 -0.91 21.86 16.15 0.14 22.24 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 26 GLU~? 31.19 CL CL A 226 C 156 GLU B 26 GLU~? 28.82 CL CL B 226 C 194 ASN B 50 ASN.? 30.91 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 44.75 23.09 5.51 46.77 22.91 6.12 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 49.75 21.00 18.12 50.45 23.02 18.26 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 84 GLU~? 12.94 CL CL B 226 C 156 GLU A 77 GLU~? 21.84 CL CL B 226 C 194 ASN B 8 ASN.? 7.79 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 44.75 23.09 5.51 46.77 22.91 6.12 40.16 -11.08 10.76 40.31 -13.18 10.50 coo 49.75 21.00 18.12 50.45 23.02 18.26 51.02 -6.75 16.28 50.85 -6.79 18.40 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 84 GLU~? 12.94 CL CL B 226 C 156 GLU B 9 GLU.? 16.36 CL CL B 226 C 194 ASN B 167 ASN.? 4.94 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 44.75 23.09 5.51 46.77 22.91 6.12 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 49.75 21.00 18.12 50.45 23.02 18.26 50.28 1.34 22.19 49.08 -0.16 21.24 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU A 84 GLU~? 12.94 CL CL B 226 C 156 GLU B 84 GLU~? 12.79 CL CL A 226 C 194 ASN B 167 ASN.? 4.94 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 44.75 23.09 5.51 46.77 22.91 6.12 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 49.75 21.00 18.12 50.45 23.02 18.26 50.28 1.34 22.19 49.08 -0.16 21.24 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU A 110 GLU~? 23.70 CL CL A 226 C 156 GLU A 112 GLU~? 32.50 CL CL A 226 C 194 ASN A 155 ASN~? 24.40 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 44.75 23.09 5.51 46.77 22.91 6.12 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 49.75 21.00 18.12 50.45 23.02 18.26 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU A 110 GLU~? 23.70 CL CL A 226 C 156 GLU A 112 GLU~? 32.50 CL CL A 226 C 194 ASN A 202 ASN~? 26.54 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 44.75 23.09 5.51 46.77 22.91 6.12 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 49.75 21.00 18.12 50.45 23.02 18.26 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU A 112 GLU~? 32.50 CL CL A 226 C 156 GLU A 110 GLU~? 23.70 CL CL A 226 C 194 ASN A 155 ASN~? 24.40 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 44.75 23.09 5.51 46.77 22.91 6.12 30.58 5.52 -3.71 32.09 6.67 -2.64 coo 49.75 21.00 18.12 50.45 23.02 18.26 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU A 112 GLU~? 32.50 CL CL A 226 C 156 GLU A 198 GLU~? 30.13 CL CL A 226 C 194 ASN A 155 ASN~? 24.40 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 31.64 -0.95 -10.58 32.34 0.04 -12.34 coo 44.75 23.09 5.51 46.77 22.91 6.12 19.84 0.58 -9.50 20.29 0.30 -11.52 coo 49.75 21.00 18.12 50.45 23.02 18.26 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 2dbt_c02 CHITINASE C user 11 3 # 11 C 147 GLU B 9 GLU.? 16.36 CL CL B 226 C 156 GLU B 11 GLU.? 11.19 CL CL B 226 C 194 ASN B 39 ASN.? 7.81 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 44.75 23.09 5.51 46.77 22.91 6.12 45.62 0.60 17.46 44.46 2.32 17.00 coo 49.75 21.00 18.12 50.45 23.02 18.26 58.04 -5.16 19.24 60.05 -4.37 19.05 ULMN 3 2dbt_c02 CHITINASE C user 12 3 # 12 C 147 GLU B 11 GLU.? 11.19 CL CL B 226 C 156 GLU B 9 GLU.? 16.36 CL CL B 226 C 194 ASN B 39 ASN.? 7.81 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 45.62 0.60 17.46 44.46 2.32 17.00 coo 44.75 23.09 5.51 46.77 22.91 6.12 47.73 -10.39 12.99 46.70 -12.24 13.09 coo 49.75 21.00 18.12 50.45 23.02 18.26 58.04 -5.16 19.24 60.05 -4.37 19.05 ULMN 3 2dbt_c02 CHITINASE C user 13 3 # 13 C 147 GLU B 26 GLU~? 28.82 CL CL B 226 C 156 GLU A 26 GLU~? 31.19 CL CL A 226 C 194 ASN A 50 ASN.? 30.77 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 44.75 23.09 5.51 46.77 22.91 6.12 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 49.75 21.00 18.12 50.45 23.02 18.26 28.00 -25.90 12.99 26.73 -27.64 12.92 ULMN 3 2dbt_c02 CHITINASE C user 14 3 # 14 C 147 GLU B 26 GLU~? 28.82 CL CL B 226 C 156 GLU A 26 GLU~? 31.19 CL CL A 226 C 194 ASN B 50 ASN.? 30.91 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 37.69 -26.04 19.16 37.25 -23.97 18.66 coo 44.75 23.09 5.51 46.77 22.91 6.12 31.04 -26.45 25.52 31.42 -26.09 27.62 coo 49.75 21.00 18.12 50.45 23.02 18.26 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 3 2dbt_c02 CHITINASE C user 15 3 # 15 C 147 GLU B 69 GLU^? 24.72 CL CL B 226 C 156 GLU B 77 GLU~? 22.22 CL CL A 226 C 194 ASN B 149 ASN.? 28.07 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 42.13 -16.51 33.43 40.68 -17.83 34.16 coo 44.75 23.09 5.51 46.77 22.91 6.12 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 49.75 21.00 18.12 50.45 23.02 18.26 39.68 -7.57 44.84 39.54 -9.68 44.58 ULMN 3 2dbt_c02 CHITINASE C user 16 3 # 16 C 147 GLU B 84 GLU~? 12.79 CL CL A 226 C 156 GLU A 9 GLU.? 16.20 CL CL A 226 C 194 ASN A 167 ASN.? 5.51 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 44.75 23.09 5.51 46.77 22.91 6.12 26.61 -7.39 28.28 26.97 -9.45 28.59 coo 49.75 21.00 18.12 50.45 23.02 18.26 27.28 3.74 18.20 27.65 2.13 19.59 ULMN 3 2dbt_c02 CHITINASE C user 17 3 # 17 C 147 GLU B 84 GLU~? 12.79 CL CL A 226 C 156 GLU A 84 GLU~? 12.94 CL CL B 226 C 194 ASN A 167 ASN.? 5.51 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 44.75 23.09 5.51 46.77 22.91 6.12 40.51 -2.33 16.64 42.51 -2.90 16.44 coo 49.75 21.00 18.12 50.45 23.02 18.26 27.28 3.74 18.20 27.65 2.13 19.59 ULMN 3 2dbt_c02 CHITINASE C user 18 3 # 18 C 147 GLU B 84 GLU~? 12.79 CL CL A 226 C 156 GLU B 77 GLU~? 22.22 CL CL A 226 C 194 ASN A 8 ASN.? 6.94 CL CL A 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 35.35 -1.73 23.75 33.22 -1.55 23.84 coo 44.75 23.09 5.51 46.77 22.91 6.12 34.33 -9.48 30.93 34.02 -11.53 31.29 coo 49.75 21.00 18.12 50.45 23.02 18.26 24.44 -3.01 24.75 23.45 -2.96 22.86 ULMN 3 2dbt_c02 CHITINASE C user 19 3 # 19 C 147 GLU B 110 GLU~? 23.32 CL CL B 226 C 156 GLU B 112 GLU~? 31.79 CL CL B 226 C 194 ASN B 155 ASN~? 24.46 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 46.60 5.74 43.54 45.54 7.20 42.48 coo 44.75 23.09 5.51 46.77 22.91 6.12 43.43 0.58 50.84 42.60 2.23 51.76 coo 49.75 21.00 18.12 50.45 23.02 18.26 44.94 -7.51 42.45 43.54 -6.44 43.59 ULMN 3 2dbt_c02 CHITINASE C user 20 3 # 20 C 147 GLU B 112 GLU~? 31.79 CL CL B 226 C 156 GLU B 110 GLU~? 23.32 CL CL B 226 C 194 ASN B 155 ASN~? 24.46 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 43.43 0.58 50.84 42.60 2.23 51.76 coo 44.75 23.09 5.51 46.77 22.91 6.12 46.60 5.74 43.54 45.54 7.20 42.48 coo 49.75 21.00 18.12 50.45 23.02 18.26 44.94 -7.51 42.45 43.54 -6.44 43.59 ULMN 3 2dbt_c02 CHITINASE C user 21 3 # 21 C 147 GLU B 112 GLU~? 31.79 CL CL B 226 C 156 GLU B 198 GLU~? 30.19 CL CL B 226 C 194 ASN B 155 ASN~? 24.46 CL CL B 226 coo 41.23 29.31 13.28 43.03 29.85 12.29 43.43 0.58 50.84 42.60 2.23 51.76 coo 44.75 23.09 5.51 46.77 22.91 6.12 55.63 -0.33 50.97 54.03 -0.19 52.37 coo 49.75 21.00 18.12 50.45 23.02 18.26 44.94 -7.51 42.45 43.54 -6.44 43.59 2dbt_c02 source 2dbt CHITINASE C : 21 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 60 LYS.? 19.24 CL CL A 226 A 184 LYS A 63 LYS.? 28.35 CL CL A 226 A 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 5.98 42.76 7.73 10.19 38.62 9.02 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 2.77 37.17 4.99 6.33 34.76 8.06 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 0.07 40.30 18.65 -0.21 42.34 18.18 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 63 LYS.? 28.35 CL CL A 226 A 184 LYS A 60 LYS.? 19.24 CL CL A 226 A 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 5.98 42.76 7.73 10.19 38.62 9.02 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 2.77 37.17 4.99 6.33 34.76 8.06 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 0.07 40.30 18.65 -0.21 42.34 18.18 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 205 LYS~? 25.48 CL CL A 226 A 184 LYS A 200 LYS~? 23.56 CL CL A 226 A 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 5.98 42.76 7.73 10.19 38.62 9.02 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 2.77 37.17 4.99 6.33 34.76 8.06 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 0.07 40.30 18.65 -0.21 42.34 18.18 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS B 205 LYS~? 25.67 CL CL B 226 A 184 LYS B 200 LYS~? 24.54 CL CL B 226 A 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 5.98 42.76 7.73 10.19 38.62 9.02 54.11 5.83 42.26 49.56 6.08 46.56 coo 2.77 37.17 4.99 6.33 34.76 8.06 60.00 0.23 45.11 63.70 -4.80 44.31 coo 0.07 40.30 18.65 -0.21 42.34 18.18 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 60 LYS.? 19.24 CL CL A 226 B 184 LYS A 63 LYS.? 28.35 CL CL A 226 B 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 40.63 7.13 9.06 35.85 7.36 8.95 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 63 LYS.? 28.35 CL CL A 226 B 184 LYS A 60 LYS.? 19.24 CL CL A 226 B 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 40.63 7.13 9.06 35.85 7.36 8.95 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 63 LYS.? 28.35 CL CL A 226 B 184 LYS A 60 LYS.? 19.24 CL CL A 226 B 345 ASP A 193 ASP~? 30.50 CL CL A 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 40.63 7.13 9.06 35.85 7.36 8.95 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 12.56 -7.85 -7.87 10.56 -8.42 -7.58 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS A 195 LYS~? 35.76 CL CL A 226 B 184 LYS A 200 LYS~? 23.56 CL CL A 226 B 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS A 200 LYS~? 23.56 CL CL A 226 B 184 LYS A 195 LYS~? 35.76 CL CL A 226 B 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 40.63 7.13 9.06 35.85 7.36 8.95 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS A 205 LYS~? 25.48 CL CL A 226 B 184 LYS A 200 LYS~? 23.56 CL CL A 226 B 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 40.63 7.13 9.06 35.85 7.36 8.95 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS B 63 LYS.? 30.86 CL CL B 226 B 184 LYS B 60 LYS.? 20.89 CL CL B 226 B 345 ASP B 193 ASP~? 31.47 CL CL B 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 61.77 -19.16 38.03 61.33 -25.31 39.26 coo 40.63 7.13 9.06 35.85 7.36 8.95 65.19 -13.54 33.83 65.46 -10.39 36.65 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS B 200 LYS~? 24.54 CL CL B 226 B 184 LYS B 195 LYS~? 36.01 CL CL B 226 B 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 60.00 0.23 45.11 63.70 -4.80 44.31 coo 40.63 7.13 9.06 35.85 7.36 8.95 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 44.68 -0.98 44.91 42.92 -2.08 45.36 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 9 3 # 9 B 182 LYS B 205 LYS~? 25.67 CL CL B 226 B 184 LYS B 200 LYS~? 24.54 CL CL B 226 B 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 38.76 2.27 4.00 34.00 5.99 4.37 54.11 5.83 42.26 49.56 6.08 46.56 coo 40.63 7.13 9.06 35.85 7.36 8.95 60.00 0.23 45.11 63.70 -4.80 44.31 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 60 LYS.? 19.24 CL CL A 226 C 184 LYS A 63 LYS.? 28.35 CL CL A 226 C 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo -5.66 12.40 71.13 -2.66 9.98 66.50 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 0.95 12.72 73.51 1.58 12.72 68.31 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -4.59 24.28 66.67 -6.26 24.34 67.99 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 63 LYS.? 28.35 CL CL A 226 C 184 LYS A 60 LYS.? 19.24 CL CL A 226 C 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo -5.66 12.40 71.13 -2.66 9.98 66.50 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 0.95 12.72 73.51 1.58 12.72 68.31 9.83 -11.93 8.36 13.65 -13.48 11.58 coo -4.59 24.28 66.67 -6.26 24.34 67.99 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 205 LYS~? 25.48 CL CL A 226 C 184 LYS A 200 LYS~? 23.56 CL CL A 226 C 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo -5.66 12.40 71.13 -2.66 9.98 66.50 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 0.95 12.72 73.51 1.58 12.72 68.31 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo -4.59 24.28 66.67 -6.26 24.34 67.99 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS B 205 LYS~? 25.67 CL CL B 226 C 184 LYS B 200 LYS~? 24.54 CL CL B 226 C 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo -5.66 12.40 71.13 -2.66 9.98 66.50 54.11 5.83 42.26 49.56 6.08 46.56 coo 0.95 12.72 73.51 1.58 12.72 68.31 60.00 0.23 45.11 63.70 -4.80 44.31 coo -4.59 24.28 66.67 -6.26 24.34 67.99 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 60 LYS.? 19.24 CL CL A 226 D 184 LYS A 63 LYS.? 28.35 CL CL A 226 D 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 60 LYS.? 19.24 CL CL A 226 D 184 LYS A 63 LYS.? 28.35 CL CL A 226 D 345 ASP A 43 ASP.? 11.79 CL CL A 226 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS A 63 LYS.? 28.35 CL CL A 226 D 184 LYS A 60 LYS.? 19.24 CL CL A 226 D 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS A 205 LYS~? 25.48 CL CL A 226 D 184 LYS A 200 LYS~? 23.56 CL CL A 226 D 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS B 205 LYS~? 25.67 CL CL B 226 D 184 LYS B 200 LYS~? 24.54 CL CL B 226 D 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 54.11 5.83 42.26 49.56 6.08 46.56 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 60.00 0.23 45.11 63.70 -4.80 44.31 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 60 LYS.? 19.24 CL CL A 226 E 184 LYS A 63 LYS.? 28.35 CL CL A 226 E 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo -21.16 62.58 121.86 -16.35 60.33 119.23 9.83 -11.93 8.36 13.65 -13.48 11.58 coo -23.22 55.98 120.74 -18.11 55.31 120.43 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -17.15 59.71 133.33 -17.96 61.54 134.01 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 60 LYS.? 19.24 CL CL A 226 E 184 LYS A 63 LYS.? 28.35 CL CL A 226 E 345 ASP A 43 ASP.? 11.79 CL CL A 226 coo -21.16 62.58 121.86 -16.35 60.33 119.23 9.83 -11.93 8.36 13.65 -13.48 11.58 coo -23.22 55.98 120.74 -18.11 55.31 120.43 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -17.15 59.71 133.33 -17.96 61.54 134.01 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS A 63 LYS.? 28.35 CL CL A 226 E 184 LYS A 60 LYS.? 19.24 CL CL A 226 E 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo -21.16 62.58 121.86 -16.35 60.33 119.23 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -23.22 55.98 120.74 -18.11 55.31 120.43 9.83 -11.93 8.36 13.65 -13.48 11.58 coo -17.15 59.71 133.33 -17.96 61.54 134.01 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS A 205 LYS~? 25.48 CL CL A 226 E 184 LYS A 200 LYS~? 23.56 CL CL A 226 E 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo -21.16 62.58 121.86 -16.35 60.33 119.23 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -23.22 55.98 120.74 -18.11 55.31 120.43 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo -17.15 59.71 133.33 -17.96 61.54 134.01 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS B 205 LYS~? 25.67 CL CL B 226 E 184 LYS B 200 LYS~? 24.54 CL CL B 226 E 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo -21.16 62.58 121.86 -16.35 60.33 119.23 54.11 5.83 42.26 49.56 6.08 46.56 coo -23.22 55.98 120.74 -18.11 55.31 120.43 60.00 0.23 45.11 63.70 -4.80 44.31 coo -17.15 59.71 133.33 -17.96 61.54 134.01 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 60 LYS.? 19.24 CL CL A 226 F 184 LYS A 63 LYS.? 28.35 CL CL A 226 F 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 10.64 34.02 91.30 6.30 35.60 95.11 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 13.75 39.76 94.12 11.42 37.23 97.89 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 16.35 26.90 99.56 16.81 25.90 97.75 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 60 LYS.? 19.24 CL CL A 226 F 184 LYS A 63 LYS.? 28.35 CL CL A 226 F 345 ASP A 43 ASP.? 11.79 CL CL A 226 coo 10.64 34.02 91.30 6.30 35.60 95.11 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 13.75 39.76 94.12 11.42 37.23 97.89 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 16.35 26.90 99.56 16.81 25.90 97.75 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS A 63 LYS.? 28.35 CL CL A 226 F 184 LYS A 60 LYS.? 19.24 CL CL A 226 F 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 10.64 34.02 91.30 6.30 35.60 95.11 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 13.75 39.76 94.12 11.42 37.23 97.89 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 16.35 26.90 99.56 16.81 25.90 97.75 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS A 205 LYS~? 25.48 CL CL A 226 F 184 LYS A 200 LYS~? 23.56 CL CL A 226 F 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 10.64 34.02 91.30 6.30 35.60 95.11 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 13.75 39.76 94.12 11.42 37.23 97.89 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 16.35 26.90 99.56 16.81 25.90 97.75 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS B 205 LYS~? 25.67 CL CL B 226 F 184 LYS B 200 LYS~? 24.54 CL CL B 226 F 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 10.64 34.02 91.30 6.30 35.60 95.11 54.11 5.83 42.26 49.56 6.08 46.56 coo 13.75 39.76 94.12 11.42 37.23 97.89 60.00 0.23 45.11 63.70 -4.80 44.31 coo 16.35 26.90 99.56 16.81 25.90 97.75 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 60 LYS.? 19.24 CL CL A 226 G 184 LYS A 63 LYS.? 28.35 CL CL A 226 G 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 39.68 42.04 76.11 43.42 46.43 74.96 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 36.69 47.69 78.93 39.38 50.40 75.35 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 33.43 44.37 65.47 33.10 42.30 65.37 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 60 LYS.? 19.24 CL CL A 226 G 184 LYS A 63 LYS.? 28.35 CL CL A 226 G 345 ASP A 43 ASP.? 11.79 CL CL A 226 coo 39.68 42.04 76.11 43.42 46.43 74.96 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 36.69 47.69 78.93 39.38 50.40 75.35 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 33.43 44.37 65.47 33.10 42.30 65.37 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 63 LYS.? 28.35 CL CL A 226 G 184 LYS A 60 LYS.? 19.24 CL CL A 226 G 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 39.68 42.04 76.11 43.42 46.43 74.96 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 36.69 47.69 78.93 39.38 50.40 75.35 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 33.43 44.37 65.47 33.10 42.30 65.37 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS A 205 LYS~? 25.48 CL CL A 226 G 184 LYS A 200 LYS~? 23.56 CL CL A 226 G 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 39.68 42.04 76.11 43.42 46.43 74.96 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 36.69 47.69 78.93 39.38 50.40 75.35 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 33.43 44.37 65.47 33.10 42.30 65.37 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS B 205 LYS~? 25.67 CL CL B 226 G 184 LYS B 200 LYS~? 24.54 CL CL B 226 G 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 39.68 42.04 76.11 43.42 46.43 74.96 54.11 5.83 42.26 49.56 6.08 46.56 coo 36.69 47.69 78.93 39.38 50.40 75.35 60.00 0.23 45.11 63.70 -4.80 44.31 coo 33.43 44.37 65.47 33.10 42.30 65.37 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 60 LYS.? 19.24 CL CL A 226 H 184 LYS A 63 LYS.? 28.35 CL CL A 226 H 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 71.58 83.18 80.51 66.88 79.77 79.84 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 73.65 78.64 75.66 68.14 79.07 75.04 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 67.43 90.73 71.39 68.27 92.30 72.52 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 60 LYS.? 19.24 CL CL A 226 H 184 LYS A 63 LYS.? 28.35 CL CL A 226 H 345 ASP A 43 ASP.? 11.79 CL CL A 226 coo 71.58 83.18 80.51 66.88 79.77 79.84 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 73.65 78.64 75.66 68.14 79.07 75.04 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 67.43 90.73 71.39 68.27 92.30 72.52 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS A 63 LYS.? 28.35 CL CL A 226 H 184 LYS A 60 LYS.? 19.24 CL CL A 226 H 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 71.58 83.18 80.51 66.88 79.77 79.84 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 73.65 78.64 75.66 68.14 79.07 75.04 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 67.43 90.73 71.39 68.27 92.30 72.52 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS A 205 LYS~? 25.48 CL CL A 226 H 184 LYS A 200 LYS~? 23.56 CL CL A 226 H 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 71.58 83.18 80.51 66.88 79.77 79.84 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 73.65 78.64 75.66 68.14 79.07 75.04 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 67.43 90.73 71.39 68.27 92.30 72.52 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS B 205 LYS~? 25.67 CL CL B 226 H 184 LYS B 200 LYS~? 24.54 CL CL B 226 H 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 71.58 83.18 80.51 66.88 79.77 79.84 54.11 5.83 42.26 49.56 6.08 46.56 coo 73.65 78.64 75.66 68.14 79.07 75.04 60.00 0.23 45.11 63.70 -4.80 44.31 coo 67.43 90.73 71.39 68.27 92.30 72.52 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 60 LYS.? 19.24 CL CL A 226 I 184 LYS A 63 LYS.? 28.35 CL CL A 226 I 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 60.20 96.92 42.53 57.60 93.13 38.67 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 54.31 95.46 46.01 55.34 91.59 42.65 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 66.35 87.81 48.53 68.10 89.01 48.77 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 60 LYS.? 19.24 CL CL A 226 I 184 LYS A 63 LYS.? 28.35 CL CL A 226 I 345 ASP A 43 ASP.? 11.79 CL CL A 226 coo 60.20 96.92 42.53 57.60 93.13 38.67 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 54.31 95.46 46.01 55.34 91.59 42.65 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 66.35 87.81 48.53 68.10 89.01 48.77 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS A 63 LYS.? 28.35 CL CL A 226 I 184 LYS A 60 LYS.? 19.24 CL CL A 226 I 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 60.20 96.92 42.53 57.60 93.13 38.67 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 54.31 95.46 46.01 55.34 91.59 42.65 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 66.35 87.81 48.53 68.10 89.01 48.77 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS A 205 LYS~? 25.48 CL CL A 226 I 184 LYS A 200 LYS~? 23.56 CL CL A 226 I 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 60.20 96.92 42.53 57.60 93.13 38.67 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 54.31 95.46 46.01 55.34 91.59 42.65 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 66.35 87.81 48.53 68.10 89.01 48.77 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS B 205 LYS~? 25.67 CL CL B 226 I 184 LYS B 200 LYS~? 24.54 CL CL B 226 I 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 60.20 96.92 42.53 57.60 93.13 38.67 54.11 5.83 42.26 49.56 6.08 46.56 coo 54.31 95.46 46.01 55.34 91.59 42.65 60.00 0.23 45.11 63.70 -4.80 44.31 coo 66.35 87.81 48.53 68.10 89.01 48.77 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 60 LYS.? 19.24 CL CL A 226 J 184 LYS A 63 LYS.? 28.35 CL CL A 226 J 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 25.22 70.55 14.03 27.64 73.07 18.65 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 31.73 69.87 11.50 32.73 70.19 16.40 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 25.87 58.42 18.79 23.95 58.54 17.90 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 63 LYS.? 28.35 CL CL A 226 J 184 LYS A 60 LYS.? 19.24 CL CL A 226 J 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 25.22 70.55 14.03 27.64 73.07 18.65 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 31.73 69.87 11.50 32.73 70.19 16.40 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 25.87 58.42 18.79 23.95 58.54 17.90 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS A 205 LYS~? 25.48 CL CL A 226 J 184 LYS A 200 LYS~? 23.56 CL CL A 226 J 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 25.22 70.55 14.03 27.64 73.07 18.65 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 31.73 69.87 11.50 32.73 70.19 16.40 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 25.87 58.42 18.79 23.95 58.54 17.90 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS B 205 LYS~? 25.67 CL CL B 226 J 184 LYS B 200 LYS~? 24.54 CL CL B 226 J 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 25.22 70.55 14.03 27.64 73.07 18.65 54.11 5.83 42.26 49.56 6.08 46.56 coo 31.73 69.87 11.50 32.73 70.19 16.40 60.00 0.23 45.11 63.70 -4.80 44.31 coo 25.87 58.42 18.79 23.95 58.54 17.90 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 60 LYS.? 19.24 CL CL A 226 K 184 LYS A 63 LYS.? 28.35 CL CL A 226 K 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 63 LYS.? 28.35 CL CL A 226 K 184 LYS A 60 LYS.? 19.24 CL CL A 226 K 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 205 LYS~? 25.48 CL CL A 226 K 184 LYS A 200 LYS~? 23.56 CL CL A 226 K 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS B 205 LYS~? 25.67 CL CL B 226 K 184 LYS B 200 LYS~? 24.54 CL CL B 226 K 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 54.11 5.83 42.26 49.56 6.08 46.56 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 60.00 0.23 45.11 63.70 -4.80 44.31 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 60 LYS.? 19.24 CL CL A 226 L 184 LYS A 63 LYS.? 28.35 CL CL A 226 L 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 63 LYS.? 28.35 CL CL A 226 L 184 LYS A 60 LYS.? 19.24 CL CL A 226 L 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 63 LYS.? 28.35 CL CL A 226 L 184 LYS A 60 LYS.? 19.24 CL CL A 226 L 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS A 63 LYS.? 28.35 CL CL A 226 L 184 LYS A 60 LYS.? 19.24 CL CL A 226 L 345 ASP A 193 ASP~? 30.50 CL CL A 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 12.56 -7.85 -7.87 10.56 -8.42 -7.58 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS A 195 LYS~? 35.76 CL CL A 226 L 184 LYS A 200 LYS~? 23.56 CL CL A 226 L 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS A 205 LYS~? 25.48 CL CL A 226 L 184 LYS A 200 LYS~? 23.56 CL CL A 226 L 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS B 63 LYS.? 30.86 CL CL B 226 L 184 LYS B 60 LYS.? 20.89 CL CL B 226 L 345 ASP B 193 ASP~? 31.47 CL CL B 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 61.77 -19.16 38.03 61.33 -25.31 39.26 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 65.19 -13.54 33.83 65.46 -10.39 36.65 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS B 200 LYS~? 24.54 CL CL B 226 L 184 LYS B 195 LYS~? 36.01 CL CL B 226 L 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 60.00 0.23 45.11 63.70 -4.80 44.31 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 44.68 -0.98 44.91 42.92 -2.08 45.36 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS B 205 LYS~? 25.67 CL CL B 226 L 184 LYS B 200 LYS~? 24.54 CL CL B 226 L 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 54.11 5.83 42.26 49.56 6.08 46.56 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 60.00 0.23 45.11 63.70 -4.80 44.31 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 60 LYS.? 19.24 CL CL A 226 M 184 LYS A 63 LYS.? 28.35 CL CL A 226 M 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 9.83 -11.93 8.36 13.65 -13.48 11.58 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 63 LYS.? 28.35 CL CL A 226 M 184 LYS A 60 LYS.? 19.24 CL CL A 226 M 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 9.83 -11.93 8.36 13.65 -13.48 11.58 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 63 LYS.? 28.35 CL CL A 226 M 184 LYS A 60 LYS.? 19.24 CL CL A 226 M 345 ASP A 193 ASP~? 30.50 CL CL A 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 9.83 -11.93 8.36 13.65 -13.48 11.58 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 12.56 -7.85 -7.87 10.56 -8.42 -7.58 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS A 195 LYS~? 35.76 CL CL A 226 M 184 LYS A 200 LYS~? 23.56 CL CL A 226 M 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS A 200 LYS~? 23.56 CL CL A 226 M 184 LYS A 195 LYS~? 35.76 CL CL A 226 M 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS A 205 LYS~? 25.48 CL CL A 226 M 184 LYS A 200 LYS~? 23.56 CL CL A 226 M 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 22.99 6.92 -1.82 27.19 5.73 -6.29 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS B 63 LYS.? 30.86 CL CL B 226 M 184 LYS B 60 LYS.? 20.89 CL CL B 226 M 345 ASP B 193 ASP~? 31.47 CL CL B 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 61.77 -19.16 38.03 61.33 -25.31 39.26 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 65.19 -13.54 33.83 65.46 -10.39 36.65 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS B 200 LYS~? 24.54 CL CL B 226 M 184 LYS B 195 LYS~? 36.01 CL CL B 226 M 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 60.00 0.23 45.11 63.70 -4.80 44.31 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 58.60 -4.05 52.32 60.39 -2.54 57.56 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 44.68 -0.98 44.91 42.92 -2.08 45.36 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 9 3 # 9 M 182 LYS B 205 LYS~? 25.67 CL CL B 226 M 184 LYS B 200 LYS~? 24.54 CL CL B 226 M 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 54.11 5.83 42.26 49.56 6.08 46.56 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 60.00 0.23 45.11 63.70 -4.80 44.31 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 60 LYS.? 19.24 CL CL A 226 N 184 LYS A 63 LYS.? 28.35 CL CL A 226 N 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 60 LYS.? 19.24 CL CL A 226 N 184 LYS A 63 LYS.? 28.35 CL CL A 226 N 345 ASP A 43 ASP.? 11.79 CL CL A 226 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS A 63 LYS.? 28.35 CL CL A 226 N 184 LYS A 60 LYS.? 19.24 CL CL A 226 N 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS A 205 LYS~? 25.48 CL CL A 226 N 184 LYS A 200 LYS~? 23.56 CL CL A 226 N 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS B 205 LYS~? 25.67 CL CL B 226 N 184 LYS B 200 LYS~? 24.54 CL CL B 226 N 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 54.11 5.83 42.26 49.56 6.08 46.56 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 60.00 0.23 45.11 63.70 -4.80 44.31 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 60 LYS.? 19.24 CL CL A 226 O 184 LYS A 63 LYS.? 28.35 CL CL A 226 O 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 60 LYS.? 19.24 CL CL A 226 O 184 LYS A 63 LYS.? 28.35 CL CL A 226 O 345 ASP A 43 ASP.? 11.79 CL CL A 226 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 16.13 -5.04 13.46 14.39 -5.59 14.60 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 63 LYS.? 28.35 CL CL A 226 O 184 LYS A 60 LYS.? 19.24 CL CL A 226 O 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS A 205 LYS~? 25.48 CL CL A 226 O 184 LYS A 200 LYS~? 23.56 CL CL A 226 O 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS B 205 LYS~? 25.67 CL CL B 226 O 184 LYS B 200 LYS~? 24.54 CL CL B 226 O 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 54.11 5.83 42.26 49.56 6.08 46.56 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 60.00 0.23 45.11 63.70 -4.80 44.31 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 60 LYS.? 19.24 CL CL A 226 P 184 LYS A 63 LYS.? 28.35 CL CL A 226 P 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 63 LYS.? 28.35 CL CL A 226 P 184 LYS A 60 LYS.? 19.24 CL CL A 226 P 345 ASP A 2 ASP.? 26.08 CL CL A 226 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 12.58 -19.85 19.79 12.48 -21.80 20.57 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 63 LYS.? 28.35 CL CL A 226 P 184 LYS A 60 LYS.? 19.24 CL CL A 226 P 345 ASP A 193 ASP~? 30.50 CL CL A 226 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 12.56 -7.85 -7.87 10.56 -8.42 -7.58 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS A 195 LYS~? 35.76 CL CL A 226 P 184 LYS A 200 LYS~? 23.56 CL CL A 226 P 345 ASP A 186 ASP.? 30.68 CL CL A 226 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 15.96 -14.00 -5.08 16.51 -16.03 -5.46 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS A 200 LYS~? 23.56 CL CL A 226 P 184 LYS A 195 LYS~? 35.76 CL CL A 226 P 345 ASP A 111 ASP~? 26.09 CL CL A 226 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 16.08 2.95 -3.95 11.11 -0.40 -2.10 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 15.39 -2.37 -10.76 12.03 -0.80 -15.65 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 31.12 -1.27 -4.41 32.14 -3.02 -5.07 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS B 63 LYS.? 30.86 CL CL B 226 P 184 LYS B 60 LYS.? 20.89 CL CL B 226 P 345 ASP B 193 ASP~? 31.47 CL CL B 226 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 61.77 -19.16 38.03 61.33 -25.31 39.26 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 65.19 -13.54 33.83 65.46 -10.39 36.65 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 60.57 -10.33 49.95 62.16 -11.61 50.53 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS B 200 LYS~? 24.54 CL CL B 226 P 184 LYS B 195 LYS~? 36.01 CL CL B 226 P 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 60.00 0.23 45.11 63.70 -4.80 44.31 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 58.60 -4.05 52.32 60.39 -2.54 57.56 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 44.68 -0.98 44.91 42.92 -2.08 45.36 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS B 205 LYS~? 25.67 CL CL B 226 P 184 LYS B 200 LYS~? 24.54 CL CL B 226 P 345 ASP B 111 ASP~? 25.68 CL CL B 226 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 54.11 5.83 42.26 49.56 6.08 46.56 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 60.00 0.23 45.11 63.70 -4.80 44.31 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 44.68 -0.98 44.91 42.92 -2.08 45.36 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 46 TYR^? 12.99 CL CL A 226 A 245 ASP A 40 ASP.? 7.65 CL CL A 226 A 273 LYS A 178 LYS~? 16.45 CL CL A 226 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 22.89 -11.80 16.43 23.58 -9.15 16.08 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 46 TYR^? 12.90 CL CL B 226 A 245 ASP B 40 ASP.? 7.91 CL CL B 226 A 273 LYS B 178 LYS~? 16.76 CL CL B 226 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 50.79 -14.19 25.59 51.15 -11.43 25.53 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 208 TYR~? 15.74 CL CL B 226 A 245 ASP B 102 ASP~? 16.83 CL CL B 226 A 273 LYS B 213 LYS~? 22.42 CL CL B 226 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 52.42 6.76 36.83 50.45 6.61 34.90 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 45.25 7.06 34.64 46.46 8.64 34.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 48.60 15.99 42.06 48.42 16.28 35.76 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 3 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 42 PHE.? 8.14 CL CL A 226 A 245 ASP A 43 ASP.? 11.79 CL CL A 226 A 273 LYS A 60 LYS.? 19.24 CL CL A 226 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 22.13 -2.28 11.68 23.85 -0.28 10.73 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 16.13 -5.04 13.46 14.39 -5.59 14.60 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 109 PHE~? 18.50 CL CL A 226 A 245 ASP A 203 ASP~? 25.03 CL CL A 226 A 273 LYS A 195 LYS~? 35.76 CL CL A 226 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 24.98 3.58 -0.85 22.97 3.50 1.05 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE B 109 PHE~? 18.73 CL CL B 226 A 245 ASP B 102 ASP~? 16.83 CL CL B 226 A 273 LYS B 96 LYS^? 24.51 CL CL B 226 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 51.52 2.89 41.40 53.63 2.11 39.78 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 45.25 7.06 34.64 46.46 8.64 34.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 35.42 10.33 36.63 41.15 11.45 39.22 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 3 hits 2gsa_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 109 PHE~? 18.50 CL CL A 226 A 263 ASP A 203 ASP~? 25.03 CL CL A 226 A 292 LYS A 195 LYS~? 35.76 CL CL A 226 coo 51.51 50.32 16.39 52.13 49.68 13.75 24.98 3.58 -0.85 22.97 3.50 1.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 63.95 45.30 16.71 59.11 49.15 16.05 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 109 PHE~? 18.50 CL CL A 226 A 263 ASP A 203 ASP~? 25.03 CL CL A 226 A 292 LYS A 213 LYS.? 30.41 CL CL A 226 coo 51.51 50.32 16.39 52.13 49.68 13.75 24.98 3.58 -0.85 22.97 3.50 1.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 63.95 45.30 16.71 59.11 49.15 16.05 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 109 PHE~? 18.73 CL CL B 226 A 263 ASP B 102 ASP~? 16.83 CL CL B 226 A 292 LYS B 213 LYS~? 22.42 CL CL B 226 coo 51.51 50.32 16.39 52.13 49.68 13.75 51.52 2.89 41.40 53.63 2.11 39.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 45.25 7.06 34.64 46.46 8.64 34.05 coo 63.95 45.30 16.71 59.11 49.15 16.05 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 109 PHE~? 18.73 CL CL B 226 A 263 ASP B 203 ASP~? 25.12 CL CL B 226 A 292 LYS B 178 LYS~? 16.76 CL CL B 226 coo 51.51 50.32 16.39 52.13 49.68 13.75 51.52 2.89 41.40 53.63 2.11 39.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 60.54 4.31 43.90 62.00 4.57 45.37 coo 63.95 45.30 16.71 59.11 49.15 16.05 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE B 109 PHE~? 18.73 CL CL B 226 A 263 ASP B 203 ASP~? 25.12 CL CL B 226 A 292 LYS B 195 LYS~? 36.01 CL CL B 226 coo 51.51 50.32 16.39 52.13 49.68 13.75 51.52 2.89 41.40 53.63 2.11 39.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 60.54 4.31 43.90 62.00 4.57 45.37 coo 63.95 45.30 16.71 59.11 49.15 16.05 58.60 -4.05 52.32 60.39 -2.54 57.56 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE B 183 PHE~? 27.12 CL CL B 226 A 263 ASP B 186 ASP.? 30.73 CL CL B 226 A 292 LYS B 63 LYS.? 30.86 CL CL B 226 coo 51.51 50.32 16.39 52.13 49.68 13.75 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 54.43 44.82 23.74 55.21 45.06 21.80 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 61.77 -19.16 38.03 61.33 -25.31 39.26 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 109 PHE~? 18.50 CL CL A 226 B 263 ASP A 203 ASP~? 25.03 CL CL A 226 B 292 LYS A 195 LYS~? 35.76 CL CL A 226 coo 49.99 26.05 6.28 51.46 26.87 8.49 24.98 3.58 -0.85 22.97 3.50 1.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 60.53 31.67 0.97 57.79 27.51 3.63 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 109 PHE~? 18.50 CL CL A 226 B 263 ASP A 203 ASP~? 25.03 CL CL A 226 B 292 LYS A 213 LYS.? 30.41 CL CL A 226 coo 49.99 26.05 6.28 51.46 26.87 8.49 24.98 3.58 -0.85 22.97 3.50 1.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 60.53 31.67 0.97 57.79 27.51 3.63 20.84 14.61 -7.95 16.28 17.34 -7.27 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE B 109 PHE~? 18.73 CL CL B 226 B 263 ASP B 102 ASP~? 16.83 CL CL B 226 B 292 LYS B 213 LYS~? 22.42 CL CL B 226 coo 49.99 26.05 6.28 51.46 26.87 8.49 51.52 2.89 41.40 53.63 2.11 39.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 45.25 7.06 34.64 46.46 8.64 34.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 109 PHE~? 18.73 CL CL B 226 B 263 ASP B 203 ASP~? 25.12 CL CL B 226 B 292 LYS B 195 LYS~? 36.01 CL CL B 226 coo 49.99 26.05 6.28 51.46 26.87 8.49 51.52 2.89 41.40 53.63 2.11 39.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 60.54 4.31 43.90 62.00 4.57 45.37 coo 60.53 31.67 0.97 57.79 27.51 3.63 58.60 -4.05 52.32 60.39 -2.54 57.56 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE B 183 PHE~? 27.12 CL CL B 226 B 263 ASP B 186 ASP.? 30.73 CL CL B 226 B 292 LYS B 63 LYS.? 30.86 CL CL B 226 coo 49.99 26.05 6.28 51.46 26.87 8.49 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 60.53 31.67 0.97 57.79 27.51 3.63 61.77 -19.16 38.03 61.33 -25.31 39.26 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 5 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 109 PHE~? 18.50 CL CL A 226 C 263 ASP A 203 ASP~? 25.03 CL CL A 226 C 292 LYS A 195 LYS~? 35.76 CL CL A 226 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 24.98 3.58 -0.85 22.97 3.50 1.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 12.82 3.49 4.98 17.80 5.59 1.90 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 109 PHE~? 18.73 CL CL B 226 C 263 ASP B 102 ASP~? 16.83 CL CL B 226 C 292 LYS B 213 LYS~? 22.42 CL CL B 226 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 51.52 2.89 41.40 53.63 2.11 39.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 45.25 7.06 34.64 46.46 8.64 34.05 coo 12.82 3.49 4.98 17.80 5.59 1.90 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 109 PHE~? 18.73 CL CL B 226 C 263 ASP B 203 ASP~? 25.12 CL CL B 226 C 292 LYS B 178 LYS~? 16.76 CL CL B 226 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 51.52 2.89 41.40 53.63 2.11 39.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 60.54 4.31 43.90 62.00 4.57 45.37 coo 12.82 3.49 4.98 17.80 5.59 1.90 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 109 PHE~? 18.73 CL CL B 226 C 263 ASP B 203 ASP~? 25.12 CL CL B 226 C 292 LYS B 195 LYS~? 36.01 CL CL B 226 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 51.52 2.89 41.40 53.63 2.11 39.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 60.54 4.31 43.90 62.00 4.57 45.37 coo 12.82 3.49 4.98 17.80 5.59 1.90 58.60 -4.05 52.32 60.39 -2.54 57.56 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE B 183 PHE~? 27.12 CL CL B 226 C 263 ASP B 186 ASP.? 30.73 CL CL B 226 C 292 LYS B 63 LYS.? 30.86 CL CL B 226 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 56.01 -9.93 46.28 55.23 -10.02 48.96 coo 19.84 12.02 9.33 18.68 11.23 7.75 56.29 -18.50 46.72 54.94 -17.46 47.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 61.77 -19.16 38.03 61.33 -25.31 39.26 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 5 hits 2oat_c05 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 203 ASP~? 25.03 CL CL A 226 A 151 LYS A 205 LYS~? 25.48 CL CL A 226 A 154 ASN A 202 ASN~? 26.54 CL CL A 226 coo 41.42 17.90 44.98 43.39 18.36 45.61 16.55 6.97 -3.38 15.26 7.22 -5.04 coo 45.75 16.58 39.61 47.43 18.26 45.54 22.99 6.92 -1.82 27.19 5.73 -6.29 coo 44.77 13.10 43.25 45.01 14.21 45.03 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 203 ASP~? 25.12 CL CL B 226 A 151 LYS B 205 LYS~? 25.67 CL CL B 226 A 154 ASN B 202 ASN~? 26.89 CL CL B 226 coo 41.42 17.90 44.98 43.39 18.36 45.61 60.54 4.31 43.90 62.00 4.57 45.37 coo 45.75 16.58 39.61 47.43 18.26 45.54 54.11 5.83 42.26 49.56 6.08 46.56 coo 44.77 13.10 43.25 45.01 14.21 45.03 56.47 4.11 47.59 54.90 3.31 48.75 2phk_c03 source 2phk MC-PEPTIDE : 2 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 2 ASP.? 26.08 CL CL A 226 166 GLY A 23 GLY~? 23.20 CL CL A 226 169 GLU B 77 GLU~? 22.22 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 12.58 -19.85 19.79 12.48 -21.80 20.57 coo -8.58 13.22 3.21 -8.90 13.15 4.05 31.11 -18.04 25.28 31.02 -18.32 24.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 40 ASP.? 7.65 CL CL A 226 166 GLY A 23 GLY~? 23.20 CL CL A 226 169 GLU A 26 GLU~? 31.19 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 31.11 -18.04 25.28 31.02 -18.32 24.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 31.04 -26.45 25.52 31.42 -26.09 27.62 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 40 ASP.? 7.65 CL CL A 226 166 GLY A 85 GLY~? 15.77 CL CL A 226 169 GLU B 11 GLU.? 11.19 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 20.12 -4.48 17.55 21.44 -4.89 15.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 37.09 1.03 13.26 36.82 0.94 14.00 coo -16.67 7.89 2.78 -17.65 6.56 1.49 45.62 0.60 17.46 44.46 2.32 17.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 43 ASP.? 11.79 CL CL A 226 166 GLY A 15 GLY~? 13.48 CL CL A 226 169 GLU A 84 GLU~? 12.94 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 16.13 -5.04 13.46 14.39 -5.59 14.60 coo -8.58 13.22 3.21 -8.90 13.15 4.05 32.14 -6.39 21.42 31.45 -6.64 21.14 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 43 ASP.? 11.79 CL CL A 226 166 GLY A 15 GLY~? 13.48 CL CL A 226 169 GLU B 77 GLU~? 22.22 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 16.13 -5.04 13.46 14.39 -5.59 14.60 coo -8.58 13.22 3.21 -8.90 13.15 4.05 32.14 -6.39 21.42 31.45 -6.64 21.14 coo -16.67 7.89 2.78 -17.65 6.56 1.49 34.33 -9.48 30.93 34.02 -11.53 31.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 102 ASP~? 17.30 CL CL A 226 166 GLY A 78 GLY~? 19.52 CL CL A 226 169 GLU A 69 GLU^? 25.00 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 32.53 7.12 5.29 31.66 9.04 5.62 coo -8.58 13.22 3.21 -8.90 13.15 4.05 36.22 -9.15 11.05 36.43 -9.16 11.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 30.56 -16.89 8.89 31.90 -18.26 8.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 111 ASP~? 26.09 CL CL A 226 166 GLY A 78 GLY~? 19.52 CL CL A 226 169 GLU A 84 GLU~? 12.94 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -8.58 13.22 3.21 -8.90 13.15 4.05 36.22 -9.15 11.05 36.43 -9.16 11.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 111 ASP~? 26.09 CL CL A 226 166 GLY A 85 GLY~? 15.77 CL CL A 226 169 GLU B 11 GLU.? 11.19 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -8.58 13.22 3.21 -8.90 13.15 4.05 37.09 1.03 13.26 36.82 0.94 14.00 coo -16.67 7.89 2.78 -17.65 6.56 1.49 45.62 0.60 17.46 44.46 2.32 17.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 111 ASP~? 26.09 CL CL A 226 166 GLY A 89 GLY~? 17.30 CL CL A 226 169 GLU A 84 GLU~? 12.94 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -8.58 13.22 3.21 -8.90 13.15 4.05 37.90 4.36 11.39 38.58 4.02 11.72 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP A 111 ASP~? 26.09 CL CL A 226 166 GLY A 89 GLY~? 17.30 CL CL A 226 169 GLU B 11 GLU.? 11.19 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -8.58 13.22 3.21 -8.90 13.15 4.05 37.90 4.36 11.39 38.58 4.02 11.72 coo -16.67 7.89 2.78 -17.65 6.56 1.49 45.62 0.60 17.46 44.46 2.32 17.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP A 111 ASP~? 26.09 CL CL A 226 166 GLY A 165 GLY.? 9.73 CL CL A 226 169 GLU A 84 GLU~? 12.94 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 31.12 -1.27 -4.41 32.14 -3.02 -5.07 coo -8.58 13.22 3.21 -8.90 13.15 4.05 30.46 -1.42 14.80 29.77 -1.25 14.46 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP A 151 ASP~? 27.89 CL CL A 226 166 GLY A 78 GLY~? 19.52 CL CL A 226 169 GLU A 84 GLU~? 12.94 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 31.07 -14.15 -4.04 29.86 -14.57 -2.39 coo -8.58 13.22 3.21 -8.90 13.15 4.05 36.22 -9.15 11.05 36.43 -9.16 11.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.51 -2.33 16.64 42.51 -2.90 16.44 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 40 ASP.? 7.91 CL CL B 226 166 GLY B 23 GLY~? 22.91 CL CL B 226 169 GLU B 26 GLU~? 28.82 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 41.69 -19.42 17.12 41.57 -19.65 17.88 coo -16.67 7.89 2.78 -17.65 6.56 1.49 37.69 -26.04 19.16 37.25 -23.97 18.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP B 40 ASP.? 7.91 CL CL B 226 166 GLY B 85 GLY~? 15.33 CL CL B 226 169 GLU A 11 GLU.? 11.48 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 55.19 -7.93 23.91 53.71 -7.92 25.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 39.45 1.04 27.01 39.73 0.94 26.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 31.29 2.41 22.91 32.62 4.08 23.08 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP B 43 ASP.? 11.93 CL CL B 226 166 GLY B 15 GLY~? 13.31 CL CL B 226 169 GLU A 77 GLU~? 21.84 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 58.62 -8.54 27.92 60.24 -9.54 27.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 42.83 -7.72 19.85 43.46 -8.04 20.13 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.16 -11.08 10.76 40.31 -13.18 10.50 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP B 43 ASP.? 11.93 CL CL B 226 166 GLY B 15 GLY~? 13.31 CL CL B 226 169 GLU B 84 GLU~? 12.79 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 58.62 -8.54 27.92 60.24 -9.54 27.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 42.83 -7.72 19.85 43.46 -8.04 20.13 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.35 -1.73 23.75 33.22 -1.55 23.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP B 102 ASP~? 16.83 CL CL B 226 166 GLY B 78 GLY~? 18.96 CL CL B 226 169 GLU B 69 GLU^? 24.72 CL CL B 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 45.25 7.06 34.64 46.46 8.64 34.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 38.61 -8.60 30.14 38.34 -8.69 29.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 42.13 -16.51 33.43 40.68 -17.83 34.16 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP B 111 ASP~? 25.68 CL CL B 226 166 GLY B 78 GLY~? 18.96 CL CL B 226 169 GLU B 84 GLU~? 12.79 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 38.61 -8.60 30.14 38.34 -8.69 29.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.35 -1.73 23.75 33.22 -1.55 23.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP B 111 ASP~? 25.68 CL CL B 226 166 GLY B 85 GLY~? 15.33 CL CL B 226 169 GLU A 11 GLU.? 11.48 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 39.45 1.04 27.01 39.73 0.94 26.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 31.29 2.41 22.91 32.62 4.08 23.08 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP B 111 ASP~? 25.68 CL CL B 226 166 GLY B 89 GLY~? 16.64 CL CL B 226 169 GLU A 11 GLU.? 11.48 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 39.61 4.74 28.75 38.89 4.60 28.39 coo -16.67 7.89 2.78 -17.65 6.56 1.49 31.29 2.41 22.91 32.62 4.08 23.08 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP B 111 ASP~? 25.68 CL CL B 226 166 GLY B 89 GLY~? 16.64 CL CL B 226 169 GLU B 84 GLU~? 12.79 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 39.61 4.74 28.75 38.89 4.60 28.39 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.35 -1.73 23.75 33.22 -1.55 23.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP B 111 ASP~? 25.68 CL CL B 226 166 GLY B 165 GLY.? 9.33 CL CL B 226 169 GLU B 84 GLU~? 12.79 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 45.52 -2.50 25.89 46.23 -2.42 26.22 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.35 -1.73 23.75 33.22 -1.55 23.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP B 111 ASP~? 25.68 CL CL B 226 166 GLY B 165 GLY.? 9.33 CL CL B 226 169 GLU B 168 GLU.? -5.97 CL CL B 226s coo 8.28 6.87 1.62 10.08 5.77 1.34 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 45.52 -2.50 25.89 46.23 -2.42 26.22 coo -16.67 7.89 2.78 -17.65 6.56 1.49 54.77 3.34 22.36 54.93 5.08 21.18 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP B 151 ASP~? 28.65 CL CL B 226 166 GLY B 78 GLY~? 18.96 CL CL B 226 169 GLU B 84 GLU~? 12.79 CL CL A 226 coo 8.28 6.87 1.62 10.08 5.77 1.34 41.86 -11.82 45.74 42.46 -13.70 45.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 38.61 -8.60 30.14 38.34 -8.69 29.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.35 -1.73 23.75 33.22 -1.55 23.84 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 24 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 87 TYR~? 13.92 CL CL A 226 A 172 HIS B 86 HIS~? 9.45 CL CL B 226 A 174 TYR B 87 TYR~? 13.52 CL CL B 226 coo 26.78 20.44 0.03 28.51 18.26 0.09 36.79 3.26 19.70 35.19 2.19 21.67 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 44.03 1.12 22.86 45.41 1.90 21.48 coo 24.73 15.69 1.93 26.72 14.32 3.31 40.26 2.88 20.56 41.63 1.41 18.60 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 87 TYR~? 13.52 CL CL B 226 A 172 HIS A 86 HIS~? 10.02 CL CL A 226 A 174 TYR A 87 TYR~? 13.92 CL CL A 226 coo 26.78 20.44 0.03 28.51 18.26 0.09 40.26 2.88 20.56 41.63 1.41 18.60 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 32.84 2.26 17.60 31.66 3.53 18.78 coo 24.73 15.69 1.93 26.72 14.32 3.31 36.79 3.26 19.70 35.19 2.19 21.67 2tmd_c02 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c02 naa= 3 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 87 TYR~? 13.92 CL CL A 226 B 172 HIS B 86 HIS~? 9.45 CL CL B 226 B 174 TYR B 87 TYR~? 13.52 CL CL B 226 coo 44.86 1.98 33.27 42.75 1.12 31.67 36.79 3.26 19.70 35.19 2.19 21.67 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 44.03 1.12 22.86 45.41 1.90 21.48 coo 45.95 0.11 28.25 43.87 0.82 26.55 40.26 2.88 20.56 41.63 1.41 18.60 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 87 TYR~? 13.52 CL CL B 226 B 172 HIS A 86 HIS~? 10.02 CL CL A 226 B 174 TYR A 87 TYR~? 13.92 CL CL A 226 coo 44.86 1.98 33.27 42.75 1.12 31.67 40.26 2.88 20.56 41.63 1.41 18.60 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 32.84 2.26 17.60 31.66 3.53 18.78 coo 45.95 0.11 28.25 43.87 0.82 26.55 36.79 3.26 19.70 35.19 2.19 21.67 2tmd_c03 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c03 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 90 TYR^? 17.82 CL CL A 226 A 214 ASP A 102 ASP~? 17.30 CL CL A 226 A 256 LYS A 205 LYS~? 25.48 CL CL A 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 38.12 1.32 8.30 36.38 -0.30 9.74 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 32.53 7.12 5.29 31.66 9.04 5.62 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 194 TYR~? 29.78 CL CL A 226 A 214 ASP A 186 ASP.? 30.68 CL CL A 226 A 256 LYS A 63 LYS.? 28.35 CL CL A 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 208 TYR~? 15.64 CL CL A 226 A 214 ASP A 203 ASP~? 25.03 CL CL A 226 A 256 LYS A 195 LYS~? 35.76 CL CL A 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 25.22 8.01 3.41 27.20 7.60 5.36 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR A 209 TYR~? 20.76 CL CL A 226 A 214 ASP A 203 ASP~? 25.03 CL CL A 226 A 256 LYS A 178 LYS~? 16.45 CL CL A 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 27.49 9.87 -0.64 29.01 7.64 0.00 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR A 209 TYR~? 20.76 CL CL A 226 A 214 ASP A 203 ASP~? 25.03 CL CL A 226 A 256 LYS A 195 LYS~? 35.76 CL CL A 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 27.49 9.87 -0.64 29.01 7.64 0.00 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR B 90 TYR^? 17.17 CL CL B 226 A 214 ASP B 102 ASP~? 16.83 CL CL B 226 A 256 LYS B 205 LYS~? 25.67 CL CL B 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 38.78 1.99 31.89 40.05 -0.11 30.63 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 45.25 7.06 34.64 46.46 8.64 34.05 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR B 90 TYR^? 17.17 CL CL B 226 A 214 ASP B 102 ASP~? 16.83 CL CL B 226 A 256 LYS B 213 LYS~? 22.42 CL CL B 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 38.78 1.99 31.89 40.05 -0.11 30.63 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 45.25 7.06 34.64 46.46 8.64 34.05 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR B 116 TYR~? 34.40 CL CL B 226 A 214 ASP B 111 ASP~? 25.68 CL CL B 226 A 256 LYS B 200 LYS~? 24.54 CL CL B 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 45.41 -5.95 53.84 44.74 -7.73 55.90 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR B 116 TYR~? 34.40 CL CL B 226 A 214 ASP B 111 ASP~? 25.68 CL CL B 226 A 256 LYS B 205 LYS~? 25.67 CL CL B 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 45.41 -5.95 53.84 44.74 -7.73 55.90 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR B 208 TYR~? 15.74 CL CL B 226 A 214 ASP B 203 ASP~? 25.12 CL CL B 226 A 256 LYS B 195 LYS~? 36.01 CL CL B 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 52.42 6.76 36.83 50.45 6.61 34.90 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 60.54 4.31 43.90 62.00 4.57 45.37 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 58.60 -4.05 52.32 60.39 -2.54 57.56 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR B 209 TYR~? 20.47 CL CL B 226 A 214 ASP B 203 ASP~? 25.12 CL CL B 226 A 256 LYS B 178 LYS~? 16.76 CL CL B 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 50.38 9.38 40.26 48.54 7.35 39.73 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 60.54 4.31 43.90 62.00 4.57 45.37 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR B 209 TYR~? 20.47 CL CL B 226 A 214 ASP B 203 ASP~? 25.12 CL CL B 226 A 256 LYS B 195 LYS~? 36.01 CL CL B 226 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 50.38 9.38 40.26 48.54 7.35 39.73 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 60.54 4.31 43.90 62.00 4.57 45.37 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 58.60 -4.05 52.32 60.39 -2.54 57.56 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 12 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 90 TYR^? 17.82 CL CL A 226 B 214 ASP A 102 ASP~? 17.30 CL CL A 226 B 256 LYS A 205 LYS~? 25.48 CL CL A 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 38.12 1.32 8.30 36.38 -0.30 9.74 coo -26.88 17.61 16.89 -26.08 17.11 15.00 32.53 7.12 5.29 31.66 9.04 5.62 coo -16.04 12.06 11.09 -17.97 10.54 5.71 22.99 6.92 -1.82 27.19 5.73 -6.29 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 194 TYR~? 29.78 CL CL A 226 B 214 ASP A 186 ASP.? 30.68 CL CL A 226 B 256 LYS A 60 LYS.? 19.24 CL CL A 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo -26.88 17.61 16.89 -26.08 17.11 15.00 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo -16.04 12.06 11.09 -17.97 10.54 5.71 9.83 -11.93 8.36 13.65 -13.48 11.58 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 194 TYR~? 29.78 CL CL A 226 B 214 ASP A 186 ASP.? 30.68 CL CL A 226 B 256 LYS A 63 LYS.? 28.35 CL CL A 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 18.48 -5.35 -10.35 20.66 -3.63 -10.45 coo -26.88 17.61 16.89 -26.08 17.11 15.00 15.96 -14.00 -5.08 16.51 -16.03 -5.46 coo -16.04 12.06 11.09 -17.97 10.54 5.71 11.10 -16.17 5.23 7.76 -19.70 7.97 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR A 208 TYR~? 15.64 CL CL A 226 B 214 ASP A 203 ASP~? 25.03 CL CL A 226 B 256 LYS A 195 LYS~? 35.76 CL CL A 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 25.22 8.01 3.41 27.20 7.60 5.36 coo -26.88 17.61 16.89 -26.08 17.11 15.00 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -16.04 12.06 11.09 -17.97 10.54 5.71 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR A 209 TYR~? 20.76 CL CL A 226 B 214 ASP A 203 ASP~? 25.03 CL CL A 226 B 256 LYS A 178 LYS~? 16.45 CL CL A 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 27.49 9.87 -0.64 29.01 7.64 0.00 coo -26.88 17.61 16.89 -26.08 17.11 15.00 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -16.04 12.06 11.09 -17.97 10.54 5.71 17.52 -4.22 5.13 11.68 -3.87 7.49 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR A 209 TYR~? 20.76 CL CL A 226 B 214 ASP A 203 ASP~? 25.03 CL CL A 226 B 256 LYS A 195 LYS~? 35.76 CL CL A 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 27.49 9.87 -0.64 29.01 7.64 0.00 coo -26.88 17.61 16.89 -26.08 17.11 15.00 16.55 6.97 -3.38 15.26 7.22 -5.04 coo -16.04 12.06 11.09 -17.97 10.54 5.71 15.39 -2.37 -10.76 12.03 -0.80 -15.65 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR B 90 TYR^? 17.17 CL CL B 226 B 214 ASP B 102 ASP~? 16.83 CL CL B 226 B 256 LYS B 205 LYS~? 25.67 CL CL B 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 38.78 1.99 31.89 40.05 -0.11 30.63 coo -26.88 17.61 16.89 -26.08 17.11 15.00 45.25 7.06 34.64 46.46 8.64 34.05 coo -16.04 12.06 11.09 -17.97 10.54 5.71 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR B 90 TYR^? 17.17 CL CL B 226 B 214 ASP B 102 ASP~? 16.83 CL CL B 226 B 256 LYS B 213 LYS~? 22.42 CL CL B 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 38.78 1.99 31.89 40.05 -0.11 30.63 coo -26.88 17.61 16.89 -26.08 17.11 15.00 45.25 7.06 34.64 46.46 8.64 34.05 coo -16.04 12.06 11.09 -17.97 10.54 5.71 48.60 15.99 42.06 48.42 16.28 35.76 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR B 116 TYR~? 34.40 CL CL B 226 B 214 ASP B 111 ASP~? 25.68 CL CL B 226 B 256 LYS B 200 LYS~? 24.54 CL CL B 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 45.41 -5.95 53.84 44.74 -7.73 55.90 coo -26.88 17.61 16.89 -26.08 17.11 15.00 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -16.04 12.06 11.09 -17.97 10.54 5.71 60.00 0.23 45.11 63.70 -4.80 44.31 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR B 116 TYR~? 34.40 CL CL B 226 B 214 ASP B 111 ASP~? 25.68 CL CL B 226 B 256 LYS B 205 LYS~? 25.67 CL CL B 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 45.41 -5.95 53.84 44.74 -7.73 55.90 coo -26.88 17.61 16.89 -26.08 17.11 15.00 44.68 -0.98 44.91 42.92 -2.08 45.36 coo -16.04 12.06 11.09 -17.97 10.54 5.71 54.11 5.83 42.26 49.56 6.08 46.56 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR B 208 TYR~? 15.74 CL CL B 226 B 214 ASP B 203 ASP~? 25.12 CL CL B 226 B 256 LYS B 195 LYS~? 36.01 CL CL B 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 52.42 6.76 36.83 50.45 6.61 34.90 coo -26.88 17.61 16.89 -26.08 17.11 15.00 60.54 4.31 43.90 62.00 4.57 45.37 coo -16.04 12.06 11.09 -17.97 10.54 5.71 58.60 -4.05 52.32 60.39 -2.54 57.56 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR B 209 TYR~? 20.47 CL CL B 226 B 214 ASP B 203 ASP~? 25.12 CL CL B 226 B 256 LYS B 178 LYS~? 16.76 CL CL B 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 50.38 9.38 40.26 48.54 7.35 39.73 coo -26.88 17.61 16.89 -26.08 17.11 15.00 60.54 4.31 43.90 62.00 4.57 45.37 coo -16.04 12.06 11.09 -17.97 10.54 5.71 57.30 -6.98 36.80 62.98 -8.03 34.22 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 13 3 # 13 B 122 TYR B 209 TYR~? 20.47 CL CL B 226 B 214 ASP B 203 ASP~? 25.12 CL CL B 226 B 256 LYS B 195 LYS~? 36.01 CL CL B 226 coo -32.67 22.74 10.17 -32.85 23.98 7.70 50.38 9.38 40.26 48.54 7.35 39.73 coo -26.88 17.61 16.89 -26.08 17.11 15.00 60.54 4.31 43.90 62.00 4.57 45.37 coo -16.04 12.06 11.09 -17.97 10.54 5.71 58.60 -4.05 52.32 60.39 -2.54 57.56 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 13 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG B 65 ARG.? 31.41 CL CL B 226 A 130 SER B 67 SER.? 20.24 CL CL B 226 A 159 LYS B 63 LYS.? 30.86 CL CL B 226 coo 18.35 45.84 20.99 16.20 47.83 21.89 55.55 -24.03 39.40 53.97 -26.61 39.95 coo 15.14 43.67 10.77 15.61 44.43 13.04 51.01 -17.39 35.57 51.85 -17.47 33.34 coo 11.57 48.49 22.18 13.51 49.99 17.21 61.77 -19.16 38.03 61.33 -25.31 39.26 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 8 ASN.? 6.94 CL CL A 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 24.44 -3.01 24.75 23.45 -2.96 22.86 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 39 ASN.? 7.49 CL CL A 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 17.97 -0.91 21.86 16.15 0.14 22.24 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 50 ASN.? 30.77 CL CL A 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 28.00 -25.90 12.99 26.73 -27.64 12.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 149 ASN.? 31.68 CL CL A 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 37.01 -8.84 -7.60 35.18 -8.21 -8.48 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 155 ASN~? 24.40 CL CL A 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 167 ASN.? 5.51 CL CL A 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 27.28 3.74 18.20 27.65 2.13 19.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 188 ASN.? 35.87 CL CL A 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.80 -17.36 -8.91 13.76 -19.28 -8.90 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 202 ASN~? 26.54 CL CL A 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 20.33 4.95 -7.07 21.62 3.54 -8.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 8 ASN.? 7.79 CL CL B 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.02 -6.75 16.28 50.85 -6.79 18.40 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 39 ASN.? 7.81 CL CL B 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.04 -5.16 19.24 60.05 -4.37 19.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 50 ASN.? 30.91 CL CL B 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 42.91 -26.63 29.90 43.43 -28.67 30.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 149 ASN.? 28.07 CL CL B 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 39.68 -7.57 44.84 39.54 -9.68 44.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 155 ASN~? 24.46 CL CL B 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 44.94 -7.51 42.45 43.54 -6.44 43.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 167 ASN.? 4.94 CL CL B 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 50.28 1.34 22.19 49.08 -0.16 21.24 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 188 ASN.? 35.33 CL CL B 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.21 -19.16 51.65 58.37 -21.08 50.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 202 ASN~? 26.89 CL CL B 226 coo 5.80 63.03 55.85 5.52 65.03 56.45 56.47 4.11 47.59 54.90 3.31 48.75 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 16 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 20 TYR~? 17.28 CL CL A 226 A 112 PHE A 10 PHE.? 15.16 CL CL A 226 A 140 ASN A 8 ASN.? 6.94 CL CL A 226 coo -6.29 44.15 17.65 -9.00 44.92 17.68 26.99 -13.27 24.47 26.16 -12.32 26.98 coo -7.38 52.77 16.75 -5.54 52.71 18.82 31.56 -5.14 25.65 32.44 -7.46 26.93 coo -4.46 50.64 12.29 -5.69 49.89 13.85 24.44 -3.01 24.75 23.45 -2.96 22.86 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR A 113 TYR~? 30.72 CL CL A 226 A 112 PHE A 114 PHE~? 22.97 CL CL A 226 A 140 ASN A 155 ASN~? 24.40 CL CL A 226 coo -6.29 44.15 17.65 -9.00 44.92 17.68 33.48 -4.69 -8.69 35.76 -3.13 -9.21 coo -7.38 52.77 16.75 -5.54 52.71 18.82 27.44 -4.93 -3.68 25.47 -5.75 -1.86 coo -4.46 50.64 12.29 -5.69 49.89 13.85 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR A 121 TYR.? 28.41 CL CL A 226 A 112 PHE A 114 PHE~? 22.97 CL CL A 226 A 140 ASN A 155 ASN~? 24.40 CL CL A 226 coo -6.29 44.15 17.65 -9.00 44.92 17.68 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo -7.38 52.77 16.75 -5.54 52.71 18.82 27.44 -4.93 -3.68 25.47 -5.75 -1.86 coo -4.46 50.64 12.29 -5.69 49.89 13.85 29.36 -7.90 -1.01 30.77 -7.17 -2.34 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 4 3 # 4 A 56 TYR B 20 TYR~? 17.36 CL CL B 226 A 112 PHE B 10 PHE.? 14.73 CL CL B 226 A 140 ASN B 8 ASN.? 7.79 CL CL B 226 coo -6.29 44.15 17.65 -9.00 44.92 17.68 46.52 -15.74 17.49 47.60 -15.27 14.94 coo -7.38 52.77 16.75 -5.54 52.71 18.82 43.79 -6.77 15.65 42.42 -8.98 14.72 coo -4.46 50.64 12.29 -5.69 49.89 13.85 51.02 -6.75 16.28 50.85 -6.79 18.40 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 5 3 # 5 A 56 TYR B 113 TYR~? 30.94 CL CL B 226 A 112 PHE B 114 PHE~? 23.12 CL CL B 226 A 140 ASN B 155 ASN~? 24.46 CL CL B 226 coo -6.29 44.15 17.65 -9.00 44.92 17.68 40.93 -2.67 49.32 39.01 -0.90 50.27 coo -7.38 52.77 16.75 -5.54 52.71 18.82 47.16 -4.85 44.78 49.00 -6.29 43.28 coo -4.46 50.64 12.29 -5.69 49.89 13.85 44.94 -7.51 42.45 43.54 -6.44 43.59 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 5 hits 1o8s_p00 naa= 3 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG A 81 ARG~? 19.72 CL CL B 226 A 148 SER A 82 SER~? 14.07 CL CL A 226 A 152 ALA A 14 ALA~? 12.29 CL CL A 226 A 194 GLU B 84 GLU~? 12.79 CL CL A 226 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 40.18 -5.93 10.28 41.49 -8.31 8.89 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 34.77 -3.21 13.72 33.13 -4.11 12.24 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 30.79 -6.03 17.88 31.85 -5.27 17.14 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 35.35 -1.73 23.75 33.22 -1.55 23.84 ULMN 4 2cl8_p00 DECTIN-1 user 2 4 # 2 A 145 ARG B 81 ARG~? 19.82 CL CL A 226 A 148 SER B 82 SER~? 13.78 CL CL B 226 A 152 ALA B 14 ALA~? 12.02 CL CL B 226 A 194 GLU A 84 GLU~? 12.94 CL CL B 226 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 35.26 -4.61 30.73 33.33 -6.15 32.58 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 41.03 -3.36 27.11 42.38 -4.54 28.72 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 44.33 -7.28 23.33 43.44 -6.30 24.13 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 40.51 -2.33 16.64 42.51 -2.90 16.44 2cl8_p00 source 2cl8 DECTIN-1 : 2 hits 2cl8_p00 naa= 4 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 167 ASN.? 5.51 CL CL A 226 A 384 ASN B 167 ASN.? 4.94 CL CL B 226 A 385 GLU B 11 GLU.? 11.19 CL CL B 226 coo 22.28 63.17 110.61 22.47 65.06 111.53 27.28 3.74 18.20 27.65 2.13 19.59 coo 7.06 50.07 96.17 8.50 48.54 96.31 50.28 1.34 22.19 49.08 -0.16 21.24 coo 11.59 49.83 99.41 10.92 47.97 100.16 45.62 0.60 17.46 44.46 2.32 17.00 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 188 ASN.? 35.87 CL CL A 226 A 384 ASN A 202 ASN~? 26.54 CL CL A 226 A 385 GLU A 198 GLU~? 30.13 CL CL A 226 coo 22.28 63.17 110.61 22.47 65.06 111.53 12.80 -17.36 -8.91 13.76 -19.28 -8.90 coo 7.06 50.07 96.17 8.50 48.54 96.31 20.33 4.95 -7.07 21.62 3.54 -8.03 coo 11.59 49.83 99.41 10.92 47.97 100.16 19.84 0.58 -9.50 20.29 0.30 -11.52 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 202 ASN~? 26.54 CL CL A 226 A 384 ASN A 188 ASN.? 35.87 CL CL A 226 A 385 GLU A 187 GLU.? 30.59 CL CL A 226 coo 22.28 63.17 110.61 22.47 65.06 111.53 20.33 4.95 -7.07 21.62 3.54 -8.03 coo 7.06 50.07 96.17 8.50 48.54 96.31 12.80 -17.36 -8.91 13.76 -19.28 -8.90 coo 11.59 49.83 99.41 10.92 47.97 100.16 10.39 -14.82 -4.45 8.65 -14.21 -3.38 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN B 149 ASN.? 28.07 CL CL B 226 A 384 ASN A 8 ASN.? 6.94 CL CL A 226 A 385 GLU A 9 GLU.? 16.20 CL CL A 226 coo 22.28 63.17 110.61 22.47 65.06 111.53 39.68 -7.57 44.84 39.54 -9.68 44.58 coo 7.06 50.07 96.17 8.50 48.54 96.31 24.44 -3.01 24.75 23.45 -2.96 22.86 coo 11.59 49.83 99.41 10.92 47.97 100.16 26.61 -7.39 28.28 26.97 -9.45 28.59 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN B 167 ASN.? 4.94 CL CL B 226 A 384 ASN A 167 ASN.? 5.51 CL CL A 226 A 385 GLU A 11 GLU.? 11.48 CL CL A 226 coo 22.28 63.17 110.61 22.47 65.06 111.53 50.28 1.34 22.19 49.08 -0.16 21.24 coo 7.06 50.07 96.17 8.50 48.54 96.31 27.28 3.74 18.20 27.65 2.13 19.59 coo 11.59 49.83 99.41 10.92 47.97 100.16 31.29 2.41 22.91 32.62 4.08 23.08 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 188 ASN.? 35.33 CL CL B 226 A 384 ASN B 202 ASN~? 26.89 CL CL B 226 A 385 GLU B 198 GLU~? 30.19 CL CL B 226 coo 22.28 63.17 110.61 22.47 65.06 111.53 58.21 -19.16 51.65 58.37 -21.08 50.71 coo 7.06 50.07 96.17 8.50 48.54 96.31 56.47 4.11 47.59 54.90 3.31 48.75 coo 11.59 49.83 99.41 10.92 47.97 100.16 55.63 -0.33 50.97 54.03 -0.19 52.37 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN B 202 ASN~? 26.89 CL CL B 226 A 384 ASN B 188 ASN.? 35.33 CL CL B 226 A 385 GLU B 187 GLU.? 29.51 CL CL B 226 coo 22.28 63.17 110.61 22.47 65.06 111.53 56.47 4.11 47.59 54.90 3.31 48.75 coo 7.06 50.07 96.17 8.50 48.54 96.31 58.21 -19.16 51.65 58.37 -21.08 50.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 61.43 -15.09 46.94 62.69 -13.43 47.32 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 7 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 19 ARG~? 20.09 CL CL A 226 B 6 THR A 22 THR~? 22.52 CL CL A 226 B 8 THR B 22 THR~? 22.16 CL CL B 226 coo 40.52 16.08 100.90 37.97 16.41 102.60 31.00 -11.00 27.75 29.53 -12.56 29.89 coo 36.11 13.64 95.03 34.54 14.86 95.91 33.29 -17.43 22.24 34.79 -15.93 22.73 coo 32.72 8.05 92.39 31.25 9.11 91.35 39.44 -18.13 19.88 38.51 -16.36 19.19 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 81 ARG~? 19.72 CL CL B 226 B 6 THR A 76 THR~? 22.08 CL CL B 226 B 8 THR B 22 THR~? 22.16 CL CL B 226 coo 40.52 16.08 100.90 37.97 16.41 102.60 40.18 -5.93 10.28 41.49 -8.31 8.89 coo 36.11 13.64 95.03 34.54 14.86 95.91 37.05 -13.37 14.54 37.57 -14.38 16.36 coo 32.72 8.05 92.39 31.25 9.11 91.35 39.44 -18.13 19.88 38.51 -16.36 19.19 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG B 19 ARG~? 20.05 CL CL B 226 B 6 THR B 22 THR~? 22.16 CL CL B 226 B 8 THR A 22 THR~? 22.52 CL CL A 226 coo 40.52 16.08 100.90 37.97 16.41 102.60 42.78 -12.99 14.20 43.98 -15.00 12.21 coo 36.11 13.64 95.03 34.54 14.86 95.91 39.44 -18.13 19.88 38.51 -16.36 19.19 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.29 -17.43 22.24 34.79 -15.93 22.73 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 81 ARG~? 19.82 CL CL A 226 B 6 THR B 76 THR~? 22.20 CL CL A 226 B 8 THR A 22 THR~? 22.52 CL CL A 226 coo 40.52 16.08 100.90 37.97 16.41 102.60 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 36.11 13.64 95.03 34.54 14.86 95.91 36.55 -12.68 27.34 35.89 -13.72 25.59 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.29 -17.43 22.24 34.79 -15.93 22.73 1b01_d00 source 1b01 GENE REGULATION/DNA : 4 hits 1b01_d00 naa= 3 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 1 4 # 1 A 15 TYR A 87 TYR~? 13.92 CL CL A 226 A 19 VAL A 88 VAL~? 16.40 CL CL B 226 A 37 PHE B 10 PHE.? 14.73 CL CL B 226 A 41 SER A 82 SER~? 14.07 CL CL A 226 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 36.79 3.26 19.70 35.19 2.19 21.67 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 39.25 5.23 14.85 41.25 5.19 15.75 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 43.79 -6.77 15.65 42.42 -8.98 14.72 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 34.77 -3.21 13.72 33.13 -4.11 12.24 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 2 4 # 2 A 15 TYR B 87 TYR~? 13.52 CL CL B 226 A 19 VAL B 88 VAL~? 16.69 CL CL A 226 A 37 PHE A 10 PHE.? 15.16 CL CL A 226 A 41 SER B 82 SER~? 13.78 CL CL B 226 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 40.26 2.88 20.56 41.63 1.41 18.60 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 38.29 5.76 25.33 36.39 5.20 24.42 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 31.56 -5.14 25.65 32.44 -7.46 26.93 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 41.03 -3.36 27.11 42.38 -4.54 28.72 1ckt_d00 source 1ckt GENE REGULATION/DNA : 2 hits 1ckt_d00 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 121 TYR.? 28.41 CL CL A 226 I 306 VAL A 184 VAL~? 24.07 CL CL A 226 I 308 VAL A 64 VAL.? 22.95 CL CL A 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.73 -11.87 -1.60 20.49 -11.25 -0.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 14.87 -16.35 5.29 16.13 -14.91 6.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 121 TYR.? 28.41 CL CL A 226 I 306 VAL A 184 VAL~? 24.07 CL CL A 226 I 308 VAL A 180 VAL~? 20.24 CL CL A 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 21.55 -13.30 -5.71 21.92 -15.10 -3.59 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.73 -11.87 -1.60 20.49 -11.25 -0.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 19.77 -5.72 0.04 21.94 -5.47 -0.25 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 160 TYR~? 15.52 CL CL A 226 I 306 VAL A 57 VAL^? 13.99 CL CL A 226 I 308 VAL A 45 VAL^? 15.93 CL CL A 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 25.03 -8.51 7.95 22.39 -8.85 7.25 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.24 -8.43 9.62 18.29 -6.40 8.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.57 -11.86 14.58 16.73 -13.05 14.59 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 208 TYR~? 15.64 CL CL A 226 I 306 VAL A 170 VAL~? 10.68 CL CL A 226 I 308 VAL A 174 VAL~? 9.86 CL CL A 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 25.22 8.01 3.41 27.20 7.60 5.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 22.03 7.10 9.94 22.85 8.84 8.93 coo 16.43 30.18 9.35 15.05 30.67 11.01 19.72 0.69 8.23 18.80 0.95 10.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR B 58 TYR.? 17.22 CL CL B 226 I 306 VAL B 57 VAL^? 14.17 CL CL B 226 I 308 VAL B 174 VAL~? 10.40 CL CL B 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 61.18 -13.09 30.12 63.87 -13.66 29.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 55.90 -10.91 32.10 55.69 -9.10 33.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 56.42 -2.04 33.02 57.43 -1.95 31.09 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 121 TYR~? 28.97 CL CL B 226 I 306 VAL B 184 VAL~? 25.14 CL CL B 226 I 308 VAL B 180 VAL~? 20.42 CL CL B 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 51.39 -13.47 48.53 51.35 -15.45 46.59 coo 23.55 29.53 9.81 23.15 27.39 10.24 54.40 -13.67 43.92 52.27 -13.43 43.68 coo 16.43 30.18 9.35 15.05 30.67 11.01 54.48 -7.53 41.50 52.61 -6.47 41.72 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 160 TYR~? 15.61 CL CL B 226 I 306 VAL B 57 VAL^? 14.17 CL CL B 226 I 308 VAL B 45 VAL^? 16.36 CL CL B 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 23.55 29.53 9.81 23.15 27.39 10.24 55.90 -10.91 32.10 55.69 -9.10 33.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 54.87 -15.18 27.73 56.44 -16.67 28.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 160 TYR~? 15.61 CL CL B 226 I 306 VAL B 57 VAL^? 14.17 CL CL B 226 I 308 VAL B 174 VAL~? 10.40 CL CL B 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 49.18 -9.89 33.69 51.74 -10.51 34.51 coo 23.55 29.53 9.81 23.15 27.39 10.24 55.90 -10.91 32.10 55.69 -9.10 33.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 56.42 -2.04 33.02 57.43 -1.95 31.09 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 208 TYR~? 15.74 CL CL B 226 I 306 VAL B 170 VAL~? 10.93 CL CL B 226 I 308 VAL B 174 VAL~? 10.40 CL CL B 226 coo 26.18 35.24 6.87 24.33 35.18 8.97 52.42 6.76 36.83 50.45 6.61 34.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 55.81 4.52 30.60 55.18 6.39 31.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 56.42 -2.04 33.02 57.43 -1.95 31.09 1cqt_d00 source 1cqt GENE REGULATION/DNA : 9 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 73 PRO.? 27.11 CL CL A 226 A 272 LEU B 25 LEU~? 26.04 CL CL B 226 A 276 ARG B 27 ARG~? 28.79 CL CL B 226 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 35.42 -21.97 15.27 36.14 -19.93 14.75 coo 10.97 0.43 16.73 11.31 2.11 18.06 39.38 -21.98 21.83 38.35 -21.94 23.71 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 46.17 -28.08 18.24 47.24 -27.87 15.37 1emh_d00 source 1emh HYDROLASE/DNA : 1 hits 1emh_d00 naa= 3 ULMN 4 1hbx_d00 GENE REGULATION user 1 4 # 1 D 140 THR B 164 THR~? 11.43 CL CL B 226 D 143 ARG B 81 ARG~? 19.82 CL CL A 226 D 158 TYR A 21 TYR~? 21.90 CL CL A 226 D 163 LYS B 74 LYS.? 25.46 CL CL A 226 coo 59.11 133.43 75.29 57.02 133.64 74.76 47.37 -5.68 26.89 46.28 -7.52 27.30 coo 52.93 123.10 78.03 50.59 121.17 78.38 35.26 -4.61 30.73 33.33 -6.15 32.58 coo 39.29 134.52 82.26 37.39 135.28 80.34 31.69 -16.23 18.31 32.96 -18.03 16.63 coo 42.67 127.66 76.73 46.82 129.80 74.10 32.81 -17.40 29.10 28.60 -18.34 31.99 1hbx_d00 source 1hbx GENE REGULATION : 1 hits 1hbx_d00 naa= 4 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 65 ARG.? 31.92 CL CL A 226 C 71 LYS A 63 LYS.? 28.35 CL CL A 226 C 72 VAL A 64 VAL.? 22.95 CL CL A 226 coo 23.89 33.54 29.21 26.59 34.86 28.68 17.05 -18.95 -0.65 15.70 -20.36 -3.04 coo 25.82 26.89 29.68 23.33 22.98 25.84 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 28.86 29.08 30.37 28.04 31.02 29.93 14.87 -16.35 5.29 16.13 -14.91 6.38 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 27 ARG~? 28.79 CL CL B 226 C 71 LYS B 29 LYS~? 31.47 CL CL B 226 C 72 VAL B 30 VAL~? 32.61 CL CL B 226 coo 23.89 33.54 29.21 26.59 34.86 28.68 46.17 -28.08 18.24 47.24 -27.87 15.37 coo 25.82 26.89 29.68 23.33 22.98 25.84 42.17 -28.64 25.12 38.26 -28.01 22.97 coo 28.86 29.08 30.37 28.04 31.02 29.93 44.39 -31.44 23.71 43.54 -32.09 21.77 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG B 65 ARG.? 31.41 CL CL B 226 C 71 LYS B 63 LYS.? 30.86 CL CL B 226 C 72 VAL B 64 VAL.? 22.85 CL CL B 226 coo 23.89 33.54 29.21 26.59 34.86 28.68 55.55 -24.03 39.40 53.97 -26.61 39.95 coo 25.82 26.89 29.68 23.33 22.98 25.84 61.77 -19.16 38.03 61.33 -25.31 39.26 coo 28.86 29.08 30.37 28.04 31.02 29.93 58.06 -18.70 37.22 57.99 -17.80 35.24 1hwt_d00 source 1hwt GENE REGULATION/DNA : 3 hits 1hwt_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS B 178 LYS~? 16.76 CL CL B 226 D 25 THR B 181 THR~? 17.66 CL CL B 226 D 27 SER B 67 SER.? 20.24 CL CL B 226 coo 86.60 33.38 44.00 87.05 39.52 42.71 57.30 -6.98 36.80 62.98 -8.03 34.22 coo 81.20 31.58 48.03 79.23 32.24 47.54 54.63 -10.58 39.28 54.41 -10.04 37.17 coo 79.09 29.82 54.20 77.17 28.90 53.05 51.01 -17.39 35.57 51.85 -17.47 33.34 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 1 hits 1mjo_d00 naa= 3 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS A 63 LYS.? 28.35 CL CL A 226 A 41 LYS A 60 LYS.? 19.24 CL CL A 226 A 42 ILE A 59 ILE.? 19.48 CL CL A 226 coo 36.07 63.73 124.22 32.72 60.75 122.39 11.10 -16.17 5.23 7.76 -19.70 7.97 coo 38.49 66.12 125.64 35.69 66.71 131.25 9.83 -11.93 8.36 13.65 -13.48 11.58 coo 41.08 63.27 123.17 40.13 62.43 122.44 12.73 -9.39 6.40 13.38 -9.17 5.20 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 1 hits 1pyi_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 63 LYS.? 28.35 CL CL A 226 A 564 VAL A 64 VAL.? 22.95 CL CL A 226 A 568 ARG A 65 ARG.? 31.92 CL CL A 226 coo -6.60 80.79 55.64 -8.55 79.48 61.01 11.10 -16.17 5.23 7.76 -19.70 7.97 coo -9.25 78.14 55.31 -11.11 77.94 56.39 14.87 -16.35 5.29 16.13 -14.91 6.38 coo -12.31 74.86 52.32 -13.99 74.91 54.92 17.05 -18.95 -0.65 15.70 -20.36 -3.04 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS B 29 LYS~? 31.47 CL CL B 226 A 564 VAL B 30 VAL~? 32.61 CL CL B 226 A 568 ARG B 27 ARG~? 28.79 CL CL B 226 coo -6.60 80.79 55.64 -8.55 79.48 61.01 42.17 -28.64 25.12 38.26 -28.01 22.97 coo -9.25 78.14 55.31 -11.11 77.94 56.39 44.39 -31.44 23.71 43.54 -32.09 21.77 coo -12.31 74.86 52.32 -13.99 74.91 54.92 46.17 -28.08 18.24 47.24 -27.87 15.37 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 563 LYS B 63 LYS.? 30.86 CL CL B 226 A 564 VAL B 64 VAL.? 22.85 CL CL B 226 A 568 ARG B 65 ARG.? 31.41 CL CL B 226 coo -6.60 80.79 55.64 -8.55 79.48 61.01 61.77 -19.16 38.03 61.33 -25.31 39.26